DrugA,DrugB,Interaction,Mechanism,risk_level
Etacrynic acid,Oxybenzone,Etacrynic acid may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oxycodone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oxycodone.,decrease,no risk
Etacrynic acid,Oxymorphone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oxymorphone.,decrease,no risk
Etacrynic acid,Oxyphenbutazone,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Etacrynic acid,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Etacrynic acid is combined with Oxyphenisatin acetate.,increase,risk
Etacrynic acid,Oxyquinoline,Etacrynic acid may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Quetiapine,Etacrynic acid may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Quinidine,Etacrynic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Etacrynic acid,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Vaborbactam,Etacrynic acid may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Etacrynic acid.,increase,no risk
Etacrynic acid,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Valbenazine,Etacrynic acid may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Valdecoxib,The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Valdecoxib.,decrease,no risk
Etacrynic acid,Valganciclovir,Etacrynic acid may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Vancomycin,Etacrynic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Etacrynic acid,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Etacrynic acid.,increase,risk
Etacrynic acid,Varenicline,Etacrynic acid may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Etacrynic acid.,increase,no risk
Etacrynic acid,Venlafaxine,Etacrynic acid may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Verapamil,Etacrynic acid may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Vericiguat,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Vericiguat.,increase,risk
Etacrynic acid,Vilanterol,The risk or severity of hypokalemia can be increased when Etacrynic acid is combined with Vilanterol.,increase,risk
Etacrynic acid,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Etacrynic acid.,decrease,no risk
Etacrynic acid,Viloxazine,Etacrynic acid may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Viomycin,The risk or severity of neuromuscular blockade can be increased when Etacrynic acid is combined with Viomycin.,increase,risk
Etacrynic acid,Vortioxetine,Etacrynic acid may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Warfarin,The protein binding of Warfarin can be decreased when combined with Etacrynic acid.,decrease,no risk
Etacrynic acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Etacrynic acid.,decrease,no risk
Etacrynic acid,Zaleplon,Etacrynic acid may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Zanamivir,Etacrynic acid may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Etacrynic acid,Ziconotide,The risk or severity of CNS depression can be increased when Etacrynic acid is combined with Ziconotide.,increase,risk
Etacrynic acid,Zidovudine,The excretion of Zidovudine can be decreased when combined with Etacrynic acid.,decrease,no risk
Etacrynic acid,Zofenopril,Etacrynic acid may increase the hypotensive activities of Zofenopril.,increase,no risk
Etacrynic acid,Zoledronic acid,The risk or severity of hypocalcemia can be increased when Etacrynic acid is combined with Zoledronic acid.,increase,risk
Ondansetron,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ondansetron.,increase,risk
Ondansetron,Bimekizumab,The metabolism of Ondansetron can be increased when combined with Bimekizumab.,increase,no risk
Ondansetron,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Biperiden,The metabolism of Ondansetron can be decreased when combined with Biperiden.,decrease,no risk
Ondansetron,Boceprevir,The metabolism of Ondansetron can be decreased when combined with Boceprevir.,decrease,no risk
Ondansetron,Bortezomib,The metabolism of Ondansetron can be decreased when combined with Bortezomib.,decrease,no risk
Ondansetron,Bosentan,The metabolism of Ondansetron can be increased when combined with Bosentan.,increase,no risk
Ondansetron,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ondansetron.,increase,risk
Ondansetron,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ondansetron.,increase,risk
Ondansetron,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ondansetron.,increase,risk
Ondansetron,Brexanolone,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brexanolone.,increase,risk
Ondansetron,Brexpiprazole,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brexpiprazole.,increase,risk
Ondansetron,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Ondansetron,Brivaracetam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brivaracetam.,increase,risk
Ondansetron,Bromazepam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bromazepam.,increase,risk
Ondansetron,Bromocriptine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bromocriptine.,increase,risk
Ondansetron,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Bromperidol,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bromperidol.,increase,risk
Ondansetron,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ondansetron.,increase,risk
Ondansetron,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ondansetron.,increase,risk
Ondansetron,Budesonide,The metabolism of Ondansetron can be increased when combined with Budesonide.,increase,no risk
Ondansetron,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ondansetron.,increase,risk
Ondansetron,Buprenorphine,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ondansetron,Bupropion,The metabolism of Ondansetron can be decreased when combined with Bupropion.,decrease,no risk
Ondansetron,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ondansetron.,increase,risk
Ondansetron,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Ondansetron.,increase,risk
Ondansetron,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ondansetron.,increase,risk
Ondansetron,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Ondansetron.,increase,risk
Ondansetron,Butaperazine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Butaperazine.,increase,risk
Ondansetron,Butobarbital,The risk or severity of CNS depression can be increased when Ondansetron is combined with Butobarbital.,increase,risk
Ondansetron,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Ondansetron.,increase,risk
Ondansetron,Butriptyline,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Butriptyline.,increase,risk
Ondansetron,Gabapentin,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gabapentin.,increase,risk
Ondansetron,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gabapentin enacarbil.,increase,risk
Ondansetron,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Ondansetron.,increase,risk
Ondansetron,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ondansetron.,increase,risk
Ondansetron,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ondansetron.,increase,risk
Ondansetron,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ondansetron is combined with Ganaxolone.",increase,risk
Ondansetron,Gatifloxacin,The metabolism of Ondansetron can be decreased when combined with Gatifloxacin.,decrease,no risk
Ondansetron,Gefitinib,The metabolism of Ondansetron can be decreased when combined with Gefitinib.,decrease,no risk
Ondansetron,Gemfibrozil,The metabolism of Ondansetron can be decreased when combined with Gemfibrozil.,decrease,no risk
Ondansetron,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Gemifloxacin.,increase,risk
Ondansetron,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Ondansetron.,increase,risk
Ondansetron,Gilteritinib,The therapeutic efficacy of Ondansetron can be decreased when used in combination with Gilteritinib.,decrease,no risk
Ondansetron,Ginkgo biloba,The metabolism of Ondansetron can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ondansetron,Givosiran,The serum concentration of Ondansetron can be increased when it is combined with Givosiran.,increase,no risk
Ondansetron,Glasdegib,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Glasdegib.,increase,risk
Ondansetron,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Glimepiride,The metabolism of Ondansetron can be decreased when combined with Glimepiride.,decrease,no risk
Ondansetron,Glipizide,The metabolism of Glipizide can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Glofitamab,The serum concentration of Ondansetron can be increased when it is combined with Glofitamab.,increase,no risk
Ondansetron,Glutethimide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Glutethimide.,increase,risk
Ondansetron,Glyburide,The metabolism of Ondansetron can be decreased when combined with Glyburide.,decrease,no risk
Ondansetron,Glycerol phenylbutyrate,The metabolism of Ondansetron can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Ondansetron,Golimumab,The metabolism of Ondansetron can be increased when combined with Golimumab.,increase,no risk
Ondansetron,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Ondansetron.,increase,risk
Ondansetron,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Ondansetron.,increase,risk
Ondansetron,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Grepafloxacin.,increase,risk
Ondansetron,Guanabenz,The metabolism of Ondansetron can be decreased when combined with Guanabenz.,decrease,no risk
Ondansetron,Guanfacine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Guanfacine.,increase,risk
Ondansetron,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ondansetron.,increase,risk
Ondansetron,Halofantrine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Halofantrine.,increase,risk
Ondansetron,Haloperidol,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Haloperidol.,increase,risk
Ondansetron,Halothane,The risk or severity of CNS depression can be increased when Ondansetron is combined with Halothane.,increase,risk
Ondansetron,Hexafluronium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Hexafluronium.,increase,risk
Ondansetron,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ondansetron.,increase,risk
Ondansetron,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ondansetron.,increase,risk
Ondansetron,Hydrocodone,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ondansetron,Hydrocortisone,The metabolism of Ondansetron can be decreased when combined with Hydrocortisone.,decrease,no risk
Ondansetron,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ondansetron.,increase,risk
Ondansetron,Hydroxychloroquine,The metabolism of Ondansetron can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Ondansetron,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Hydroxyzine.,increase,risk
Ondansetron,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ondansetron.,increase,risk
Ondansetron,Ketamine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ketamine.,increase,risk
Ondansetron,Ketazolam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ketazolam.,increase,risk
Ondansetron,Ketoconazole,The metabolism of Ondansetron can be decreased when combined with Ketoconazole.,decrease,no risk
Ondansetron,Ketorolac,The metabolism of Ondansetron can be decreased when combined with Ketorolac.,decrease,no risk
Ondansetron,Obeticholic acid,The metabolism of Ondansetron can be decreased when combined with Obeticholic acid.,decrease,no risk
Ondansetron,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ondansetron.,increase,risk
Ondansetron,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ofloxacin.,increase,risk
Ondansetron,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Ondansetron.,increase,risk
Ondansetron,Olaparib,The metabolism of Olaparib can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ondansetron is combined with Oliceridine.",increase,risk
Ondansetron,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Ondansetron.,increase,risk
Ondansetron,Omaveloxolone,The serum concentration of Ondansetron can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ondansetron,Opium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Opium.,increase,risk
Ondansetron,Oritavancin,The metabolism of Ondansetron can be decreased when combined with Oritavancin.,decrease,no risk
Ondansetron,Orphenadrine,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ondansetron,Osilodrostat,The metabolism of Ondansetron can be decreased when combined with Osilodrostat.,decrease,no risk
Ondansetron,Osimertinib,The serum concentration of Ondansetron can be decreased when it is combined with Osimertinib.,decrease,no risk
Ondansetron,Ospemifene,The metabolism of Ondansetron can be decreased when combined with Ospemifene.,decrease,no risk
Ondansetron,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ondansetron.,increase,risk
Ondansetron,Oxamniquine,The metabolism of Ondansetron can be decreased when combined with Oxamniquine.,decrease,no risk
Ondansetron,Oxandrolone,The metabolism of Ondansetron can be decreased when combined with Oxandrolone.,decrease,no risk
Ondansetron,Oxatomide,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Oxatomide.,increase,risk
Ondansetron,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ondansetron.,increase,risk
Ondansetron,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ondansetron.,increase,risk
Ondansetron,Oxitriptan,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxitriptan.,increase,risk
Ondansetron,Oxprenolol,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxprenolol.,increase,risk
Ondansetron,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ondansetron.,increase,risk
Ondansetron,Oxybutynin,The metabolism of Ondansetron can be decreased when combined with Oxybutynin.,decrease,no risk
Ondansetron,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Ondansetron.,increase,risk
Ondansetron,Oxymorphone,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxymorphone.,increase,risk
Ondansetron,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ondansetron.,increase,risk
Ondansetron,Quazepam,The risk or severity of CNS depression can be increased when Ondansetron is combined with Quazepam.,increase,risk
Ondansetron,Quetiapine,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Quetiapine.,increase,risk
Ondansetron,Quinidine,The metabolism of Quinidine can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Quinine,The metabolism of Ondansetron can be decreased when combined with Quinine.,decrease,no risk
Ondansetron,Quinupramine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Quinupramine.,increase,risk
Ondansetron,Quizartinib,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Quizartinib.,increase,risk
Ondansetron,Udenafil,The metabolism of Udenafil can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Urethane,The risk or severity of CNS depression can be increased when Ondansetron is combined with Urethane.,increase,risk
Ondansetron,Vadadustat,The serum concentration of Ondansetron can be increased when it is combined with Vadadustat.,increase,no risk
Ondansetron,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Valdecoxib,The metabolism of Ondansetron can be decreased when combined with Valdecoxib.,decrease,no risk
Ondansetron,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Valproate bismuth.,increase,risk
Ondansetron,Valproic acid,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Valproic acid.,increase,risk
Ondansetron,Valsartan,The metabolism of Ondansetron can be decreased when combined with Valsartan.,decrease,no risk
Ondansetron,Vandetanib,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Vandetanib.,increase,risk
Ondansetron,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ondansetron.,increase,risk
Ondansetron,Vecuronium,The risk or severity of CNS depression can be increased when Ondansetron is combined with Vecuronium.,increase,risk
Ondansetron,Vemurafenib,The serum concentration of Ondansetron can be increased when it is combined with Vemurafenib.,increase,no risk
Ondansetron,Venetoclax,The metabolism of Ondansetron can be decreased when combined with Venetoclax.,decrease,no risk
Ondansetron,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Venlafaxine.,increase,risk
Ondansetron,Verapamil,The metabolism of Ondansetron can be decreased when combined with Verapamil.,decrease,no risk
Ondansetron,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ondansetron.,increase,risk
Ondansetron,Vigabatrin,The risk or severity of CNS depression can be increased when Ondansetron is combined with Vigabatrin.,increase,risk
Ondansetron,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Ondansetron.,increase,risk
Ondansetron,Vilazodone,The metabolism of Ondansetron can be decreased when combined with Vilazodone.,decrease,no risk
Ondansetron,Viloxazine,The metabolism of Ondansetron can be decreased when combined with Viloxazine.,decrease,no risk
Ondansetron,Vinblastine,The metabolism of Ondansetron can be decreased when combined with Vinblastine.,decrease,no risk
Ondansetron,Vincristine,The metabolism of Vincristine can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Vinorelbine,The metabolism of Ondansetron can be decreased when combined with Vinorelbine.,decrease,no risk
Ondansetron,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Voriconazole,The metabolism of Ondansetron can be decreased when combined with Voriconazole.,decrease,no risk
Ondansetron,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ondansetron.,increase,risk
Ondansetron,Vortioxetine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Vortioxetine.,increase,risk
Ondansetron,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Warfarin,The metabolism of Ondansetron can be decreased when combined with Warfarin.,decrease,no risk
Ondansetron,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Ondansetron.,decrease,no risk
Ondansetron,Yohimbine,The therapeutic efficacy of Ondansetron can be increased when used in combination with Yohimbine.,increase,no risk
Ondansetron,Zafirlukast,The metabolism of Ondansetron can be decreased when combined with Zafirlukast.,decrease,no risk
Ondansetron,Zaleplon,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zaleplon.,increase,risk
Ondansetron,Ziconotide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ziconotide.,increase,risk
Ondansetron,Zidovudine,The metabolism of Ondansetron can be decreased when combined with Zidovudine.,decrease,no risk
Ondansetron,Zileuton,The metabolism of Ondansetron can be decreased when combined with Zileuton.,decrease,no risk
Ondansetron,Zimelidine,The risk or severity of adverse effects can be increased when Ondansetron is combined with Zimelidine.,increase,risk
Ondansetron,Ziprasidone,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Ziprasidone.,increase,risk
Ondansetron,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ondansetron.,increase,risk
Ondansetron,Zolpidem,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ondansetron,Zonisamide,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zonisamide.,increase,risk
Ondansetron,Zopiclone,The risk or severity of adverse effects can be increased when Ondansetron is combined with Zopiclone.,increase,risk
Ondansetron,Zotepine,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zotepine.,increase,risk
Ondansetron,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Zuclopenthixol.,increase,risk
Ondansetron,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ondansetron.,increase,risk
Bimatoprost,Olmesartan,Olmesartan may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Oxaprozin,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxaprozin.,decrease,no risk
Bimatoprost,Oxprenolol,Bimatoprost may increase the hypotensive activities of Oxprenolol.,increase,no risk
Bimatoprost,Oxyphenbutazone,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Bimatoprost,Quetiapine,Quetiapine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Quinapril,Quinapril may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Quinine,Quinine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Unoprostone,Bimatoprost may increase the hypotensive activities of Unoprostone.,increase,no risk
Bimatoprost,Valdecoxib,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Valdecoxib.,decrease,no risk
Bimatoprost,Valsartan,Valsartan may increase the hypotensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Bimatoprost.,increase,no risk
Bimatoprost,Zofenopril,Bimatoprost may increase the hypotensive activities of Zofenopril.,increase,no risk
Tiagabine,Gabapentin,The risk or severity of CNS depression can be increased when Tiagabine is combined with Gabapentin.,increase,risk
Tiagabine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tiagabine is combined with Gabapentin enacarbil.,increase,risk
Tiagabine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tiagabine.,increase,risk
Tiagabine,Gamolenic acid,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Tiagabine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tiagabine is combined with Ganaxolone.",increase,risk
Tiagabine,Ganciclovir,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Ganciclovir.,decrease,no risk
Tiagabine,Gemfibrozil,The metabolism of Tiagabine can be decreased when combined with Gemfibrozil.,decrease,no risk
Tiagabine,Gepirone,The risk or severity of CNS depression can be increased when Tiagabine is combined with Gepirone.,increase,risk
Tiagabine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Glecaprevir,The metabolism of Tiagabine can be decreased when combined with Glecaprevir.,decrease,no risk
Tiagabine,Glofitamab,The serum concentration of Tiagabine can be increased when it is combined with Glofitamab.,increase,no risk
Tiagabine,Glutethimide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Glutethimide.,increase,risk
Tiagabine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tiagabine.,increase,risk
Tiagabine,Guanfacine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Guanfacine.,increase,risk
Tiagabine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tiagabine.,increase,risk
Tiagabine,Halofantrine,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Halofantrine.,decrease,no risk
Tiagabine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tiagabine.,increase,risk
Tiagabine,Halothane,The risk or severity of CNS depression can be increased when Tiagabine is combined with Halothane.,increase,risk
Tiagabine,Hexafluronium,The risk or severity of CNS depression can be increased when Tiagabine is combined with Hexafluronium.,increase,risk
Tiagabine,Hydrocodone,Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tiagabine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tiagabine.,increase,risk
Tiagabine,Hydroxychloroquine,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Tiagabine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.,increase,no risk
Tiagabine,Ketamine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Ketamine.,increase,risk
Tiagabine,Ketazolam,The risk or severity of CNS depression can be increased when Tiagabine is combined with Ketazolam.,increase,risk
Tiagabine,Ketoconazole,The metabolism of Tiagabine can be decreased when combined with Ketoconazole.,decrease,no risk
Tiagabine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tiagabine.,increase,risk
Tiagabine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tiagabine is combined with Oliceridine.",increase,risk
Tiagabine,Omaveloxolone,The serum concentration of Tiagabine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tiagabine,Ombitasvir,The metabolism of Tiagabine can be decreased when combined with Ombitasvir.,decrease,no risk
Tiagabine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tiagabine.,increase,risk
Tiagabine,Opium,The risk or severity of CNS depression can be increased when Tiagabine is combined with Opium.,increase,risk
Tiagabine,Orlistat,Orlistat can cause a decrease in the absorption of Tiagabine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tiagabine,Orphenadrine,Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tiagabine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tiagabine.,increase,risk
Tiagabine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Tiagabine.,increase,risk
Tiagabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tiagabine is combined with Oxetacaine.,increase,risk
Tiagabine,Oxitriptan,The risk or severity of CNS depression can be increased when Tiagabine is combined with Oxitriptan.,increase,risk
Tiagabine,Oxprenolol,The risk or severity of CNS depression can be increased when Tiagabine is combined with Oxprenolol.,increase,risk
Tiagabine,Oxtriphylline,Tiagabine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tiagabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tiagabine is combined with Oxybuprocaine.,increase,risk
Tiagabine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tiagabine.,increase,risk
Tiagabine,Oxymorphone,The risk or severity of CNS depression can be increased when Tiagabine is combined with Oxymorphone.,increase,risk
Tiagabine,Quazepam,The risk or severity of CNS depression can be increased when Tiagabine is combined with Quazepam.,increase,risk
Tiagabine,Quetiapine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Quetiapine.,increase,risk
Tiagabine,Quinidine,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Quinidine.,decrease,no risk
Tiagabine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Tiagabine.,increase,risk
Tiagabine,Quinupramine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Quinupramine.,increase,risk
Tiagabine,Quizartinib,The metabolism of Tiagabine can be decreased when combined with Quizartinib.,decrease,no risk
Tiagabine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tiagabine.,increase,no risk
Tiagabine,Urethane,The risk or severity of CNS depression can be increased when Tiagabine is combined with Urethane.,increase,risk
Tiagabine,Vadadustat,The serum concentration of Tiagabine can be increased when it is combined with Vadadustat.,increase,no risk
Tiagabine,Valganciclovir,The therapeutic efficacy of Tiagabine can be decreased when used in combination with Valganciclovir.,decrease,no risk
Tiagabine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Tiagabine.,increase,risk
Tiagabine,Vecuronium,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vecuronium.,increase,risk
Tiagabine,Venetoclax,The metabolism of Tiagabine can be decreased when combined with Venetoclax.,decrease,no risk
Tiagabine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tiagabine.,increase,risk
Tiagabine,Verapamil,The metabolism of Tiagabine can be decreased when combined with Verapamil.,decrease,no risk
Tiagabine,Vigabatrin,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vigabatrin.,increase,risk
Tiagabine,Vilazodone,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vilazodone.,increase,risk
Tiagabine,Viloxazine,The metabolism of Tiagabine can be decreased when combined with Viloxazine.,decrease,no risk
Tiagabine,Voriconazole,The metabolism of Tiagabine can be decreased when combined with Voriconazole.,decrease,no risk
Tiagabine,Vortioxetine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Vortioxetine.,increase,risk
Tiagabine,Yohimbine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Yohimbine.,increase,risk
Tiagabine,Zaleplon,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zaleplon.,increase,risk
Tiagabine,Ziconotide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Ziconotide.,increase,risk
Tiagabine,Zidovudine,The metabolism of Tiagabine can be increased when combined with Zidovudine.,increase,no risk
Tiagabine,Zimelidine,The risk or severity of adverse effects can be increased when Tiagabine is combined with Zimelidine.,increase,risk
Tiagabine,Ziprasidone,The risk or severity of adverse effects can be increased when Tiagabine is combined with Ziprasidone.,increase,risk
Tiagabine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tiagabine.,increase,risk
Tiagabine,Zolpidem,Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tiagabine,Zonisamide,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zonisamide.,increase,risk
Tiagabine,Zopiclone,The risk or severity of adverse effects can be increased when Tiagabine is combined with Zopiclone.,increase,risk
Tiagabine,Zotepine,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zotepine.,increase,risk
Tiagabine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Tiagabine is combined with Zuclopenthixol.,increase,risk
Tiagabine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tiagabine.,increase,risk
Cocaine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Benzocaine.,increase,risk
Cocaine,Benzonatate,The serum concentration of Cocaine can be increased when it is combined with Benzonatate.,increase,no risk
Cocaine,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Cocaine.,increase,risk
Cocaine,Benzthiazide,The serum concentration of Benzthiazide can be increased when it is combined with Cocaine.,increase,no risk
Cocaine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Benzyl alcohol.,increase,risk
Cocaine,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Cocaine.,increase,risk
Cocaine,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Cocaine.,increase,risk
Cocaine,Bepridil,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Bepridil.,increase,risk
Cocaine,Berotralstat,The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Cocaine.,increase,risk
Cocaine,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Cocaine.,increase,risk
Cocaine,Betaine,Betaine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Cocaine.,increase,risk
Cocaine,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Cocaine.,increase,risk
Cocaine,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Cocaine.,increase,risk
Cocaine,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Cocaine.,increase,risk
Cocaine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Cocaine.,increase,risk
Cocaine,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Cocaine.,increase,risk
Cocaine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Cocaine.,increase,risk
Cocaine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Cocaine.,increase,risk
Cocaine,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Cocaine.,increase,risk
Cocaine,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Cocaine.,increase,risk
Cocaine,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Cocaine.,increase,risk
Cocaine,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Cocaine.,increase,risk
Cocaine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Cocaine is combined with Botulinum toxin type A.,increase,risk
Cocaine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Cocaine is combined with Botulinum toxin type B.,increase,risk
Cocaine,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Cocaine.,increase,risk
Cocaine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Cocaine.,increase,risk
Cocaine,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Cocaine.,increase,risk
Cocaine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Cocaine.,increase,risk
Cocaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Cocaine.,increase,risk
Cocaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Cocaine.,increase,risk
Cocaine,Bromocriptine,The risk or severity of Tachycardia can be increased when Cocaine is combined with Bromocriptine.,increase,risk
Cocaine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Cocaine.,increase,risk
Cocaine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Cocaine.,increase,risk
Cocaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Cocaine.,increase,risk
Cocaine,Buprenorphine,The risk or severity of adverse effects can be increased when Cocaine is combined with Buprenorphine.,increase,risk
Cocaine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Cocaine.,increase,risk
Cocaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Cocaine.,increase,risk
Cocaine,Buspirone,The metabolism of Buspirone can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Cocaine.,increase,risk
Cocaine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Cocaine.,increase,risk
Cocaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Butacaine.,increase,risk
Cocaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Cocaine.,increase,risk
Cocaine,Butamben,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Butamben.,increase,risk
Cocaine,Butobarbital,The risk or severity of adverse effects can be increased when Cocaine is combined with Butobarbital.,increase,risk
Cocaine,Butorphanol,The risk or severity of adverse effects can be increased when Cocaine is combined with Butorphanol.,increase,risk
Cocaine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Cocaine.,increase,risk
Cocaine,Butylscopolamine,The risk or severity of adverse effects can be increased when Cocaine is combined with Butylscopolamine.,increase,risk
Cocaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Cocaine.,increase,risk
Cocaine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Cocaine.,increase,risk
Cocaine,Galantamine,Galantamine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Gallamine triethiodide,Gallamine triethiodide may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Ganaxolone,The risk or severity of methemoglobinemia can be increased when Ganaxolone is combined with Cocaine.,increase,risk
Cocaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Cocaine.,increase,risk
Cocaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Cocaine.,increase,risk
Cocaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Cocaine.,increase,risk
Cocaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Cocaine.,increase,risk
Cocaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Cocaine.,increase,risk
Cocaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Cocaine.,increase,risk
Cocaine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Cocaine.,increase,risk
Cocaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Cocaine.,increase,risk
Cocaine,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Glasdegib,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Glasdegib.,increase,risk
Cocaine,Glofitamab,The serum concentration of Cocaine can be increased when it is combined with Glofitamab.,increase,no risk
Cocaine,Glucagon,Cocaine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Cocaine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Glycopyrronium,The risk or severity of adverse effects can be increased when Cocaine is combined with Glycopyrronium.,increase,risk
Cocaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Cocaine.,increase,risk
Cocaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Cocaine.,increase,risk
Cocaine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Cocaine.,increase,risk
Cocaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Cocaine.,increase,risk
Cocaine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Cocaine.,increase,risk
Cocaine,Guanfacine,The risk or severity of Tachycardia can be increased when Cocaine is combined with Guanfacine.,increase,risk
Cocaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Cocaine.,increase,risk
Cocaine,Haloperidol,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Haloperidol.,increase,risk
Cocaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Cocaine.,increase,risk
Cocaine,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Hexocyclium,The risk or severity of adverse effects can be increased when Cocaine is combined with Hexocyclium.,increase,risk
Cocaine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Cocaine.,increase,risk
Cocaine,Homatropine,The risk or severity of adverse effects can be increased when Cocaine is combined with Homatropine.,increase,risk
Cocaine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Cocaine.,increase,risk
Cocaine,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Hydralazine,The therapeutic efficacy of Hydralazine can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Cocaine.,increase,risk
Cocaine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Cocaine.,increase,risk
Cocaine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Cocaine.,increase,no risk
Cocaine,Hydromorphone,The risk or severity of adverse effects can be increased when Cocaine is combined with Hydromorphone.,increase,risk
Cocaine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Cocaine.,increase,risk
Cocaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Cocaine.,increase,risk
Cocaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Cocaine.,increase,risk
Cocaine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Hydroxyzine.,increase,risk
Cocaine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cocaine.,increase,risk
Cocaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Cocaine.,increase,risk
Cocaine,Ketamine,Ketamine may increase the neuromuscular blocking activities of Cocaine.,increase,no risk
Cocaine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Cocaine.,increase,risk
Cocaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Cocaine.,increase,risk
Cocaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Cocaine.,increase,risk
Cocaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Cocaine.,increase,risk
Cocaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Cocaine.,increase,risk
Cocaine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Cocaine.,increase,risk
Cocaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Cocaine.,increase,risk
Cocaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Cocaine.,increase,risk
Cocaine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Oliceridine.,increase,risk
Cocaine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Cocaine.,increase,risk
Cocaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Cocaine.,increase,risk
Cocaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Cocaine.,increase,risk
Cocaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Cocaine.,increase,risk
Cocaine,Omaveloxolone,The serum concentration of Cocaine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cocaine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Cocaine.,increase,risk
Cocaine,Opium,The risk or severity of adverse effects can be increased when Cocaine is combined with Opium.,increase,risk
Cocaine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Cocaine.,increase,risk
Cocaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Cocaine.,increase,risk
Cocaine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Cocaine.,increase,risk
Cocaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Cocaine.,increase,risk
Cocaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Cocaine.,increase,risk
Cocaine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Cocaine.,increase,risk
Cocaine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Cocaine.,increase,risk
Cocaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Cocaine.,increase,risk
Cocaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cocaine is combined with Oxetacaine.,increase,risk
Cocaine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Cocaine.,increase,risk
Cocaine,Oxybutynin,The risk or severity of adverse effects can be increased when Cocaine is combined with Oxybutynin.,increase,risk
Cocaine,Oxycodone,The risk or severity of adverse effects can be increased when Cocaine is combined with Oxycodone.,increase,risk
Cocaine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Cocaine is combined with Oxymetazoline.,increase,risk
Cocaine,Oxymorphone,The risk or severity of adverse effects can be increased when Cocaine is combined with Oxymorphone.,increase,risk
Cocaine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Cocaine.,increase,risk
Cocaine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Cocaine.,decrease,no risk
Cocaine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cocaine.,increase,risk
Cocaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Cocaine.,increase,risk
Cocaine,Oxytocin,The risk or severity of hypertension can be increased when Cocaine is combined with Oxytocin.,increase,risk
Cocaine,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Cocaine.,increase,risk
Cocaine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Cocaine.,increase,no risk
Cocaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Cocaine.,increase,risk
Cocaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Cocaine.,increase,risk
Cocaine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Quinupramine.,increase,risk
Cocaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Cocaine.,increase,risk
Cocaine,Quizartinib,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Quizartinib.,increase,risk
Cocaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Cocaine.,increase,risk
Cocaine,Umeclidinium,The risk or severity of adverse effects can be increased when Cocaine is combined with Umeclidinium.,increase,risk
Cocaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Cocaine.,increase,risk
Cocaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Cocaine.,increase,risk
Cocaine,Vadadustat,The serum concentration of Cocaine can be increased when it is combined with Vadadustat.,increase,no risk
Cocaine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Valproate bismuth.,increase,risk
Cocaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Cocaine.,increase,risk
Cocaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Cocaine.,increase,risk
Cocaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Cocaine.,increase,risk
Cocaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Cocaine.,increase,risk
Cocaine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cocaine.,increase,risk
Cocaine,Vecuronium,The risk or severity of adverse effects can be increased when Cocaine is combined with Vecuronium.,increase,risk
Cocaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Cocaine.,increase,risk
Cocaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Cocaine.,increase,risk
Cocaine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Venlafaxine.,increase,risk
Cocaine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Cocaine.,increase,risk
Cocaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Cocaine.,increase,risk
Cocaine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Cocaine.,increase,risk
Cocaine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Viloxazine,The metabolism of Cocaine can be decreased when combined with Viloxazine.,decrease,no risk
Cocaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Cocaine.,increase,risk
Cocaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Cocaine.,increase,risk
Cocaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Cocaine.,increase,risk
Cocaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Cocaine.,increase,risk
Cocaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Cocaine.,increase,risk
Cocaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Cocaine.,increase,risk
Cocaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Cocaine.,increase,risk
Cocaine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Cocaine.,increase,risk
Cocaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Cocaine.,increase,risk
Cocaine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Xamoterol,The risk or severity of Tachycardia can be increased when Cocaine is combined with Xamoterol.,increase,risk
Cocaine,Xylometazoline,The risk or severity of Tachycardia can be increased when Cocaine is combined with Xylometazoline.,increase,risk
Cocaine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Cocaine.,increase,risk
Cocaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Cocaine.,increase,risk
Cocaine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Zimelidine.,increase,risk
Cocaine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Ziprasidone.,increase,risk
Cocaine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Cocaine.,increase,risk
Cocaine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Cocaine.,decrease,no risk
Cocaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Cocaine.,increase,risk
Cocaine,Zotepine,The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Zotepine.,increase,risk
Cocaine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Cocaine is combined with Zuclopenthixol.,increase,risk
Quinidine,Bacitracin,Bacitracin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Baclofen,Baclofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Balsalazide,Balsalazide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Beclomethasone dipropionate,The metabolism of Quinidine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Quinidine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Bedaquiline.,increase,risk
Quinidine,Belantamab mafodotin,Quinidine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Quinidine,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Belladonna,The risk or severity of adverse effects can be increased when Quinidine is combined with Belladonna.,increase,risk
Quinidine,Belumosudil,The serum concentration of Quinidine can be increased when it is combined with Belumosudil.,increase,no risk
Quinidine,Belzutifan,The serum concentration of Quinidine can be decreased when it is combined with Belzutifan.,decrease,no risk
Quinidine,Bemiparin,The therapeutic efficacy of Bemiparin can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Benazepril,Quinidine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Quinidine,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Benorilate,Benorilate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benserazide,Benserazide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Quinidine is combined with Benzhydrocodone.,increase,risk
Quinidine,Benznidazole,Benznidazole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Benzocaine.,increase,risk
Quinidine,Benzphetamine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Benzphetamine.,decrease,no risk
Quinidine,Benzthiazide,Benzthiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Benzydamine,Benzydamine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Benzyl alcohol.,increase,risk
Quinidine,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Bepotastine,Bepotastine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bepridil,Quinidine may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Quinidine,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Betaine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Betaine.,decrease,no risk
Quinidine,Betamethasone,The metabolism of Quinidine can be increased when combined with Betamethasone.,increase,no risk
Quinidine,Betamethasone phosphate,The metabolism of Quinidine can be increased when combined with Betamethasone phosphate.,increase,no risk
Quinidine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Quinidine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bexarotene,The metabolism of Quinidine can be increased when combined with Bexarotene.,increase,no risk
Quinidine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Bicisate,Bicisate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bifonazole,The metabolism of Quinidine can be decreased when combined with Bifonazole.,decrease,no risk
Quinidine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Quinidine.,increase,risk
Quinidine,Bimekizumab,The metabolism of Quinidine can be increased when combined with Bimekizumab.,increase,no risk
Quinidine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bioallethrin,Quinidine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Quinidine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Quinidine.,increase,risk
Quinidine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Bismuth subgallate,Bismuth subgallate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bismuth subnitrate,Bismuth subnitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bisoprolol,The therapeutic efficacy of Quinidine can be increased when used in combination with Bisoprolol.,increase,no risk
Quinidine,Bisoxatin,Bisoxatin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bivalirudin,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Bleomycin,Bleomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Boceprevir,The metabolism of Quinidine can be decreased when combined with Boceprevir.,decrease,no risk
Quinidine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bosentan,The metabolism of Quinidine can be increased when combined with Bosentan.,increase,no risk
Quinidine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum toxin type A.,increase,risk
Quinidine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum toxin type B.,increase,risk
Quinidine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Bretylium,Quinidine may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Quinidine,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Brivaracetam,Brivaracetam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Bromocriptine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.",increase,no risk
Quinidine,Bromotheophylline,The serum concentration of Bromotheophylline can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Quinidine.,increase,risk
Quinidine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Quinidine.,increase,risk
Quinidine,Budesonide,The metabolism of Quinidine can be increased when combined with Budesonide.,increase,no risk
Quinidine,Bumadizone,Bumadizone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bumetanide,Bumetanide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Bupivacaine.,increase,risk
Quinidine,Buprenorphine,The risk or severity of adverse effects can be increased when Quinidine is combined with Buprenorphine.,increase,risk
Quinidine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Quinidine.,increase,risk
Quinidine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Quinidine.,increase,risk
Quinidine,Buspirone,The metabolism of Quinidine can be decreased when combined with Buspirone.,decrease,no risk
Quinidine,Busulfan,The metabolism of Busulfan can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Butabarbital,Butabarbital may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Butacaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Butacaine.,increase,risk
Quinidine,Butalbital,The metabolism of Quinidine can be increased when combined with Butalbital.,increase,no risk
Quinidine,Butamben,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Butamben.,increase,risk
Quinidine,Butaperazine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Butaperazine.,increase,risk
Quinidine,Butobarbital,The risk or severity of adverse effects can be increased when Quinidine is combined with Butobarbital.,increase,risk
Quinidine,Butorphanol,The risk or severity of adverse effects can be increased when Quinidine is combined with Butorphanol.,increase,risk
Quinidine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Quinidine.,increase,risk
Quinidine,Butylscopolamine,The risk or severity of adverse effects can be increased when Quinidine is combined with Butylscopolamine.,increase,risk
Quinidine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Quinidine.,increase,risk
Quinidine,Gadodiamide,Gadodiamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadoteridol,Gadoteridol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Galantamine,The metabolism of Galantamine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Ganciclovir,Ganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Quinidine.,increase,risk
Quinidine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Quinidine.,increase,risk
Quinidine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Quinidine.,increase,risk
Quinidine,Gimeracil,Gimeracil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Ginkgo biloba,The metabolism of Quinidine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Quinidine,Givosiran,Givosiran may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Glasdegib,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Glasdegib.,increase,risk
Quinidine,Glecaprevir,The serum concentration of Quinidine can be increased when it is combined with Glecaprevir.,increase,no risk
Quinidine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Glimepiride,Quinidine may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Quinidine,Glipizide,Glipizide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Glofitamab,The serum concentration of Quinidine can be increased when it is combined with Glofitamab.,increase,no risk
Quinidine,Glucagon,Quinidine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Quinidine,Glyburide,The metabolism of Quinidine can be decreased when combined with Glyburide.,decrease,no risk
Quinidine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Glycerol phenylbutyrate,The metabolism of Quinidine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Quinidine,Glycopyrronium,The risk or severity of adverse effects can be increased when Quinidine is combined with Glycopyrronium.,increase,risk
Quinidine,Glycyrrhizic acid,Quinidine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Quinidine,Golimumab,The metabolism of Quinidine can be increased when combined with Golimumab.,increase,no risk
Quinidine,Golodirsen,Golodirsen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinidine.,increase,risk
Quinidine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quinidine.,increase,risk
Quinidine,Grapefruit,The serum concentration of Quinidine can be increased when it is combined with Grapefruit.,increase,no risk
Quinidine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Quinidine.,increase,risk
Quinidine,Griseofulvin,The metabolism of Quinidine can be increased when combined with Griseofulvin.,increase,no risk
Quinidine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Guanadrel,Quinidine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Quinidine,Guanethidine,Guanethidine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Guanfacine,Guanfacine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Guanoxan,Quinidine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Quinidine,Halofantrine,"The risk or severity of QTc prolongation, ventricular arrhythmias, torsade de pointes, and convulsion can be increased when Quinidine is combined with Halofantrine.",increase,risk
Quinidine,Haloperidol,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Haloperidol.,increase,risk
Quinidine,Halothane,The metabolism of Halothane can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Hexafluronium,The risk or severity of adverse effects can be increased when Quinidine is combined with Hexafluronium.,increase,risk
Quinidine,Hexocyclium,The risk or severity of adverse effects can be increased when Quinidine is combined with Hexocyclium.,increase,risk
Quinidine,Histamine,The serum concentration of Histamine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quinidine.,increase,risk
Quinidine,Homatropine,The risk or severity of adverse effects can be increased when Quinidine is combined with Homatropine.,increase,risk
Quinidine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Quinidine.,increase,risk
Quinidine,Huperzine A,The therapeutic efficacy of Quinidine can be decreased when used in combination with Huperzine A.,decrease,no risk
Quinidine,Hydralazine,The serum concentration of Quinidine can be increased when it is combined with Hydralazine.,increase,no risk
Quinidine,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Hydrocortamate,The metabolism of Quinidine can be increased when combined with Hydrocortamate.,increase,no risk
Quinidine,Hydrocortisone,The metabolism of Quinidine can be increased when combined with Hydrocortisone.,increase,no risk
Quinidine,Hydrocortisone acetate,The metabolism of Quinidine can be increased when combined with Hydrocortisone acetate.,increase,no risk
Quinidine,Hydrocortisone butyrate,The metabolism of Quinidine can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Quinidine,Hydrocortisone cypionate,The metabolism of Quinidine can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Quinidine,Hydrocortisone phosphate,The metabolism of Quinidine can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Quinidine,Hydrocortisone succinate,The metabolism of Quinidine can be increased when combined with Hydrocortisone succinate.,increase,no risk
Quinidine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Hydromorphone,The risk or severity of adverse effects can be increased when Quinidine is combined with Hydromorphone.,increase,risk
Quinidine,Hydrotalcite,Hydrotalcite may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Quinidine.,increase,risk
Quinidine,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Hydroxyzine.,increase,risk
Quinidine,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Quinidine,Kanamycin,Kanamycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Kaolin,Kaolin can cause a decrease in the absorption of Quinidine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Quinidine,Ketamine,Ketamine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Ketazolam,The serum concentration of Quinidine can be increased when it is combined with Ketazolam.,increase,no risk
Quinidine,Ketoconazole,The metabolism of Quinidine can be decreased when combined with Ketoconazole.,decrease,no risk
Quinidine,Ketoprofen,Ketoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Ketorolac,Ketorolac may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Obeticholic acid,The risk or severity of adverse effects can be increased when Quinidine is combined with Obeticholic acid.,increase,risk
Quinidine,Octinoxate,Octinoxate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Octreotide,The serum concentration of Quinidine can be increased when it is combined with Octreotide.,increase,no risk
Quinidine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Quinidine.,increase,risk
Quinidine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.",increase,no risk
Quinidine,Olaparib,The metabolism of Olaparib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Olmesartan,The risk or severity of liver damage can be increased when Olmesartan is combined with Quinidine.,increase,risk
Quinidine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Olsalazine,Olsalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Olutasidenib,The metabolism of Quinidine can be increased when combined with Olutasidenib.,increase,no risk
Quinidine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Omaveloxolone,The serum concentration of Quinidine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Quinidine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Ondansetron,The metabolism of Quinidine can be decreased when combined with Ondansetron.,decrease,no risk
Quinidine,Opicapone,The serum concentration of Opicapone can be decreased when it is combined with Quinidine.,decrease,no risk
Quinidine,Opium,The risk or severity of adverse effects can be increased when Quinidine is combined with Opium.,increase,risk
Quinidine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Oritavancin,The metabolism of Quinidine can be increased when combined with Oritavancin.,increase,no risk
Quinidine,Orphenadrine,The metabolism of Quinidine can be decreased when combined with Orphenadrine.,decrease,no risk
Quinidine,Oseltamivir,Oseltamivir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Osilodrostat,The metabolism of Quinidine can be decreased when combined with Osilodrostat.,decrease,no risk
Quinidine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Oxacillin,Oxacillin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Quinidine.,increase,risk
Quinidine,Oxaprozin,Oxaprozin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Quinidine.,increase,risk
Quinidine,Oxazepam,Oxazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxcarbazepine,The metabolism of Quinidine can be increased when combined with Oxcarbazepine.,increase,no risk
Quinidine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Oxetacaine.,increase,risk
Quinidine,Oxprenolol,Quinidine may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Quinidine,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Oxybenzone,Oxybenzone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Oxybuprocaine.,increase,risk
Quinidine,Oxybutynin,The serum concentration of Quinidine can be increased when it is combined with Oxybutynin.,increase,no risk
Quinidine,Oxycodone,The risk or severity of adverse effects can be increased when Quinidine is combined with Oxycodone.,increase,risk
Quinidine,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Oxymorphone,The risk or severity of adverse effects can be increased when Quinidine is combined with Oxymorphone.,increase,risk
Quinidine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Quinidine.,increase,risk
Quinidine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quinidine.,increase,risk
Quinidine,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quinidine.,increase,risk
Quinidine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Quetiapine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Quinidine,Quinapril,The excretion of Quinapril can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Quinethazone,Quinethazone may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quinidine,Quinine,The serum concentration of Quinidine can be increased when it is combined with Quinine.,increase,no risk
Quinidine,Quinupramine,The risk or severity of adverse effects can be increased when Quinidine is combined with Quinupramine.,increase,risk
Quinidine,Quinupristin,The metabolism of Quinidine can be decreased when combined with Quinupristin.,decrease,no risk
Quinidine,Quizartinib,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Quizartinib.,increase,risk
Quinidine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Quinidine.,increase,risk
Quinidine,Umbralisib,The serum concentration of Quinidine can be increased when it is combined with Umbralisib.,increase,no risk
Quinidine,Umeclidinium,The risk or severity of adverse effects can be increased when Quinidine is combined with Umeclidinium.,increase,risk
Quinidine,Urokinase,The therapeutic efficacy of Urokinase can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Ursodeoxycholic acid,Quinidine may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Quinidine,Vaborbactam,Vaborbactam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Valaciclovir,Valaciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Valdecoxib,Valdecoxib may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Valganciclovir,Valganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Valproic acid,The serum concentration of Quinidine can be increased when it is combined with Valproic acid.,increase,no risk
Quinidine,Valsartan,The metabolism of Valsartan can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vancomycin,Vancomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Vandetanib,The serum concentration of Quinidine can be increased when it is combined with Vandetanib.,increase,no risk
Quinidine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Varenicline,The excretion of Varenicline can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Velpatasvir,The serum concentration of Quinidine can be increased when it is combined with Velpatasvir.,increase,no risk
Quinidine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quinidine.,increase,risk
Quinidine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Verapamil,Verapamil may increase the hypotensive activities of Quinidine.,increase,no risk
Quinidine,Vernakalant,Quinidine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Quinidine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Quinidine.,increase,risk
Quinidine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Viloxazine,The metabolism of Quinidine can be decreased when combined with Viloxazine.,decrease,no risk
Quinidine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Vincristine,The excretion of Vincristine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vindesine,The metabolism of Vindesine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Viomycin,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Viomycin.,increase,risk
Quinidine,Vitamin E,The metabolism of Quinidine can be increased when combined with Vitamin E.,increase,no risk
Quinidine,Voclosporin,The serum concentration of Quinidine can be increased when it is combined with Voclosporin.,increase,no risk
Quinidine,Vorapaxar,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Voriconazole,The risk or severity of QTc prolongation and torsade de pointes can be increased when Voriconazole is combined with Quinidine.,increase,risk
Quinidine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Quinidine.,increase,risk
Quinidine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Voxelotor,The serum concentration of Quinidine can be increased when it is combined with Voxelotor.,increase,no risk
Quinidine,Voxilaprevir,The serum concentration of Quinidine can be increased when it is combined with Voxilaprevir.,increase,no risk
Quinidine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Quinidine.,increase,no risk
Quinidine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Quinidine.,decrease,no risk
Quinidine,Ximelagatran,The therapeutic efficacy of Ximelagatran can be increased when used in combination with Quinidine.,increase,no risk
Quinidine,Xylometazoline,Quinidine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Quinidine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zafirlukast,The serum concentration of Quinidine can be increased when it is combined with Zafirlukast.,increase,no risk
Quinidine,Zaleplon,The metabolism of Quinidine can be decreased when combined with Zaleplon.,decrease,no risk
Quinidine,Zanamivir,Zanamivir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Quinidine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Ziconotide,Quinidine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Quinidine,Zidovudine,The excretion of Zidovudine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zileuton,The metabolism of Zileuton can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zimelidine,The metabolism of Quinidine can be decreased when combined with Zimelidine.,decrease,no risk
Quinidine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Ziprasidone.,increase,risk
Quinidine,Zofenopril,Quinidine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Quinidine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zonisamide,Quinidine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Quinidine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zotepine,The metabolism of Zotepine can be decreased when combined with Quinidine.,decrease,no risk
Quinidine,Zuclopenthixol,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Zonisamide,Bacitracin,Bacitracin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Zonisamide,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Zonisamide,Balsalazide,The risk or severity of adverse effects can be increased when Balsalazide is combined with Zonisamide.,increase,risk
Zonisamide,Baricitinib,Zonisamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Beclomethasone dipropionate,The metabolism of Zonisamide can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Zonisamide,Bedaquiline,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Bedaquiline.,increase,risk
Zonisamide,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bemiparin,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Bemiparin.,increase,risk
Zonisamide,Benazepril,The risk or severity of hyperkalemia can be increased when Benazepril is combined with Zonisamide.,increase,risk
Zonisamide,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benorilate,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Benorilate.,increase,risk
Zonisamide,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Benoxaprofen.,increase,risk
Zonisamide,Benperidol,The risk or severity of CNS depression can be increased when Zonisamide is combined with Benperidol.,increase,risk
Zonisamide,Benserazide,Zonisamide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzatropine,Zonisamide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzhydrocodone,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Zonisamide,Benznidazole,Zonisamide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Benzocaine.,increase,risk
Zonisamide,Benzphetamine,Zonisamide may decrease the excretion rate of Benzphetamine which could result in a higher serum level.,decrease,no risk
Zonisamide,Benzthiazide,Benzthiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzydamine,Zonisamide may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Benzyl alcohol.,increase,risk
Zonisamide,Benzylpenicillin,Zonisamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Zonisamide,Bepotastine,Zonisamide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bepridil,Zonisamide may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Zonisamide,Beractant,Zonisamide may increase the bradycardic activities of Beractant.,increase,no risk
Zonisamide,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Betamethasone,The metabolism of Zonisamide can be increased when combined with Betamethasone.,increase,no risk
Zonisamide,Betamethasone phosphate,The metabolism of Zonisamide can be increased when combined with Betamethasone phosphate.,increase,no risk
Zonisamide,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Bicisate,Zonisamide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Bilastine,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Bilastine.,increase,risk
Zonisamide,Bimekizumab,The metabolism of Zonisamide can be increased when combined with Bimekizumab.,increase,no risk
Zonisamide,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bioallethrin,Zonisamide may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Zonisamide,Bisacodyl,The risk or severity of dehydration can be increased when Zonisamide is combined with Bisacodyl.,increase,risk
Zonisamide,Bismuth subgallate,Zonisamide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bismuth subsalicylate,The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Zonisamide.,increase,risk
Zonisamide,Bisoprolol,The therapeutic efficacy of Zonisamide can be increased when used in combination with Bisoprolol.,increase,no risk
Zonisamide,Bisoxatin,The risk or severity of dehydration can be increased when Zonisamide is combined with Bisoxatin.,increase,risk
Zonisamide,Bleomycin,Zonisamide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Boceprevir,The serum concentration of Zonisamide can be increased when it is combined with Boceprevir.,increase,no risk
Zonisamide,Borage oil,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Borage oil.,decrease,no risk
Zonisamide,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zonisamide.,increase,risk
Zonisamide,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zonisamide.,increase,risk
Zonisamide,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Bretylium,Zonisamide may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Zonisamide,Brexanolone,The risk or severity of CNS depression can be increased when Zonisamide is combined with Brexanolone.,increase,risk
Zonisamide,Brexpiprazole,The risk or severity of CNS depression can be increased when Zonisamide is combined with Brexpiprazole.,increase,risk
Zonisamide,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Zonisamide,Brinzolamide,The risk or severity of adverse effects can be increased when Brinzolamide is combined with Zonisamide.,increase,risk
Zonisamide,Brivaracetam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Brivaracetam.,increase,risk
Zonisamide,Bromazepam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bromazepam.,increase,risk
Zonisamide,Bromocriptine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bromocriptine.,increase,risk
Zonisamide,Bromotheophylline,Zonisamide may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bromperidol,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bromperidol.,increase,risk
Zonisamide,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Zonisamide.,increase,risk
Zonisamide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Zonisamide.,increase,risk
Zonisamide,Budesonide,Zonisamide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bumadizone,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Bumadizone.,increase,risk
Zonisamide,Bumetanide,Bumetanide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Bupivacaine.,increase,risk
Zonisamide,Buprenorphine,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Zonisamide,Bupropion,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bupropion.,increase,risk
Zonisamide,Buserelin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Buserelin.,increase,risk
Zonisamide,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Zonisamide.,increase,risk
Zonisamide,Butabarbital,The metabolism of Zonisamide can be increased when combined with Butabarbital.,increase,no risk
Zonisamide,Butacaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Butacaine.,increase,risk
Zonisamide,Butalbital,The metabolism of Zonisamide can be increased when combined with Butalbital.,increase,no risk
Zonisamide,Butamben,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Butamben.,increase,risk
Zonisamide,Butaperazine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butaperazine.,increase,risk
Zonisamide,Butobarbital,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butobarbital.,increase,risk
Zonisamide,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Zonisamide.,increase,risk
Zonisamide,Butriptyline,The risk or severity of CNS depression can be increased when Zonisamide is combined with Butriptyline.,increase,risk
Zonisamide,Gabapentin,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gabapentin.,increase,risk
Zonisamide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gabapentin enacarbil.,increase,risk
Zonisamide,Gadobenic acid,Zonisamide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadodiamide,Zonisamide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadofosveset trisodium,Zonisamide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadopentetic acid,Zonisamide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadoteric acid,Zonisamide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gadoteridol,Zonisamide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Galantamine,Galantamine may increase the bradycardic activities of Zonisamide.,increase,no risk
Zonisamide,Gallamine triethiodide,Zonisamide may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Zonisamide,Gamolenic acid,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Zonisamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zonisamide is combined with Ganaxolone.",increase,risk
Zonisamide,Ganciclovir,Zonisamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Gatifloxacin.,increase,risk
Zonisamide,Gefitinib,The metabolism of Zonisamide can be decreased when combined with Gefitinib.,decrease,no risk
Zonisamide,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Gemfibrozil,The metabolism of Zonisamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Zonisamide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Gemifloxacin.,increase,risk
Zonisamide,Gentamicin,Zonisamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Zonisamide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Zonisamide.,increase,risk
Zonisamide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Gimeracil,Zonisamide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Givosiran,Givosiran may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Zonisamide,Glasdegib,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Glasdegib.,increase,risk
Zonisamide,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glofitamab,The serum concentration of Zonisamide can be increased when it is combined with Glofitamab.,increase,no risk
Zonisamide,Gluconic Acid,The risk or severity of dehydration can be increased when Zonisamide is combined with Gluconic Acid.,increase,risk
Zonisamide,Glutethimide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Glutethimide.,increase,risk
Zonisamide,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Glycerin,The risk or severity of dehydration can be increased when Zonisamide is combined with Glycerin.,increase,risk
Zonisamide,Glycerol phenylbutyrate,Zonisamide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Golimumab,The metabolism of Zonisamide can be increased when combined with Golimumab.,increase,no risk
Zonisamide,Golodirsen,Zonisamide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Goserelin,Zonisamide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Zonisamide.,increase,risk
Zonisamide,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Grepafloxacin.,increase,risk
Zonisamide,Guanethidine,Zonisamide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Guanfacine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Guanfacine.,increase,risk
Zonisamide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Zonisamide.,increase,risk
Zonisamide,Halofantrine,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Halofantrine.,increase,risk
Zonisamide,Haloperidol,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Haloperidol.,increase,risk
Zonisamide,Halothane,The risk or severity of CNS depression can be increased when Zonisamide is combined with Halothane.,increase,risk
Zonisamide,Heparin,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Heparin.,increase,risk
Zonisamide,Hexafluronium,The risk or severity of CNS depression can be increased when Zonisamide is combined with Hexafluronium.,increase,risk
Zonisamide,Histrelin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Histrelin.,increase,risk
Zonisamide,Hydralazine,Zonisamide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydrocodone,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zonisamide,Hydrocortisone,The metabolism of Zonisamide can be decreased when combined with Hydrocortisone.,decrease,no risk
Zonisamide,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Zonisamide.,increase,risk
Zonisamide,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Zonisamide.,increase,risk
Zonisamide,Hydroxocobalamin,Zonisamide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydroxychloroquine,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Zonisamide,Hydroxyethyl Starch,Zonisamide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Zonisamide.,increase,no risk
Zonisamide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Hydroxyzine.,increase,risk
Zonisamide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Kanamycin,Zonisamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Zonisamide,Ketamine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ketamine.,increase,risk
Zonisamide,Ketazolam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ketazolam.,increase,risk
Zonisamide,Ketoconazole,The metabolism of Zonisamide can be decreased when combined with Ketoconazole.,decrease,no risk
Zonisamide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zonisamide.,increase,risk
Zonisamide,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Zonisamide.,increase,risk
Zonisamide,Octinoxate,Zonisamide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Zonisamide.,increase,no risk
Zonisamide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Ofloxacin.,increase,risk
Zonisamide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Zonisamide.,increase,risk
Zonisamide,Olaparib,The metabolism of Olaparib can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zonisamide is combined with Oliceridine.",increase,risk
Zonisamide,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Zonisamide.,increase,risk
Zonisamide,Olodaterol,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Olodaterol.,increase,risk
Zonisamide,Olsalazine,The risk or severity of adverse effects can be increased when Olsalazine is combined with Zonisamide.,increase,risk
Zonisamide,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Omaveloxolone,The serum concentration of Zonisamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Zonisamide,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Omeprazole,The metabolism of Zonisamide can be decreased when combined with Omeprazole.,decrease,no risk
Zonisamide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zonisamide.,increase,risk
Zonisamide,Opium,The risk or severity of CNS depression can be increased when Zonisamide is combined with Opium.,increase,risk
Zonisamide,Oritavancin,The metabolism of Zonisamide can be decreased when combined with Oritavancin.,decrease,no risk
Zonisamide,Orlistat,Orlistat can cause a decrease in the absorption of Zonisamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zonisamide,Orphenadrine,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Zonisamide,Oseltamivir,Zonisamide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Osilodrostat,The metabolism of Zonisamide can be decreased when combined with Osilodrostat.,decrease,no risk
Zonisamide,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Zonisamide.,increase,no risk
Zonisamide,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Zonisamide.,increase,no risk
Zonisamide,Oxacillin,Zonisamide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Zonisamide.,increase,risk
Zonisamide,Oxaprozin,Zonisamide may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxatomide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Oxatomide.,increase,risk
Zonisamide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zonisamide.,increase,risk
Zonisamide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Zonisamide.,increase,risk
Zonisamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Oxetacaine.,increase,risk
Zonisamide,Oxitriptan,The risk or severity of CNS depression can be increased when Zonisamide is combined with Oxitriptan.,increase,risk
Zonisamide,Oxprenolol,Zonisamide may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Zonisamide,Oxtriphylline,Zonisamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxybenzone,Zonisamide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Oxybuprocaine.,increase,risk
Zonisamide,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Zonisamide.,increase,risk
Zonisamide,Oxymorphone,The risk or severity of CNS depression can be increased when Zonisamide is combined with Oxymorphone.,increase,risk
Zonisamide,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Oxyphenbutazone.,increase,risk
Zonisamide,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Zonisamide is combined with Oxyphenisatin acetate.,increase,risk
Zonisamide,Oxyquinoline,Zonisamide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Zonisamide.,increase,risk
Zonisamide,Quazepam,The risk or severity of CNS depression can be increased when Zonisamide is combined with Quazepam.,increase,risk
Zonisamide,Quetiapine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Quetiapine.,increase,risk
Zonisamide,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Zonisamide.,increase,risk
Zonisamide,Quinethazone,Quinethazone may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zonisamide,Quinidine,Quinidine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Zonisamide,Quinine,The excretion of Quinine can be decreased when combined with Zonisamide.,decrease,no risk
Zonisamide,Quinupramine,The risk or severity of CNS depression can be increased when Zonisamide is combined with Quinupramine.,increase,risk
Zonisamide,Quizartinib,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Quizartinib.,increase,risk
Paricalcitol,Hydrochlorothiazide,The risk or severity of hypercalcemia can be increased when Hydrochlorothiazide is combined with Paricalcitol.,increase,risk
Paricalcitol,Hydrocortisone,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Paricalcitol,Hydrocortisone acetate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Paricalcitol,Hydrocortisone butyrate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Paricalcitol,Hydrocortisone cypionate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Paricalcitol,Hydrocortisone succinate,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Paricalcitol,Hydroflumethiazide,The risk or severity of hypercalcemia can be increased when Hydroflumethiazide is combined with Paricalcitol.,increase,risk
Paricalcitol,Hydrotalcite,The serum concentration of Hydrotalcite can be increased when it is combined with Paricalcitol.,increase,no risk
Paricalcitol,Ketoconazole,The metabolism of Paricalcitol can be decreased when combined with Ketoconazole.,decrease,no risk
Paricalcitol,Omaveloxolone,The serum concentration of Paricalcitol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Paricalcitol,Orlistat,Orlistat can cause a decrease in the absorption of Paricalcitol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Paricalcitol,Ouabain,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Paricalcitol is combined with Ouabain.,increase,risk
Paricalcitol,Quinethazone,The risk or severity of hypokalemia can be increased when Paricalcitol is combined with Quinethazone.,increase,risk
Paricalcitol,Vadadustat,The serum concentration of Paricalcitol can be increased when it is combined with Vadadustat.,increase,no risk
Paricalcitol,Vamorolone,The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Paricalcitol,Venetoclax,The metabolism of Paricalcitol can be decreased when combined with Venetoclax.,decrease,no risk
Paricalcitol,Verapamil,The metabolism of Paricalcitol can be decreased when combined with Verapamil.,decrease,no risk
Paricalcitol,Viloxazine,The metabolism of Paricalcitol can be decreased when combined with Viloxazine.,decrease,no risk
Paricalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Paricalcitol is combined with Vitamin D.,increase,risk
Paricalcitol,Voriconazole,The metabolism of Paricalcitol can be decreased when combined with Voriconazole.,decrease,no risk
Paricalcitol,Zimelidine,The metabolism of Paricalcitol can be decreased when combined with Zimelidine.,decrease,no risk
Paricalcitol,Ziprasidone,The metabolism of Paricalcitol can be decreased when combined with Ziprasidone.,decrease,no risk
Tinidazole,Gabapentin enacarbil,Tinidazole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadodiamide,Gadodiamide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadofosveset trisodium,Tinidazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadoteric acid,Tinidazole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tinidazole,Gadoteridol,Gadoteridol may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Tinidazole.,increase,no risk
Tinidazole,Ganciclovir,Tinidazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Tinidazole,Gemcitabine,Gemcitabine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Gemfibrozil,Tinidazole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Tinidazole,Gentamicin,Tinidazole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tinidazole,Gimeracil,Tinidazole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tinidazole,Givosiran,Givosiran may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Glimepiride,Glimepiride may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Glipizide,Tinidazole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tinidazole,Glofitamab,The serum concentration of Tinidazole can be increased when it is combined with Glofitamab.,increase,no risk
Tinidazole,Glyburide,Glyburide may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Glycerol phenylbutyrate,Tinidazole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tinidazole,Glycyrrhizic acid,Tinidazole may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Tinidazole,Golodirsen,Tinidazole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tinidazole,Goserelin,Goserelin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Guanethidine,Tinidazole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Tinidazole,Guanfacine,Tinidazole may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Tinidazole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tinidazole.,increase,no risk
Tinidazole,Hydralazine,Tinidazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Tinidazole,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tinidazole,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tinidazole,Hydromorphone,Hydromorphone may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Hydroxyethyl Starch,Tinidazole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tinidazole,Kanamycin,Tinidazole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketamine,Tinidazole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketazolam,Tinidazole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketoconazole,The metabolism of Tinidazole can be decreased when combined with Ketoconazole.,decrease,no risk
Tinidazole,Ketoprofen,Ketoprofen may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Ketorolac,Ketorolac may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Octinoxate,Tinidazole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tinidazole,Ofloxacin,Tinidazole may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Tinidazole,Olmesartan,Olmesartan may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Olsalazine,Olsalazine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Omaveloxolone,The serum concentration of Tinidazole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tinidazole,Opium,Tinidazole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tinidazole,Oseltamivir,Oseltamivir may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxacillin,Oxacillin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxaprozin,Oxaprozin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxazepam,Oxazepam may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tinidazole is combined with Oxetacaine.,increase,risk
Tinidazole,Oxybenzone,Tinidazole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tinidazole is combined with Oxybuprocaine.,increase,risk
Tinidazole,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Oxyquinoline,Tinidazole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tinidazole,Quetiapine,Tinidazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Tinidazole,Quinethazone,Quinethazone may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tinidazole,Quinidine,Tinidazole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tinidazole,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Vaborbactam,Tinidazole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tinidazole,Vadadustat,The serum concentration of Tinidazole can be increased when it is combined with Vadadustat.,increase,no risk
Tinidazole,Valaciclovir,Valaciclovir may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Valbenazine,Tinidazole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tinidazole,Valdecoxib,Valdecoxib may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Valganciclovir,Tinidazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Tinidazole,Vancomycin,Tinidazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tinidazole,Varenicline,Tinidazole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Tinidazole,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Tinidazole.,increase,no risk
Tinidazole,Venetoclax,The metabolism of Tinidazole can be decreased when combined with Venetoclax.,decrease,no risk
Tinidazole,Venlafaxine,Venlafaxine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Verapamil,The metabolism of Tinidazole can be decreased when combined with Verapamil.,decrease,no risk
Tinidazole,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tinidazole.,decrease,no risk
Tinidazole,Vilanterol,Tinidazole may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Tinidazole,Viloxazine,The metabolism of Tinidazole can be decreased when combined with Viloxazine.,decrease,no risk
Tinidazole,Vinblastine,Vinblastine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Vincristine,Vincristine may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Voriconazole,The metabolism of Tinidazole can be decreased when combined with Voriconazole.,decrease,no risk
Tinidazole,Vortioxetine,Tinidazole may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Tinidazole,Warfarin,Tinidazole may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Tinidazole,Zaleplon,Tinidazole may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Tinidazole,Zanamivir,Zanamivir may decrease the excretion rate of Tinidazole which could result in a higher serum level.,decrease,no risk
Tinidazole,Zimelidine,The metabolism of Tinidazole can be decreased when combined with Zimelidine.,decrease,no risk
Tinidazole,Ziprasidone,The metabolism of Tinidazole can be decreased when combined with Ziprasidone.,decrease,no risk
Tinidazole,Zonisamide,Zonisamide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Repaglinide,Gatifloxacin,The therapeutic efficacy of Repaglinide can be increased when used in combination with Gatifloxacin.,increase,no risk
Repaglinide,Gefapixant,The therapeutic efficacy of Repaglinide can be increased when used in combination with Gefapixant.,increase,no risk
Repaglinide,Gemfibrozil,The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.,increase,no risk
Repaglinide,Gemifloxacin,The therapeutic efficacy of Repaglinide can be increased when used in combination with Gemifloxacin.,increase,no risk
Repaglinide,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Glecaprevir,The excretion of Repaglinide can be decreased when combined with Glecaprevir.,decrease,no risk
Repaglinide,Gliclazide,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Gliclazide.,increase,risk
Repaglinide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Repaglinide.,increase,risk
Repaglinide,Glipizide,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Glipizide.,increase,risk
Repaglinide,Gliquidone,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Gliquidone.,increase,risk
Repaglinide,Glofitamab,The serum concentration of Repaglinide can be increased when it is combined with Glofitamab.,increase,no risk
Repaglinide,Glyburide,Glyburide may decrease the excretion rate of Repaglinide which could result in a higher serum level.,decrease,no risk
Repaglinide,Glycyrrhizic acid,Repaglinide may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Repaglinide,Glymidine,The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Glymidine.,increase,risk
Repaglinide,Golimumab,The metabolism of Repaglinide can be increased when combined with Golimumab.,increase,no risk
Repaglinide,Goserelin,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Goserelin.,decrease,no risk
Repaglinide,Grepafloxacin,The therapeutic efficacy of Repaglinide can be increased when used in combination with Grepafloxacin.,increase,no risk
Repaglinide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Repaglinide.,increase,risk
Repaglinide,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Repaglinide.,increase,no risk
Repaglinide,Histrelin,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Histrelin.,decrease,no risk
Repaglinide,Hydrochlorothiazide,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Repaglinide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Repaglinide.,increase,risk
Repaglinide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Repaglinide.,increase,risk
Repaglinide,Hydroflumethiazide,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Repaglinide,Hydroxychloroquine,The therapeutic efficacy of Repaglinide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Repaglinide,Hydroxyprogesterone caproate,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Repaglinide,Ketamine,The metabolism of Ketamine can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Ketoconazole,The serum concentration of Repaglinide can be increased when it is combined with Ketoconazole.,increase,no risk
Repaglinide,Ketoprofen,The metabolism of Repaglinide can be decreased when combined with Ketoprofen.,decrease,no risk
Repaglinide,Ketorolac,The metabolism of Repaglinide can be decreased when combined with Ketorolac.,decrease,no risk
Repaglinide,Ketotifen,The risk or severity of thrombocytopenia can be increased when Repaglinide is combined with Ketotifen.,increase,risk
Repaglinide,Octreotide,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Octreotide.,decrease,no risk
Repaglinide,Ofloxacin,The therapeutic efficacy of Repaglinide can be increased when used in combination with Ofloxacin.,increase,no risk
Repaglinide,Olanzapine,The therapeutic efficacy of Repaglinide can be decreased when used in combination with Olanzapine.,decrease,no risk
Repaglinide,Olmesartan,Olmesartan may decrease the excretion rate of Repaglinide which could result in a higher serum level.,decrease,no risk
Repaglinide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Omaveloxolone,The serum concentration of Repaglinide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Repaglinide,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Repaglinide.,decrease,no risk
Repaglinide,Ouabain,The excretion of Repaglinide can be decreased when combined with Ouabain.,decrease,no risk
Repaglinide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Oxprenolol,The therapeutic efficacy of Repaglinide can be increased when used in combination with Oxprenolol.,increase,no risk
Repaglinide,Oxybutynin,The metabolism of Repaglinide can be decreased when combined with Oxybutynin.,decrease,no risk
Repaglinide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Repaglinide.,increase,no risk
Repaglinide,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Repaglinide.,decrease,no risk
Anileridine,Halothane,The therapeutic efficacy of Halothane can be increased when used in combination with Anileridine.,increase,no risk
Anileridine,Ketamine,The therapeutic efficacy of Ketamine can be increased when used in combination with Anileridine.,increase,no risk
Anileridine,Urethane,The therapeutic efficacy of Urethane can be increased when used in combination with Anileridine.,increase,no risk
Phenformin,Galantamine,The metabolism of Phenformin can be decreased when combined with Galantamine.,decrease,no risk
Phenformin,Ganciclovir,The risk or severity of adverse effects can be increased when Phenformin is combined with Ganciclovir.,increase,risk
Phenformin,Gatifloxacin,The therapeutic efficacy of Phenformin can be increased when used in combination with Gatifloxacin.,increase,no risk
Phenformin,Gefapixant,The therapeutic efficacy of Phenformin can be increased when used in combination with Gefapixant.,increase,no risk
Phenformin,Gefitinib,The metabolism of Phenformin can be decreased when combined with Gefitinib.,decrease,no risk
Phenformin,Gemifloxacin,The therapeutic efficacy of Phenformin can be increased when used in combination with Gemifloxacin.,increase,no risk
Phenformin,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Phenformin.,increase,no risk
Phenformin,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Phenformin.,increase,risk
Phenformin,Givosiran,The serum concentration of Phenformin can be increased when it is combined with Givosiran.,increase,no risk
Phenformin,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Phenformin.,increase,risk
Phenformin,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Phenformin.,increase,risk
Phenformin,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Phenformin.,increase,risk
Phenformin,Gliquidone,The risk or severity of hypoglycemia can be increased when Phenformin is combined with Gliquidone.,increase,risk
Phenformin,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Phenformin.,increase,risk
Phenformin,Glycerol phenylbutyrate,The metabolism of Phenformin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Phenformin,Glymidine,The therapeutic efficacy of Phenformin can be increased when used in combination with Glymidine.,increase,no risk
Phenformin,Golimumab,The metabolism of Phenformin can be increased when combined with Golimumab.,increase,no risk
Phenformin,Goserelin,The therapeutic efficacy of Phenformin can be decreased when used in combination with Goserelin.,decrease,no risk
Phenformin,Grepafloxacin,The therapeutic efficacy of Phenformin can be increased when used in combination with Grepafloxacin.,increase,no risk
Phenformin,Guanfacine,The risk or severity of adverse effects can be increased when Phenformin is combined with Guanfacine.,increase,risk
Phenformin,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Phenformin.,increase,risk
Phenformin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Phenformin.,increase,risk
Phenformin,Halofantrine,The metabolism of Phenformin can be decreased when combined with Halofantrine.,decrease,no risk
Phenformin,Haloperidol,The serum concentration of Phenformin can be increased when it is combined with Haloperidol.,increase,no risk
Phenformin,Histamine,The serum concentration of Histamine can be increased when it is combined with Phenformin.,increase,no risk
Phenformin,Histrelin,The therapeutic efficacy of Phenformin can be decreased when used in combination with Histrelin.,decrease,no risk
Phenformin,Hydrochlorothiazide,The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Phenformin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Phenformin.,increase,risk
Phenformin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Phenformin.,increase,risk
Phenformin,Hydroflumethiazide,The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Phenformin,Hydroxychloroquine,The therapeutic efficacy of Phenformin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Phenformin,Hydroxyprogesterone caproate,The therapeutic efficacy of Phenformin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Phenformin,Hydroxyzine,The metabolism of Phenformin can be decreased when combined with Hydroxyzine.,decrease,no risk
Phenformin,Ketoconazole,The metabolism of Phenformin can be decreased when combined with Ketoconazole.,decrease,no risk
Phenformin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Phenformin is combined with Ketotifen.,increase,risk
Phenformin,Octreotide,The therapeutic efficacy of Phenformin can be decreased when used in combination with Octreotide.,decrease,no risk
Phenformin,Ofloxacin,The therapeutic efficacy of Phenformin can be increased when used in combination with Ofloxacin.,increase,no risk
Phenformin,Olanzapine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Olanzapine.,decrease,no risk
Phenformin,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Ondansetron,The metabolism of Phenformin can be decreased when combined with Ondansetron.,decrease,no risk
Phenformin,Opium,The metabolism of Opium can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Oritavancin,The metabolism of Phenformin can be decreased when combined with Oritavancin.,decrease,no risk
Phenformin,Orphenadrine,The metabolism of Phenformin can be decreased when combined with Orphenadrine.,decrease,no risk
Phenformin,Osilodrostat,The metabolism of Phenformin can be decreased when combined with Osilodrostat.,decrease,no risk
Phenformin,Ospemifene,The metabolism of Phenformin can be decreased when combined with Ospemifene.,decrease,no risk
Phenformin,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Phenformin.,increase,no risk
Phenformin,Oxamniquine,The metabolism of Phenformin can be decreased when combined with Oxamniquine.,decrease,no risk
Phenformin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Oxprenolol,The therapeutic efficacy of Phenformin can be increased when used in combination with Oxprenolol.,increase,no risk
Phenformin,Oxybutynin,The metabolism of Phenformin can be decreased when combined with Oxybutynin.,decrease,no risk
Phenformin,Oxycodone,The metabolism of Phenformin can be decreased when combined with Oxycodone.,decrease,no risk
Phenformin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Phenformin.,increase,no risk
Phenformin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Quetiapine,The therapeutic efficacy of Phenformin can be decreased when used in combination with Quetiapine.,decrease,no risk
Phenformin,Quinethazone,The therapeutic efficacy of Phenformin can be decreased when used in combination with Quinethazone.,decrease,no risk
Phenformin,Quinidine,The metabolism of Phenformin can be decreased when combined with Quinidine.,decrease,no risk
Phenformin,Quinine,The metabolism of Phenformin can be decreased when combined with Quinine.,decrease,no risk
Phenformin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Phenformin.,decrease,no risk
Phenformin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Phenformin.,increase,risk
Phenformin,Udenafil,The therapeutic efficacy of Phenformin can be increased when used in combination with Udenafil.,increase,no risk
Phenformin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Phenformin.,increase,risk
Phenformin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Valdecoxib,The therapeutic efficacy of Phenformin can be increased when used in combination with Valdecoxib.,increase,no risk
Phenformin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Phenformin.,increase,risk
Phenformin,Varenicline,The excretion of Varenicline can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Vemurafenib,The therapeutic efficacy of Phenformin can be increased when used in combination with Vemurafenib.,increase,no risk
Phenformin,Venlafaxine,The metabolism of Phenformin can be decreased when combined with Venlafaxine.,decrease,no risk
Phenformin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Phenformin.,increase,risk
Phenformin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Vilazodone,The metabolism of Phenformin can be decreased when combined with Vilazodone.,decrease,no risk
Phenformin,Vildagliptin,The risk or severity of hypoglycemia can be increased when Phenformin is combined with Vildagliptin.,increase,risk
Phenformin,Viloxazine,The metabolism of Phenformin can be decreased when combined with Viloxazine.,decrease,no risk
Phenformin,Vinblastine,The metabolism of Phenformin can be decreased when combined with Vinblastine.,decrease,no risk
Phenformin,Vinorelbine,The metabolism of Phenformin can be decreased when combined with Vinorelbine.,decrease,no risk
Phenformin,Vorinostat,The therapeutic efficacy of Phenformin can be decreased when used in combination with Vorinostat.,decrease,no risk
Phenformin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Phenformin.,increase,risk
Phenformin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Phenformin.,decrease,no risk
Phenformin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Phenformin.,increase,risk
Phenformin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Phenformin.,increase,risk
Phenformin,Ziprasidone,The therapeutic efficacy of Phenformin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Phenformin,Zolpidem,The metabolism of Phenformin can be decreased when combined with Zolpidem.,decrease,no risk
Phenformin,Zonisamide,The therapeutic efficacy of Phenformin can be increased when used in combination with Zonisamide.,increase,no risk
Amantadine,Bilastine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Bilastine.,increase,risk
Amantadine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Amantadine.,increase,risk
Amantadine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Bismuth subgallate,Amantadine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Amantadine,Bisoprolol,Bisoprolol may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Bisoxatin,Amantadine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Amantadine,Bleomycin,Bleomycin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Amantadine.,increase,risk
Amantadine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Amantadine is combined with Botulinum toxin type A.,increase,risk
Amantadine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Amantadine is combined with Botulinum toxin type B.,increase,risk
Amantadine,Bretylium,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Bretylium.,increase,risk
Amantadine,Brexpiprazole,The therapeutic efficacy of Amantadine can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Amantadine,Brivaracetam,Amantadine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Amantadine,Bromazepam,Amantadine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Amantadine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Amantadine.,increase,risk
Amantadine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Amantadine.,increase,risk
Amantadine,Budesonide,Amantadine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Amantadine,Bumadizone,Bumadizone may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Bumetanide,Bumetanide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Buprenorphine,The risk or severity of adverse effects can be increased when Amantadine is combined with Buprenorphine.,increase,risk
Amantadine,Bupropion,The excretion of Amantadine can be decreased when combined with Bupropion.,decrease,no risk
Amantadine,Buserelin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Buserelin.,increase,risk
Amantadine,Buspirone,The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Amantadine.,increase,risk
Amantadine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Amantadine.,increase,risk
Amantadine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Amantadine.,increase,risk
Amantadine,Butobarbital,The risk or severity of adverse effects can be increased when Amantadine is combined with Butobarbital.,increase,risk
Amantadine,Butorphanol,The risk or severity of adverse effects can be increased when Amantadine is combined with Butorphanol.,increase,risk
Amantadine,Butriptyline,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Butriptyline.,increase,risk
Amantadine,Butylscopolamine,The risk or severity of adverse effects can be increased when Amantadine is combined with Butylscopolamine.,increase,risk
Amantadine,Gabapentin enacarbil,Amantadine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Amantadine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Gadobenic acid.,increase,risk
Amantadine,Gadodiamide,Gadodiamide may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Gadofosveset trisodium,Amantadine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Amantadine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Gadoteric acid,Amantadine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Amantadine,Gadoteridol,Gadoteridol may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Galantamine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Galantamine.,decrease,no risk
Amantadine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Amantadine.,increase,risk
Amantadine,Ganciclovir,The risk or severity of adverse effects can be increased when Amantadine is combined with Ganciclovir.,increase,risk
Amantadine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Gatifloxacin.,increase,risk
Amantadine,Gemcitabine,Gemcitabine may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Gemfibrozil,Amantadine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Amantadine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Gemifloxacin.,increase,risk
Amantadine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Amantadine.,increase,no risk
Amantadine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Amantadine.,increase,risk
Amantadine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Amantadine.,increase,risk
Amantadine,Gimeracil,Amantadine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Amantadine,Ginkgo biloba,The therapeutic efficacy of Amantadine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Amantadine,Givosiran,Givosiran may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Glasdegib,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Glasdegib.,increase,risk
Amantadine,Glipizide,Amantadine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Amantadine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Glycerol phenylbutyrate,Amantadine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Amantadine,Glycopyrronium,Amantadine may increase the anticholinergic activities of Glycopyrronium.,increase,no risk
Amantadine,Golodirsen,Amantadine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Amantadine,Goserelin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Goserelin.,increase,risk
Amantadine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Amantadine.,increase,risk
Amantadine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Grepafloxacin.,increase,risk
Amantadine,Guanethidine,Amantadine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Amantadine,Guanfacine,The risk or severity of adverse effects can be increased when Amantadine is combined with Guanfacine.,increase,risk
Amantadine,Guanidine,The serum concentration of Amantadine can be increased when it is combined with Guanidine.,increase,no risk
Amantadine,Halofantrine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Halofantrine.,increase,risk
Amantadine,Haloperidol,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Haloperidol.,increase,risk
Amantadine,Hexafluronium,The risk or severity of adverse effects can be increased when Amantadine is combined with Hexafluronium.,increase,risk
Amantadine,Hexocyclium,The risk or severity of adverse effects can be increased when Amantadine is combined with Hexocyclium.,increase,risk
Amantadine,Histamine,The serum concentration of Histamine can be increased when it is combined with Amantadine.,increase,no risk
Amantadine,Histrelin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Histrelin.,increase,risk
Amantadine,Homatropine,The risk or severity of adverse effects can be increased when Amantadine is combined with Homatropine.,increase,risk
Amantadine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Amantadine.,increase,risk
Amantadine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Huperzine A,The therapeutic efficacy of Amantadine can be decreased when used in combination with Huperzine A.,decrease,no risk
Amantadine,Hydralazine,Amantadine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Amantadine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Amantadine.,increase,risk
Amantadine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Hydromorphone,The risk or severity of adverse effects can be increased when Amantadine is combined with Hydromorphone.,increase,risk
Amantadine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Hydroxychloroquine.,increase,risk
Amantadine,Hydroxyethyl Starch,Amantadine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Amantadine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Hydroxyzine.,increase,risk
Amantadine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Amantadine.,increase,risk
Amantadine,Kanamycin,Amantadine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Amantadine,Ketamine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Ketamine.,decrease,no risk
Amantadine,Ketazolam,Amantadine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Amantadine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ketoconazole.,increase,risk
Amantadine,Ketoprofen,Ketoprofen may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Ketorolac,Ketorolac may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Octinoxate,Amantadine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Amantadine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Amantadine.,increase,risk
Amantadine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ofloxacin.,increase,risk
Amantadine,Olanzapine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Olanzapine.,decrease,no risk
Amantadine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Oliceridine.,increase,risk
Amantadine,Olodaterol,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Olodaterol.,increase,risk
Amantadine,Olsalazine,Olsalazine may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Amantadine.,increase,risk
Amantadine,Opium,The risk or severity of adverse effects can be increased when Amantadine is combined with Opium.,increase,risk
Amantadine,Orphenadrine,The risk or severity of adverse effects can be increased when Amantadine is combined with Orphenadrine.,increase,risk
Amantadine,Oseltamivir,Oseltamivir may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxacillin,Oxacillin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Amantadine.,increase,risk
Amantadine,Oxaprozin,Oxaprozin may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxatomide,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Oxatomide.,increase,risk
Amantadine,Oxazepam,Oxazepam may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxprenolol,The serum concentration of Amantadine can be increased when it is combined with Oxprenolol.,increase,no risk
Amantadine,Oxybenzone,Amantadine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Amantadine,Oxybutynin,The risk or severity of adverse effects can be increased when Amantadine is combined with Oxybutynin.,increase,risk
Amantadine,Oxycodone,The risk or severity of adverse effects can be increased when Amantadine is combined with Oxycodone.,increase,risk
Amantadine,Oxymorphone,The risk or severity of adverse effects can be increased when Amantadine is combined with Oxymorphone.,increase,risk
Amantadine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Amantadine.,increase,risk
Amantadine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Amantadine.,increase,risk
Amantadine,Oxyquinoline,Amantadine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Amantadine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amantadine.,increase,risk
Amantadine,Quetiapine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Quetiapine.,decrease,no risk
Amantadine,Quinethazone,Quinethazone may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Quinidine,Amantadine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Amantadine,Quinine,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Quinine.,increase,risk
Amantadine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Quinupramine.,increase,risk
Amantadine,Quizartinib,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Quizartinib.,increase,risk
Amantadine,Umeclidinium,The risk or severity of adverse effects can be increased when Amantadine is combined with Umeclidinium.,increase,risk
Amantadine,Vaborbactam,Amantadine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Amantadine,Valaciclovir,Valaciclovir may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Valbenazine,Amantadine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Amantadine,Valdecoxib,Valdecoxib may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Valganciclovir,Amantadine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Amantadine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Valproate bismuth.,increase,risk
Amantadine,Valproic acid,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Valproic acid.,increase,risk
Amantadine,Vancomycin,Amantadine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Amantadine,Vandetanib,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vandetanib.,increase,risk
Amantadine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Amantadine.,increase,risk
Amantadine,Varenicline,The excretion of Varenicline can be decreased when combined with Amantadine.,decrease,no risk
Amantadine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Vecuronium,The risk or severity of adverse effects can be increased when Amantadine is combined with Vecuronium.,increase,risk
Amantadine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Amantadine.,increase,risk
Amantadine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Venlafaxine.,increase,risk
Amantadine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Amantadine.,increase,risk
Amantadine,Vernakalant,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vernakalant.,increase,risk
Amantadine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Amantadine.,increase,risk
Amantadine,Vilazodone,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Vilazodone.,increase,risk
Amantadine,Viloxazine,Amantadine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Amantadine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Amantadine.,increase,risk
Amantadine,Vorinostat,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Vorinostat.,increase,risk
Amantadine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Vortioxetine.,increase,risk
Amantadine,Warfarin,Amantadine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Amantadine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Amantadine.,decrease,no risk
Amantadine,Yohimbine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Yohimbine.,increase,risk
Amantadine,Zaleplon,Amantadine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Amantadine,Zanamivir,Zanamivir may decrease the excretion rate of Amantadine which could result in a higher serum level.,decrease,no risk
Amantadine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Zimelidine.,increase,risk
Amantadine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ziprasidone.,increase,risk
Amantadine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Amantadine.,increase,risk
Amantadine,Zonisamide,Zonisamide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amantadine,Zotepine,The therapeutic efficacy of Amantadine can be decreased when used in combination with Zotepine.,decrease,no risk
Amantadine,Zuclopenthixol,The therapeutic efficacy of Amantadine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Metronidazole,Buserelin,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Buserelin.,increase,risk
Metronidazole,Buspirone,The metabolism of Metronidazole can be decreased when combined with Buspirone.,decrease,no risk
Metronidazole,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Metronidazole.,increase,no risk
Metronidazole,Butacaine,The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Butacaine.,increase,risk
Metronidazole,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Metronidazole.,decrease,no risk
Metronidazole,Butamben,The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Butamben.,increase,risk
Metronidazole,Butriptyline,The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Butriptyline.,increase,risk
Dinoprostone,Ganciclovir,The excretion of Dinoprostone can be decreased when combined with Ganciclovir.,decrease,no risk
Dinoprostone,Gemfibrozil,The excretion of Dinoprostone can be decreased when combined with Gemfibrozil.,decrease,no risk
Dinoprostone,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Glecaprevir,The excretion of Dinoprostone can be decreased when combined with Glecaprevir.,decrease,no risk
Dinoprostone,Glyburide,The excretion of Dinoprostone can be decreased when combined with Glyburide.,decrease,no risk
Dinoprostone,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Guanfacine,The risk or severity of adverse effects can be increased when Dinoprostone is combined with Guanfacine.,increase,risk
Dinoprostone,Guanidine,The excretion of Dinoprostone can be decreased when combined with Guanidine.,decrease,no risk
Dinoprostone,Histamine,The serum concentration of Histamine can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Ketoconazole,The excretion of Dinoprostone can be decreased when combined with Ketoconazole.,decrease,no risk
Dinoprostone,Ketoprofen,The excretion of Dinoprostone can be decreased when combined with Ketoprofen.,decrease,no risk
Dinoprostone,Ofloxacin,The excretion of Dinoprostone can be decreased when combined with Ofloxacin.,decrease,no risk
Dinoprostone,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Ouabain,The excretion of Dinoprostone can be decreased when combined with Ouabain.,decrease,no risk
Dinoprostone,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Oxyphenbutazone,The excretion of Dinoprostone can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Dinoprostone,Oxytetracycline,The excretion of Dinoprostone can be decreased when combined with Oxytetracycline.,decrease,no risk
Dinoprostone,Oxytocin,The risk or severity of adverse effects can be increased when Dinoprostone is combined with Oxytocin.,increase,risk
Dinoprostone,Quinapril,The excretion of Quinapril can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Quinidine,The excretion of Dinoprostone can be decreased when combined with Quinidine.,decrease,no risk
Dinoprostone,Quinine,The risk or severity of adverse effects can be increased when Dinoprostone is combined with Quinine.,increase,risk
Dinoprostone,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Dinoprostone.,increase,no risk
Dinoprostone,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Valproic acid,The excretion of Valproic acid can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Valsartan,The excretion of Dinoprostone can be decreased when combined with Valsartan.,decrease,no risk
Dinoprostone,Varenicline,The excretion of Varenicline can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Velpatasvir,The excretion of Dinoprostone can be decreased when combined with Velpatasvir.,decrease,no risk
Dinoprostone,Venetoclax,The excretion of Dinoprostone can be decreased when combined with Venetoclax.,decrease,no risk
Dinoprostone,Vinblastine,The excretion of Dinoprostone can be decreased when combined with Vinblastine.,decrease,no risk
Dinoprostone,Vincristine,The excretion of Dinoprostone can be decreased when combined with Vincristine.,decrease,no risk
Dinoprostone,Voxilaprevir,The excretion of Dinoprostone can be decreased when combined with Voxilaprevir.,decrease,no risk
Dinoprostone,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Dinoprostone.,decrease,no risk
Dinoprostone,Zidovudine,The excretion of Dinoprostone can be decreased when combined with Zidovudine.,decrease,no risk
Almotriptan,Benoxaprofen,The risk or severity of hypertension can be increased when Almotriptan is combined with Benoxaprofen.,increase,risk
Almotriptan,Benperidol,The risk or severity of adverse effects can be increased when Almotriptan is combined with Benperidol.,increase,risk
Almotriptan,Benserazide,Almotriptan may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Almotriptan,Benzatropine,Benzatropine may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Benznidazole,Almotriptan may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Almotriptan,Benzocaine,The risk or severity of CNS depression can be increased when Almotriptan is combined with Benzocaine.,increase,risk
Almotriptan,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Almotriptan.,increase,risk
Almotriptan,Benzthiazide,Benzthiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Benzydamine,The risk or severity of hypertension can be increased when Almotriptan is combined with Benzydamine.,increase,risk
Almotriptan,Benzyl alcohol,The risk or severity of CNS depression can be increased when Almotriptan is combined with Benzyl alcohol.,increase,risk
Almotriptan,Bepotastine,Almotriptan may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Almotriptan,Bepridil,The metabolism of Almotriptan can be decreased when combined with Bepridil.,decrease,no risk
Almotriptan,Berotralstat,The metabolism of Almotriptan can be decreased when combined with Berotralstat.,decrease,no risk
Almotriptan,Betamethasone,The metabolism of Almotriptan can be increased when combined with Betamethasone.,increase,no risk
Almotriptan,Betaxolol,Almotriptan may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Almotriptan,Bethanidine,Almotriptan may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Almotriptan,Bexarotene,The metabolism of Almotriptan can be decreased when combined with Bexarotene.,decrease,no risk
Almotriptan,Bezafibrate,The metabolism of Almotriptan can be decreased when combined with Bezafibrate.,decrease,no risk
Almotriptan,Bicisate,Almotriptan may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Almotriptan,Bimekizumab,The metabolism of Almotriptan can be increased when combined with Bimekizumab.,increase,no risk
Almotriptan,Biperiden,The metabolism of Almotriptan can be decreased when combined with Biperiden.,decrease,no risk
Almotriptan,Bismuth subgallate,Almotriptan may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Almotriptan,Bisoprolol,Almotriptan may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Almotriptan,Bisoxatin,Almotriptan may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Almotriptan,Bleomycin,Bleomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Boceprevir,The metabolism of Almotriptan can be decreased when combined with Boceprevir.,decrease,no risk
Almotriptan,Bortezomib,The metabolism of Almotriptan can be decreased when combined with Bortezomib.,decrease,no risk
Almotriptan,Bosentan,Almotriptan may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Almotriptan,Bosutinib,The metabolism of Almotriptan can be decreased when combined with Bosutinib.,decrease,no risk
Almotriptan,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Almotriptan.,increase,risk
Almotriptan,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Almotriptan.,increase,risk
Almotriptan,Bretylium,Almotriptan may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Almotriptan,Brexanolone,The risk or severity of CNS depression can be increased when Almotriptan is combined with Brexanolone.,increase,risk
Almotriptan,Brexpiprazole,The risk or severity of adverse effects can be increased when Almotriptan is combined with Brexpiprazole.,increase,risk
Almotriptan,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Almotriptan.,decrease,no risk
Almotriptan,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.,increase,no risk
Almotriptan,Brivaracetam,The risk or severity of CNS depression can be increased when Almotriptan is combined with Brivaracetam.,increase,risk
Almotriptan,Bromazepam,The risk or severity of CNS depression can be increased when Almotriptan is combined with Bromazepam.,increase,risk
Almotriptan,Bromocriptine,Bromocriptine may increase the vasoconstricting activities of Almotriptan.,increase,no risk
Almotriptan,Bromotheophylline,Bromotheophylline may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Bromperidol,The risk or severity of adverse effects can be increased when Almotriptan is combined with Bromperidol.,increase,risk
Almotriptan,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Almotriptan.,increase,risk
Almotriptan,Budesonide,Almotriptan may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Almotriptan,Bumadizone,The risk or severity of hypertension can be increased when Almotriptan is combined with Bumadizone.,increase,risk
Almotriptan,Bumetanide,Bumetanide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Almotriptan.,increase,risk
Almotriptan,Buprenorphine,Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Almotriptan,Bupropion,The metabolism of Almotriptan can be decreased when combined with Bupropion.,decrease,no risk
Almotriptan,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Almotriptan.,increase,risk
Almotriptan,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Almotriptan.,increase,risk
Almotriptan,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Almotriptan.,increase,risk
Almotriptan,Butaperazine,The risk or severity of adverse effects can be increased when Almotriptan is combined with Butaperazine.,increase,risk
Almotriptan,Butobarbital,The risk or severity of CNS depression can be increased when Almotriptan is combined with Butobarbital.,increase,risk
Almotriptan,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Almotriptan.,increase,risk
Almotriptan,Butriptyline,The risk or severity of CNS depression can be increased when Almotriptan is combined with Butriptyline.,increase,risk
Almotriptan,Gabapentin,The risk or severity of CNS depression can be increased when Almotriptan is combined with Gabapentin.,increase,risk
Almotriptan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Almotriptan is combined with Gabapentin enacarbil.,increase,risk
Almotriptan,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadodiamide,Gadodiamide may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadofosveset trisodium,Almotriptan may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadoteric acid,Almotriptan may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Almotriptan,Gadoteridol,Gadoteridol may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Galantamine,The metabolism of Almotriptan can be decreased when combined with Galantamine.,decrease,no risk
Almotriptan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Almotriptan.,increase,risk
Almotriptan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Almotriptan is combined with Ganaxolone.",increase,risk
Almotriptan,Ganciclovir,Almotriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Almotriptan,Gefitinib,The metabolism of Almotriptan can be decreased when combined with Gefitinib.,decrease,no risk
Almotriptan,Gemcitabine,Gemcitabine may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Gemfibrozil,The metabolism of Almotriptan can be decreased when combined with Gemfibrozil.,decrease,no risk
Almotriptan,Gentamicin,Almotriptan may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Almotriptan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Almotriptan.,increase,risk
Almotriptan,Gilteritinib,The therapeutic efficacy of Almotriptan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Almotriptan,Gimeracil,Almotriptan may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Almotriptan,Ginkgo biloba,The metabolism of Almotriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Almotriptan,Givosiran,The serum concentration of Almotriptan can be increased when it is combined with Givosiran.,increase,no risk
Almotriptan,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Almotriptan.,decrease,no risk
Almotriptan,Glipizide,Almotriptan may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Almotriptan,Glofitamab,The serum concentration of Almotriptan can be increased when it is combined with Glofitamab.,increase,no risk
Almotriptan,Glutethimide,The risk or severity of CNS depression can be increased when Almotriptan is combined with Glutethimide.,increase,risk
Almotriptan,Glycerol phenylbutyrate,The metabolism of Almotriptan can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Almotriptan,Golimumab,The metabolism of Almotriptan can be increased when combined with Golimumab.,increase,no risk
Almotriptan,Golodirsen,Almotriptan may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Almotriptan,Goserelin,Goserelin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Almotriptan.,increase,risk
Almotriptan,Guanabenz,Almotriptan may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Almotriptan,Guanadrel,Almotriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Almotriptan,Guanethidine,Almotriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Almotriptan,Guanfacine,The risk or severity of CNS depression can be increased when Almotriptan is combined with Guanfacine.,increase,risk
Almotriptan,Guanoxan,Almotriptan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Almotriptan,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Almotriptan.,increase,risk
Almotriptan,Halofantrine,The metabolism of Almotriptan can be decreased when combined with Halofantrine.,decrease,no risk
Almotriptan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Almotriptan.,increase,risk
Almotriptan,Halothane,The risk or severity of CNS depression can be increased when Almotriptan is combined with Halothane.,increase,risk
Almotriptan,Hexafluronium,The risk or severity of CNS depression can be increased when Almotriptan is combined with Hexafluronium.,increase,risk
Almotriptan,Hydralazine,Almotriptan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Almotriptan,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Hydrocodone,Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Almotriptan,Hydrocortisone,The metabolism of Almotriptan can be increased when combined with Hydrocortisone.,increase,no risk
Almotriptan,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Almotriptan,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Almotriptan.,increase,risk
Almotriptan,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,decrease,no risk
Almotriptan,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Almotriptan.,decrease,no risk
Almotriptan,Hydroxyethyl Starch,Almotriptan may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Almotriptan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.,increase,no risk
Almotriptan,Kanamycin,Almotriptan may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Almotriptan,Ketamine,The risk or severity of CNS depression can be increased when Almotriptan is combined with Ketamine.,increase,risk
Almotriptan,Ketazolam,The risk or severity of CNS depression can be increased when Almotriptan is combined with Ketazolam.,increase,risk
Almotriptan,Ketoconazole,The metabolism of Almotriptan can be decreased when combined with Ketoconazole.,decrease,no risk
Almotriptan,Ketoprofen,The risk or severity of hypertension can be increased when Almotriptan is combined with Ketoprofen.,increase,risk
Almotriptan,Ketorolac,The metabolism of Almotriptan can be decreased when combined with Ketorolac.,decrease,no risk
Spectinomycin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Spectinomycin.,decrease,no risk
Spectinomycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Benzocaine.,increase,risk
Spectinomycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Benzyl alcohol.,increase,risk
Spectinomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Bupivacaine.,increase,risk
Spectinomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Butacaine.,increase,risk
Spectinomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Butamben.,increase,risk
Spectinomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Oxetacaine.,increase,risk
Spectinomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Oxybuprocaine.,increase,risk
Spectinomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Spectinomycin.,decrease,no risk
Spectinomycin,Warfarin,The risk or severity of bleeding can be increased when Spectinomycin is combined with Warfarin.,increase,risk
Ketotifen,Benzphetamine,Benzphetamine may decrease the sedative activities of Ketotifen.,decrease,no risk
Ketotifen,Benzylpenicilloyl polylysine,Ketotifen may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Ketotifen,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Ketotifen.,decrease,no risk
Ketotifen,Bexagliflozin,The risk or severity of thrombocytopenia can be increased when Bexagliflozin is combined with Ketotifen.,increase,risk
Ketotifen,Gliclazide,The risk or severity of thrombocytopenia can be increased when Gliclazide is combined with Ketotifen.,increase,risk
Ketotifen,Glimepiride,The risk or severity of thrombocytopenia can be increased when Glimepiride is combined with Ketotifen.,increase,risk
Ketotifen,Glipizide,The risk or severity of thrombocytopenia can be increased when Glipizide is combined with Ketotifen.,increase,risk
Ketotifen,Gliquidone,The risk or severity of thrombocytopenia can be increased when Gliquidone is combined with Ketotifen.,increase,risk
Ketotifen,Glyburide,The risk or severity of thrombocytopenia can be increased when Glyburide is combined with Ketotifen.,increase,risk
Ketotifen,Glymidine,The risk or severity of thrombocytopenia can be increased when Glymidine is combined with Ketotifen.,increase,risk
Ketotifen,Hyoscyamine,Ketotifen may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Ketotifen,Vildagliptin,The risk or severity of thrombocytopenia can be increased when Vildagliptin is combined with Ketotifen.,increase,risk
Buprenorphine,Betamethasone,The metabolism of Buprenorphine can be increased when combined with Betamethasone.,increase,no risk
Buprenorphine,Betamethasone phosphate,The metabolism of Buprenorphine can be increased when combined with Betamethasone phosphate.,increase,no risk
Buprenorphine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Bexarotene,The metabolism of Buprenorphine can be decreased when combined with Bexarotene.,decrease,no risk
Buprenorphine,Bezafibrate,The metabolism of Buprenorphine can be decreased when combined with Bezafibrate.,decrease,no risk
Buprenorphine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Bimekizumab,The metabolism of Buprenorphine can be increased when combined with Bimekizumab.,increase,no risk
Buprenorphine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Buprenorphine.,increase,risk
Buprenorphine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Boceprevir,The serum concentration of Buprenorphine can be increased when it is combined with Boceprevir.,increase,no risk
Buprenorphine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Bosentan,The metabolism of Buprenorphine can be increased when combined with Bosentan.,increase,no risk
Buprenorphine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Botulinum toxin type A,Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Botulinum toxin type B,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Brexanolone,Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brexpiprazole,Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brivaracetam,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bromazepam,Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bromotheophylline,The therapeutic efficacy of Bromotheophylline can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Buprenorphine.,increase,risk
Buprenorphine,Budesonide,The metabolism of Buprenorphine can be increased when combined with Budesonide.,increase,no risk
Buprenorphine,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Bupivacaine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Bupropion,Bupropion may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Buspirone,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Busulfan,The metabolism of Busulfan can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butorphanol,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butriptyline,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Buprenorphine.,increase,risk
Buprenorphine,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Galantamine,The metabolism of Galantamine can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Gefitinib,Buprenorphine may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Buprenorphine,Gemfibrozil,The metabolism of Buprenorphine can be decreased when combined with Gemfibrozil.,decrease,no risk
Buprenorphine,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Ginkgo biloba,The metabolism of Buprenorphine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Buprenorphine,Givosiran,The serum concentration of Buprenorphine can be increased when it is combined with Givosiran.,increase,no risk
Buprenorphine,Glasdegib,Buprenorphine may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Buprenorphine,Glecaprevir,Buprenorphine may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Buprenorphine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Glimepiride,The metabolism of Buprenorphine can be decreased when combined with Glimepiride.,decrease,no risk
Buprenorphine,Glipizide,The metabolism of Glipizide can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Glofitamab,The serum concentration of Buprenorphine can be increased when it is combined with Glofitamab.,increase,no risk
Buprenorphine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Glyburide,Buprenorphine may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Buprenorphine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Glycerol phenylbutyrate,The metabolism of Buprenorphine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Buprenorphine,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Buprenorphine.,increase,risk
Buprenorphine,Golimumab,The metabolism of Buprenorphine can be increased when combined with Golimumab.,increase,no risk
Buprenorphine,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Halofantrine,The metabolism of Buprenorphine can be decreased when combined with Halofantrine.,decrease,no risk
Buprenorphine,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Buprenorphine.,increase,risk
Buprenorphine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Buprenorphine.,increase,risk
Buprenorphine,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocodone,The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone,The metabolism of Buprenorphine can be increased when combined with Hydrocortisone.,increase,no risk
Buprenorphine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Buprenorphine,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Buprenorphine.,decrease,no risk
Buprenorphine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Buprenorphine.,increase,risk
Buprenorphine,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Buprenorphine,Ketoconazole,The metabolism of Buprenorphine can be decreased when combined with Ketoconazole.,decrease,no risk
Buprenorphine,Ketoprofen,The metabolism of Buprenorphine can be decreased when combined with Ketoprofen.,decrease,no risk
Buprenorphine,Ketorolac,The metabolism of Buprenorphine can be decreased when combined with Ketorolac.,decrease,no risk
Levosimendan,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Levosimendan.,increase,risk
Levosimendan,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Levosimendan.,increase,risk
Levosimendan,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Levosimendan.,increase,risk
Levosimendan,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Gemifloxacin.,increase,risk
Levosimendan,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Levosimendan.,increase,risk
Levosimendan,Gilteritinib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Gilteritinib.,increase,risk
Levosimendan,Glasdegib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Glasdegib.,increase,risk
Levosimendan,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levosimendan.,increase,risk
Levosimendan,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Levosimendan.,increase,risk
Levosimendan,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Grepafloxacin.,increase,risk
Levosimendan,Guanabenz,Levosimendan may increase the hypotensive activities of Guanabenz.,increase,no risk
Levosimendan,Guanadrel,Levosimendan may increase the hypotensive activities of Guanadrel.,increase,no risk
Levosimendan,Guanethidine,Levosimendan may increase the hypotensive activities of Guanethidine.,increase,no risk
Levosimendan,Guanfacine,The risk or severity of adverse effects can be increased when Levosimendan is combined with Guanfacine.,increase,risk
Levosimendan,Guanoxan,Levosimendan may increase the hypotensive activities of Guanoxan.,increase,no risk
Levosimendan,Halofantrine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Halofantrine.,increase,risk
Levosimendan,Haloperidol,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Haloperidol.,increase,risk
Levosimendan,Halothane,The risk or severity of adverse effects can be increased when Levosimendan is combined with Halothane.,increase,risk
Levosimendan,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Levosimendan.,increase,risk
Levosimendan,Hydralazine,The risk or severity of adverse effects can be increased when Levosimendan is combined with Hydralazine.,increase,risk
Levosimendan,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Levosimendan.,increase,risk
Levosimendan,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Levosimendan.,increase,risk
Levosimendan,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Levosimendan.,increase,risk
Levosimendan,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Hydroxyzine.,increase,risk
Levosimendan,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Levosimendan.,increase,risk
Levosimendan,Obinutuzumab,The risk or severity of adverse effects can be increased when Levosimendan is combined with Obinutuzumab.,increase,risk
Levosimendan,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Levosimendan.,increase,risk
Levosimendan,Ofloxacin,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ofloxacin.,increase,risk
Levosimendan,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Levosimendan.,increase,risk
Levosimendan,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Levosimendan.,increase,risk
Levosimendan,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Levosimendan.,increase,risk
Levosimendan,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levosimendan.,increase,risk
Levosimendan,Opicapone,The risk or severity of adverse effects can be increased when Levosimendan is combined with Opicapone.,increase,risk
Levosimendan,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Levosimendan.,increase,risk
Levosimendan,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Levosimendan.,increase,risk
Levosimendan,Oxatomide,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Oxatomide.,increase,risk
Levosimendan,Oxprenolol,Levosimendan may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Levosimendan,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Levosimendan.,increase,risk
Levosimendan,Quetiapine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quetiapine.,increase,risk
Levosimendan,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Levosimendan.,increase,risk
Levosimendan,Quinidine,Quinidine may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Quinine,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quinine.,increase,risk
Levosimendan,Quizartinib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Quizartinib.,increase,risk
Levosimendan,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Levosimendan.,increase,risk
Levosimendan,Valproic acid,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Valproic acid.,increase,risk
Levosimendan,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Levosimendan.,increase,risk
Levosimendan,Vandetanib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Vandetanib.,increase,risk
Levosimendan,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Levosimendan.,increase,risk
Levosimendan,Vemurafenib,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Vemurafenib.,increase,risk
Levosimendan,Verapamil,Verapamil may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Vericiguat,The risk or severity of adverse effects can be increased when Levosimendan is combined with Vericiguat.,increase,risk
Levosimendan,Vernakalant,Levosimendan may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Levosimendan,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Levosimendan.,increase,risk
Levosimendan,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Levosimendan.,increase,risk
Levosimendan,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Levosimendan.,increase,risk
Levosimendan,Xylometazoline,Levosimendan may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Levosimendan,Ziconotide,Levosimendan may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Levosimendan,Ziprasidone,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Ziprasidone.,increase,risk
Levosimendan,Zofenopril,Levosimendan may increase the hypotensive activities of Zofenopril.,increase,no risk
Levosimendan,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Levosimendan.,increase,no risk
Levosimendan,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Zuclopenthixol.,increase,risk
Ceforanide,Gabapentin enacarbil,Ceforanide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadobenic acid,Ceforanide may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadodiamide,Ceforanide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadofosveset trisodium,Ceforanide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadopentetic acid,Ceforanide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadoteric acid,Ceforanide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceforanide,Gadoteridol,Ceforanide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ceforanide,Ganciclovir,Ceforanide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ceforanide,Gemcitabine,Ceforanide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ceforanide,Gemfibrozil,Ceforanide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ceforanide,Gentamicin,Ceforanide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceforanide,Gimeracil,Ceforanide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceforanide,Givosiran,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Givosiran.,increase,risk
Ceforanide,Glipizide,Ceforanide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ceforanide,Glycerol phenylbutyrate,Ceforanide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ceforanide,Golodirsen,Ceforanide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceforanide,Goserelin,Ceforanide may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ceforanide,Guanethidine,Ceforanide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ceforanide,Guanfacine,Ceforanide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ceforanide,Haloperidol,Ceforanide may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ceforanide,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Hydralazine,Ceforanide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ceforanide,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Hydrochlorothiazide.,increase,risk
Ceforanide,Hydromorphone,Ceforanide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ceforanide,Hydroxocobalamin,Ceforanide may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ceforanide,Hydroxyethyl Starch,Ceforanide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceforanide,Kanamycin,Ceforanide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceforanide,Ketamine,Ceforanide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ceforanide,Ketazolam,Ceforanide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ceforanide,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Ketoprofen.,increase,risk
Ceforanide,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Ceforanide.,increase,risk
Ceforanide,Octinoxate,Ceforanide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceforanide,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Olsalazine.,increase,risk
Ceforanide,Opium,Ceforanide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceforanide,Oseltamivir,Ceforanide may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxacillin,Ceforanide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ceforanide.,increase,risk
Ceforanide,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Oxaprozin.,increase,risk
Ceforanide,Oxazepam,Ceforanide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceforanide is combined with Oxetacaine.,increase,risk
Ceforanide,Oxybenzone,Ceforanide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ceforanide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceforanide is combined with Oxybuprocaine.,increase,risk
Ceforanide,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Oxyphenbutazone.,increase,risk
Ceforanide,Oxyquinoline,Ceforanide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceforanide,Quetiapine,Ceforanide may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ceforanide,Quinidine,Ceforanide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ceforanide,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Vaborbactam,Ceforanide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ceforanide,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Ceforanide.,increase,risk
Ceforanide,Valbenazine,Ceforanide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ceforanide,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Ceforanide.,increase,risk
Ceforanide,Valganciclovir,Ceforanide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ceforanide,Vancomycin,Ceforanide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ceforanide,Varenicline,Ceforanide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ceforanide,Venlafaxine,Ceforanide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Ceforanide,Verapamil,Ceforanide may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ceforanide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Vilanterol,Ceforanide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ceforanide,Viloxazine,Ceforanide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ceforanide,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Vortioxetine,Ceforanide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ceforanide,Warfarin,Ceforanide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ceforanide,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ceforanide.,decrease,no risk
Ceforanide,Zaleplon,Ceforanide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ceforanide,Zanamivir,Ceforanide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ceforanide,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceforanide is combined with Zoledronic acid.,increase,risk
Ceforanide,Zonisamide,Ceforanide may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Cyclobenzaprine,Gabapentin,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gabapentin.,increase,risk
Cyclobenzaprine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gabapentin enacarbil.,increase,risk
Cyclobenzaprine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gallamine triethiodide.,increase,risk
Cyclobenzaprine,Ganaxolone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ganaxolone.,increase,risk
Cyclobenzaprine,Gatifloxacin,The metabolism of Cyclobenzaprine can be decreased when combined with Gatifloxacin.,decrease,no risk
Cyclobenzaprine,Gemfibrozil,The metabolism of Cyclobenzaprine can be decreased when combined with Gemfibrozil.,decrease,no risk
Cyclobenzaprine,Gemifloxacin,The metabolism of Cyclobenzaprine can be decreased when combined with Gemifloxacin.,decrease,no risk
Cyclobenzaprine,Gepirone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Gepirone.,increase,risk
Cyclobenzaprine,Gilteritinib,The therapeutic efficacy of Cyclobenzaprine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cyclobenzaprine,Givosiran,The serum concentration of Cyclobenzaprine can be increased when it is combined with Givosiran.,increase,no risk
Cyclobenzaprine,Glofitamab,The serum concentration of Cyclobenzaprine can be increased when it is combined with Glofitamab.,increase,no risk
Cyclobenzaprine,Glutethimide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Glutethimide.,increase,risk
Cyclobenzaprine,Golimumab,The metabolism of Cyclobenzaprine can be increased when combined with Golimumab.,increase,no risk
Cyclobenzaprine,Granisetron,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Granisetron.,increase,risk
Cyclobenzaprine,Grepafloxacin,The metabolism of Cyclobenzaprine can be decreased when combined with Grepafloxacin.,decrease,no risk
Cyclobenzaprine,Guanabenz,The metabolism of Cyclobenzaprine can be decreased when combined with Guanabenz.,decrease,no risk
Cyclobenzaprine,Guanfacine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Guanfacine.,increase,risk
Cyclobenzaprine,Halazepam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Halazepam.,increase,risk
Cyclobenzaprine,Haloperidol,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Haloperidol.,increase,risk
Cyclobenzaprine,Halothane,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Halothane.,increase,risk
Cyclobenzaprine,Hexafluronium,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Hexafluronium.,increase,risk
Cyclobenzaprine,Hydrocodone,Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cyclobenzaprine,Hydromorphone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Hydromorphone.,increase,risk
Cyclobenzaprine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Cyclobenzaprine.,increase,risk
Cyclobenzaprine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cyclobenzaprine.,increase,no risk
Cyclobenzaprine,Ketamine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ketamine.,increase,risk
Cyclobenzaprine,Ketazolam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ketazolam.,increase,risk
Cyclobenzaprine,Ketoconazole,The metabolism of Cyclobenzaprine can be decreased when combined with Ketoconazole.,decrease,no risk
Cyclobenzaprine,Obeticholic acid,The metabolism of Cyclobenzaprine can be decreased when combined with Obeticholic acid.,decrease,no risk
Cyclobenzaprine,Olanzapine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Olanzapine.,increase,risk
Cyclobenzaprine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cyclobenzaprine is combined with Oliceridine.",increase,risk
Cyclobenzaprine,Omaveloxolone,The serum concentration of Cyclobenzaprine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cyclobenzaprine,Ondansetron,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ondansetron.,increase,risk
Cyclobenzaprine,Opium,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Opium.,increase,risk
Cyclobenzaprine,Orphenadrine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Orphenadrine.,increase,risk
Cyclobenzaprine,Osilodrostat,The metabolism of Cyclobenzaprine can be decreased when combined with Osilodrostat.,decrease,no risk
Cyclobenzaprine,Osimertinib,The serum concentration of Cyclobenzaprine can be decreased when it is combined with Osimertinib.,decrease,no risk
Cyclobenzaprine,Oxazepam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxazepam.,increase,risk
Cyclobenzaprine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxcarbazepine.,increase,risk
Cyclobenzaprine,Oxitriptan,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxitriptan.,increase,risk
Cyclobenzaprine,Oxprenolol,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxprenolol.,increase,risk
Cyclobenzaprine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Cyclobenzaprine.,decrease,no risk
Cyclobenzaprine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxybuprocaine.,increase,risk
Cyclobenzaprine,Oxycodone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxycodone.,increase,risk
Cyclobenzaprine,Oxymorphone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Oxymorphone.,increase,risk
Cyclobenzaprine,Quazepam,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quazepam.,increase,risk
Cyclobenzaprine,Quetiapine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quetiapine.,increase,risk
Cyclobenzaprine,Quinidine,The metabolism of Cyclobenzaprine can be decreased when combined with Quinidine.,decrease,no risk
Cyclobenzaprine,Quinine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quinine.,increase,risk
Cyclobenzaprine,Quinupramine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Quinupramine.,increase,risk
Cyclobenzaprine,Urethane,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Urethane.,increase,risk
Cyclobenzaprine,Vadadustat,The serum concentration of Cyclobenzaprine can be increased when it is combined with Vadadustat.,increase,no risk
Cyclobenzaprine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Cyclobenzaprine is combined with Valproate bismuth.,increase,risk
Cyclobenzaprine,Valproic acid,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Valproic acid.,increase,risk
Cyclobenzaprine,Vecuronium,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vecuronium.,increase,risk
Cyclobenzaprine,Vemurafenib,The serum concentration of Cyclobenzaprine can be increased when it is combined with Vemurafenib.,increase,no risk
Cyclobenzaprine,Venetoclax,The metabolism of Cyclobenzaprine can be decreased when combined with Venetoclax.,decrease,no risk
Cyclobenzaprine,Venlafaxine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Venlafaxine.,increase,risk
Cyclobenzaprine,Verapamil,The metabolism of Cyclobenzaprine can be decreased when combined with Verapamil.,decrease,no risk
Cyclobenzaprine,Vigabatrin,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vigabatrin.,increase,risk
Cyclobenzaprine,Vilazodone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vilazodone.,increase,risk
Cyclobenzaprine,Viloxazine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Viloxazine.,increase,risk
Cyclobenzaprine,Vincristine,Vincristine may increase the neurotoxic activities of Cyclobenzaprine.,increase,no risk
Cyclobenzaprine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Cyclobenzaprine.,increase,no risk
Cyclobenzaprine,Viomycin,Cyclobenzaprine may increase the neurotoxic activities of Viomycin.,increase,no risk
Cyclobenzaprine,Voriconazole,The metabolism of Cyclobenzaprine can be decreased when combined with Voriconazole.,decrease,no risk
Cyclobenzaprine,Vortioxetine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Vortioxetine.,increase,risk
Cyclobenzaprine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Cyclobenzaprine.,decrease,no risk
Cyclobenzaprine,Warfarin,The metabolism of Cyclobenzaprine can be decreased when combined with Warfarin.,decrease,no risk
Cyclobenzaprine,Yohimbine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Yohimbine.,increase,risk
Cyclobenzaprine,Zaleplon,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zaleplon.,increase,risk
Cyclobenzaprine,Ziconotide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ziconotide.,increase,risk
Cyclobenzaprine,Zileuton,The metabolism of Cyclobenzaprine can be decreased when combined with Zileuton.,decrease,no risk
Cyclobenzaprine,Zimelidine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zimelidine.,increase,risk
Cyclobenzaprine,Ziprasidone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ziprasidone.,increase,risk
Cyclobenzaprine,Zolmitriptan,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zolmitriptan.,increase,risk
Cyclobenzaprine,Zolpidem,Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cyclobenzaprine,Zonisamide,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zonisamide.,increase,risk
Cyclobenzaprine,Zopiclone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zopiclone.,increase,risk
Cyclobenzaprine,Zotepine,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zotepine.,increase,risk
Cyclobenzaprine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zuclopenthixol.,increase,risk
Cyclobenzaprine,Zuranolone,The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zuranolone.,increase,risk
Phenoxybenzamine,Ganciclovir,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Ganciclovir.,increase,risk
Phenoxybenzamine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Glycol salicylate,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Phenoxybenzamine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Guanadrel,Phenoxybenzamine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Phenoxybenzamine,Guanethidine,Phenoxybenzamine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Phenoxybenzamine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Guanoxan,Phenoxybenzamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Phenoxybenzamine,Halothane,Halothane may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Histamine,The serum concentration of Histamine can be increased when it is combined with Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Hydralazine,Phenoxybenzamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Phenoxybenzamine,Hydrochlorothiazide,The therapeutic efficacy of Phenoxybenzamine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Phenoxybenzamine,Hydroflumethiazide,The therapeutic efficacy of Phenoxybenzamine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Phenoxybenzamine,Ketoprofen,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Phenoxybenzamine,Ketorolac,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Ketorolac.,decrease,no risk
Phenoxybenzamine,Obinutuzumab,Phenoxybenzamine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Phenoxybenzamine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.",increase,no risk
Phenoxybenzamine,Olmesartan,Phenoxybenzamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Phenoxybenzamine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Opicapone,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Opicapone.,increase,risk
Phenoxybenzamine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Oxaprozin,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Phenoxybenzamine,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Oxymetazoline,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Phenoxybenzamine,Oxyphenbutazone,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Phenoxybenzamine,Quetiapine,Quetiapine may increase the hypotensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Quinapril,Phenoxybenzamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Phenoxybenzamine,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.",increase,no risk
Phenoxybenzamine,Quinine,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Quinine.,increase,risk
Phenoxybenzamine,Quinupramine,Quinupramine may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Phenoxybenzamine.,increase,risk
Phenoxybenzamine,Unoprostone,Phenoxybenzamine may increase the hypotensive activities of Unoprostone.,increase,no risk
Phenoxybenzamine,Valdecoxib,The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Valdecoxib.,decrease,no risk
Phenoxybenzamine,Valsartan,Phenoxybenzamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Phenoxybenzamine,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Phenoxybenzamine.,increase,risk
Phenoxybenzamine,Varenicline,The excretion of Varenicline can be decreased when combined with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Verapamil,The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Verapamil.,increase,risk
Phenoxybenzamine,Vericiguat,The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Vericiguat.,increase,risk
Phenoxybenzamine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Vilazodone,Vilazodone may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Yohimbine,Yohimbine may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Ziconotide,The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Ziconotide.,increase,risk
Phenoxybenzamine,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Phenoxybenzamine.,increase,no risk
Phenoxybenzamine,Zofenopril,Phenoxybenzamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Phenoxybenzamine,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Phenoxybenzamine.,decrease,no risk
Phenoxybenzamine,Zonisamide,The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Zonisamide.,increase,risk
Phenoxybenzamine,Zuclopenthixol,"Phenoxybenzamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Etretinate,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Etretinate.,decrease,no risk
Etretinate,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Etretinate is combined with Omadacycline.,increase,risk
Etretinate,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Etretinate is combined with Oxytetracycline.,increase,risk
Etretinate,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Etretinate.,increase,no risk
Etretinate,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Etretinate.,increase,risk
Famotidine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gadobenic acid.,increase,risk
Famotidine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Famotidine.,increase,risk
Famotidine,Ganciclovir,The excretion of Famotidine can be decreased when combined with Ganciclovir.,decrease,no risk
Famotidine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gatifloxacin.,increase,risk
Famotidine,Gefitinib,Famotidine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Gemfibrozil,The excretion of Famotidine can be decreased when combined with Gemfibrozil.,decrease,no risk
Famotidine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gemifloxacin.,increase,risk
Famotidine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Famotidine.,increase,risk
Famotidine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Gilteritinib.,increase,risk
Famotidine,Glasdegib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Glasdegib.,increase,risk
Famotidine,Goserelin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Goserelin.,increase,risk
Famotidine,Granisetron,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Granisetron.,increase,risk
Famotidine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Grepafloxacin.,increase,risk
Famotidine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Guanidine,The excretion of Famotidine can be decreased when combined with Guanidine.,decrease,no risk
Famotidine,Halofantrine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Halofantrine.,increase,risk
Famotidine,Haloperidol,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Haloperidol.,increase,risk
Famotidine,Histamine,The serum concentration of Histamine can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Histrelin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Histrelin.,increase,risk
Famotidine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Famotidine.,decrease,no risk
Famotidine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Famotidine.,decrease,no risk
Famotidine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Famotidine.,decrease,no risk
Famotidine,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Hydroxychloroquine.,increase,risk
Famotidine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Hydroxyzine.,increase,risk
Famotidine,Hyoscyamine,Famotidine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Famotidine,Ketoconazole,Famotidine can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Ketoprofen,The excretion of Famotidine can be decreased when combined with Ketoprofen.,decrease,no risk
Famotidine,Octreotide,Famotidine can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ofloxacin.,increase,risk
Famotidine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Famotidine.,increase,risk
Famotidine,Olodaterol,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Olodaterol.,increase,risk
Famotidine,Ondansetron,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ondansetron.,increase,risk
Famotidine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Orphenadrine.,increase,risk
Famotidine,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Oteseconazole,Famotidine can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Ouabain,The excretion of Famotidine can be decreased when combined with Ouabain.,decrease,no risk
Famotidine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Famotidine.,increase,risk
Famotidine,Oxatomide,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Oxatomide.,increase,risk
Famotidine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Oxytetracycline,The excretion of Famotidine can be decreased when combined with Oxytetracycline.,decrease,no risk
Famotidine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Famotidine.,increase,risk
Famotidine,Quetiapine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quetiapine.,increase,risk
Famotidine,Quinapril,The excretion of Quinapril can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Quinidine,The excretion of Famotidine can be decreased when combined with Quinidine.,decrease,no risk
Famotidine,Quinine,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quinine.,increase,risk
Famotidine,Quizartinib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Quizartinib.,increase,risk
Famotidine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Famotidine.,increase,no risk
Famotidine,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Valproic acid,The excretion of Valproic acid can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Vandetanib,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vandetanib.,increase,risk
Famotidine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Famotidine.,increase,risk
Famotidine,Varenicline,The excretion of Varenicline can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Famotidine.,increase,risk
Famotidine,Verapamil,The metabolism of Verapamil can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Vernakalant,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vernakalant.,increase,risk
Famotidine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Famotidine.,increase,risk
Famotidine,Voriconazole,Famotidine can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Famotidine,Vorinostat,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Vorinostat.,increase,risk
Famotidine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Warfarin,The metabolism of Warfarin can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zidovudine,The excretion of Famotidine can be decreased when combined with Zidovudine.,decrease,no risk
Famotidine,Zileuton,The metabolism of Zileuton can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ziprasidone.,increase,risk
Famotidine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Famotidine.,increase,risk
Famotidine,Zotepine,The metabolism of Zotepine can be decreased when combined with Famotidine.,decrease,no risk
Famotidine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Famotidine is combined with Zuclopenthixol.,increase,risk
Azacitidine,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Azacitidine.,increase,risk
Azacitidine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Azacitidine.,increase,risk
Azacitidine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Azacitidine.,increase,risk
Azacitidine,Bicisate,Azacitidine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Azacitidine,Bimekizumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Bimekizumab.,increase,risk
Azacitidine,Bismuth subgallate,Azacitidine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Azacitidine,Bisoprolol,Bisoprolol may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Bisoxatin,Azacitidine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Azacitidine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Azacitidine.,increase,risk
Azacitidine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Azacitidine.,increase,risk
Azacitidine,Blinatumomab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Blinatumomab.,increase,risk
Azacitidine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Azacitidine.",decrease,no risk
Azacitidine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Azacitidine.,increase,risk
Azacitidine,Bosutinib,The risk or severity of adverse effects can be increased when Azacitidine is combined with Bosutinib.,increase,risk
Azacitidine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Azacitidine is combined with Brentuximab vedotin.,increase,risk
Azacitidine,Brivaracetam,Azacitidine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Azacitidine,Brodalumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Brodalumab.,increase,risk
Azacitidine,Bromazepam,Azacitidine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Azacitidine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Budesonide,The risk or severity of adverse effects can be increased when Azacitidine is combined with Budesonide.,increase,risk
Azacitidine,Bumadizone,Bumadizone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Bumetanide,Bumetanide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Bupivacaine.,increase,risk
Azacitidine,Bupropion,Azacitidine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Azacitidine,Buspirone,Buspirone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Busulfan,The risk or severity of adverse effects can be increased when Azacitidine is combined with Busulfan.,increase,risk
Azacitidine,Butabarbital,Butabarbital may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Butacaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Butacaine.,increase,risk
Azacitidine,Butamben,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Butamben.,increase,risk
Azacitidine,Gabapentin enacarbil,Azacitidine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadodiamide,Gadodiamide may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadofosveset trisodium,Azacitidine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadoteric acid,Azacitidine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Azacitidine,Gadoteridol,Gadoteridol may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Ganciclovir,Azacitidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Azacitidine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Azacitidine.,increase,risk
Azacitidine,Gemfibrozil,Azacitidine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Azacitidine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Azacitidine.,increase,risk
Azacitidine,Gentamicin,Azacitidine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Azacitidine,Gimeracil,Azacitidine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Azacitidine,Givosiran,Givosiran may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Glatiramer,The risk or severity of adverse effects can be increased when Azacitidine is combined with Glatiramer.,increase,risk
Azacitidine,Glipizide,Azacitidine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Azacitidine,Glycerol phenylbutyrate,Azacitidine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Azacitidine,Golimumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Golimumab.,increase,risk
Azacitidine,Golodirsen,Azacitidine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Azacitidine,Goserelin,Goserelin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Guanethidine,Azacitidine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Guanfacine,Azacitidine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Azacitidine,Guselkumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Guselkumab.,increase,risk
Azacitidine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Haloperidol,Haloperidol may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Azacitidine.,increase,risk
Azacitidine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Azacitidine.,increase,risk
Azacitidine,Hydralazine,Azacitidine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydrocortisone acetate.,increase,risk
Azacitidine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydrocortisone butyrate.,increase,risk
Azacitidine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydrocortisone succinate.,increase,risk
Azacitidine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azacitidine,Hydromorphone,Hydromorphone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydroxychloroquine.,increase,risk
Azacitidine,Hydroxyethyl Starch,Azacitidine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Azacitidine,Hydroxyurea,The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydroxyurea.,increase,risk
Azacitidine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Azacitidine.,decrease,no risk
Azacitidine,Kanamycin,Azacitidine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketamine,Azacitidine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketazolam,Azacitidine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketoprofen,Ketoprofen may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Ketorolac,Ketorolac may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Obinutuzumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Obinutuzumab.,increase,risk
Azacitidine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Azacitidine.,increase,no risk
Azacitidine,Octinoxate,Azacitidine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Azacitidine,Ofatumumab,The risk or severity of adverse effects can be increased when Azacitidine is combined with Ofatumumab.,increase,risk
Azacitidine,Olaparib,The risk or severity of adverse effects can be increased when Azacitidine is combined with Olaparib.,increase,risk
Azacitidine,Olsalazine,Olsalazine may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Opium,Azacitidine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Azacitidine,Oseltamivir,Oseltamivir may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxacillin,Oxacillin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Azacitidine.,increase,risk
Azacitidine,Oxaprozin,Oxaprozin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxazepam,Oxazepam may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Oxetacaine.,increase,risk
Azacitidine,Oxybenzone,Azacitidine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Oxybuprocaine.,increase,risk
Azacitidine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Azacitidine which could result in a higher serum level.,decrease,no risk
Azacitidine,Oxyquinoline,Azacitidine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Azacitidine,Ozanimod,The risk or severity of adverse effects can be increased when Azacitidine is combined with Ozanimod.,increase,risk
Misoprostol,Hydrotalcite,The risk or severity of adverse effects can be increased when Hydrotalcite is combined with Misoprostol.,increase,risk
Misoprostol,Oxytocin,The risk or severity of adverse effects can be increased when Misoprostol is combined with Oxytocin.,increase,risk
Colesevelam,Ketorolac,Colesevelam can cause a decrease in the absorption of Ketorolac resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Obeticholic acid,Colesevelam can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Odevixibat,The therapeutic efficacy of Odevixibat can be decreased when used in combination with Colesevelam.,decrease,no risk
Colesevelam,Olmesartan,Colesevelam can cause a decrease in the absorption of Olmesartan resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Omadacycline,Colesevelam can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Ouabain,Colesevelam can cause a decrease in the absorption of Ouabain resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Oxaprozin,Colesevelam can cause a decrease in the absorption of Oxaprozin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Oxyphenbutazone,Colesevelam can cause a decrease in the absorption of Oxyphenbutazone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Oxytetracycline,Colesevelam can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Quinethazone,Colesevelam can cause a decrease in the absorption of Quinethazone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Udenafil,Colesevelam can cause a decrease in the absorption of Udenafil resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Ursodeoxycholic acid,Colesevelam can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Valdecoxib,Colesevelam can cause a decrease in the absorption of Valdecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Vancomycin,The therapeutic efficacy of Vancomycin can be decreased when used in combination with Colesevelam.,decrease,no risk
Colesevelam,Vemurafenib,Colesevelam can cause a decrease in the absorption of Vemurafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Vitamin D,The serum concentration of Vitamin D can be decreased when it is combined with Colesevelam.,decrease,no risk
Colesevelam,Warfarin,Colesevelam can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colesevelam,Zonisamide,Colesevelam can cause a decrease in the absorption of Zonisamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Metacycline.,increase,no risk
Metacycline,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Metacycline.,increase,risk
Metacycline,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Hetacillin,The therapeutic efficacy of Hetacillin can be decreased when used in combination with Metacycline.,decrease,no risk
Metacycline,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Kanamycin.,increase,risk
Metacycline,Oxacillin,The therapeutic efficacy of Oxacillin can be decreased when used in combination with Metacycline.,decrease,no risk
Metacycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Metacycline is combined with Oxetacaine.,increase,risk
Metacycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Metacycline is combined with Oxybuprocaine.,increase,risk
Metacycline,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Metacycline.,increase,risk
Metacycline,Quinapril,Quinapril can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Quinidine,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Metacycline.,increase,risk
Metacycline,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Metacycline.,increase,risk
Metacycline,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Metacycline.,decrease,no risk
Metacycline,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Metacycline.,increase,risk
Metacycline,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Metacycline.,increase,no risk
Metacycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Metacycline.,decrease,no risk
Metacycline,Viomycin,The risk or severity of neuromuscular blockade can be increased when Metacycline is combined with Viomycin.,increase,risk
Metacycline,Vitamin A,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Metacycline.,increase,risk
Metacycline,Warfarin,Metacycline may increase the anticoagulant activities of Warfarin.,increase,no risk
Metacycline,Zinc,Zinc can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metacycline,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Tipranavir,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bepridil,"The risk or severity of QTc prolongation, torsade de pointes, and Cardiac Arrhythmia can be increased when Tipranavir is combined with Bepridil.",increase,risk
Tipranavir,Berotralstat,The serum concentration of Berotralstat can be decreased when it is combined with Tipranavir.,decrease,no risk
Tipranavir,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Bexagliflozin,The metabolism of Bexagliflozin can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bimekizumab,The metabolism of Tipranavir can be increased when combined with Bimekizumab.,increase,no risk
Tipranavir,Binimetinib,The serum concentration of Binimetinib can be decreased when it is combined with Tipranavir.,decrease,no risk
Tipranavir,Biperiden,The metabolism of Tipranavir can be decreased when combined with Biperiden.,decrease,no risk
Tipranavir,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tipranavir,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Bivalirudin.,increase,risk
Tipranavir,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Budesonide,The metabolism of Budesonide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Bupropion,The metabolism of Tipranavir can be decreased when combined with Bupropion.,decrease,no risk
Tipranavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Busulfan,The metabolism of Busulfan can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Garlic,Garlic can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tipranavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gemcitabine,The serum concentration of Gemcitabine can be decreased when it is combined with Tipranavir.,decrease,no risk
Tipranavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Givosiran,The serum concentration of Tipranavir can be increased when it is combined with Givosiran.,increase,no risk
Tipranavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Glimepiride,Tipranavir may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Tipranavir,Glipizide,Tipranavir may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Tipranavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Glofitamab,The serum concentration of Tipranavir can be increased when it is combined with Glofitamab.,increase,no risk
Tipranavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Glycerol phenylbutyrate,The metabolism of Tipranavir can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Tipranavir,Glycyrrhizic acid,Tipranavir may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Tipranavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Golimumab,The metabolism of Tipranavir can be increased when combined with Golimumab.,increase,no risk
Tipranavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Heparin.,increase,risk
Tipranavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Tipranavir.,decrease,no risk
Tipranavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tipranavir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ketoprofen,The metabolism of Ketoprofen can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Obeticholic acid,The risk or severity of adverse effects can be increased when Tipranavir is combined with Obeticholic acid.,increase,risk
Tipranavir,Ofloxacin,Tipranavir may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Tipranavir,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Olaparib,The metabolism of Olaparib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Olmesartan,Olmesartan may decrease the excretion rate of Tipranavir which could result in a higher serum level.,decrease,no risk
Tipranavir,Olutasidenib,The therapeutic efficacy of Tipranavir can be decreased when used in combination with Olutasidenib.,decrease,no risk
Tipranavir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Omeprazole,The metabolism of Omeprazole can be increased when combined with Tipranavir.,increase,no risk
Tipranavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Opium,The metabolism of Opium can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oritavancin,The metabolism of Tipranavir can be decreased when combined with Oritavancin.,decrease,no risk
Tipranavir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Ouabain,The excretion of Ouabain can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxamniquine,The metabolism of Tipranavir can be decreased when combined with Oxamniquine.,decrease,no risk
Tipranavir,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Quazepam,The metabolism of Quazepam can be decreased when combined with Tipranavir.,decrease,no risk
Tipranavir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Tipranavir.,increase,no risk
Tipranavir,Quinidine,The risk or severity of torsade de pointes and Cardiac Arrhythmia can be increased when Tipranavir is combined with Quinidine.,increase,risk
Tipranavir,Quinine,The risk or severity of torsade de pointes and Cardiac Arrhythmia can be increased when Tipranavir is combined with Quinine.,increase,risk
Tipranavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Tipranavir.,increase,no risk
Mesoridazine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Mesoridazine.,increase,risk
Mesoridazine,Buprenorphine,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Mesoridazine,Bupropion,The metabolism of Mesoridazine can be decreased when combined with Bupropion.,decrease,no risk
Mesoridazine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mesoridazine.,increase,risk
Mesoridazine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Mesoridazine.,increase,risk
Mesoridazine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Mesoridazine.,increase,risk
Mesoridazine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Mesoridazine.,increase,risk
Mesoridazine,Butaperazine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Butaperazine.,increase,risk
Mesoridazine,Butobarbital,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Butobarbital.,increase,risk
Mesoridazine,Butorphanol,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Butorphanol.,increase,risk
Mesoridazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Gabapentin,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Gabapentin.,increase,risk
Mesoridazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Gabapentin enacarbil.,increase,risk
Mesoridazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Mesoridazine.,increase,risk
Mesoridazine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Mesoridazine.,increase,risk
Mesoridazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Mesoridazine.,increase,risk
Mesoridazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Mesoridazine is combined with Ganaxolone.",increase,risk
Mesoridazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mesoridazine.,increase,risk
Mesoridazine,Gefitinib,The metabolism of Mesoridazine can be decreased when combined with Gefitinib.,decrease,no risk
Mesoridazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Gemifloxacin.,increase,risk
Mesoridazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Mesoridazine.,increase,risk
Mesoridazine,Gilteritinib,The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Mesoridazine,Givosiran,The serum concentration of Mesoridazine can be increased when it is combined with Givosiran.,increase,no risk
Mesoridazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Glasdegib.,increase,risk
Mesoridazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glutethimide,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Glutethimide.,increase,risk
Mesoridazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Glycerol phenylbutyrate,The metabolism of Mesoridazine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Mesoridazine,Golimumab,The metabolism of Mesoridazine can be increased when combined with Golimumab.,increase,no risk
Mesoridazine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mesoridazine.,increase,risk
Mesoridazine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Mesoridazine.,increase,risk
Mesoridazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Grepafloxacin.,increase,risk
Mesoridazine,Guanfacine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Guanfacine.,increase,risk
Mesoridazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Mesoridazine.,increase,risk
Mesoridazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Mesoridazine.,increase,risk
Mesoridazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Haloperidol.,increase,risk
Mesoridazine,Halothane,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Halothane.,increase,risk
Mesoridazine,Hexafluronium,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Hexafluronium.,increase,risk
Mesoridazine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mesoridazine.,increase,risk
Mesoridazine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Mesoridazine.,increase,risk
Mesoridazine,Hydrocodone,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Mesoridazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Hydromorphone.,increase,risk
Mesoridazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mesoridazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Mesoridazine.,increase,risk
Mesoridazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Hydroxyzine.,increase,risk
Mesoridazine,Hyoscyamine,Mesoridazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Mesoridazine,Ketamine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Ketamine.,increase,risk
Mesoridazine,Ketazolam,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Ketazolam.,increase,risk
Mesoridazine,Ketoconazole,The metabolism of Mesoridazine can be decreased when combined with Ketoconazole.,decrease,no risk
Mesoridazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mesoridazine.,increase,risk
Mesoridazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ofloxacin.,increase,risk
Mesoridazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Mesoridazine.,increase,risk
Mesoridazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mesoridazine is combined with Oliceridine.",increase,risk
Mesoridazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Mesoridazine.,increase,risk
Mesoridazine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mesoridazine.,increase,risk
Mesoridazine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Opium.,increase,risk
Mesoridazine,Oritavancin,The metabolism of Mesoridazine can be decreased when combined with Oritavancin.,decrease,no risk
Mesoridazine,Orphenadrine,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Mesoridazine,Osilodrostat,The metabolism of Mesoridazine can be decreased when combined with Osilodrostat.,decrease,no risk
Mesoridazine,Ospemifene,The metabolism of Mesoridazine can be decreased when combined with Ospemifene.,decrease,no risk
Mesoridazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxamniquine,The metabolism of Mesoridazine can be decreased when combined with Oxamniquine.,decrease,no risk
Mesoridazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Oxatomide.,increase,risk
Mesoridazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxitriptan,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Oxitriptan.,increase,risk
Mesoridazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Mesoridazine.,increase,risk
Mesoridazine,Oxybutynin,The metabolism of Mesoridazine can be decreased when combined with Oxybutynin.,decrease,no risk
Mesoridazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Oxycodone.,increase,risk
Mesoridazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Oxymorphone.,increase,risk
Mesoridazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mesoridazine.,increase,risk
Mesoridazine,Quazepam,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Quazepam.,increase,risk
Mesoridazine,Quetiapine,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Quetiapine.,increase,risk
Mesoridazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Mesoridazine.,decrease,no risk
Mesoridazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Mesoridazine.,increase,risk
Mesoridazine,Quinine,The metabolism of Mesoridazine can be decreased when combined with Quinine.,decrease,no risk
Mesoridazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Mesoridazine.,increase,no risk
Mesoridazine,Quizartinib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Quizartinib.,increase,risk
Mesoridazine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Mesoridazine.,decrease,no risk
Mesoridazine,Urethane,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Urethane.,increase,risk
Mesoridazine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Mesoridazine.,decrease,no risk
Mesoridazine,Valproate bismuth,Mesoridazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Mesoridazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Valproic acid.,increase,risk
Mesoridazine,Vandetanib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Vandetanib.,increase,risk
Mesoridazine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mesoridazine.,increase,risk
Mesoridazine,Vecuronium,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Vecuronium.,increase,risk
Mesoridazine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Vemurafenib.,increase,risk
Mesoridazine,Venlafaxine,The metabolism of Mesoridazine can be decreased when combined with Venlafaxine.,decrease,no risk
Mesoridazine,Verapamil,The metabolism of Mesoridazine can be decreased when combined with Verapamil.,decrease,no risk
Mesoridazine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mesoridazine.,increase,risk
Mesoridazine,Vigabatrin,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Vigabatrin.,increase,risk
Mesoridazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Mesoridazine.,increase,risk
Mesoridazine,Vilazodone,The metabolism of Mesoridazine can be decreased when combined with Vilazodone.,decrease,no risk
Mesoridazine,Viloxazine,The metabolism of Mesoridazine can be decreased when combined with Viloxazine.,decrease,no risk
Mesoridazine,Vinblastine,The metabolism of Mesoridazine can be decreased when combined with Vinblastine.,decrease,no risk
Mesoridazine,Vincristine,Vincristine may increase the neurotoxic activities of Mesoridazine.,increase,no risk
Mesoridazine,Vinorelbine,The metabolism of Mesoridazine can be decreased when combined with Vinorelbine.,decrease,no risk
Mesoridazine,Viomycin,Mesoridazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Mesoridazine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Mesoridazine.,increase,risk
Mesoridazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mesoridazine.,increase,risk
Mesoridazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Mesoridazine.,increase,risk
Mesoridazine,Warfarin,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Warfarin.,increase,risk
Mesoridazine,Yohimbine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Yohimbine.,increase,risk
Mesoridazine,Zaleplon,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Zaleplon.,increase,risk
Mesoridazine,Ziconotide,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Ziconotide.,increase,risk
Mesoridazine,Zimelidine,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zimelidine.,increase,risk
Mesoridazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ziprasidone.,increase,risk
Mesoridazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mesoridazine.,increase,risk
Mesoridazine,Zolpidem,Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Mesoridazine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Mesoridazine.,increase,risk
Mesoridazine,Zopiclone,The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zopiclone.,increase,risk
Mesoridazine,Zotepine,The risk or severity of CNS depression can be increased when Mesoridazine is combined with Zotepine.,increase,risk
Mesoridazine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Zuclopenthixol.,increase,risk
Mesoridazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Mesoridazine.,increase,risk
Maprotiline,Bacitracin,Bacitracin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.,increase,no risk
Maprotiline,Balsalazide,Balsalazide may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Baricitinib,Maprotiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Maprotiline,Bedaquiline,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bedaquiline.,increase,risk
Maprotiline,Belinostat,The metabolism of Maprotiline can be increased when combined with Belinostat.,increase,no risk
Maprotiline,Belladonna,The risk or severity of adverse effects can be increased when Maprotiline is combined with Belladonna.,increase,risk
Maprotiline,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Maprotiline.,decrease,no risk
Maprotiline,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Benorilate,Benorilate may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Benperidol,The risk or severity of adverse effects can be increased when Maprotiline is combined with Benperidol.,increase,risk
Maprotiline,Benserazide,Maprotiline may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Maprotiline,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Maprotiline.,increase,risk
Maprotiline,Benzhydrocodone,The risk or severity of adverse effects can be increased when Maprotiline is combined with Benzhydrocodone.,increase,risk
Maprotiline,Benznidazole,Maprotiline may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Maprotiline,Benzocaine,The risk or severity of CNS depression can be increased when Maprotiline is combined with Benzocaine.,increase,risk
Maprotiline,Benzphetamine,Benzphetamine may decrease the sedative activities of Maprotiline.,decrease,no risk
Maprotiline,Benzthiazide,Benzthiazide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Benzydamine,Benzydamine may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Benzyl alcohol,The risk or severity of CNS depression can be increased when Maprotiline is combined with Benzyl alcohol.,increase,risk
Maprotiline,Benzylpenicilloyl polylysine,Maprotiline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Maprotiline,Bepotastine,Maprotiline may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Maprotiline,Bepridil,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bepridil.,increase,risk
Maprotiline,Berotralstat,The metabolism of Maprotiline can be decreased when combined with Berotralstat.,decrease,no risk
Maprotiline,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Maprotiline.,decrease,no risk
Maprotiline,Betaine,The therapeutic efficacy of Maprotiline can be decreased when used in combination with Betaine.,decrease,no risk
Maprotiline,Betaxolol,The metabolism of Maprotiline can be decreased when combined with Betaxolol.,decrease,no risk
Maprotiline,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Maprotiline.,increase,risk
Maprotiline,Bicisate,Maprotiline may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Maprotiline,Bilastine,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bilastine.,increase,risk
Maprotiline,Bimekizumab,The metabolism of Maprotiline can be increased when combined with Bimekizumab.,increase,no risk
Maprotiline,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Maprotiline.,decrease,no risk
Maprotiline,Biperiden,The metabolism of Maprotiline can be decreased when combined with Biperiden.,decrease,no risk
Maprotiline,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Maprotiline.,decrease,no risk
Maprotiline,Bismuth subgallate,Maprotiline may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Maprotiline,Bisoprolol,Bisoprolol may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Maprotiline.,decrease,no risk
Maprotiline,Bleomycin,Bleomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Bortezomib,The metabolism of Maprotiline can be decreased when combined with Bortezomib.,decrease,no risk
Maprotiline,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum toxin type A.,increase,risk
Maprotiline,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum toxin type B.,increase,risk
Maprotiline,Bretylium,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bretylium.,increase,risk
Maprotiline,Brexanolone,The risk or severity of CNS depression can be increased when Maprotiline is combined with Brexanolone.,increase,risk
Maprotiline,Brexpiprazole,The risk or severity of adverse effects can be increased when Maprotiline is combined with Brexpiprazole.,increase,risk
Maprotiline,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.,increase,no risk
Maprotiline,Brivaracetam,The risk or severity of CNS depression can be increased when Maprotiline is combined with Brivaracetam.,increase,risk
Maprotiline,Bromazepam,The risk or severity of CNS depression can be increased when Maprotiline is combined with Bromazepam.,increase,risk
Maprotiline,Bromocriptine,The risk or severity of adverse effects can be increased when Maprotiline is combined with Bromocriptine.,increase,risk
Maprotiline,Bromotheophylline,Bromotheophylline may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Bromperidol,The risk or severity of adverse effects can be increased when Maprotiline is combined with Bromperidol.,increase,risk
Maprotiline,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Maprotiline.,increase,risk
Maprotiline,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Maprotiline.,increase,risk
Maprotiline,Budesonide,Maprotiline may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Maprotiline,Bumadizone,Bumadizone may decrease the excretion rate of Maprotiline which could result in a higher serum level.,decrease,no risk
Maprotiline,Bumetanide,Bumetanide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Maprotiline,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Maprotiline.,increase,risk
Maprotiline,Buprenorphine,Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Maprotiline,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Maprotiline.,increase,risk
Maprotiline,Buserelin,The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Buserelin.,increase,risk
Maprotiline,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Maprotiline.,increase,risk
Maprotiline,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Maprotiline.,increase,risk
Maprotiline,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Maprotiline.,increase,risk
Maprotiline,Butaperazine,The risk or severity of adverse effects can be increased when Maprotiline is combined with Butaperazine.,increase,risk
Maprotiline,Butobarbital,The risk or severity of CNS depression can be increased when Maprotiline is combined with Butobarbital.,increase,risk
Maprotiline,Butorphanol,The risk or severity of adverse effects can be increased when Maprotiline is combined with Butorphanol.,increase,risk
Maprotiline,Butriptyline,The risk or severity of CNS depression can be increased when Maprotiline is combined with Butriptyline.,increase,risk
Maprotiline,Butylscopolamine,The risk or severity of adverse effects can be increased when Maprotiline is combined with Butylscopolamine.,increase,risk
Oxymetazoline,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Glycopyrronium,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Glycopyrronium.,increase,risk
Oxymetazoline,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Halothane,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Halothane.,increase,risk
Oxymetazoline,Hexocyclium,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Hexocyclium.,increase,risk
Oxymetazoline,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Hydralazine,The therapeutic efficacy of Hydralazine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Ketamine,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Ketamine.,increase,risk
Oxymetazoline,Ketoprofen,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Ketoprofen.,increase,risk
Oxymetazoline,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Olanzapine,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Olanzapine.,decrease,no risk
Oxymetazoline,Olmesartan,The therapeutic efficacy of Olmesartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Olodaterol,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Olodaterol.,increase,risk
Oxymetazoline,Olopatadine,The absorption of Olopatadine can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Orphenadrine,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Orphenadrine.,increase,risk
Oxymetazoline,Ouabain,The therapeutic efficacy of Ouabain can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Oxaprozin,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxaprozin.,increase,risk
Oxymetazoline,Oxprenolol,The risk or severity of cardiovascular complications can be increased when Oxprenolol is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Oxtriphylline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Oxtriphylline.,increase,risk
Oxymetazoline,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Oxybutynin.,increase,risk
Oxymetazoline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxyphenbutazone.,increase,risk
Oxymetazoline,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Oxytocin,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxytocin.,increase,risk
Oxymetazoline,Quetiapine,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quetiapine.,decrease,no risk
Oxymetazoline,Quinapril,The therapeutic efficacy of Quinapril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Quinidine,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quinidine.,decrease,no risk
Oxymetazoline,Quinupramine,Quinupramine may increase the vasopressor activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Umeclidinium,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Umeclidinium.,increase,risk
Oxymetazoline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Valsartan,The therapeutic efficacy of Valsartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Venlafaxine,Venlafaxine may increase the tachycardic activities of Oxymetazoline.,increase,no risk
Oxymetazoline,Verapamil,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Verapamil.,decrease,no risk
Oxymetazoline,Vilanterol,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vilanterol.,increase,risk
Oxymetazoline,Vilazodone,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vilazodone.,increase,risk
Oxymetazoline,Vitamin A,The absorption of Vitamin A can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Vortioxetine,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vortioxetine.,increase,risk
Oxymetazoline,Xamoterol,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Xamoterol.,increase,risk
Oxymetazoline,Xylometazoline,The absorption of Xylometazoline can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Yohimbine,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Yohimbine.,increase,risk
Oxymetazoline,Zavegepant,The absorption of Zavegepant can be decreased when combined with Oxymetazoline.,decrease,no risk
Oxymetazoline,Ziprasidone,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Oxymetazoline,Zofenopril,The therapeutic efficacy of Zofenopril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Oxymetazoline,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxymetazoline.,increase,risk
Oxymetazoline,Zuclopenthixol,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Salicylic acid,Bacitracin,The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Salicylic acid.,increase,risk
Salicylic acid,Baclofen,Salicylic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Salicylic acid,Balsalazide,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Balsalazide.,increase,risk
Salicylic acid,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Salicylic acid.,increase,no risk
Salicylic acid,Beclomethasone dipropionate,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Salicylic acid.,increase,risk
Salicylic acid,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Bemiparin.,increase,risk
Salicylic acid,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylic acid is combined with Benazepril.",increase,risk
Salicylic acid,Bendazac,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bendazac.,increase,risk
Salicylic acid,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Benorilate,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Benorilate.,increase,risk
Salicylic acid,Benoxaprofen,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Benoxaprofen.,increase,risk
Salicylic acid,Benserazide,Salicylic acid may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Salicylic acid,Benzatropine,Salicylic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Benznidazole,Salicylic acid may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Salicylic acid,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Salicylic acid.,increase,risk
Salicylic acid,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Benzydamine,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Benzydamine.,increase,risk
Salicylic acid,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Bepotastine,Salicylic acid may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Salicylic acid.,increase,risk
Salicylic acid,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Salicylic acid.,increase,risk
Salicylic acid,Betaxolol,Salicylic acid may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Salicylic acid,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Salicylic acid.,increase,risk
Salicylic acid,Betulinic Acid,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Betulinic Acid.,increase,risk
Salicylic acid,Bexagliflozin,Salicylic acid may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Salicylic acid,Bexarotene,The metabolism of Salicylic acid can be decreased when combined with Bexarotene.,decrease,no risk
Salicylic acid,Bicisate,Salicylic acid may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Bimekizumab,The metabolism of Salicylic acid can be increased when combined with Bimekizumab.,increase,no risk
Salicylic acid,Bismuth subgallate,Salicylic acid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bismuth subsalicylate,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Salicylic acid is combined with Bismuth subsalicylate.",increase,risk
Salicylic acid,Bisoprolol,Salicylic acid may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Salicylic acid,Bisoxatin,Salicylic acid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Bivalirudin.,increase,risk
Salicylic acid,Bleomycin,Salicylic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bortezomib,The metabolism of Salicylic acid can be decreased when combined with Bortezomib.,decrease,no risk
Salicylic acid,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Brexpiprazole,The risk or severity of hypertension can be increased when Salicylic acid is combined with Brexpiprazole.,increase,risk
Salicylic acid,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Salicylic acid.,increase,risk
Salicylic acid,Brivaracetam,Salicylic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bromazepam,Salicylic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Bromfenac,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bromfenac.,increase,risk
Salicylic acid,Bromocriptine,Salicylic acid may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Salicylic acid,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Salicylic acid.,increase,risk
Salicylic acid,Bufexamac,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bufexamac.,increase,risk
Salicylic acid,Bumadizone,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Bumadizone.,increase,risk
Salicylic acid,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Buprenorphine,The metabolism of Salicylic acid can be decreased when combined with Buprenorphine.,decrease,no risk
Salicylic acid,Bupropion,Salicylic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Salicylic acid,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Salicylic acid.,increase,risk
Salicylic acid,Butabarbital,Salicylic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Salicylic acid,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Salicylic acid.,increase,risk
Salicylic acid,Gabapentin enacarbil,Salicylic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadobenic acid,Salicylic acid may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadodiamide,Salicylic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadofosveset trisodium,Salicylic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadopentetic acid,Salicylic acid may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadoteric acid,Salicylic acid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gadoteridol,Salicylic acid may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ganciclovir,Salicylic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gatifloxacin,Salicylic acid may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Salicylic acid,Gemcitabine,Salicylic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gemfibrozil,The metabolism of Salicylic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Salicylic acid,Gemifloxacin,Salicylic acid may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Salicylic acid,Gentamicin,Salicylic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Gimeracil,Salicylic acid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Salicylic acid.,increase,risk
Salicylic acid,Givosiran,The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Givosiran.,increase,risk
Salicylic acid,Gliclazide,Salicylic acid may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Salicylic acid,Glimepiride,Salicylic acid may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Salicylic acid,Glipizide,Salicylic acid may increase the hypoglycemic activities of Glipizide.,increase,no risk
Salicylic acid,Gliquidone,Salicylic acid may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Salicylic acid,Glofitamab,The serum concentration of Salicylic acid can be increased when it is combined with Glofitamab.,increase,no risk
Salicylic acid,Glyburide,Salicylic acid may increase the hypoglycemic activities of Glyburide.,increase,no risk
Salicylic acid,Glycerol phenylbutyrate,Salicylic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Glycol salicylate,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Glycol salicylate.,increase,risk
Salicylic acid,Glymidine,Salicylic acid may increase the hypoglycemic activities of Glymidine.,increase,no risk
Salicylic acid,Golimumab,The metabolism of Salicylic acid can be increased when combined with Golimumab.,increase,no risk
Salicylic acid,Golodirsen,Salicylic acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Salicylic acid,Goserelin,Salicylic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Grepafloxacin,Salicylic acid may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Salicylic acid,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Salicylic acid.,increase,no risk
Salicylic acid,Halothane,The risk or severity of hypertension can be increased when Salicylic acid is combined with Halothane.,increase,risk
Salicylic acid,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Heparin.,increase,risk
Salicylic acid,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hydralazine,Salicylic acid may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Salicylic acid,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Salicylic acid.,increase,risk
Salicylic acid,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Hydromorphone,Salicylic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Salicylic acid,Hydroxocobalamin,Salicylic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Hydroxyethyl Starch,Salicylic acid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Salicylic acid,Kanamycin,Salicylic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ketamine,Salicylic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ketazolam,Salicylic acid may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ketoconazole,The risk or severity of hyperkalemia can be increased when Salicylic acid is combined with Ketoconazole.,increase,risk
Salicylic acid,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Salicylic acid is combined with Ketoprofen.,increase,risk
Salicylic acid,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Salicylic acid.,increase,risk
Salicylic acid,Octinoxate,Salicylic acid may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Salicylic acid,Ofloxacin,Salicylic acid may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Salicylic acid,Olanzapine,The metabolism of Salicylic acid can be decreased when combined with Olanzapine.,decrease,no risk
Salicylic acid,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Salicylic acid.",increase,risk
Salicylic acid,Olodaterol,The risk or severity of hypertension can be increased when Salicylic acid is combined with Olodaterol.,increase,risk
Salicylic acid,Olsalazine,The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Olsalazine.,increase,risk
Salicylic acid,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Salicylic acid is combined with Omacetaxine mepesuccinate.,increase,risk
Salicylic acid,Ondansetron,The metabolism of Salicylic acid can be decreased when combined with Ondansetron.,decrease,no risk
Salicylic acid,Opium,Salicylic acid may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Salicylic acid,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Salicylic acid.,increase,risk
Salicylic acid,Oritavancin,The metabolism of Salicylic acid can be decreased when combined with Oritavancin.,decrease,no risk
Salicylic acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Salicylic acid.,decrease,no risk
Salicylic acid,Oxacillin,Salicylic acid may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Salicylic acid.,increase,risk
Salicylic acid,Oxandrolone,The metabolism of Salicylic acid can be decreased when combined with Oxandrolone.,decrease,no risk
Salicylic acid,Oxaprozin,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Oxaprozin.,increase,risk
Salicylic acid,Oxazepam,Salicylic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oxprenolol,Salicylic acid may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Salicylic acid,Oxybenzone,Salicylic acid may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Salicylic acid.,increase,risk
Salicylic acid,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Salicylic acid is combined with Oxyphenbutazone.,increase,risk
Salicylic acid,Oxyquinoline,Salicylic acid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Salicylic acid,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Quetiapine,The risk or severity of hypertension can be increased when Salicylic acid is combined with Quetiapine.,increase,risk
Salicylic acid,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylic acid is combined with Quinapril.",increase,risk
Salicylic acid,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Quinidine,Salicylic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Quinine,Salicylic acid may increase the hypoglycemic activities of Quinine.,increase,no risk
Salicylic acid,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Salicylic acid.,increase,risk
Salicylic acid,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Salicylic acid.,decrease,no risk
Salicylic acid,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Urokinase.,increase,risk
Salicylic acid,Vaborbactam,Salicylic acid may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Salicylic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Salicylic acid.,increase,no risk
Salicylic acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Salicylic acid.,decrease,no risk
Salicylic acid,Valbenazine,Salicylic acid may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Salicylic acid.,increase,risk
Salicylic acid,Valganciclovir,Salicylic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Salicylic acid,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Salicylic acid.,increase,no risk
Salicylic acid,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Salicylic acid.",increase,risk
Salicylic acid,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Salicylic acid.,increase,risk
Salicylic acid,Vancomycin,Salicylic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Salicylic acid,Vardenafil,The metabolism of Salicylic acid can be decreased when combined with Vardenafil.,decrease,no risk
Salicylic acid,Varenicline,Salicylic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Salicylic acid,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Salicylic acid is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Salicylic acid,Vemurafenib,The metabolism of Salicylic acid can be decreased when combined with Vemurafenib.,decrease,no risk
Salicylic acid,Venlafaxine,Venlafaxine may increase the antiplatelet activities of Salicylic acid.,increase,no risk
Salicylic acid,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Salicylic acid.,increase,risk
Salicylic acid,Vilanterol,The risk or severity of hypertension can be increased when Salicylic acid is combined with Vilanterol.,increase,risk
Salicylic acid,Vilazodone,The risk or severity of hypertension can be increased when Salicylic acid is combined with Vilazodone.,increase,risk
Salicylic acid,Vildagliptin,Salicylic acid may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Salicylic acid,Viloxazine,Salicylic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Salicylic acid,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Vorapaxar.,increase,risk
Salicylic acid,Voriconazole,The serum concentration of Salicylic acid can be increased when it is combined with Voriconazole.,increase,no risk
Diethylpropion,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Diethylpropion.,increase,risk
Diethylpropion,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Diethylpropion.,increase,risk
Diethylpropion,Butaperazine,Butaperazine may decrease the stimulatory activities of Diethylpropion.,decrease,no risk
Diethylpropion,Butobarbital,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Butobarbital.,increase,risk
Diethylpropion,Butorphanol,Diethylpropion may increase the analgesic activities of Butorphanol.,increase,no risk
Diethylpropion,Butriptyline,Diethylpropion may decrease the sedative activities of Butriptyline.,decrease,no risk
Diethylpropion,Butylscopolamine,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Butylscopolamine.,increase,risk
Diethylpropion,Gabapentin,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Gabapentin.,increase,risk
Diethylpropion,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Gabapentin enacarbil.,increase,risk
Diethylpropion,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Diethylpropion.,increase,risk
Diethylpropion,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Diethylpropion is combined with Ganaxolone.",increase,risk
Diethylpropion,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Diethylpropion.,increase,risk
Diethylpropion,Glutamic acid,The serum concentration of Diethylpropion can be decreased when it is combined with Glutamic acid.,decrease,no risk
Diethylpropion,Glutethimide,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Glutethimide.,increase,risk
Diethylpropion,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Glycopyrronium,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Glycopyrronium.,increase,risk
Diethylpropion,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Diethylpropion.,increase,risk
Diethylpropion,Guanabenz,Diethylpropion may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Diethylpropion,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Guanethidine,The serum concentration of Diethylpropion can be decreased when it is combined with Guanethidine.,decrease,no risk
Diethylpropion,Guanfacine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Guanfacine.,increase,risk
Diethylpropion,Guanoxan,Diethylpropion may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Diethylpropion,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Diethylpropion.,increase,risk
Diethylpropion,Haloperidol,The therapeutic efficacy of Diethylpropion can be decreased when used in combination with Haloperidol.,decrease,no risk
Diethylpropion,Halothane,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Halothane.,increase,risk
Diethylpropion,Hexafluronium,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Hexafluronium.,increase,risk
Diethylpropion,Hexocyclium,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Hexocyclium.,increase,risk
Diethylpropion,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Diethylpropion.,increase,risk
Diethylpropion,Hydralazine,Diethylpropion may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Diethylpropion,Hydrochlorothiazide,Diethylpropion may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Diethylpropion,Hydrocodone,Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Diethylpropion,Hydroflumethiazide,Diethylpropion may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Diethylpropion,Hydromorphone,Diethylpropion may increase the analgesic activities of Hydromorphone.,increase,no risk
Diethylpropion,Hydrotalcite,The serum concentration of Diethylpropion can be increased when it is combined with Hydrotalcite.,increase,no risk
Diethylpropion,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Diethylpropion.,increase,no risk
Diethylpropion,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Diethylpropion.,increase,risk
Diethylpropion,Ketamine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Ketamine.,increase,risk
Diethylpropion,Ketazolam,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Ketazolam.,increase,risk
Diethylpropion,Ketoprofen,The risk or severity of hypertension can be increased when Diethylpropion is combined with Ketoprofen.,increase,risk
Diethylpropion,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Diethylpropion.,increase,risk
Diethylpropion,Ketotifen,Diethylpropion may decrease the sedative activities of Ketotifen.,decrease,no risk
Diethylpropion,Olanzapine,Diethylpropion may decrease the sedative activities of Olanzapine.,decrease,no risk
Diethylpropion,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Diethylpropion is combined with Oliceridine.",increase,risk
Diethylpropion,Olmesartan,Diethylpropion may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Diethylpropion,Olodaterol,The risk or severity of hypertension can be increased when Diethylpropion is combined with Olodaterol.,increase,risk
Diethylpropion,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Diethylpropion.,increase,risk
Diethylpropion,Opium,Diethylpropion may increase the analgesic activities of Opium.,increase,no risk
Diethylpropion,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Diethylpropion.,increase,risk
Diethylpropion,Orphenadrine,Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Diethylpropion,Oxaprozin,The risk or severity of hypertension can be increased when Diethylpropion is combined with Oxaprozin.,increase,risk
Diethylpropion,Oxatomide,Diethylpropion may decrease the sedative activities of Oxatomide.,decrease,no risk
Diethylpropion,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxitriptan,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Oxitriptan.,increase,risk
Diethylpropion,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Oxtriphylline,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Oxtriphylline.,increase,risk
Diethylpropion,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxybutynin,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Oxybutynin.,increase,risk
Diethylpropion,Oxycodone,Diethylpropion may increase the analgesic activities of Oxycodone.,increase,no risk
Diethylpropion,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxymorphone,Diethylpropion may increase the analgesic activities of Oxymorphone.,increase,no risk
Diethylpropion,Oxyphenbutazone,The risk or severity of hypertension can be increased when Diethylpropion is combined with Oxyphenbutazone.,increase,risk
Diethylpropion,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Diethylpropion.,increase,risk
Diethylpropion,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Diethylpropion.,increase,risk
Diethylpropion,Quazepam,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Quazepam.,increase,risk
Diethylpropion,Quetiapine,Diethylpropion may decrease the sedative activities of Quetiapine.,decrease,no risk
Diethylpropion,Quinapril,Diethylpropion may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Diethylpropion,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Diethylpropion.,increase,risk
Diethylpropion,Quinupramine,The therapeutic efficacy of Quinupramine can be increased when used in combination with Diethylpropion.,increase,no risk
Diethylpropion,Umeclidinium,The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Umeclidinium.,increase,risk
Diethylpropion,Urethane,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Urethane.,increase,risk
Diethylpropion,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Diethylpropion.,increase,risk
Diethylpropion,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Diethylpropion is combined with Valproate bismuth.,increase,risk
Diethylpropion,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Diethylpropion.,increase,risk
Diethylpropion,Valsartan,Diethylpropion may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Diethylpropion,Vecuronium,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vecuronium.,increase,risk
Diethylpropion,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Diethylpropion is combined with Venlafaxine.,increase,risk
Diethylpropion,Verapamil,The therapeutic efficacy of Verapamil can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Vigabatrin,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vigabatrin.,increase,risk
Diethylpropion,Vilanterol,The risk or severity of hypertension can be increased when Diethylpropion is combined with Vilanterol.,increase,risk
Diethylpropion,Vilazodone,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vilazodone.,increase,risk
Diethylpropion,Viloxazine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Viloxazine.,increase,risk
Diethylpropion,Vortioxetine,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Vortioxetine.,increase,risk
Diethylpropion,Xamoterol,The risk or severity of hypertension can be increased when Diethylpropion is combined with Xamoterol.,increase,risk
Diethylpropion,Xylometazoline,The risk or severity of hypertension can be increased when Diethylpropion is combined with Xylometazoline.,increase,risk
Diethylpropion,Yohimbine,The therapeutic efficacy of Yohimbine can be decreased when used in combination with Diethylpropion.,decrease,no risk
Diethylpropion,Zaleplon,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Zaleplon.,increase,risk
Diethylpropion,Ziconotide,The risk or severity of CNS depression can be increased when Diethylpropion is combined with Ziconotide.,increase,risk
Diethylpropion,Zimelidine,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Zimelidine.,increase,risk
Diethylpropion,Zinc ascorbate,The serum concentration of Diethylpropion can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Diethylpropion,Ziprasidone,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Ziprasidone.,increase,risk
Diethylpropion,Zofenopril,Diethylpropion may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Diethylpropion,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Diethylpropion.,increase,risk
Diethylpropion,Zolpidem,Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Diethylpropion,Zonisamide,Zonisamide may decrease the excretion rate of Diethylpropion which could result in a higher serum level.,decrease,no risk
Diethylpropion,Zopiclone,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Zopiclone.,increase,risk
Diethylpropion,Zotepine,Zotepine may decrease the stimulatory activities of Diethylpropion.,decrease,no risk
Diethylpropion,Zuclopenthixol,Diethylpropion may decrease the sedative activities of Zuclopenthixol.,decrease,no risk
Diethylpropion,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Diethylpropion.,increase,risk
Salmeterol,Bosentan,Salmeterol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Salmeterol,Bretylium,Salmeterol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Salmeterol,Brexpiprazole,The therapeutic efficacy of Salmeterol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Salmeterol,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Salmeterol.,increase,no risk
Salmeterol,Bromotheophylline,The risk or severity of hypokalemia can be increased when Bromotheophylline is combined with Salmeterol.,increase,risk
Salmeterol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Salmeterol.,increase,risk
Salmeterol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Salmeterol.,increase,risk
Salmeterol,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Salmeterol.,increase,risk
Salmeterol,Bumadizone,The risk or severity of hypertension can be increased when Salmeterol is combined with Bumadizone.,increase,risk
Salmeterol,Bumetanide,The risk or severity of hypokalemia can be increased when Salmeterol is combined with Bumetanide.,increase,risk
Salmeterol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Buserelin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Buserelin.,increase,risk
Salmeterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Salmeterol.,increase,risk
Salmeterol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Salmeterol.,increase,risk
Salmeterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Salmeterol is combined with Butylscopolamine.,increase,risk
Salmeterol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Gadobenic acid.,increase,risk
Salmeterol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Salmeterol.,increase,risk
Salmeterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Salmeterol.,increase,risk
Salmeterol,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Ganciclovir.",increase,risk
Salmeterol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Gatifloxacin.,increase,risk
Salmeterol,Gefitinib,The metabolism of Salmeterol can be decreased when combined with Gefitinib.,decrease,no risk
Salmeterol,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Gemfibrozil.",increase,risk
Salmeterol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Gemifloxacin.,increase,risk
Salmeterol,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Salmeterol.,increase,no risk
Salmeterol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Salmeterol.,increase,risk
Salmeterol,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Salmeterol.,increase,risk
Salmeterol,Glasdegib,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Glasdegib.,increase,risk
Salmeterol,Glofitamab,The serum concentration of Salmeterol can be increased when it is combined with Glofitamab.,increase,no risk
Salmeterol,Glyburide,The metabolism of Glyburide can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Salmeterol is combined with Glycopyrronium.,increase,risk
Salmeterol,Golimumab,The metabolism of Salmeterol can be increased when combined with Golimumab.,increase,no risk
Salmeterol,Goserelin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Goserelin.,increase,risk
Salmeterol,Granisetron,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Granisetron.,increase,risk
Salmeterol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Grepafloxacin.,increase,risk
Salmeterol,Guanabenz,Salmeterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Salmeterol,Guanadrel,Salmeterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Salmeterol,Guanethidine,Salmeterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Salmeterol,Guanfacine,The risk or severity of adverse effects can be increased when Salmeterol is combined with Guanfacine.,increase,risk
Salmeterol,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Salmeterol.,increase,risk
Salmeterol,Guanoxan,Salmeterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Salmeterol,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Haloperidol,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Haloperidol.,increase,risk
Salmeterol,Halothane,The risk or severity of hypertension can be increased when Salmeterol is combined with Halothane.,increase,risk
Salmeterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Salmeterol is combined with Hexocyclium.,increase,risk
Salmeterol,Histamine,The serum concentration of Histamine can be increased when it is combined with Salmeterol.,increase,no risk
Salmeterol,Histrelin,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Histrelin.,increase,risk
Salmeterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Salmeterol.,increase,risk
Salmeterol,Hydralazine,Salmeterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Salmeterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Salmeterol is combined with Hydrochlorothiazide.,increase,risk
Salmeterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Salmeterol.,increase,risk
Salmeterol,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Salmeterol.,increase,risk
Salmeterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Salmeterol is combined with Hydroflumethiazide.,increase,risk
Salmeterol,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Hydroxyzine.,increase,risk
Salmeterol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Salmeterol.,increase,risk
Salmeterol,Ketamine,The metabolism of Ketamine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Ketoconazole,The metabolism of Salmeterol can be decreased when combined with Ketoconazole.,decrease,no risk
Salmeterol,Ketoprofen,The risk or severity of hypertension can be increased when Salmeterol is combined with Ketoprofen.,increase,risk
Salmeterol,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Salmeterol.,increase,risk
Salmeterol,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Ofloxacin.",increase,risk
Salmeterol,Olanzapine,The therapeutic efficacy of Salmeterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Salmeterol,Olaparib,The metabolism of Olaparib can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Olmesartan,Salmeterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Salmeterol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Omaveloxolone,The serum concentration of Salmeterol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Salmeterol,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Ondansetron,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Ondansetron.,increase,risk
Salmeterol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Salmeterol.,increase,risk
Salmeterol,Orphenadrine,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Orphenadrine.,increase,risk
Salmeterol,Osilodrostat,The metabolism of Salmeterol can be decreased when combined with Osilodrostat.,decrease,no risk
Salmeterol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Salmeterol.,increase,risk
Salmeterol,Oxaprozin,The risk or severity of hypertension can be increased when Salmeterol is combined with Oxaprozin.,increase,risk
Salmeterol,Oxatomide,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Oxatomide.,increase,risk
Salmeterol,Oxcarbazepine,The metabolism of Salmeterol can be increased when combined with Oxcarbazepine.,increase,no risk
Salmeterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Salmeterol.,decrease,no risk
Salmeterol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Salmeterol.,increase,risk
Salmeterol,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Oxycodone,The metabolism of Salmeterol can be decreased when combined with Oxycodone.,decrease,no risk
Salmeterol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Salmeterol.,increase,risk
Salmeterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Salmeterol is combined with Oxyphenbutazone.,increase,risk
Salmeterol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Salmeterol.,increase,risk
Salmeterol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Salmeterol.,increase,risk
Salmeterol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Salmeterol.,increase,risk
Salmeterol,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Quetiapine,The therapeutic efficacy of Salmeterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Salmeterol,Quinapril,Salmeterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Salmeterol,Quinethazone,Salmeterol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Salmeterol,Quinidine,The metabolism of Quinidine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Quinine,The metabolism of Quinine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Salmeterol.,increase,risk
Salmeterol,Quizartinib,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Quizartinib.,increase,risk
Salmeterol,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Ubidecarenone.",increase,risk
Salmeterol,Udenafil,The metabolism of Udenafil can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Umeclidinium,The risk or severity of Tachycardia can be increased when Salmeterol is combined with Umeclidinium.,increase,risk
Salmeterol,Vadadustat,The serum concentration of Salmeterol can be increased when it is combined with Vadadustat.,increase,no risk
Salmeterol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Salmeterol.,increase,risk
Salmeterol,Valproic acid,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Valproic acid.,increase,risk
Salmeterol,Valsartan,Salmeterol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Salmeterol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Salmeterol.,increase,risk
Salmeterol,Vandetanib,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Vandetanib.,increase,risk
Salmeterol,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Salmeterol.,increase,risk
Salmeterol,Varenicline,The excretion of Varenicline can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Salmeterol.,increase,risk
Salmeterol,Venetoclax,The metabolism of Salmeterol can be decreased when combined with Venetoclax.,decrease,no risk
Salmeterol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Salmeterol.,increase,no risk
Salmeterol,Verapamil,The metabolism of Salmeterol can be decreased when combined with Verapamil.,decrease,no risk
Salmeterol,Vernakalant,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Vernakalant.,increase,risk
Salmeterol,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Salmeterol.,increase,risk
Salmeterol,Vilazodone,The risk or severity of hypertension can be increased when Salmeterol is combined with Vilazodone.,increase,risk
Salmeterol,Viloxazine,The metabolism of Salmeterol can be decreased when combined with Viloxazine.,decrease,no risk
Salmeterol,Vincristine,The metabolism of Vincristine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Voriconazole,The metabolism of Salmeterol can be decreased when combined with Voriconazole.,decrease,no risk
Salmeterol,Vorinostat,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Vorinostat.,increase,risk
Salmeterol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Xamoterol,The risk or severity of hypertension can be increased when Salmeterol is combined with Xamoterol.,increase,risk
Salmeterol,Xylometazoline,The risk or severity of hypertension can be increased when Salmeterol is combined with Xylometazoline.,increase,risk
Salmeterol,Yohimbine,The risk or severity of hypertension can be increased when Salmeterol is combined with Yohimbine.,increase,risk
Salmeterol,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Salmeterol.,decrease,no risk
Salmeterol,Zimelidine,The metabolism of Salmeterol can be decreased when combined with Zimelidine.,decrease,no risk
Salmeterol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Ziprasidone.,increase,risk
Salmeterol,Zofenopril,Salmeterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Salmeterol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Salmeterol.,increase,risk
Salmeterol,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Salmeterol.,increase,risk
Salmeterol,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Salmeterol.,decrease,no risk
Meclofenamic acid,Betaxolol,Meclofenamic acid may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Meclofenamic acid,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Meclofenamic acid.,decrease,no risk
Meclofenamic acid,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Meclofenamic acid.,increase,risk
Meclofenamic acid,Betulinic Acid,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Betulinic Acid.,increase,risk
Meclofenamic acid,Bicisate,Meclofenamic acid may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Meclofenamic acid.,decrease,no risk
Meclofenamic acid,Bismuth subgallate,Meclofenamic acid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Meclofenamic acid.,decrease,no risk
Meclofenamic acid,Bisoprolol,Meclofenamic acid may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Meclofenamic acid,Bisoxatin,Meclofenamic acid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Bivalirudin.,increase,risk
Meclofenamic acid,Bleomycin,Meclofenamic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Meclofenamic acid.,decrease,no risk
Meclofenamic acid,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Meclofenamic acid.,decrease,no risk
Meclofenamic acid,Brexpiprazole,The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Brexpiprazole.,increase,risk
Meclofenamic acid,Brivaracetam,Meclofenamic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Bromazepam,Meclofenamic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Bromfenac,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Bromfenac.,increase,risk
Meclofenamic acid,Bromocriptine,The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Bromocriptine.,increase,risk
Meclofenamic acid,Bromotheophylline,Bromotheophylline may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Meclofenamic acid,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Meclofenamic acid.,increase,risk
Meclofenamic acid,Bufexamac,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Bufexamac.,increase,risk
Meclofenamic acid,Bumadizone,The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Bumadizone.,increase,risk
Meclofenamic acid,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Meclofenamic acid.,decrease,no risk
Meclofenamic acid,Bupropion,Meclofenamic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Meclofenamic acid.,increase,risk
Meclofenamic acid,Butabarbital,Meclofenamic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Meclofenamic acid,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Meclofenamic acid.,increase,risk
Methantheline,Galantamine,The therapeutic efficacy of Methantheline can be decreased when used in combination with Galantamine.,decrease,no risk
Methantheline,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Methantheline.,increase,risk
Methantheline,Gefitinib,Methantheline can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methantheline,Ginkgo biloba,The therapeutic efficacy of Methantheline can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Methantheline,Glucagon,Methantheline may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Methantheline,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Methantheline.,decrease,no risk
Methantheline,Glycopyrronium,The risk or severity of adverse effects can be increased when Methantheline is combined with Glycopyrronium.,increase,risk
Methantheline,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Methantheline.,increase,risk
Methantheline,Guanfacine,The risk or severity of Tachycardia can be increased when Methantheline is combined with Guanfacine.,increase,risk
Methantheline,Hexafluronium,The risk or severity of adverse effects can be increased when Methantheline is combined with Hexafluronium.,increase,risk
Methantheline,Hexocyclium,The risk or severity of adverse effects can be increased when Methantheline is combined with Hexocyclium.,increase,risk
Methantheline,Homatropine,The risk or severity of adverse effects can be increased when Methantheline is combined with Homatropine.,increase,risk
Methantheline,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Methantheline.,increase,risk
Methantheline,Huperzine A,The therapeutic efficacy of Methantheline can be decreased when used in combination with Huperzine A.,decrease,no risk
Methantheline,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methantheline.,decrease,no risk
Methantheline,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Methantheline.,decrease,no risk
Methantheline,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Methantheline.,decrease,no risk
Methantheline,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Methantheline.,increase,no risk
Methantheline,Hydrocodone,The risk or severity of adverse effects can be increased when Methantheline is combined with Hydrocodone.,increase,risk
Methantheline,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Methantheline.,increase,no risk
Methantheline,Hydromorphone,The risk or severity of adverse effects can be increased when Methantheline is combined with Hydromorphone.,increase,risk
Methantheline,Hyoscyamine,Methantheline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Methantheline,Ketamine,The therapeutic efficacy of Methantheline can be decreased when used in combination with Ketamine.,decrease,no risk
Methantheline,Ketoconazole,Methantheline can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methantheline,Octreotide,Methantheline can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methantheline,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Methantheline.,increase,risk
Methantheline,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Methantheline is combined with Oliceridine.",increase,risk
Methantheline,Olodaterol,The risk or severity of Tachycardia can be increased when Methantheline is combined with Olodaterol.,increase,risk
Methantheline,Opium,The risk or severity of adverse effects can be increased when Methantheline is combined with Opium.,increase,risk
Methantheline,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Methantheline.,increase,risk
Methantheline,Orphenadrine,The risk or severity of adverse effects can be increased when Methantheline is combined with Orphenadrine.,increase,risk
Methantheline,Oteseconazole,Methantheline can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methantheline,Oxybutynin,The risk or severity of adverse effects can be increased when Methantheline is combined with Oxybutynin.,increase,risk
Methantheline,Oxycodone,The risk or severity of adverse effects can be increased when Methantheline is combined with Oxycodone.,increase,risk
Methantheline,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Methantheline.,increase,risk
Methantheline,Oxymorphone,The risk or severity of adverse effects can be increased when Methantheline is combined with Oxymorphone.,increase,risk
Methantheline,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Methantheline.,increase,risk
Methantheline,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Methantheline.,decrease,no risk
Methantheline,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methantheline.,increase,risk
Methantheline,Quetiapine,The risk or severity of adverse effects can be increased when Methantheline is combined with Quetiapine.,increase,risk
Methantheline,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Methantheline.,increase,no risk
Methantheline,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Methantheline.,increase,risk
Methantheline,Quinupramine,The risk or severity of adverse effects can be increased when Methantheline is combined with Quinupramine.,increase,risk
Methantheline,Umeclidinium,The risk or severity of adverse effects can be increased when Methantheline is combined with Umeclidinium.,increase,risk
Methantheline,Vecuronium,The risk or severity of adverse effects can be increased when Methantheline is combined with Vecuronium.,increase,risk
Methantheline,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Methantheline.,increase,risk
Methantheline,Vilanterol,The risk or severity of Tachycardia can be increased when Methantheline is combined with Vilanterol.,increase,risk
Methantheline,Voriconazole,Methantheline can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methantheline,Xamoterol,The risk or severity of Tachycardia can be increased when Methantheline is combined with Xamoterol.,increase,risk
Methantheline,Xylometazoline,The risk or severity of Tachycardia can be increased when Methantheline is combined with Xylometazoline.,increase,risk
Methantheline,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Methantheline.,increase,risk
Hexafluronium,Gabapentin,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gabapentin.,increase,risk
Hexafluronium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gabapentin enacarbil.,increase,risk
Hexafluronium,Galantamine,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Galantamine.,decrease,no risk
Hexafluronium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Hexafluronium.,increase,risk
Hexafluronium,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Hexafluronium is combined with Ganaxolone.",increase,risk
Hexafluronium,Gepirone,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gepirone.,increase,risk
Hexafluronium,Ginkgo biloba,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Hexafluronium,Glutethimide,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Glutethimide.,increase,risk
Hexafluronium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hexafluronium.,decrease,no risk
Hexafluronium,Glycopyrronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Glycopyrronium.,increase,risk
Hexafluronium,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Hexafluronium.,increase,risk
Hexafluronium,Guanfacine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Guanfacine.,increase,risk
Hexafluronium,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Hexafluronium.,increase,risk
Hexafluronium,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Hexafluronium.,increase,risk
Hexafluronium,Halothane,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Halothane.,increase,risk
Hexafluronium,Hexocyclium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Hexocyclium.,increase,risk
Hexafluronium,Homatropine,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Homatropine.,increase,risk
Hexafluronium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Hexafluronium.,increase,risk
Hexafluronium,Huperzine A,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Huperzine A.,decrease,no risk
Hexafluronium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Hexafluronium.,increase,no risk
Hexafluronium,Hydrocodone,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hexafluronium,Hydrocortisone,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Hexafluronium,Hydrocortisone acetate,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Hexafluronium,Hydrocortisone butyrate,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Hexafluronium,Hydrocortisone cypionate,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Hexafluronium,Hydrocortisone succinate,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Hexafluronium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Hexafluronium.,increase,no risk
Hexafluronium,Hydromorphone,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Hydromorphone.,increase,risk
Hexafluronium,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Hexafluronium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hexafluronium.,increase,risk
Hexafluronium,Ketamine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ketamine.,increase,risk
Hexafluronium,Ketazolam,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ketazolam.,increase,risk
Hexafluronium,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Hexafluronium.,increase,risk
Hexafluronium,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Hexafluronium is combined with Oliceridine.",increase,risk
Hexafluronium,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Hexafluronium.,increase,risk
Hexafluronium,Opium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Opium.,increase,risk
Hexafluronium,Orphenadrine,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Hexafluronium,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Hexafluronium.,increase,risk
Hexafluronium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Hexafluronium.,increase,risk
Hexafluronium,Oxitriptan,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Oxitriptan.,increase,risk
Hexafluronium,Oxprenolol,Hexafluronium may increase the bradycardic activities of Oxprenolol.,increase,no risk
Hexafluronium,Oxybuprocaine,Hexafluronium may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Hexafluronium,Oxybutynin,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Oxybutynin.,increase,risk
Hexafluronium,Oxycodone,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Oxycodone.,increase,risk
Hexafluronium,Oxymorphone,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Oxymorphone.,increase,risk
Hexafluronium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hexafluronium.,increase,risk
Hexafluronium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hexafluronium.,decrease,no risk
Hexafluronium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hexafluronium.,increase,risk
Hexafluronium,Quazepam,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Quazepam.,increase,risk
Hexafluronium,Quetiapine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Quetiapine.,increase,risk
Hexafluronium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Hexafluronium.,increase,no risk
Hexafluronium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Hexafluronium.,increase,risk
Hexafluronium,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Hexafluronium.,increase,risk
Hexafluronium,Quinupramine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Quinupramine.,increase,risk
Hexafluronium,Umeclidinium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Umeclidinium.,increase,risk
Hexafluronium,Urethane,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Urethane.,increase,risk
Hexafluronium,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Hexafluronium.,increase,risk
Hexafluronium,Vamorolone,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Vamorolone.,decrease,no risk
Hexafluronium,Varenicline,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Varenicline.,increase,risk
Hexafluronium,Vecuronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vecuronium.,increase,risk
Hexafluronium,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Hexafluronium.,increase,risk
Hexafluronium,Vigabatrin,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vigabatrin.,increase,risk
Hexafluronium,Vilazodone,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vilazodone.,increase,risk
Hexafluronium,Viloxazine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Viloxazine.,increase,risk
Hexafluronium,Vortioxetine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vortioxetine.,increase,risk
Hexafluronium,Yohimbine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Yohimbine.,increase,risk
Hexafluronium,Zaleplon,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Zaleplon.,increase,risk
Hexafluronium,Ziconotide,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ziconotide.,increase,risk
Hexafluronium,Zimelidine,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Zimelidine.,increase,risk
Hexafluronium,Ziprasidone,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Ziprasidone.,increase,risk
Hexafluronium,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Hexafluronium.,increase,risk
Hexafluronium,Zolpidem,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Hexafluronium,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Hexafluronium.,increase,risk
Hexafluronium,Zopiclone,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Zopiclone.,increase,risk
Hexafluronium,Zotepine,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Zotepine.,increase,risk
Hexafluronium,Zuclopenthixol,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Zuclopenthixol.,increase,risk
Cycrimine,Galantamine,The therapeutic efficacy of Cycrimine can be decreased when used in combination with Galantamine.,decrease,no risk
Cycrimine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Cycrimine.,increase,risk
Cycrimine,Ginkgo biloba,The therapeutic efficacy of Cycrimine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Cycrimine,Glucagon,Cycrimine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Cycrimine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Cycrimine.,decrease,no risk
Cycrimine,Glycopyrronium,The risk or severity of adverse effects can be increased when Cycrimine is combined with Glycopyrronium.,increase,risk
Cycrimine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Cycrimine.,increase,risk
Cycrimine,Guanfacine,The risk or severity of Tachycardia can be increased when Cycrimine is combined with Guanfacine.,increase,risk
Cycrimine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Cycrimine.,increase,risk
Cycrimine,Hexocyclium,The risk or severity of adverse effects can be increased when Cycrimine is combined with Hexocyclium.,increase,risk
Cycrimine,Homatropine,The risk or severity of adverse effects can be increased when Cycrimine is combined with Homatropine.,increase,risk
Cycrimine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Cycrimine.,increase,risk
Cycrimine,Huperzine A,The therapeutic efficacy of Cycrimine can be decreased when used in combination with Huperzine A.,decrease,no risk
Cycrimine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Cycrimine.,increase,no risk
Cycrimine,Hydrocodone,The risk or severity of adverse effects can be increased when Cycrimine is combined with Hydrocodone.,increase,risk
Cycrimine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Cycrimine.,increase,no risk
Cycrimine,Hydromorphone,The risk or severity of adverse effects can be increased when Cycrimine is combined with Hydromorphone.,increase,risk
Cycrimine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Cycrimine.,increase,risk
Cycrimine,Ketamine,The therapeutic efficacy of Cycrimine can be decreased when used in combination with Ketamine.,decrease,no risk
Cycrimine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Cycrimine.,increase,risk
Cycrimine,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Cycrimine is combined with Oliceridine.",increase,risk
Cycrimine,Olodaterol,The risk or severity of Tachycardia can be increased when Cycrimine is combined with Olodaterol.,increase,risk
Cycrimine,Opium,The risk or severity of adverse effects can be increased when Cycrimine is combined with Opium.,increase,risk
Cycrimine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Cycrimine.,increase,risk
Cycrimine,Orphenadrine,The risk or severity of adverse effects can be increased when Cycrimine is combined with Orphenadrine.,increase,risk
Cycrimine,Oxybutynin,The risk or severity of adverse effects can be increased when Cycrimine is combined with Oxybutynin.,increase,risk
Cycrimine,Oxycodone,The risk or severity of adverse effects can be increased when Cycrimine is combined with Oxycodone.,increase,risk
Cycrimine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Cycrimine.,increase,risk
Cycrimine,Oxymorphone,The risk or severity of adverse effects can be increased when Cycrimine is combined with Oxymorphone.,increase,risk
Cycrimine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Cycrimine.,increase,risk
Cycrimine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Cycrimine.,decrease,no risk
Cycrimine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cycrimine.,increase,risk
Cycrimine,Quetiapine,The risk or severity of adverse effects can be increased when Cycrimine is combined with Quetiapine.,increase,risk
Cycrimine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Cycrimine.,increase,no risk
Cycrimine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Cycrimine.,increase,risk
Cycrimine,Quinupramine,The risk or severity of adverse effects can be increased when Cycrimine is combined with Quinupramine.,increase,risk
Cycrimine,Umeclidinium,The risk or severity of adverse effects can be increased when Cycrimine is combined with Umeclidinium.,increase,risk
Cycrimine,Vecuronium,The risk or severity of adverse effects can be increased when Cycrimine is combined with Vecuronium.,increase,risk
Cycrimine,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Cycrimine.,increase,risk
Cycrimine,Vilanterol,The risk or severity of Tachycardia can be increased when Cycrimine is combined with Vilanterol.,increase,risk
Cycrimine,Xamoterol,The risk or severity of Tachycardia can be increased when Cycrimine is combined with Xamoterol.,increase,risk
Cycrimine,Xylometazoline,The risk or severity of Tachycardia can be increased when Cycrimine is combined with Xylometazoline.,increase,risk
Cycrimine,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Cycrimine.,increase,risk
Zalcitabine,Valganciclovir,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Zalcitabine.,increase,risk
Zalcitabine,Valproic acid,The excretion of Zalcitabine can be decreased when combined with Valproic acid.,decrease,no risk
Zalcitabine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Zalcitabine.,decrease,no risk
Zalcitabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Zalcitabine.,decrease,no risk
Zalcitabine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Zalcitabine.,decrease,no risk
Demecarium,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Oxprenolol,Demecarium may increase the bradycardic activities of Oxprenolol.,increase,no risk
Demecarium,Oxybuprocaine,Demecarium may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Demecarium,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Vamorolone,The therapeutic efficacy of Demecarium can be decreased when used in combination with Vamorolone.,decrease,no risk
Demecarium,Varenicline,The risk or severity of adverse effects can be increased when Demecarium is combined with Varenicline.,increase,risk
Demecarium,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Demecarium.,decrease,no risk
Demecarium,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Demecarium.,decrease,no risk
Aspirin,Bacitracin,The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Baclofen,Acetylsalicylic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Aspirin,Balsalazide,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Acetylsalicylic acid.,decrease,no risk
Aspirin,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Acetylsalicylic acid.,increase,no risk
Aspirin,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Belinostat,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Belinostat.,increase,risk
Aspirin,Bemiparin,Acetylsalicylic acid may increase the anticoagulant activities of Bemiparin.,increase,no risk
Aspirin,Benazepril,The therapeutic efficacy of Benazepril can be decreased when used in combination with Acetylsalicylic acid.,decrease,no risk
Aspirin,Bendamustine,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bendamustine.,increase,risk
Aspirin,Bendazac,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Bendazac.,increase,risk
Aspirin,Bendroflumethiazide,Acetylsalicylic acid may decrease the excretion rate of Bendroflumethiazide which could result in a higher serum level.,decrease,no risk
Aspirin,Benorilate,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Benorilate.,increase,risk
Aspirin,Benoxaprofen,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Benoxaprofen.,increase,risk
Aspirin,Benserazide,Acetylsalicylic acid may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Aspirin,Benzatropine,Acetylsalicylic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Aspirin,Benziodarone,The therapeutic efficacy of Benziodarone can be decreased when used in combination with Acetylsalicylic acid.,decrease,no risk
Aspirin,Benznidazole,Acetylsalicylic acid may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Aspirin,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Benzthiazide,Acetylsalicylic acid may decrease the excretion rate of Benzthiazide which could result in a higher serum level.,decrease,no risk
Aspirin,Benzydamine,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Benzydamine.,increase,risk
Aspirin,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Acetylsalicylic acid.,decrease,no risk
Aspirin,Bepotastine,Acetylsalicylic acid may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Aspirin,Bepridil,Acetylsalicylic acid may decrease the antihypertensive activities of Bepridil.,decrease,no risk
Aspirin,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Betamethasone phosphate,The risk or severity of adverse effects can be increased when Betamethasone phosphate is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Betaxolol,Acetylsalicylic acid may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Aspirin,Bethanidine,Acetylsalicylic acid may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Aspirin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Betulinic Acid,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betulinic Acid.,increase,risk
Aspirin,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Bexagliflozin.,increase,risk
Aspirin,Bexarotene,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bexarotene.,increase,risk
Aspirin,Bicisate,Acetylsalicylic acid may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Aspirin,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acetylsalicylic acid.,decrease,no risk
Aspirin,Bimekizumab,The metabolism of Acetylsalicylic acid can be increased when combined with Bimekizumab.,increase,no risk
Aspirin,Binimetinib,The metabolism of Binimetinib can be increased when combined with Acetylsalicylic acid.,increase,no risk
Aspirin,Bismuth subgallate,Acetylsalicylic acid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Aspirin,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Acetylsalicylic acid.,decrease,no risk
Aspirin,Bisoprolol,Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Aspirin,Bisoxatin,Acetylsalicylic acid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Aspirin,Bivalirudin,Acetylsalicylic acid may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Aspirin,Bleomycin,Acetylsalicylic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Aspirin,Blinatumomab,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Blinatumomab.,increase,risk
Aspirin,Bortezomib,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bortezomib.,increase,risk
Aspirin,Bosentan,The metabolism of Acetylsalicylic acid can be increased when combined with Bosentan.,increase,no risk
Aspirin,Bosutinib,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Bosutinib.,increase,risk
Aspirin,Bretylium,Acetylsalicylic acid may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Aspirin,Brexpiprazole,The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Brexpiprazole.,increase,risk
Aspirin,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Brivaracetam,Acetylsalicylic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Aspirin,Bromazepam,Acetylsalicylic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Aspirin,Bromfenac,The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Bromfenac.,decrease,no risk
Aspirin,Bromocriptine,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Bromocriptine.,increase,risk
Aspirin,Bromotheophylline,Acetylsalicylic acid may decrease the excretion rate of Bromotheophylline which could result in a higher serum level.,decrease,no risk
Aspirin,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Bufexamac,The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Bufexamac.,decrease,no risk
Aspirin,Bumadizone,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Bumadizone.,increase,risk
Aspirin,Bumetanide,Acetylsalicylic acid may decrease the excretion rate of Bumetanide which could result in a higher serum level.,decrease,no risk
Aspirin,Buprenorphine,The metabolism of Acetylsalicylic acid can be decreased when combined with Buprenorphine.,decrease,no risk
Aspirin,Bupropion,Acetylsalicylic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Aspirin,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Acetylsalicylic acid.,increase,risk
Aspirin,Busulfan,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Busulfan.,increase,risk
Aspirin,Butabarbital,Acetylsalicylic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Aspirin,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Acetylsalicylic acid.,increase,risk
Phenprocoumon,Bemiparin,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Bemiparin.,increase,risk
Phenprocoumon,Bendamustine,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Bendamustine.,increase,risk
Phenprocoumon,Bendroflumethiazide,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Phenprocoumon,Benorilate,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Benoxaprofen,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Benzoic acid,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Benzoic acid.,increase,no risk
Phenprocoumon,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Benzthiazide,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Benzthiazide.,decrease,no risk
Phenprocoumon,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Benzyl alcohol,The metabolism of Phenprocoumon can be decreased when combined with Benzyl alcohol.,decrease,no risk
Phenprocoumon,Benzylpenicillin,Benzylpenicillin may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Benzylpenicilloyl polylysine,Benzylpenicilloyl polylysine may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Phenprocoumon.,decrease,no risk
Phenprocoumon,Berotralstat,The serum concentration of Phenprocoumon can be increased when it is combined with Berotralstat.,increase,no risk
Phenprocoumon,Betamethasone,Betamethasone may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Betamethasone phosphate,Betamethasone phosphate may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Betrixaban,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Betrixaban.,increase,risk
Phenprocoumon,Bexarotene,The metabolism of Phenprocoumon can be increased when combined with Bexarotene.,increase,no risk
Phenprocoumon,Bezafibrate,The metabolism of Phenprocoumon can be decreased when combined with Bezafibrate.,decrease,no risk
Phenprocoumon,Bicalutamide,The metabolism of Phenprocoumon can be decreased when combined with Bicalutamide.,decrease,no risk
Phenprocoumon,Bifonazole,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Bifonazole.,increase,no risk
Phenprocoumon,Bimekizumab,The metabolism of Phenprocoumon can be increased when combined with Bimekizumab.,increase,no risk
Phenprocoumon,Bismuth subsalicylate,Bismuth subsalicylate may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Blinatumomab,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Blinatumomab.,increase,risk
Phenprocoumon,Boceprevir,The metabolism of Phenprocoumon can be decreased when combined with Boceprevir.,decrease,no risk
Phenprocoumon,Bortezomib,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Bortezomib.,increase,risk
Phenprocoumon,Bosentan,The metabolism of Phenprocoumon can be increased when combined with Bosentan.,increase,no risk
Phenprocoumon,Bosutinib,The metabolism of Phenprocoumon can be decreased when combined with Bosutinib.,decrease,no risk
Phenprocoumon,Brentuximab vedotin,The serum concentration of Phenprocoumon can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Phenprocoumon,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Brexpiprazole,The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Phenprocoumon.,decrease,no risk
Phenprocoumon,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Phenprocoumon.,decrease,no risk
Phenprocoumon,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Budesonide,Budesonide may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Buprenorphine,The metabolism of Phenprocoumon can be decreased when combined with Buprenorphine.,decrease,no risk
Phenprocoumon,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Busulfan,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Busulfan.,increase,risk
Phenprocoumon,Butabarbital,The metabolism of Phenprocoumon can be increased when combined with Butabarbital.,increase,no risk
Phenprocoumon,Butalbital,The metabolism of Phenprocoumon can be increased when combined with Butalbital.,increase,no risk
Phenprocoumon,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Gatifloxacin,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Gatifloxacin.,increase,no risk
Phenprocoumon,Gefitinib,Gefitinib may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Gemcitabine,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Gemcitabine.,increase,no risk
Phenprocoumon,Gemfibrozil,The metabolism of Phenprocoumon can be decreased when combined with Gemfibrozil.,decrease,no risk
Phenprocoumon,Gemifloxacin,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Gemifloxacin.,increase,no risk
Phenprocoumon,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Gemtuzumab ozogamicin.,increase,risk
Phenprocoumon,Gentamicin,The risk or severity of bleeding can be increased when Gentamicin is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Gilteritinib,The metabolism of Phenprocoumon can be decreased when combined with Gilteritinib.,decrease,no risk
Phenprocoumon,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Glasdegib,The metabolism of Phenprocoumon can be decreased when combined with Glasdegib.,decrease,no risk
Phenprocoumon,Glecaprevir,The metabolism of Phenprocoumon can be decreased when combined with Glecaprevir.,decrease,no risk
Phenprocoumon,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Phenprocoumon.,increase,no risk
Phenprocoumon,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Phenprocoumon.,increase,no risk
Phenprocoumon,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Phenprocoumon.,increase,no risk
Phenprocoumon,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Phenprocoumon.,increase,no risk
Phenprocoumon,Glofitamab,The serum concentration of Phenprocoumon can be increased when it is combined with Glofitamab.,increase,no risk
Phenprocoumon,Glucagon,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Glucagon.,increase,no risk
Phenprocoumon,Glutethimide,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Glutethimide.,decrease,no risk
Phenprocoumon,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Phenprocoumon.,increase,no risk
Phenprocoumon,Glycerol phenylbutyrate,The metabolism of Phenprocoumon can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Phenprocoumon,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Golimumab,The metabolism of Phenprocoumon can be increased when combined with Golimumab.,increase,no risk
Phenprocoumon,Gramicidin D,The risk or severity of bleeding can be increased when Gramicidin D is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Grapefruit,The serum concentration of Phenprocoumon can be increased when it is combined with Grapefruit.,increase,no risk
Phenprocoumon,Grepafloxacin,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Grepafloxacin.,increase,no risk
Phenprocoumon,Griseofulvin,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Griseofulvin.,increase,no risk
Phenprocoumon,Halofantrine,The metabolism of Phenprocoumon can be decreased when combined with Halofantrine.,decrease,no risk
Phenprocoumon,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Phenprocoumon.,increase,no risk
Phenprocoumon,Haloprogin,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Haloprogin.,increase,no risk
Phenprocoumon,Halothane,The metabolism of Halothane can be decreased when combined with Phenprocoumon.,decrease,no risk
Phenprocoumon,Hemin,Hemin may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Heparin,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Heparin.,increase,risk
Phenprocoumon,Hetacillin,Hetacillin may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Hexetidine,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Hexetidine.,increase,no risk
Phenprocoumon,Hydralazine,The serum concentration of Phenprocoumon can be increased when it is combined with Hydralazine.,increase,no risk
Phenprocoumon,Hydrochlorothiazide,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Phenprocoumon,Hydrocortamate,The metabolism of Phenprocoumon can be increased when combined with Hydrocortamate.,increase,no risk
Phenprocoumon,Hydrocortisone,Hydrocortisone may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Hydrocortisone acetate,Hydrocortisone acetate may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Hydrocortisone succinate,Hydrocortisone succinate may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Hydroflumethiazide,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Phenprocoumon,Hydromorphone,The metabolism of Phenprocoumon can be decreased when combined with Hydromorphone.,decrease,no risk
Phenprocoumon,Hydroxychloroquine,The metabolism of Phenprocoumon can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Phenprocoumon,Hydroxyprogesterone caproate,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Phenprocoumon,Hydroxyurea,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Hydroxyurea.,increase,risk
Phenprocoumon,Kanamycin,The risk or severity of bleeding can be increased when Kanamycin is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Ketamine,The metabolism of Phenprocoumon can be decreased when combined with Ketamine.,decrease,no risk
Phenprocoumon,Ketazolam,The serum concentration of Phenprocoumon can be increased when it is combined with Ketazolam.,increase,no risk
Phenprocoumon,Ketoconazole,The metabolism of Phenprocoumon can be decreased when combined with Ketoconazole.,decrease,no risk
Phenprocoumon,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Phenprocoumon is combined with Obeticholic acid.,increase,risk
Phenprocoumon,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Phenprocoumon is combined with Obinutuzumab.,increase,risk
Phenprocoumon,Octreotide,The serum concentration of Phenprocoumon can be increased when it is combined with Octreotide.,increase,no risk
Phenprocoumon,Ofloxacin,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Ofloxacin.,increase,no risk
Phenprocoumon,Olanzapine,The metabolism of Phenprocoumon can be decreased when combined with Olanzapine.,decrease,no risk
Phenprocoumon,Olaparib,The metabolism of Phenprocoumon can be decreased when combined with Olaparib.,decrease,no risk
Phenprocoumon,Olive oil,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Olive oil.,decrease,no risk
Phenprocoumon,Olodaterol,The metabolism of Phenprocoumon can be decreased when combined with Olodaterol.,decrease,no risk
Phenprocoumon,Olsalazine,Olsalazine may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Olutasidenib,The metabolism of Phenprocoumon can be increased when combined with Olutasidenib.,increase,no risk
Phenprocoumon,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Omacetaxine mepesuccinate.,increase,risk
Phenprocoumon,Omadacycline,Omadacycline may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Omaveloxolone,The serum concentration of Phenprocoumon can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Phenprocoumon,Ombitasvir,The metabolism of Phenprocoumon can be decreased when combined with Ombitasvir.,decrease,no risk
Phenprocoumon,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Omega-3-carboxylic acids,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Phenprocoumon,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Oritavancin,The metabolism of Phenprocoumon can be increased when combined with Oritavancin.,increase,no risk
Phenprocoumon,Orphenadrine,The metabolism of Phenprocoumon can be decreased when combined with Orphenadrine.,decrease,no risk
Phenprocoumon,Osilodrostat,The metabolism of Phenprocoumon can be decreased when combined with Osilodrostat.,decrease,no risk
Phenprocoumon,Osimertinib,The metabolism of Phenprocoumon can be decreased when combined with Osimertinib.,decrease,no risk
Phenprocoumon,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Phenprocoumon.,decrease,no risk
Phenprocoumon,Oxacillin,Oxacillin may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Oxandrolone,The metabolism of Phenprocoumon can be decreased when combined with Oxandrolone.,decrease,no risk
Phenprocoumon,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Oxcarbazepine,The metabolism of Phenprocoumon can be increased when combined with Oxcarbazepine.,increase,no risk
Phenprocoumon,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Oxybutynin,The serum concentration of Phenprocoumon can be increased when it is combined with Oxybutynin.,increase,no risk
Phenprocoumon,Oxymetholone,Oxymetholone may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Oxytetracycline,Oxytetracycline may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Ozanimod,The metabolism of Phenprocoumon can be decreased when combined with Ozanimod.,decrease,no risk
Phenprocoumon,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Quinestrol,Quinestrol may decrease the anticoagulant activities of Phenprocoumon.,decrease,no risk
Phenprocoumon,Quinidine,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Quinidine.,increase,no risk
Phenprocoumon,Quinine,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Quinine.,increase,no risk
Phenprocoumon,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Quinupristin,The metabolism of Phenprocoumon can be decreased when combined with Quinupristin.,decrease,no risk
Phenprocoumon,Ubidecarenone,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Ubidecarenone.,decrease,no risk
Phenprocoumon,Ulipristal,The therapeutic efficacy of Phenprocoumon can be decreased when used in combination with Ulipristal.,decrease,no risk
Phenprocoumon,Urokinase,Urokinase may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Phenprocoumon is combined with Ursodeoxycholic acid.,increase,risk
Phenprocoumon,Vadadustat,The serum concentration of Phenprocoumon can be increased when it is combined with Vadadustat.,increase,no risk
Phenprocoumon,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Valproic acid,The serum concentration of Phenprocoumon can be increased when it is combined with Valproic acid.,increase,no risk
Phenprocoumon,Valsartan,The metabolism of Phenprocoumon can be decreased when combined with Valsartan.,decrease,no risk
Phenprocoumon,Vamorolone,Vamorolone may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Vancomycin,The risk or severity of bleeding can be increased when Vancomycin is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Vardenafil,The metabolism of Phenprocoumon can be decreased when combined with Vardenafil.,decrease,no risk
Phenprocoumon,Velpatasvir,The metabolism of Phenprocoumon can be decreased when combined with Velpatasvir.,decrease,no risk
Phenprocoumon,Vemurafenib,The metabolism of Phenprocoumon can be increased when combined with Vemurafenib.,increase,no risk
Phenprocoumon,Venetoclax,The metabolism of Phenprocoumon can be decreased when combined with Venetoclax.,decrease,no risk
Phenprocoumon,Venlafaxine,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Venlafaxine.,increase,risk
Phenprocoumon,Verapamil,The metabolism of Phenprocoumon can be decreased when combined with Verapamil.,decrease,no risk
Phenprocoumon,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Viloxazine,The metabolism of Phenprocoumon can be decreased when combined with Viloxazine.,decrease,no risk
Phenprocoumon,Vinblastine,The metabolism of Phenprocoumon can be increased when combined with Vinblastine.,increase,no risk
Phenprocoumon,Vindesine,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Vindesine.,increase,risk
Phenprocoumon,Vinorelbine,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Vinorelbine.,increase,risk
Phenprocoumon,Viomycin,The risk or severity of bleeding can be increased when Viomycin is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Vitamin E,Vitamin E may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Phenprocoumon.,decrease,no risk
Phenprocoumon,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Voriconazole,The metabolism of Phenprocoumon can be decreased when combined with Voriconazole.,decrease,no risk
Phenprocoumon,Vorinostat,Vorinostat may increase the anticoagulant activities of Phenprocoumon.,increase,no risk
Phenprocoumon,Vortioxetine,The metabolism of Phenprocoumon can be decreased when combined with Vortioxetine.,decrease,no risk
Phenprocoumon,Voxelotor,The serum concentration of Phenprocoumon can be increased when it is combined with Voxelotor.,increase,no risk
Phenprocoumon,Voxilaprevir,The metabolism of Phenprocoumon can be decreased when combined with Voxilaprevir.,decrease,no risk
Phenprocoumon,Warfarin,The metabolism of Phenprocoumon can be increased when combined with Warfarin.,increase,no risk
Phenprocoumon,Ximelagatran,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Ximelagatran.,increase,risk
Phenprocoumon,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Zafirlukast,The serum concentration of Phenprocoumon can be increased when it is combined with Zafirlukast.,increase,no risk
Phenprocoumon,Zidovudine,The metabolism of Phenprocoumon can be decreased when combined with Zidovudine.,decrease,no risk
Phenprocoumon,Zileuton,The metabolism of Phenprocoumon can be decreased when combined with Zileuton.,decrease,no risk
Phenprocoumon,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Ziprasidone,The metabolism of Phenprocoumon can be decreased when combined with Ziprasidone.,decrease,no risk
Phenprocoumon,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Zolpidem,The metabolism of Phenprocoumon can be decreased when combined with Zolpidem.,decrease,no risk
Phenprocoumon,Zopiclone,The metabolism of Phenprocoumon can be decreased when combined with Zopiclone.,decrease,no risk
Phenprocoumon,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Phenprocoumon.,increase,risk
Phenprocoumon,Zuclopenthixol,The metabolism of Phenprocoumon can be decreased when combined with Zuclopenthixol.,decrease,no risk
Fulvestrant,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Benzocaine.,increase,risk
Fulvestrant,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Benzyl alcohol.,increase,risk
Fulvestrant,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Bupivacaine.,increase,risk
Fulvestrant,Butacaine,The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Butacaine.,increase,risk
Fulvestrant,Butamben,The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Butamben.,increase,risk
Fulvestrant,Gemfibrozil,The metabolism of Fulvestrant can be decreased when combined with Gemfibrozil.,decrease,no risk
Fulvestrant,Glecaprevir,The metabolism of Fulvestrant can be decreased when combined with Glecaprevir.,decrease,no risk
Fulvestrant,Ketoconazole,The metabolism of Fulvestrant can be decreased when combined with Ketoconazole.,decrease,no risk
Fulvestrant,Ombitasvir,The metabolism of Fulvestrant can be decreased when combined with Ombitasvir.,decrease,no risk
Fulvestrant,Ospemifene,The risk or severity of adverse effects can be increased when Fulvestrant is combined with Ospemifene.,increase,risk
Fulvestrant,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Oxetacaine.,increase,risk
Fulvestrant,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Oxybuprocaine.,increase,risk
Fulvestrant,Quizartinib,The metabolism of Fulvestrant can be decreased when combined with Quizartinib.,decrease,no risk
Fulvestrant,Valproic acid,The metabolism of Fulvestrant can be decreased when combined with Valproic acid.,decrease,no risk
Fulvestrant,Zidovudine,The metabolism of Fulvestrant can be increased when combined with Zidovudine.,increase,no risk
Mezlocillin,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Mezlocillin.,decrease,no risk
Mezlocillin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Mezlocillin.,increase,no risk
Mezlocillin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mezlocillin.,decrease,no risk
Mezlocillin,Warfarin,Mezlocillin may increase the anticoagulant activities of Warfarin.,increase,no risk
Felbamate,Brexanolone,The risk or severity of CNS depression can be increased when Felbamate is combined with Brexanolone.,increase,risk
Felbamate,Brexpiprazole,The risk or severity of CNS depression can be increased when Felbamate is combined with Brexpiprazole.,increase,risk
Felbamate,Brigatinib,The metabolism of Brigatinib can be increased when combined with Felbamate.,increase,no risk
Felbamate,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Felbamate.,increase,no risk
Felbamate,Brivaracetam,The risk or severity of CNS depression can be increased when Felbamate is combined with Brivaracetam.,increase,risk
Felbamate,Bromazepam,The risk or severity of CNS depression can be increased when Felbamate is combined with Bromazepam.,increase,risk
Felbamate,Bromocriptine,The risk or severity of CNS depression can be increased when Felbamate is combined with Bromocriptine.,increase,risk
Felbamate,Bromotheophylline,Felbamate may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Felbamate,Bromperidol,The risk or severity of CNS depression can be increased when Felbamate is combined with Bromperidol.,increase,risk
Felbamate,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Felbamate.,increase,risk
Felbamate,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Felbamate.,increase,risk
Felbamate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Felbamate is combined with Bupivacaine.,increase,risk
Felbamate,Buprenorphine,Felbamate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Felbamate,Bupropion,The risk or severity of CNS depression can be increased when Felbamate is combined with Bupropion.,increase,risk
Felbamate,Buserelin,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Buserelin.,increase,risk
Felbamate,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Felbamate.,increase,risk
Felbamate,Busulfan,The metabolism of Busulfan can be increased when combined with Felbamate.,increase,no risk
Felbamate,Butabarbital,The serum concentration of Butabarbital can be increased when it is combined with Felbamate.,increase,no risk
Felbamate,Butacaine,The risk or severity of methemoglobinemia can be increased when Felbamate is combined with Butacaine.,increase,risk
Felbamate,Butalbital,The serum concentration of Butalbital can be increased when it is combined with Felbamate.,increase,no risk
Felbamate,Butamben,The risk or severity of methemoglobinemia can be increased when Felbamate is combined with Butamben.,increase,risk
Felbamate,Butaperazine,The risk or severity of CNS depression can be increased when Felbamate is combined with Butaperazine.,increase,risk
Felbamate,Butobarbital,The risk or severity of CNS depression can be increased when Felbamate is combined with Butobarbital.,increase,risk
Felbamate,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Felbamate.,increase,risk
Felbamate,Butriptyline,The risk or severity of CNS depression can be increased when Felbamate is combined with Butriptyline.,increase,risk
Felbamate,Gabapentin,The risk or severity of CNS depression can be increased when Felbamate is combined with Gabapentin.,increase,risk
Felbamate,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Felbamate is combined with Gabapentin enacarbil.,increase,risk
Felbamate,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Gadobenic acid.,increase,risk
Felbamate,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Felbamate.,increase,risk
Felbamate,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Felbamate.,increase,risk
Felbamate,Gamolenic acid,The therapeutic efficacy of Felbamate can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Felbamate,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Felbamate is combined with Ganaxolone.",increase,risk
Felbamate,Ganciclovir,The therapeutic efficacy of Felbamate can be decreased when used in combination with Ganciclovir.,decrease,no risk
Felbamate,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Gatifloxacin.,increase,risk
Felbamate,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Gemifloxacin.,increase,risk
Felbamate,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Felbamate.,increase,risk
Felbamate,Gestrinone,The metabolism of Gestrinone can be increased when combined with Felbamate.,increase,no risk
Felbamate,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Felbamate.,increase,no risk
Felbamate,Glasdegib,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Glasdegib.,increase,risk
Felbamate,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Glipizide,The metabolism of Glipizide can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Glofitamab,The serum concentration of Felbamate can be increased when it is combined with Glofitamab.,increase,no risk
Felbamate,Glutethimide,The risk or severity of CNS depression can be increased when Felbamate is combined with Glutethimide.,increase,risk
Felbamate,Glyburide,The metabolism of Glyburide can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Glycerin,The metabolism of Felbamate can be increased when combined with Glycerin.,increase,no risk
Felbamate,Golimumab,The metabolism of Felbamate can be increased when combined with Golimumab.,increase,no risk
Felbamate,Goserelin,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Goserelin.,increase,risk
Felbamate,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Felbamate.,increase,risk
Felbamate,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Grepafloxacin.,increase,risk
Felbamate,Guanfacine,The risk or severity of CNS depression can be increased when Felbamate is combined with Guanfacine.,increase,risk
Felbamate,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Felbamate.,increase,risk
Felbamate,Halofantrine,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Halofantrine.,increase,risk
Felbamate,Haloperidol,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Haloperidol.,increase,risk
Felbamate,Halothane,The risk or severity of CNS depression can be increased when Felbamate is combined with Halothane.,increase,risk
Felbamate,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Felbamate.,increase,risk
Felbamate,Histrelin,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Histrelin.,increase,risk
Felbamate,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Hydrochlorothiazide.,increase,risk
Felbamate,Hydrocodone,Felbamate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Felbamate,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Felbamate.,increase,risk
Felbamate,Hydroxychloroquine,The therapeutic efficacy of Felbamate can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Felbamate,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Felbamate.,increase,no risk
Felbamate,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Hydroxyzine.,increase,risk
Felbamate,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Felbamate.,increase,risk
Felbamate,Ketamine,The risk or severity of CNS depression can be increased when Felbamate is combined with Ketamine.,increase,risk
Felbamate,Ketazolam,The risk or severity of CNS depression can be increased when Felbamate is combined with Ketazolam.,increase,risk
Felbamate,Ketoconazole,The metabolism of Felbamate can be decreased when combined with Ketoconazole.,decrease,no risk
Felbamate,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Felbamate.,increase,risk
Felbamate,Ofloxacin,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Ofloxacin.,increase,risk
Felbamate,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Felbamate.,increase,risk
Felbamate,Olaparib,The metabolism of Olaparib can be increased when combined with Felbamate.,increase,no risk
Felbamate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Felbamate is combined with Oliceridine.",increase,risk
Felbamate,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Omaveloxolone,The serum concentration of Felbamate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Felbamate,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Felbamate.,increase,risk
Felbamate,Opium,The risk or severity of CNS depression can be increased when Felbamate is combined with Opium.,increase,risk
Felbamate,Orlistat,Orlistat can cause a decrease in the absorption of Felbamate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Felbamate,Orphenadrine,Felbamate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Felbamate,Osimertinib,The metabolism of Osimertinib can be increased when combined with Felbamate.,increase,no risk
Felbamate,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Felbamate.,increase,risk
Felbamate,Oxatomide,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Oxatomide.,increase,risk
Felbamate,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Felbamate.,increase,risk
Felbamate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Felbamate.,increase,risk
Felbamate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Felbamate is combined with Oxetacaine.,increase,risk
Felbamate,Oxitriptan,The risk or severity of CNS depression can be increased when Felbamate is combined with Oxitriptan.,increase,risk
Felbamate,Oxprenolol,The risk or severity of CNS depression can be increased when Felbamate is combined with Oxprenolol.,increase,risk
Felbamate,Oxtriphylline,Felbamate may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Felbamate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Felbamate is combined with Oxybuprocaine.,increase,risk
Felbamate,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Felbamate.,increase,risk
Felbamate,Oxymorphone,The risk or severity of CNS depression can be increased when Felbamate is combined with Oxymorphone.,increase,risk
Felbamate,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Felbamate.,increase,risk
Felbamate,Quazepam,The risk or severity of CNS depression can be increased when Felbamate is combined with Quazepam.,increase,risk
Felbamate,Quetiapine,The risk or severity of CNS depression can be increased when Felbamate is combined with Quetiapine.,increase,risk
Felbamate,Quinidine,The metabolism of Quinidine can be increased when combined with Felbamate.,increase,no risk
Felbamate,Quinine,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Quinine.,increase,risk
Felbamate,Quinupramine,The risk or severity of CNS depression can be increased when Felbamate is combined with Quinupramine.,increase,risk
Felbamate,Quizartinib,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Quizartinib.,increase,risk
Felbamate,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Felbamate.,decrease,no risk
Felbamate,Ulipristal,The metabolism of Ulipristal can be increased when combined with Felbamate.,increase,no risk
Felbamate,Urethane,The risk or severity of CNS depression can be increased when Felbamate is combined with Urethane.,increase,risk
Felbamate,Vadadustat,The serum concentration of Felbamate can be increased when it is combined with Vadadustat.,increase,no risk
Felbamate,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Valganciclovir,The therapeutic efficacy of Felbamate can be decreased when used in combination with Valganciclovir.,decrease,no risk
Felbamate,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Felbamate.,increase,no risk
Felbamate,Valsartan,The metabolism of Valsartan can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Vandetanib,The metabolism of Vandetanib can be increased when combined with Felbamate.,increase,no risk
Felbamate,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Vasopressin,Felbamate may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Felbamate,Vayarin,The metabolism of Felbamate can be decreased when combined with Vayarin.,decrease,no risk
Felbamate,Vecuronium,The risk or severity of CNS depression can be increased when Felbamate is combined with Vecuronium.,increase,risk
Felbamate,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Felbamate.,increase,risk
Felbamate,Venetoclax,The metabolism of Venetoclax can be increased when combined with Felbamate.,increase,no risk
Felbamate,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Felbamate.,increase,risk
Felbamate,Verapamil,The metabolism of Felbamate can be decreased when combined with Verapamil.,decrease,no risk
Felbamate,Vernakalant,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Vernakalant.,increase,risk
Felbamate,Vigabatrin,The risk or severity of CNS depression can be increased when Felbamate is combined with Vigabatrin.,increase,risk
Felbamate,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Felbamate.,increase,risk
Felbamate,Vilazodone,The risk or severity of CNS depression can be increased when Felbamate is combined with Vilazodone.,increase,risk
Felbamate,Viloxazine,The metabolism of Felbamate can be decreased when combined with Viloxazine.,decrease,no risk
Felbamate,Vinblastine,The metabolism of Vinblastine can be increased when combined with Felbamate.,increase,no risk
Felbamate,Vincristine,The metabolism of Vincristine can be increased when combined with Felbamate.,increase,no risk
Felbamate,Vindesine,The metabolism of Vindesine can be increased when combined with Felbamate.,increase,no risk
Felbamate,Vinflunine,The metabolism of Vinflunine can be increased when combined with Felbamate.,increase,no risk
Felbamate,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Felbamate.,increase,no risk
Felbamate,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Felbamate.,increase,no risk
Felbamate,Voriconazole,The metabolism of Felbamate can be decreased when combined with Voriconazole.,decrease,no risk
Felbamate,Vorinostat,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Vorinostat.,increase,risk
Felbamate,Vortioxetine,The risk or severity of CNS depression can be increased when Felbamate is combined with Vortioxetine.,increase,risk
Felbamate,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Warfarin,The metabolism of Warfarin can be increased when combined with Felbamate.,increase,no risk
Felbamate,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Yohimbine,The risk or severity of CNS depression can be increased when Felbamate is combined with Yohimbine.,increase,risk
Felbamate,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Zaleplon,The risk or severity of CNS depression can be increased when Felbamate is combined with Zaleplon.,increase,risk
Felbamate,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Felbamate.,increase,no risk
Felbamate,Ziconotide,The risk or severity of CNS depression can be increased when Felbamate is combined with Ziconotide.,increase,risk
Felbamate,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Zileuton,The metabolism of Zileuton can be decreased when combined with Felbamate.,decrease,no risk
Felbamate,Zimelidine,The risk or severity of adverse effects can be increased when Felbamate is combined with Zimelidine.,increase,risk
Felbamate,Ziprasidone,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Ziprasidone.,increase,risk
Felbamate,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Felbamate.,increase,risk
Felbamate,Zolpidem,Felbamate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Felbamate,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Felbamate.,increase,risk
Felbamate,Zopiclone,The risk or severity of adverse effects can be increased when Felbamate is combined with Zopiclone.,increase,risk
Felbamate,Zotepine,The risk or severity of CNS depression can be increased when Felbamate is combined with Zotepine.,increase,risk
Felbamate,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Felbamate is combined with Zuclopenthixol.,increase,risk
Felbamate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Felbamate.,increase,risk
Fexofenadine,Ganciclovir,The excretion of Fexofenadine can be decreased when combined with Ganciclovir.,decrease,no risk
Fexofenadine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Gemfibrozil,The excretion of Fexofenadine can be decreased when combined with Gemfibrozil.,decrease,no risk
Fexofenadine,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Glasdegib,The serum concentration of Fexofenadine can be increased when it is combined with Glasdegib.,increase,no risk
Fexofenadine,Glecaprevir,The serum concentration of Fexofenadine can be increased when it is combined with Glecaprevir.,increase,no risk
Fexofenadine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Guanidine,The excretion of Fexofenadine can be decreased when combined with Guanidine.,decrease,no risk
Fexofenadine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Fexofenadine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fexofenadine,Hyoscyamine,Fexofenadine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Fexofenadine,Ketoconazole,The serum concentration of Fexofenadine can be increased when it is combined with Ketoconazole.,increase,no risk
Fexofenadine,Ketoprofen,The excretion of Fexofenadine can be decreased when combined with Ketoprofen.,decrease,no risk
Fexofenadine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Ouabain,The excretion of Fexofenadine can be decreased when combined with Ouabain.,decrease,no risk
Fexofenadine,Oxytetracycline,The excretion of Fexofenadine can be decreased when combined with Oxytetracycline.,decrease,no risk
Fexofenadine,Quinidine,The excretion of Fexofenadine can be decreased when combined with Quinidine.,decrease,no risk
Fexofenadine,Quinine,The serum concentration of Fexofenadine can be increased when it is combined with Quinine.,increase,no risk
Fexofenadine,Quizartinib,The serum concentration of Fexofenadine can be increased when it is combined with Quizartinib.,increase,no risk
Fexofenadine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Umbralisib,The serum concentration of Fexofenadine can be increased when it is combined with Umbralisib.,increase,no risk
Fexofenadine,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Vadadustat,The serum concentration of Fexofenadine can be increased when it is combined with Vadadustat.,increase,no risk
Fexofenadine,Valproic acid,The excretion of Fexofenadine can be decreased when combined with Valproic acid.,decrease,no risk
Fexofenadine,Valsartan,The excretion of Fexofenadine can be decreased when combined with Valsartan.,decrease,no risk
Fexofenadine,Vandetanib,The serum concentration of Fexofenadine can be increased when it is combined with Vandetanib.,increase,no risk
Fexofenadine,Vardenafil,The serum concentration of Fexofenadine can be increased when it is combined with Vardenafil.,increase,no risk
Fexofenadine,Velpatasvir,The serum concentration of Fexofenadine can be increased when it is combined with Velpatasvir.,increase,no risk
Fexofenadine,Vemurafenib,The serum concentration of Fexofenadine can be increased when it is combined with Vemurafenib.,increase,no risk
Fexofenadine,Venetoclax,The serum concentration of Fexofenadine can be increased when it is combined with Venetoclax.,increase,no risk
Fexofenadine,Verapamil,The serum concentration of Fexofenadine can be increased when it is combined with Verapamil.,increase,no risk
Fexofenadine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Fexofenadine.,increase,no risk
Fexofenadine,Voclosporin,The serum concentration of Fexofenadine can be increased when it is combined with Voclosporin.,increase,no risk
Fexofenadine,Vorapaxar,The serum concentration of Fexofenadine can be increased when it is combined with Vorapaxar.,increase,no risk
Fexofenadine,Voxilaprevir,The serum concentration of Fexofenadine can be increased when it is combined with Voxilaprevir.,increase,no risk
Fexofenadine,Zidovudine,The excretion of Fexofenadine can be decreased when combined with Zidovudine.,decrease,no risk
Fexofenadine,Zonisamide,The serum concentration of Fexofenadine can be increased when it is combined with Zonisamide.,increase,no risk
Isoniazid,Bacitracin,Bacitracin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Baclofen,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Isoniazid.",increase,risk
Isoniazid,Balsalazide,Balsalazide may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Beclomethasone dipropionate,The serum concentration of Isoniazid can be decreased when it is combined with Beclomethasone dipropionate.,decrease,no risk
Isoniazid,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Isoniazid.,increase,no risk
Isoniazid,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isoniazid,Benorilate,Benorilate may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Benserazide,Isoniazid may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Isoniazid,Benzatropine,Benzatropine may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Benznidazole,Isoniazid may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Isoniazid,Benzocaine,The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Benzocaine.,increase,risk
Isoniazid,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Benzthiazide,Benzthiazide may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isoniazid,Benzydamine,Benzydamine may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Benzyl alcohol.,increase,risk
Isoniazid,Bepotastine,Isoniazid may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Isoniazid,Bepridil,The metabolism of Bepridil can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Betamethasone,The serum concentration of Isoniazid can be decreased when it is combined with Betamethasone.,decrease,no risk
Isoniazid,Betamethasone phosphate,The serum concentration of Isoniazid can be decreased when it is combined with Betamethasone phosphate.,decrease,no risk
Isoniazid,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bicisate,Isoniazid may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Isoniazid,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bismuth subgallate,Isoniazid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Isoniazid,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bisoxatin,Isoniazid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Isoniazid,Bleomycin,Bleomycin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bosentan,The metabolism of Bosentan can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Bromotheophylline,The serum concentration of Bromotheophylline can be increased when it is combined with Isoniazid.,increase,no risk
Isoniazid,Budesonide,The serum concentration of Isoniazid can be decreased when it is combined with Budesonide.,decrease,no risk
Isoniazid,Bumadizone,Bumadizone may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Bumetanide,Bumetanide may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isoniazid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Bupivacaine.,increase,risk
Isoniazid,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Isoniazid.,increase,risk
Isoniazid,Buspirone,The metabolism of Buspirone can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Busulfan,The metabolism of Busulfan can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Butabarbital,Butabarbital may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Butacaine,The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Butacaine.,increase,risk
Isoniazid,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Butamben,The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Butamben.,increase,risk
Isoniazid,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Isoniazid.,increase,risk
Isoniazid,Butriptyline,The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Butriptyline.,increase,risk
Isoniazid,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Gabapentin enacarbil,Isoniazid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Isoniazid,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Gadodiamide,Gadodiamide may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Gadofosveset trisodium,Isoniazid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Isoniazid,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Gadoteric acid,Isoniazid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Isoniazid,Gadoteridol,Gadoteridol may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Galantamine,The metabolism of Galantamine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isoniazid is combined with Ganciclovir.",increase,risk
Isoniazid,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Gemcitabine,Gemcitabine may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Gentamicin,Isoniazid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Isoniazid,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Isoniazid.,increase,no risk
Isoniazid,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Gimeracil,Isoniazid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Isoniazid,Givosiran,Givosiran may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Glycerol phenylbutyrate,Isoniazid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Isoniazid,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Golodirsen,Isoniazid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Isoniazid,Goserelin,Goserelin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Granisetron,The metabolism of Granisetron can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Guanethidine,Isoniazid may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Isoniazid,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Halcinonide,The serum concentration of Isoniazid can be decreased when it is combined with Halcinonide.,decrease,no risk
Isoniazid,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Isoniazid.,increase,no risk
Isoniazid,Halothane,The metabolism of Halothane can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Hydralazine,Isoniazid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Isoniazid,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isoniazid,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Isoniazid.,increase,risk
Isoniazid,Hydrocortisone,The serum concentration of Isoniazid can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Isoniazid,Hydrocortisone acetate,The serum concentration of Isoniazid can be decreased when it is combined with Hydrocortisone acetate.,decrease,no risk
Isoniazid,Hydrocortisone butyrate,The serum concentration of Isoniazid can be decreased when it is combined with Hydrocortisone butyrate.,decrease,no risk
Isoniazid,Hydrocortisone cypionate,The serum concentration of Isoniazid can be decreased when it is combined with Hydrocortisone cypionate.,decrease,no risk
Isoniazid,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Hydrocortisone probutate,The serum concentration of Isoniazid can be decreased when it is combined with Hydrocortisone probutate.,decrease,no risk
Isoniazid,Hydrocortisone succinate,The serum concentration of Isoniazid can be decreased when it is combined with Hydrocortisone succinate.,decrease,no risk
Isoniazid,Hydrocortisone valerate,The serum concentration of Isoniazid can be decreased when it is combined with Hydrocortisone valerate.,decrease,no risk
Isoniazid,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isoniazid,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Isoniazid.,increase,risk
Isoniazid,Hydroxyethyl Starch,Isoniazid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Isoniazid,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Kanamycin,Isoniazid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Isoniazid,Ketamine,The metabolism of Ketamine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Ketoconazole,The serum concentration of Ketoconazole can be decreased when it is combined with Isoniazid.,decrease,no risk
Isoniazid,Ketoprofen,Ketoprofen may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Octinoxate,Isoniazid may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Isoniazid,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isoniazid is combined with Ofloxacin.",increase,risk
Isoniazid,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Olaparib,The metabolism of Olaparib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Isoniazid.,increase,no risk
Isoniazid,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Olsalazine,Olsalazine may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Isoniazid.,increase,no risk
Isoniazid,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Opium,The metabolism of Opium can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Oseltamivir,Oseltamivir may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Oxacillin,Oxacillin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Oxaprozin,Oxaprozin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Oxazepam,Oxazepam may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Isoniazid.,decrease,no risk
Isoniazid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Oxetacaine.,increase,risk
Isoniazid,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Isoniazid.,increase,no risk
Isoniazid,Oxybenzone,Isoniazid may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Isoniazid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Oxybuprocaine.,increase,risk
Isoniazid,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Isoniazid which could result in a higher serum level.,decrease,no risk
Isoniazid,Oxyquinoline,Isoniazid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Isoniazid,Quazepam,The metabolism of Quazepam can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Quinethazone,Quinethazone may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isoniazid,Quinidine,The metabolism of Quinidine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Quinine,The metabolism of Quinine can be decreased when combined with Isoniazid.,decrease,no risk
Isoniazid,Quinupramine,The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Quinupramine.,increase,risk
Isoniazid,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Isoniazid.,decrease,no risk
Naratriptan,Gabapentin,The risk or severity of CNS depression can be increased when Naratriptan is combined with Gabapentin.,increase,risk
Naratriptan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Naratriptan is combined with Gabapentin enacarbil.,increase,risk
Naratriptan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Naratriptan.,increase,risk
Naratriptan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Naratriptan is combined with Ganaxolone.",increase,risk
Naratriptan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Naratriptan.,increase,risk
Naratriptan,Gilteritinib,The therapeutic efficacy of Naratriptan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Naratriptan,Ginkgo biloba,The metabolism of Naratriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Naratriptan,Glutethimide,The risk or severity of CNS depression can be increased when Naratriptan is combined with Glutethimide.,increase,risk
Naratriptan,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Naratriptan.,increase,risk
Naratriptan,Guanabenz,Naratriptan may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Naratriptan,Guanadrel,Naratriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Naratriptan,Guanethidine,Naratriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Naratriptan,Guanfacine,The risk or severity of CNS depression can be increased when Naratriptan is combined with Guanfacine.,increase,risk
Naratriptan,Guanoxan,Naratriptan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Naratriptan,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Naratriptan.,increase,risk
Naratriptan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Naratriptan.,increase,risk
Naratriptan,Halothane,The risk or severity of CNS depression can be increased when Naratriptan is combined with Halothane.,increase,risk
Naratriptan,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Naratriptan.,increase,risk
Naratriptan,Hydralazine,Naratriptan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Naratriptan,Hydrochlorothiazide,Naratriptan may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Naratriptan,Hydrocodone,Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Naratriptan,Hydroflumethiazide,Naratriptan may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Naratriptan,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Naratriptan.,increase,risk
Naratriptan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Naratriptan.,increase,no risk
Naratriptan,Ketamine,The risk or severity of CNS depression can be increased when Naratriptan is combined with Ketamine.,increase,risk
Naratriptan,Ketazolam,The risk or severity of CNS depression can be increased when Naratriptan is combined with Ketazolam.,increase,risk
Naratriptan,Ketoprofen,The risk or severity of hypertension can be increased when Naratriptan is combined with Ketoprofen.,increase,risk
Naratriptan,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Naratriptan.,increase,risk
Naratriptan,Olanzapine,The risk or severity of adverse effects can be increased when Naratriptan is combined with Olanzapine.,increase,risk
Naratriptan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Naratriptan is combined with Oliceridine.",increase,risk
Naratriptan,Olmesartan,Naratriptan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Naratriptan,Olodaterol,The risk or severity of hypertension can be increased when Naratriptan is combined with Olodaterol.,increase,risk
Naratriptan,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Naratriptan.,increase,risk
Naratriptan,Opium,The risk or severity of CNS depression can be increased when Naratriptan is combined with Opium.,increase,risk
Naratriptan,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Naratriptan.,increase,risk
Naratriptan,Orphenadrine,Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Naratriptan,Oxaprozin,The risk or severity of hypertension can be increased when Naratriptan is combined with Oxaprozin.,increase,risk
Naratriptan,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Naratriptan.,increase,risk
Naratriptan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Naratriptan.,increase,risk
Naratriptan,Oxitriptan,The risk or severity of CNS depression can be increased when Naratriptan is combined with Oxitriptan.,increase,risk
Naratriptan,Oxprenolol,The risk or severity of CNS depression can be increased when Naratriptan is combined with Oxprenolol.,increase,risk
Naratriptan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Naratriptan.,increase,risk
Naratriptan,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Naratriptan.,increase,risk
Naratriptan,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Naratriptan.,increase,risk
Naratriptan,Oxymorphone,The risk or severity of CNS depression can be increased when Naratriptan is combined with Oxymorphone.,increase,risk
Naratriptan,Oxyphenbutazone,The risk or severity of hypertension can be increased when Naratriptan is combined with Oxyphenbutazone.,increase,risk
Naratriptan,Oxytocin,The risk or severity of hypertension can be increased when Naratriptan is combined with Oxytocin.,increase,risk
Naratriptan,Quazepam,The risk or severity of CNS depression can be increased when Naratriptan is combined with Quazepam.,increase,risk
Naratriptan,Quetiapine,The risk or severity of adverse effects can be increased when Naratriptan is combined with Quetiapine.,increase,risk
Naratriptan,Quinapril,Naratriptan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Naratriptan,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Naratriptan.,increase,risk
Naratriptan,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Naratriptan.,increase,risk
Naratriptan,Quinupramine,The risk or severity of CNS depression can be increased when Naratriptan is combined with Quinupramine.,increase,risk
Naratriptan,Urethane,The risk or severity of CNS depression can be increased when Naratriptan is combined with Urethane.,increase,risk
Naratriptan,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Naratriptan.,increase,risk
Naratriptan,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Naratriptan is combined with Valproate bismuth.,increase,risk
Naratriptan,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Naratriptan.,increase,risk
Naratriptan,Valsartan,Naratriptan may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Naratriptan,Vecuronium,The risk or severity of CNS depression can be increased when Naratriptan is combined with Vecuronium.,increase,risk
Naratriptan,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Naratriptan is combined with Venlafaxine.,increase,risk
Naratriptan,Vigabatrin,The risk or severity of CNS depression can be increased when Naratriptan is combined with Vigabatrin.,increase,risk
Naratriptan,Vilanterol,The risk or severity of hypertension can be increased when Naratriptan is combined with Vilanterol.,increase,risk
Naratriptan,Vilazodone,The risk or severity of adverse effects can be increased when Naratriptan is combined with Vilazodone.,increase,risk
Naratriptan,Viloxazine,The risk or severity of CNS depression can be increased when Naratriptan is combined with Viloxazine.,increase,risk
Naratriptan,Vortioxetine,The risk or severity of adverse effects can be increased when Naratriptan is combined with Vortioxetine.,increase,risk
Naratriptan,Warfarin,The risk or severity of adverse effects can be increased when Naratriptan is combined with Warfarin.,increase,risk
Naratriptan,Xamoterol,The risk or severity of hypertension can be increased when Naratriptan is combined with Xamoterol.,increase,risk
Naratriptan,Xylometazoline,The risk or severity of hypertension can be increased when Naratriptan is combined with Xylometazoline.,increase,risk
Naratriptan,Yohimbine,The risk or severity of CNS depression can be increased when Naratriptan is combined with Yohimbine.,increase,risk
Naratriptan,Zaleplon,The risk or severity of CNS depression can be increased when Naratriptan is combined with Zaleplon.,increase,risk
Naratriptan,Ziconotide,The risk or severity of CNS depression can be increased when Naratriptan is combined with Ziconotide.,increase,risk
Naratriptan,Zimelidine,The metabolism of Naratriptan can be decreased when combined with Zimelidine.,decrease,no risk
Naratriptan,Ziprasidone,The risk or severity of adverse effects can be increased when Naratriptan is combined with Ziprasidone.,increase,risk
Naratriptan,Zofenopril,Naratriptan may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Naratriptan,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Naratriptan is combined with Zolmitriptan.,increase,risk
Naratriptan,Zolpidem,Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Naratriptan,Zonisamide,The metabolism of Naratriptan can be decreased when combined with Zonisamide.,decrease,no risk
Naratriptan,Zopiclone,The risk or severity of adverse effects can be increased when Naratriptan is combined with Zopiclone.,increase,risk
Naratriptan,Zotepine,The risk or severity of adverse effects can be increased when Naratriptan is combined with Zotepine.,increase,risk
Naratriptan,Zuclopenthixol,The risk or severity of adverse effects can be increased when Naratriptan is combined with Zuclopenthixol.,increase,risk
Naratriptan,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Naratriptan.,increase,risk
Rizatriptan,Bupropion,Rizatriptan may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Rizatriptan,Buspirone,The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Rizatriptan.,increase,risk
Rizatriptan,Butabarbital,Butabarbital may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Butaperazine,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Butaperazine.,increase,risk
Rizatriptan,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Rizatriptan.,increase,risk
Rizatriptan,Butriptyline,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Butriptyline.,increase,risk
Rizatriptan,Gabapentin enacarbil,Rizatriptan may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gadodiamide,Gadodiamide may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gadofosveset trisodium,Rizatriptan may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gadoteric acid,Rizatriptan may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gadoteridol,Gadoteridol may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Ganciclovir,Rizatriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gemcitabine,Gemcitabine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gemfibrozil,Rizatriptan may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gentamicin,Rizatriptan may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Rizatriptan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Rizatriptan.,increase,risk
Rizatriptan,Gilteritinib,The therapeutic efficacy of Rizatriptan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Rizatriptan,Gimeracil,Rizatriptan may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Rizatriptan,Ginkgo biloba,The metabolism of Rizatriptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Rizatriptan,Givosiran,Givosiran may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Glipizide,Rizatriptan may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Rizatriptan,Glycerol phenylbutyrate,Rizatriptan may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Rizatriptan,Golodirsen,Rizatriptan may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Rizatriptan,Goserelin,Goserelin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Rizatriptan.,increase,risk
Rizatriptan,Guanabenz,Rizatriptan may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Rizatriptan,Guanadrel,Rizatriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Rizatriptan,Guanethidine,Rizatriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Rizatriptan,Guanfacine,Rizatriptan may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Rizatriptan,Guanoxan,Rizatriptan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Rizatriptan,Haloperidol,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Haloperidol.,increase,risk
Rizatriptan,Halothane,The risk or severity of hypertension can be increased when Rizatriptan is combined with Halothane.,increase,risk
Rizatriptan,Hydralazine,Rizatriptan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Rizatriptan,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rizatriptan,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Rizatriptan.,increase,risk
Rizatriptan,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rizatriptan,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Rizatriptan.,increase,risk
Rizatriptan,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Hydroxyethyl Starch,Rizatriptan may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Rizatriptan,Kanamycin,Rizatriptan may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Rizatriptan,Ketamine,Rizatriptan may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Rizatriptan,Ketazolam,Rizatriptan may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Rizatriptan,Ketoprofen,The risk or severity of hypertension can be increased when Rizatriptan is combined with Ketoprofen.,increase,risk
Rizatriptan,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Rizatriptan.,increase,risk
Rizatriptan,Octinoxate,Rizatriptan may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Rizatriptan,Olanzapine,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Olanzapine.,increase,risk
Rizatriptan,Oliceridine,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Oliceridine.,increase,risk
Rizatriptan,Olmesartan,Rizatriptan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Rizatriptan,Olodaterol,The risk or severity of hypertension can be increased when Rizatriptan is combined with Olodaterol.,increase,risk
Rizatriptan,Olsalazine,Olsalazine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Rizatriptan.,increase,risk
Rizatriptan,Opium,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Opium.,increase,risk
Rizatriptan,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Rizatriptan.,increase,risk
Rizatriptan,Oseltamivir,Oseltamivir may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Oxacillin,Oxacillin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Oxaprozin,The risk or severity of hypertension can be increased when Rizatriptan is combined with Oxaprozin.,increase,risk
Rizatriptan,Oxazepam,Oxazepam may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Oxprenolol,Rizatriptan may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Rizatriptan,Oxybenzone,Rizatriptan may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Rizatriptan,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Rizatriptan.,increase,risk
Rizatriptan,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Rizatriptan.,increase,risk
Rizatriptan,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Oxymorphone.,increase,risk
Rizatriptan,Oxyphenbutazone,The risk or severity of hypertension can be increased when Rizatriptan is combined with Oxyphenbutazone.,increase,risk
Rizatriptan,Oxyquinoline,Rizatriptan may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Rizatriptan,Quetiapine,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Quetiapine.,increase,risk
Rizatriptan,Quinapril,Rizatriptan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Rizatriptan,Quinethazone,Quinethazone may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rizatriptan,Quinidine,Rizatriptan may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Rizatriptan,Quinupramine,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Quinupramine.,increase,risk
Rizatriptan,Vaborbactam,Rizatriptan may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Rizatriptan,Valaciclovir,Valaciclovir may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Valbenazine,Rizatriptan may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Rizatriptan,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Rizatriptan.,increase,risk
Rizatriptan,Valganciclovir,Rizatriptan may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Rizatriptan,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Valproate bismuth.,increase,risk
Rizatriptan,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Rizatriptan.,increase,risk
Rizatriptan,Valsartan,Rizatriptan may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Rizatriptan,Vancomycin,Rizatriptan may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Rizatriptan,Varenicline,Rizatriptan may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Rizatriptan,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Venlafaxine.,increase,risk
Rizatriptan,Verapamil,Verapamil may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Vilanterol,The risk or severity of hypertension can be increased when Rizatriptan is combined with Vilanterol.,increase,risk
Rizatriptan,Vilazodone,The risk or severity of vasospastic reactions can be increased when Vilazodone is combined with Rizatriptan.,increase,risk
Rizatriptan,Viloxazine,Rizatriptan may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Rizatriptan,Vortioxetine,The risk or severity of vasospastic reactions can be increased when Vortioxetine is combined with Rizatriptan.,increase,risk
Rizatriptan,Warfarin,Rizatriptan may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Rizatriptan,Xamoterol,The risk or severity of hypertension can be increased when Rizatriptan is combined with Xamoterol.,increase,risk
Rizatriptan,Xylometazoline,The risk or severity of hypertension can be increased when Rizatriptan is combined with Xylometazoline.,increase,risk
Rizatriptan,Yohimbine,The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Yohimbine.,increase,risk
Rizatriptan,Zaleplon,Rizatriptan may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Rizatriptan,Zanamivir,Zanamivir may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,decrease,no risk
Rizatriptan,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Rizatriptan.,increase,risk
Rizatriptan,Ziprasidone,The risk or severity of vasospastic reactions can be increased when Ziprasidone is combined with Rizatriptan.,increase,risk
Rizatriptan,Zofenopril,Rizatriptan may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Rizatriptan,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Rizatriptan is combined with Zolmitriptan.,increase,risk
Rizatriptan,Zonisamide,The metabolism of Rizatriptan can be decreased when combined with Zonisamide.,decrease,no risk
Rizatriptan,Zotepine,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Zotepine.,increase,risk
Rizatriptan,Zuclopenthixol,The risk or severity of adverse effects can be increased when Rizatriptan is combined with Zuclopenthixol.,increase,risk
Dirithromycin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Dirithromycin.,decrease,no risk
Dirithromycin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dirithromycin is combined with Oxetacaine.,increase,risk
Dirithromycin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Dirithromycin.,decrease,no risk
Dirithromycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dirithromycin is combined with Oxybuprocaine.,increase,risk
Dirithromycin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Quinine,The serum concentration of Quinine can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dirithromycin.,decrease,no risk
Dirithromycin,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dirithromycin.,decrease,no risk
Dirithromycin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Dirithromycin.,decrease,no risk
Dirithromycin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Dirithromycin.,increase,no risk
Dirithromycin,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Dirithromycin.,decrease,no risk
Dirithromycin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dirithromycin.,decrease,no risk
Dirithromycin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Dirithromycin.,decrease,no risk
Netilmicin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gadodiamide,Gadodiamide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gadoteridol,Gadoteridol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Netilmicin.,increase,no risk
Netilmicin,Ganciclovir,Ganciclovir may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gemcitabine,Gemcitabine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gentamicin,Gentamicin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Gimeracil,Gimeracil may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Givosiran,Givosiran may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Glipizide,Glipizide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Netilmicin.,increase,risk
Netilmicin,Golodirsen,Golodirsen may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Goserelin,Goserelin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Guanethidine,Guanethidine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Guanfacine,Guanfacine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Haloperidol,Haloperidol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Heparin,The therapeutic efficacy of Netilmicin can be decreased when used in combination with Heparin.,decrease,no risk
Netilmicin,Hetacillin,The serum concentration of Netilmicin can be decreased when it is combined with Hetacillin.,decrease,no risk
Netilmicin,Hydralazine,Hydralazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Hydromorphone,Hydromorphone may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Kanamycin,Netilmicin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Netilmicin,Ketamine,Ketamine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Ketazolam,Ketazolam may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Ketoprofen,Ketoprofen may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Ketorolac,Ketorolac may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Octinoxate,Octinoxate may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Netilmicin is combined with Olsalazine.,increase,risk
Netilmicin,Opium,Opium may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Oseltamivir,Oseltamivir may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Ouabain,The risk or severity of adverse effects can be increased when Netilmicin is combined with Ouabain.,increase,risk
Netilmicin,Oxacillin,Oxacillin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Netilmicin.,increase,risk
Netilmicin,Oxaprozin,Oxaprozin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Oxazepam,Oxazepam may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Netilmicin is combined with Oxetacaine.,increase,risk
Netilmicin,Oxybenzone,Oxybenzone may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Netilmicin is combined with Oxybuprocaine.,increase,risk
Netilmicin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Netilmicin.,increase,risk
Netilmicin,Quetiapine,Quetiapine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Quinidine,Netilmicin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Netilmicin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Netilmicin.,increase,risk
Netilmicin,Vaborbactam,Vaborbactam may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Valaciclovir,Valaciclovir may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Valbenazine,Valbenazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Valdecoxib,Valdecoxib may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Valganciclovir,Valganciclovir may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Vancomycin,Vancomycin may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Varenicline,Varenicline may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Netilmicin.,increase,no risk
Netilmicin,Venlafaxine,Venlafaxine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Verapamil,Verapamil may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Netilmicin.,decrease,no risk
Netilmicin,Vilanterol,Vilanterol may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Viloxazine,Viloxazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Netilmicin is combined with Viomycin.,increase,risk
Netilmicin,Vortioxetine,Vortioxetine may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Warfarin,Netilmicin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Netilmicin,Zaleplon,Zaleplon may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Zanamivir,Zanamivir may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Netilmicin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Netilmicin is combined with Zoledronic acid.,increase,risk
Netilmicin,Zonisamide,Zonisamide may decrease the excretion rate of Netilmicin which could result in a higher serum level.,decrease,no risk
Hydrocodone,Gabapentin,The serum concentration of Hydrocodone can be decreased when it is combined with Gabapentin.,decrease,no risk
Hydrocodone,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Gefitinib,The metabolism of Hydrocodone can be decreased when combined with Gefitinib.,decrease,no risk
Hydrocodone,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Givosiran,The serum concentration of Hydrocodone can be increased when it is combined with Givosiran.,increase,no risk
Hydrocodone,Glofitamab,The serum concentration of Hydrocodone can be increased when it is combined with Glofitamab.,increase,no risk
Hydrocodone,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Hydrocodone.,decrease,no risk
Hydrocodone,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hydrocodone.,decrease,no risk
Hydrocodone,Glycerol phenylbutyrate,The metabolism of Hydrocodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Hydrocodone,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Hydrocodone.,increase,risk
Hydrocodone,Golimumab,The metabolism of Hydrocodone can be increased when combined with Golimumab.,increase,no risk
Hydrocodone,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Halofantrine,The metabolism of Hydrocodone can be decreased when combined with Halofantrine.,decrease,no risk
Hydrocodone,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Hydrocodone.,increase,risk
Hydrocodone,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Hydrocodone,Hydrocortisone,The metabolism of Hydrocodone can be increased when combined with Hydrocortisone.,increase,no risk
Hydrocodone,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Hydrocodone,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Hydroxychloroquine,The metabolism of Hydrocodone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydrocodone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hydrocodone.,increase,risk
Hydrocodone,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Ketoconazole,The metabolism of Hydrocodone can be decreased when combined with Ketoconazole.,decrease,no risk
Hydrocodone,Olanzapine,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Hydrocodone is combined with Oliceridine.",increase,risk
Hydrocodone,Omaveloxolone,The serum concentration of Hydrocodone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Hydrocodone,Ondansetron,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Opium,Opium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oritavancin,The metabolism of Hydrocodone can be decreased when combined with Oritavancin.,decrease,no risk
Hydrocodone,Orphenadrine,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Hydrocodone.,decrease,no risk
Hydrocodone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Hydrocodone.,decrease,no risk
Hydrocodone,Oxamniquine,The metabolism of Hydrocodone can be decreased when combined with Oxamniquine.,decrease,no risk
Hydrocodone,Oxazepam,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oxcarbazepine,Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oxitriptan,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oxprenolol,Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oxybuprocaine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hydrocodone.,increase,risk
Hydrocodone,Oxycodone,Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oxymorphone,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hydrocodone.,increase,risk
Hydrocodone,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hydrocodone.,decrease,no risk
Hydrocodone,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hydrocodone.,increase,risk
Hydrocodone,Quazepam,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Quetiapine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Hydrocodone.,decrease,no risk
Hydrocodone,Quinidine,The metabolism of Hydrocodone can be decreased when combined with Quinidine.,decrease,no risk
Hydrocodone,Quinine,Quinine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Quinupramine,Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Hydrocodone.,increase,risk
Hydrocodone,Urethane,Urethane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Vadadustat,The serum concentration of Hydrocodone can be decreased when it is combined with Vadadustat.,decrease,no risk
Hydrocodone,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Valproate bismuth.,increase,risk
Hydrocodone,Valproic acid,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Vecuronium,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Hydrocodone.,decrease,no risk
Hydrocodone,Vemurafenib,The metabolism of Hydrocodone can be decreased when combined with Vemurafenib.,decrease,no risk
Hydrocodone,Venetoclax,The metabolism of Hydrocodone can be decreased when combined with Venetoclax.,decrease,no risk
Hydrocodone,Venlafaxine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Verapamil,The metabolism of Hydrocodone can be decreased when combined with Verapamil.,decrease,no risk
Hydrocodone,Vigabatrin,Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Vilazodone,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Viloxazine,Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Vinblastine,The metabolism of Hydrocodone can be decreased when combined with Vinblastine.,decrease,no risk
Hydrocodone,Vinorelbine,The metabolism of Hydrocodone can be decreased when combined with Vinorelbine.,decrease,no risk
Hydrocodone,Voriconazole,The metabolism of Hydrocodone can be decreased when combined with Voriconazole.,decrease,no risk
Hydrocodone,Vortioxetine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Hydrocodone.,decrease,no risk
Hydrocodone,Yohimbine,Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zaleplon,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Hydrocodone.,decrease,no risk
Hydrocodone,Ziconotide,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zimelidine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Ziprasidone,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zolmitriptan,Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zolpidem,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zonisamide,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zopiclone,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zotepine,Zotepine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zuclopenthixol,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Hydrocodone,Zuranolone,Zuranolone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Norgestimate,Brompheniramine,The metabolism of Norgestimate can be decreased when combined with Brompheniramine.,decrease,no risk
Norgestimate,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Buprenorphine,The metabolism of Norgestimate can be decreased when combined with Buprenorphine.,decrease,no risk
Norgestimate,Bupropion,The metabolism of Bupropion can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Busulfan,The metabolism of Busulfan can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Butalbital,The metabolism of Norgestimate can be increased when combined with Butalbital.,increase,no risk
Norgestimate,Gabapentin,The metabolism of Norgestimate can be increased when combined with Gabapentin.,increase,no risk
Norgestimate,Ganaxolone,The metabolism of Norgestimate can be increased when combined with Ganaxolone.,increase,no risk
Norgestimate,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Gemfibrozil,The metabolism of Norgestimate can be decreased when combined with Gemfibrozil.,decrease,no risk
Norgestimate,Gestrinone,The metabolism of Gestrinone can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Ginkgo biloba,The metabolism of Norgestimate can be decreased when combined with Ginkgo biloba.,decrease,no risk
Norgestimate,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Glofitamab,The serum concentration of Norgestimate can be increased when it is combined with Glofitamab.,increase,no risk
Norgestimate,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Glycerol phenylbutyrate,The metabolism of Norgestimate can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Norgestimate,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Golimumab,The metabolism of Norgestimate can be increased when combined with Golimumab.,increase,no risk
Norgestimate,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Griseofulvin,The metabolism of Norgestimate can be increased when combined with Griseofulvin.,increase,no risk
Norgestimate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Halothane,The metabolism of Halothane can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Heparin,The risk or severity of adverse effects can be increased when Norgestimate is combined with Heparin.,increase,risk
Norgestimate,Hetacillin,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Hetacillin.,decrease,no risk
Norgestimate,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Norgestimate is combined with Human C1-esterase inhibitor.,increase,risk
Norgestimate,Hydrocodone,The metabolism of Norgestimate can be decreased when combined with Hydrocodone.,decrease,no risk
Norgestimate,Hydrocortamate,The metabolism of Norgestimate can be increased when combined with Hydrocortamate.,increase,no risk
Norgestimate,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Hydromorphone,The metabolism of Norgestimate can be decreased when combined with Hydromorphone.,decrease,no risk
Norgestimate,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Ketamine,The metabolism of Ketamine can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Ketoconazole,The metabolism of Norgestimate can be decreased when combined with Ketoconazole.,decrease,no risk
Norgestimate,Ketorolac,The metabolism of Norgestimate can be decreased when combined with Ketorolac.,decrease,no risk
Norgestimate,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Octreotide,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Octreotide.,decrease,no risk
Norgestimate,Olanzapine,The metabolism of Norgestimate can be decreased when combined with Olanzapine.,decrease,no risk
Norgestimate,Olaparib,The metabolism of Olaparib can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Norgestimate.,decrease,no risk
Norgestimate,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Olutasidenib,The metabolism of Norgestimate can be increased when combined with Olutasidenib.,increase,no risk
Norgestimate,Omadacycline,The serum concentration of Norgestimate can be decreased when it is combined with Omadacycline.,decrease,no risk
Norgestimate,Omaveloxolone,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Norgestimate,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Ondansetron,The metabolism of Norgestimate can be decreased when combined with Ondansetron.,decrease,no risk
Norgestimate,Oritavancin,The metabolism of Norgestimate can be increased when combined with Oritavancin.,increase,no risk
Norgestimate,Orphenadrine,The metabolism of Norgestimate can be decreased when combined with Orphenadrine.,decrease,no risk
Norgestimate,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Ox bile extract,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Oxacillin,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Oxacillin.,decrease,no risk
Norgestimate,Oxandrolone,The metabolism of Norgestimate can be decreased when combined with Oxandrolone.,decrease,no risk
Norgestimate,Oxcarbazepine,The metabolism of Norgestimate can be increased when combined with Oxcarbazepine.,increase,no risk
Norgestimate,Oxytetracycline,The serum concentration of Norgestimate can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Norgestimate,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Ulipristal,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Ulipristal.,decrease,no risk
Norgestimate,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Urokinase,The risk or severity of adverse effects can be increased when Norgestimate is combined with Urokinase.,increase,risk
Norgestimate,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Vadadustat,The serum concentration of Norgestimate can be decreased when it is combined with Vadadustat.,decrease,no risk
Norgestimate,Valdecoxib,The metabolism of Norgestimate can be decreased when combined with Valdecoxib.,decrease,no risk
Norgestimate,Valproic acid,The metabolism of Norgestimate can be increased when combined with Valproic acid.,increase,no risk
Norgestimate,Valsartan,The metabolism of Norgestimate can be decreased when combined with Valsartan.,decrease,no risk
Norgestimate,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Vandetanib,The metabolism of Vandetanib can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Verapamil,The metabolism of Norgestimate can be decreased when combined with Verapamil.,decrease,no risk
Norgestimate,Vigabatrin,The metabolism of Norgestimate can be increased when combined with Vigabatrin.,increase,no risk
Norgestimate,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Norgestimate.,decrease,no risk
Norgestimate,Viloxazine,The metabolism of Norgestimate can be decreased when combined with Viloxazine.,decrease,no risk
Norgestimate,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Vincristine,The excretion of Vincristine can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Vindesine,The metabolism of Vindesine can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Vitamin A,The therapeutic efficacy of Norgestimate can be decreased when used in combination with Vitamin A.,decrease,no risk
Norgestimate,Vitamin E,The metabolism of Norgestimate can be increased when combined with Vitamin E.,increase,no risk
Norgestimate,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Vorapaxar,The risk or severity of adverse effects can be increased when Norgestimate is combined with Vorapaxar.,increase,risk
Norgestimate,Voriconazole,The metabolism of Norgestimate can be decreased when combined with Voriconazole.,decrease,no risk
Norgestimate,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Norgestimate.,increase,no risk
Norgestimate,Warfarin,The metabolism of Warfarin can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Ximelagatran,The risk or severity of adverse effects can be increased when Norgestimate is combined with Ximelagatran.,increase,risk
Norgestimate,Zafirlukast,The metabolism of Norgestimate can be decreased when combined with Zafirlukast.,decrease,no risk
Norgestimate,Zaleplon,The metabolism of Norgestimate can be increased when combined with Zaleplon.,increase,no risk
Norgestimate,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Zidovudine,The metabolism of Norgestimate can be increased when combined with Zidovudine.,increase,no risk
Norgestimate,Zileuton,The metabolism of Norgestimate can be decreased when combined with Zileuton.,decrease,no risk
Norgestimate,Zimelidine,The metabolism of Norgestimate can be decreased when combined with Zimelidine.,decrease,no risk
Norgestimate,Ziprasidone,The metabolism of Norgestimate can be decreased when combined with Ziprasidone.,decrease,no risk
Norgestimate,Zolpidem,The metabolism of Zolpidem can be increased when combined with Norgestimate.,increase,no risk
Norgestimate,Zonisamide,The metabolism of Norgestimate can be increased when combined with Zonisamide.,increase,no risk
Norgestimate,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Norgestimate.,decrease,no risk
Norgestimate,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Norgestimate.,increase,no risk
Carboplatin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Benzyl alcohol.,increase,risk
Carboplatin,Bepotastine,Carboplatin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Carboplatin,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Carboplatin.,increase,risk
Carboplatin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Carboplatin.,increase,risk
Carboplatin,Bexarotene,The serum concentration of Bexarotene can be increased when it is combined with Carboplatin.,increase,no risk
Carboplatin,Bicisate,Carboplatin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Carboplatin,Bimekizumab,The risk or severity of adverse effects can be increased when Carboplatin is combined with Bimekizumab.,increase,risk
Carboplatin,Bismuth subgallate,Carboplatin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Carboplatin,Bisoprolol,Carboplatin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Carboplatin,Bisoxatin,Carboplatin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Carboplatin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Carboplatin.,increase,risk
Carboplatin,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Carboplatin.,increase,risk
Carboplatin,Blinatumomab,The risk or severity of adverse effects can be increased when Carboplatin is combined with Blinatumomab.,increase,risk
Carboplatin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Carboplatin.",decrease,no risk
Carboplatin,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Carboplatin.,increase,risk
Carboplatin,Bosutinib,The risk or severity of adverse effects can be increased when Carboplatin is combined with Bosutinib.,increase,risk
Carboplatin,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Carboplatin is combined with Brentuximab vedotin.,increase,risk
Carboplatin,Brivaracetam,Carboplatin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Carboplatin,Brodalumab,The risk or severity of adverse effects can be increased when Carboplatin is combined with Brodalumab.,increase,risk
Carboplatin,Bromazepam,Carboplatin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Carboplatin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carboplatin,Budesonide,The risk or severity of adverse effects can be increased when Carboplatin is combined with Budesonide.,increase,risk
Carboplatin,Bumadizone,The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Bumadizone.,increase,risk
Carboplatin,Bumetanide,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Carboplatin.,increase,risk
Carboplatin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Bupivacaine.,increase,risk
Carboplatin,Bupropion,Carboplatin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Carboplatin,Buspirone,Carboplatin may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Carboplatin,Busulfan,The risk or severity of adverse effects can be increased when Carboplatin is combined with Busulfan.,increase,risk
Carboplatin,Butabarbital,Carboplatin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Carboplatin,Butacaine,The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Butacaine.,increase,risk
Carboplatin,Butamben,The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Butamben.,increase,risk
Carboplatin,Gabapentin enacarbil,Carboplatin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Carboplatin,Gadobenic acid,Carboplatin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Carboplatin,Gadodiamide,Carboplatin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Carboplatin,Gadofosveset trisodium,Carboplatin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Carboplatin,Gadopentetic acid,Carboplatin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Carboplatin,Gadoteric acid,Carboplatin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Carboplatin,Gadoteridol,Carboplatin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Carboplatin,Ganciclovir,Carboplatin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Carboplatin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Carboplatin.,increase,risk
Carboplatin,Gemfibrozil,Carboplatin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Carboplatin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carboplatin.,increase,risk
Carboplatin,Gentamicin,The risk or severity of ototoxicity and nephrotoxicity can be increased when Gentamicin is combined with Carboplatin.,increase,risk
Carboplatin,Gimeracil,Carboplatin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Carboplatin,Givosiran,The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Givosiran.,increase,risk
Carboplatin,Glatiramer,The risk or severity of adverse effects can be increased when Carboplatin is combined with Glatiramer.,increase,risk
Carboplatin,Glipizide,Carboplatin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Carboplatin,Glycerol phenylbutyrate,Carboplatin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Carboplatin,Golimumab,The risk or severity of adverse effects can be increased when Carboplatin is combined with Golimumab.,increase,risk
Carboplatin,Golodirsen,Carboplatin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Carboplatin,Goserelin,Carboplatin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Carboplatin,Guanethidine,Carboplatin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Carboplatin,Guanfacine,Carboplatin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Carboplatin,Guselkumab,The risk or severity of adverse effects can be increased when Carboplatin is combined with Guselkumab.,increase,risk
Carboplatin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Carboplatin.,decrease,no risk
Carboplatin,Haloperidol,Carboplatin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Carboplatin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Carboplatin.,increase,risk
Carboplatin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Carboplatin.,decrease,no risk
Carboplatin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Carboplatin.,decrease,no risk
Carboplatin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Carboplatin.,increase,risk
Carboplatin,Hydralazine,Carboplatin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Carboplatin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Hydrochlorothiazide.,increase,risk
Carboplatin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Carboplatin is combined with Hydrocortisone acetate.,increase,risk
Carboplatin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Carboplatin is combined with Hydrocortisone butyrate.,increase,risk
Carboplatin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Carboplatin is combined with Hydrocortisone succinate.,increase,risk
Carboplatin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carboplatin,Hydromorphone,Carboplatin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Carboplatin,Hydroxocobalamin,Carboplatin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Carboplatin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Carboplatin is combined with Hydroxychloroquine.,increase,risk
Carboplatin,Hydroxyethyl Starch,Carboplatin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Carboplatin,Hydroxyurea,The risk or severity of adverse effects can be increased when Carboplatin is combined with Hydroxyurea.,increase,risk
Carboplatin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Carboplatin.,decrease,no risk
Carboplatin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Carboplatin.,decrease,no risk
Carboplatin,Kanamycin,The risk or severity of ototoxicity and nephrotoxicity can be increased when Kanamycin is combined with Carboplatin.,increase,risk
Carboplatin,Ketamine,Carboplatin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Carboplatin,Ketazolam,Carboplatin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Carboplatin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Ketoprofen.,increase,risk
Carboplatin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Carboplatin.,increase,risk
Carboplatin,Obinutuzumab,The risk or severity of adverse effects can be increased when Carboplatin is combined with Obinutuzumab.,increase,risk
Carboplatin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Carboplatin.,increase,no risk
Carboplatin,Octinoxate,Carboplatin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Carboplatin,Ofatumumab,The risk or severity of adverse effects can be increased when Carboplatin is combined with Ofatumumab.,increase,risk
Carboplatin,Olaparib,The risk or severity of adverse effects can be increased when Carboplatin is combined with Olaparib.,increase,risk
Carboplatin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Olsalazine.,increase,risk
Carboplatin,Opium,Carboplatin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Carboplatin,Oseltamivir,Carboplatin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Carboplatin,Oxacillin,Carboplatin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Carboplatin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Carboplatin.,increase,risk
Carboplatin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Oxaprozin.,increase,risk
Carboplatin,Oxazepam,Carboplatin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Carboplatin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Oxetacaine.,increase,risk
Carboplatin,Oxybenzone,Carboplatin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Carboplatin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Oxybuprocaine.,increase,risk
Carboplatin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Oxyphenbutazone.,increase,risk
Carboplatin,Oxyquinoline,Carboplatin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Carboplatin,Ozanimod,The risk or severity of adverse effects can be increased when Carboplatin is combined with Ozanimod.,increase,risk
Carboplatin,Quetiapine,Carboplatin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Carboplatin,Quinethazone,Quinethazone may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Carboplatin,Quinidine,Carboplatin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Methylprednisolone,Bortezomib,The metabolism of Bortezomib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Bosutinib,The metabolism of Bosutinib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Methylprednisolone.,increase,risk
Methylprednisolone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Brigatinib,The metabolism of Brigatinib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Brodalumab,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Brodalumab.,increase,risk
Methylprednisolone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Bromocriptine.,increase,risk
Methylprednisolone,Budesonide,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Budesonide.,increase,risk
Methylprednisolone,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Bumadizone.,increase,risk
Methylprednisolone,Bumetanide,The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Bumetanide.,increase,risk
Methylprednisolone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Methylprednisolone is combined with Bupivacaine.,increase,risk
Methylprednisolone,Busulfan,The metabolism of Busulfan can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Butacaine,The risk or severity of methemoglobinemia can be increased when Methylprednisolone is combined with Butacaine.,increase,risk
Methylprednisolone,Butamben,The risk or severity of methemoglobinemia can be increased when Methylprednisolone is combined with Butamben.,increase,risk
Methylprednisolone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Gatifloxacin,The risk or severity of tendinopathy can be increased when Methylprednisolone is combined with Gatifloxacin.,increase,risk
Methylprednisolone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Methylprednisolone.,increase,risk
Methylprednisolone,Gemifloxacin,The risk or severity of tendinopathy can be increased when Methylprednisolone is combined with Gemifloxacin.,increase,risk
Methylprednisolone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Methylprednisolone.,increase,risk
Methylprednisolone,Gestrinone,The serum concentration of Methylprednisolone can be increased when it is combined with Gestrinone.,increase,no risk
Methylprednisolone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Glatiramer,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Glatiramer.,increase,risk
Methylprednisolone,Gliclazide,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Gliclazide.,increase,risk
Methylprednisolone,Glimepiride,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Glimepiride.,increase,risk
Methylprednisolone,Glipizide,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Glipizide.,increase,risk
Methylprednisolone,Gliquidone,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Gliquidone.,increase,risk
Methylprednisolone,Glofitamab,The serum concentration of Methylprednisolone can be increased when it is combined with Glofitamab.,increase,no risk
Methylprednisolone,Glyburide,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Glyburide.,increase,risk
Methylprednisolone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Glycol salicylate.,increase,risk
Methylprednisolone,Glymidine,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Glymidine.,increase,risk
Methylprednisolone,Golimumab,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Golimumab.,increase,risk
Methylprednisolone,Grepafloxacin,The risk or severity of tendinopathy can be increased when Methylprednisolone is combined with Grepafloxacin.,increase,risk
Methylprednisolone,Guselkumab,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Guselkumab.,increase,risk
Methylprednisolone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Methylprednisolone is combined with Hydrochlorothiazide.,increase,risk
Methylprednisolone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Hydrocortisone acetate.,increase,risk
Methylprednisolone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Hydrocortisone butyrate.,increase,risk
Methylprednisolone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Hydrocortisone succinate.,increase,risk
Methylprednisolone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Methylprednisolone is combined with Hydroflumethiazide.,increase,risk
Methylprednisolone,Hydrotalcite,The bioavailability of Methylprednisolone can be decreased when combined with Hydrotalcite.,decrease,no risk
Methylprednisolone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Hydroxychloroquine.,increase,risk
Methylprednisolone,Hydroxyprogesterone caproate,The serum concentration of Methylprednisolone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Methylprednisolone,Hydroxyurea,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Hydroxyurea.,increase,risk
Methylprednisolone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Ketoconazole,The metabolism of Methylprednisolone can be decreased when combined with Ketoconazole.,decrease,no risk
Methylprednisolone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Ketoprofen.,increase,risk
Methylprednisolone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Ketorolac.,increase,risk
Methylprednisolone,Obinutuzumab,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Obinutuzumab.,increase,risk
Methylprednisolone,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Methylprednisolone.,increase,no risk
Methylprednisolone,Ofatumumab,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Ofatumumab.,increase,risk
Methylprednisolone,Ofloxacin,The risk or severity of tendinopathy can be increased when Methylprednisolone is combined with Ofloxacin.,increase,risk
Methylprednisolone,Olaparib,The metabolism of Olaparib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Methylprednisolone.,decrease,no risk
Methylprednisolone,Olodaterol,The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Olodaterol.,increase,risk
Methylprednisolone,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Methylprednisolone.,decrease,no risk
Methylprednisolone,Omaveloxolone,The serum concentration of Methylprednisolone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Methylprednisolone,Orciprenaline,The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Orciprenaline.,increase,risk
Methylprednisolone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Methylprednisolone.,increase,risk
Methylprednisolone,Oxandrolone,The risk or severity of fluid retention can be increased when Methylprednisolone is combined with Oxandrolone.,increase,risk
Methylprednisolone,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Oxaprozin.,increase,risk
Methylprednisolone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Methylprednisolone is combined with Oxetacaine.,increase,risk
Methylprednisolone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Methylprednisolone is combined with Oxybuprocaine.,increase,risk
Methylprednisolone,Oxymetholone,The risk or severity of fluid retention can be increased when Methylprednisolone is combined with Oxymetholone.,increase,risk
Methylprednisolone,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Oxyphenbutazone.,increase,risk
Methylprednisolone,Ozanimod,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Ozanimod.,increase,risk
Methylprednisolone,Quinestrol,The serum concentration of Methylprednisolone can be increased when it is combined with Quinestrol.,increase,no risk
Methylprednisolone,Quinethazone,Methylprednisolone may increase the hypokalemic activities of Quinethazone.,increase,no risk
Methylprednisolone,Quinidine,The metabolism of Quinidine can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Quinine,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Quinine.,increase,risk
Methylprednisolone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Methylprednisolone.,increase,risk
Methylprednisolone,Ulipristal,The serum concentration of Methylprednisolone can be increased when it is combined with Ulipristal.,increase,no risk
Methylprednisolone,Upadacitinib,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Upadacitinib.,increase,risk
Methylprednisolone,Vadadustat,The serum concentration of Methylprednisolone can be increased when it is combined with Vadadustat.,increase,no risk
Methylprednisolone,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Valdecoxib.,increase,risk
Methylprednisolone,Vandetanib,The metabolism of Vandetanib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Methylprednisolone.,increase,risk
Methylprednisolone,Vedolizumab,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Vedolizumab.,increase,risk
Methylprednisolone,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Venetoclax,The metabolism of Venetoclax can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Verapamil,The metabolism of Methylprednisolone can be decreased when combined with Verapamil.,decrease,no risk
Methylprednisolone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Vilanterol,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Vilanterol.,increase,risk
Methylprednisolone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Vildagliptin.,increase,risk
Methylprednisolone,Viloxazine,The metabolism of Methylprednisolone can be decreased when combined with Viloxazine.,decrease,no risk
Methylprednisolone,Vinblastine,The metabolism of Vinblastine can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Vincristine,The metabolism of Vincristine can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Vindesine,The metabolism of Vindesine can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Vinflunine,The metabolism of Vinflunine can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Voclosporin,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Voclosporin.,increase,risk
Methylprednisolone,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Voriconazole,The serum concentration of Methylprednisolone can be increased when it is combined with Voriconazole.,increase,no risk
Methylprednisolone,Vorinostat,The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Vorinostat.,increase,risk
Methylprednisolone,Warfarin,Methylprednisolone may increase the anticoagulant activities of Warfarin.,increase,no risk
Methylprednisolone,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Methylprednisolone.,decrease,no risk
Methylprednisolone,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Methylprednisolone.,increase,risk
Methylprednisolone,Zimelidine,The metabolism of Methylprednisolone can be decreased when combined with Zimelidine.,decrease,no risk
Methylprednisolone,Ziprasidone,The metabolism of Methylprednisolone can be decreased when combined with Ziprasidone.,decrease,no risk
Methylprednisolone,Zolpidem,The metabolism of Zolpidem can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Methylprednisolone.,increase,no risk
Methylprednisolone,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Methylprednisolone.,decrease,no risk
Pindolol,Bacitracin,Bacitracin may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Pindolol.,increase,risk
Pindolol,Balsalazide,Balsalazide may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Baricitinib,Pindolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Pindolol,Bemiparin,The risk or severity of hyperkalemia can be increased when Pindolol is combined with Bemiparin.,increase,risk
Pindolol,Benazepril,Benazepril may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Bendroflumethiazide,The therapeutic efficacy of Pindolol can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Pindolol,Benorilate,Benorilate may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Benoxaprofen,Benoxaprofen may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Benperidol,The risk or severity of CNS depression can be increased when Pindolol is combined with Benperidol.,increase,risk
Pindolol,Benserazide,Pindolol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Pindolol,Benzatropine,Benzatropine may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Benznidazole,Pindolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Pindolol,Benzocaine,The risk or severity of CNS depression can be increased when Pindolol is combined with Benzocaine.,increase,risk
Pindolol,Benzphetamine,The therapeutic efficacy of Pindolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Pindolol,Benzthiazide,The therapeutic efficacy of Pindolol can be increased when used in combination with Benzthiazide.,increase,no risk
Pindolol,Benzydamine,Benzydamine may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Benzyl alcohol,The risk or severity of CNS depression can be increased when Pindolol is combined with Benzyl alcohol.,increase,risk
Pindolol,Bepotastine,Pindolol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Pindolol,Bepridil,The risk or severity of bradycardia can be increased when Bepridil is combined with Pindolol.,increase,risk
Pindolol,Beractant,Pindolol may increase the bradycardic activities of Beractant.,increase,no risk
Pindolol,Berotralstat,The metabolism of Pindolol can be decreased when combined with Berotralstat.,decrease,no risk
Pindolol,Betaine,Betaine may increase the bradycardic activities of Pindolol.,increase,no risk
Pindolol,Betaxolol,Betaxolol may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Bethanechol,The risk or severity of adverse effects can be increased when Pindolol is combined with Bethanechol.,increase,risk
Pindolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Pindolol.,decrease,no risk
Pindolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Bicisate,Pindolol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Pindolol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Bimekizumab,The metabolism of Pindolol can be increased when combined with Bimekizumab.,increase,no risk
Pindolol,Biperiden,The metabolism of Pindolol can be decreased when combined with Biperiden.,decrease,no risk
Pindolol,Bismuth subgallate,Pindolol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Pindolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pindolol.,increase,risk
Pindolol,Bisoxatin,Pindolol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Pindolol,Bleomycin,Bleomycin may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Pindolol.,decrease,no risk
Pindolol,Bosentan,Bosentan may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Pindolol.,increase,risk
Pindolol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Pindolol.,increase,risk
Pindolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Pindolol.,increase,risk
Pindolol,Bretylium,Pindolol may increase the hypotensive activities of Bretylium.,increase,no risk
Pindolol,Brexanolone,The risk or severity of CNS depression can be increased when Pindolol is combined with Brexanolone.,increase,risk
Pindolol,Brexpiprazole,Pindolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Pindolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Pindolol.,increase,no risk
Pindolol,Brivaracetam,The risk or severity of CNS depression can be increased when Pindolol is combined with Brivaracetam.,increase,risk
Pindolol,Bromazepam,The risk or severity of CNS depression can be increased when Pindolol is combined with Bromazepam.,increase,risk
Pindolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Pindolol is combined with Bromotheophylline.,increase,risk
Pindolol,Bromperidol,The risk or severity of CNS depression can be increased when Pindolol is combined with Bromperidol.,increase,risk
Pindolol,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Pindolol.,increase,risk
Pindolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Pindolol.,increase,risk
Pindolol,Budesonide,Pindolol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Pindolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Bumetanide,Bumetanide may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pindolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Pindolol.,increase,no risk
Pindolol,Buprenorphine,Pindolol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Pindolol,Bupropion,The metabolism of Pindolol can be decreased when combined with Bupropion.,decrease,no risk
Pindolol,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Pindolol.,increase,risk
Pindolol,Butabarbital,Butabarbital may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Butalbital,Butalbital may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Butaperazine,The serum concentration of Pindolol can be increased when it is combined with Butaperazine.,increase,no risk
Pindolol,Butobarbital,The risk or severity of CNS depression can be increased when Pindolol is combined with Butobarbital.,increase,risk
Pindolol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Pindolol.,increase,risk
Pindolol,Butriptyline,The risk or severity of CNS depression can be increased when Pindolol is combined with Butriptyline.,increase,risk
Pindolol,Gabapentin,The risk or severity of CNS depression can be increased when Pindolol is combined with Gabapentin.,increase,risk
Pindolol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pindolol is combined with Gabapentin enacarbil.,increase,risk
Pindolol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Gadodiamide,Gadodiamide may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Gadofosveset trisodium,Pindolol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pindolol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Gadoteric acid,Pindolol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pindolol,Gadoteridol,Gadoteridol may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Galantamine,Galantamine may increase the bradycardic activities of Pindolol.,increase,no risk
Pindolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Pindolol.,increase,no risk
Pindolol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pindolol is combined with Ganaxolone.",increase,risk
Pindolol,Ganciclovir,Pindolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Pindolol,Gefitinib,The metabolism of Pindolol can be decreased when combined with Gefitinib.,decrease,no risk
Pindolol,Gemcitabine,Gemcitabine may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Gemfibrozil,Pindolol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Pindolol,Gentamicin,Pindolol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pindolol,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Pindolol.,increase,risk
Pindolol,Gilteritinib,The therapeutic efficacy of Pindolol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Pindolol,Gimeracil,Pindolol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pindolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Pindolol.,increase,no risk
Pindolol,Givosiran,The serum concentration of Pindolol can be increased when it is combined with Givosiran.,increase,no risk
Pindolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Glucagon,The therapeutic efficacy of Pindolol can be decreased when used in combination with Glucagon.,decrease,no risk
Pindolol,Glutethimide,The risk or severity of CNS depression can be increased when Pindolol is combined with Glutethimide.,increase,risk
Pindolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Glycerol phenylbutyrate,The metabolism of Pindolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Pindolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Pindolol.,increase,no risk
Pindolol,Golimumab,The metabolism of Pindolol can be increased when combined with Golimumab.,increase,no risk
Pindolol,Golodirsen,Pindolol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pindolol,Goserelin,Goserelin may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Pindolol.,increase,risk
Pindolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Pindolol.,decrease,no risk
Pindolol,Guanadrel,Guanadrel may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Guanethidine,Guanethidine may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Pindolol.,decrease,no risk
Pindolol,Guanoxan,Pindolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Pindolol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Pindolol.,increase,risk
Pindolol,Halofantrine,The metabolism of Pindolol can be decreased when combined with Halofantrine.,decrease,no risk
Pindolol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pindolol.,increase,risk
Pindolol,Halothane,The risk or severity of CNS depression can be increased when Pindolol is combined with Halothane.,increase,risk
Pindolol,Heparin,The risk or severity of hyperkalemia can be increased when Pindolol is combined with Heparin.,increase,risk
Pindolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Pindolol.,increase,no risk
Pindolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Pindolol.,increase,risk
Pindolol,Huperzine A,Huperzine A may increase the bradycardic activities of Pindolol.,increase,no risk
Pindolol,Hydralazine,Pindolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Pindolol,Hydrocodone,Pindolol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pindolol,Hydroflumethiazide,The therapeutic efficacy of Pindolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Pindolol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Pindolol.,increase,risk
Pindolol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Pindolol.,decrease,risk
Pindolol,Hydroxyethyl Starch,Pindolol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pindolol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pindolol.,increase,no risk
Pindolol,Kanamycin,Pindolol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pindolol,Ketamine,Ketamine may increase the bradycardic activities of Pindolol.,increase,no risk
Pindolol,Ketazolam,The risk or severity of CNS depression can be increased when Pindolol is combined with Ketazolam.,increase,risk
Pindolol,Ketoconazole,The metabolism of Pindolol can be decreased when combined with Ketoconazole.,decrease,no risk
Pindolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Pindolol.,increase,risk
Pindolol,Obinutuzumab,Pindolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Pindolol,Octinoxate,Pindolol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pindolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Pindolol.,increase,no risk
Pindolol,Olanzapine,Pindolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Pindolol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pindolol is combined with Oliceridine.",increase,risk
Pindolol,Olmesartan,Olmesartan may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Olodaterol,Pindolol may decrease the bronchodilatory activities of Olodaterol.,decrease,no risk
Pindolol,Olsalazine,Olsalazine may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Pindolol.,increase,risk
Pindolol,Opicapone,The risk or severity of adverse effects can be increased when Pindolol is combined with Opicapone.,increase,risk
Pindolol,Opium,The risk or severity of CNS depression can be increased when Pindolol is combined with Opium.,increase,risk
Pindolol,Orciprenaline,Pindolol may decrease the bronchodilatory activities of Orciprenaline.,decrease,no risk
Pindolol,Oritavancin,The metabolism of Pindolol can be decreased when combined with Oritavancin.,decrease,no risk
Pindolol,Orphenadrine,Pindolol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pindolol,Oseltamivir,Oseltamivir may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Osilodrostat,The metabolism of Pindolol can be decreased when combined with Osilodrostat.,decrease,no risk
Pindolol,Ospemifene,The metabolism of Pindolol can be decreased when combined with Ospemifene.,decrease,no risk
Pindolol,Ouabain,Pindolol may increase the bradycardic activities of Ouabain.,increase,no risk
Pindolol,Oxacillin,Oxacillin may decrease the excretion rate of Pindolol which could result in a higher serum level.,decrease,no risk
Pindolol,Oxamniquine,The metabolism of Pindolol can be decreased when combined with Oxamniquine.,decrease,no risk
Pindolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Pindolol.,increase,risk
Pindolol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Pindolol.,increase,risk
Pindolol,Oxitriptan,The risk or severity of CNS depression can be increased when Pindolol is combined with Oxitriptan.,increase,risk
Pindolol,Oxprenolol,The risk or severity of CNS depression can be increased when Pindolol is combined with Oxprenolol.,increase,risk
Pindolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Pindolol is combined with Oxtriphylline.,increase,risk
Pindolol,Oxybenzone,Pindolol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Pindolol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Pindolol.,increase,risk
Pindolol,Oxybutynin,The metabolism of Pindolol can be decreased when combined with Oxybutynin.,decrease,no risk
Pindolol,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Pindolol.,increase,risk
Pindolol,Oxymetazoline,The risk or severity of cardiovascular complications can be increased when Pindolol is combined with Oxymetazoline.,increase,risk
Pindolol,Oxymorphone,The risk or severity of CNS depression can be increased when Pindolol is combined with Oxymorphone.,increase,risk
Pindolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Pindolol.,decrease,no risk
Pindolol,Oxyquinoline,Pindolol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pindolol,Quazepam,The risk or severity of CNS depression can be increased when Pindolol is combined with Quazepam.,increase,risk
Pindolol,Quetiapine,Quetiapine may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Quinapril,Quinapril may increase the hypotensive activities of Pindolol.,increase,no risk
Pindolol,Quinethazone,Quinethazone may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pindolol,Quinidine,The metabolism of Pindolol can be decreased when combined with Quinidine.,decrease,no risk
Pindolol,Quinine,The metabolism of Pindolol can be decreased when combined with Quinine.,decrease,no risk
Pindolol,Quinupramine,The risk or severity of CNS depression can be increased when Pindolol is combined with Quinupramine.,increase,risk
Mepivacaine,Bacampicillin,The risk or severity of methemoglobinemia can be increased when Bacampicillin is combined with Mepivacaine.,increase,risk
Mepivacaine,Bacitracin,The risk or severity of methemoglobinemia can be increased when Bacitracin is combined with Mepivacaine.,increase,risk
Mepivacaine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.,increase,no risk
Mepivacaine,Balsalazide,Balsalazide may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Baricitinib,Mepivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Mepivacaine,Bedaquiline,The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Mepivacaine.,increase,risk
Mepivacaine,Belinostat,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Mepivacaine.,increase,risk
Mepivacaine,Belzutifan,The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Mepivacaine.,increase,risk
Mepivacaine,Bendamustine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Mepivacaine.,increase,risk
Mepivacaine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mepivacaine,Benorilate,Benorilate may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Benperidol,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Benperidol.,increase,risk
Mepivacaine,Benserazide,Mepivacaine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Mepivacaine,Benzatropine,Benzatropine may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Benznidazole,Mepivacaine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Mepivacaine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Mepivacaine is combined with Benzocaine.,increase,risk
Mepivacaine,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Mepivacaine.,increase,risk
Mepivacaine,Benzthiazide,Benzthiazide may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mepivacaine,Benzydamine,Benzydamine may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Mepivacaine is combined with Benzyl alcohol.,increase,risk
Mepivacaine,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Mepivacaine.,increase,risk
Mepivacaine,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Mepivacaine.,increase,risk
Mepivacaine,Bepotastine,Mepivacaine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Mepivacaine.,increase,risk
Mepivacaine,Betaxolol,The serum concentration of Mepivacaine can be increased when it is combined with Betaxolol.,increase,no risk
Mepivacaine,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Mepivacaine.,increase,risk
Mepivacaine,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Mepivacaine.,increase,risk
Mepivacaine,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Mepivacaine.,increase,risk
Mepivacaine,Bicisate,Mepivacaine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Mepivacaine,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Bismuth subgallate,Mepivacaine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Mepivacaine,Bisoprolol,The serum concentration of Mepivacaine can be increased when it is combined with Bisoprolol.,increase,no risk
Mepivacaine,Bisoxatin,Mepivacaine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Mepivacaine,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Mepivacaine.,increase,risk
Mepivacaine,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Mepivacaine.,increase,risk
Mepivacaine,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Mepivacaine.,increase,risk
Mepivacaine,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Mepivacaine.,increase,risk
Mepivacaine,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Mepivacaine.,increase,risk
Mepivacaine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Mepivacaine.,increase,risk
Mepivacaine,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Mepivacaine.,increase,risk
Mepivacaine,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Mepivacaine.,increase,risk
Mepivacaine,Brexpiprazole,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Brexpiprazole.,increase,risk
Mepivacaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Mepivacaine.,increase,risk
Mepivacaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.,increase,no risk
Mepivacaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Mepivacaine.,increase,risk
Mepivacaine,Bromazepam,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Bromazepam.,increase,risk
Mepivacaine,Bromocriptine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Bromocriptine.,increase,risk
Mepivacaine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mepivacaine,Bromperidol,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Bromperidol.,increase,risk
Mepivacaine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Mepivacaine.,increase,risk
Mepivacaine,Budesonide,Mepivacaine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Mepivacaine,Bumadizone,Bumadizone may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Bumetanide,Bumetanide may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mepivacaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Mepivacaine.,increase,risk
Mepivacaine,Buprenorphine,Mepivacaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Mepivacaine,Bupropion,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Bupropion.,increase,risk
Mepivacaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Mepivacaine.,increase,risk
Mepivacaine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Mepivacaine.,increase,risk
Mepivacaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Mepivacaine.,increase,risk
Mepivacaine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Mepivacaine.,increase,risk
Mepivacaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Mepivacaine is combined with Butacaine.,increase,risk
Mepivacaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Mepivacaine.,increase,risk
Mepivacaine,Butamben,The risk or severity of methemoglobinemia can be increased when Mepivacaine is combined with Butamben.,increase,risk
Mepivacaine,Butaperazine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Butaperazine.,increase,risk
Mepivacaine,Butobarbital,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Butobarbital.,increase,risk
Mepivacaine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Mepivacaine.,increase,risk
Mepivacaine,Butriptyline,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Butriptyline.,increase,risk
Mepivacaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Mepivacaine.,increase,risk
Mepivacaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Gabapentin enacarbil.,increase,risk
Mepivacaine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gadodiamide,Gadodiamide may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gadofosveset trisodium,Mepivacaine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gadoteric acid,Mepivacaine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gadoteridol,Gadoteridol may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Mepivacaine.,increase,risk
Mepivacaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Mepivacaine is combined with Ganaxolone.",increase,risk
Mepivacaine,Ganciclovir,Mepivacaine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Mepivacaine.,increase,risk
Mepivacaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Mepivacaine.,increase,risk
Mepivacaine,Gemfibrozil,Mepivacaine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Mepivacaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Mepivacaine.,increase,risk
Mepivacaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Mepivacaine.,increase,risk
Mepivacaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Mepivacaine.,increase,risk
Mepivacaine,Gepirone,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Gepirone.,increase,risk
Mepivacaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Gimeracil,Mepivacaine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Mepivacaine,Givosiran,Givosiran may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Mepivacaine.,increase,risk
Mepivacaine,Glipizide,Mepivacaine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Mepivacaine,Glutethimide,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Glutethimide.,increase,risk
Mepivacaine,Glycerol phenylbutyrate,Mepivacaine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Mepivacaine,Golodirsen,Mepivacaine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Mepivacaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Mepivacaine.,increase,risk
Mepivacaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Mepivacaine.,increase,risk
Mepivacaine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Mepivacaine.,increase,risk
Mepivacaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Mepivacaine.,increase,risk
Mepivacaine,Guanethidine,Mepivacaine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Guanfacine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Guanfacine.,increase,risk
Mepivacaine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Mepivacaine.,increase,risk
Mepivacaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Mepivacaine.,increase,risk
Mepivacaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Mepivacaine.,increase,risk
Mepivacaine,Halothane,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Halothane.,increase,risk
Mepivacaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Mepivacaine.,increase,risk
Mepivacaine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Mepivacaine.,increase,risk
Mepivacaine,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Mepivacaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Mepivacaine,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Mepivacaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Mepivacaine,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Mepivacaine resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Mepivacaine,Hydralazine,Mepivacaine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mepivacaine,Hydrocodone,Mepivacaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Mepivacaine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mepivacaine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Mepivacaine.,increase,risk
Mepivacaine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Mepivacaine.,increase,risk
Mepivacaine,Hydroxyethyl Starch,Mepivacaine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Mepivacaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Mepivacaine.,increase,risk
Mepivacaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Mepivacaine.,increase,risk
Mepivacaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.,increase,no risk
Mepivacaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Mepivacaine.,increase,risk
Mepivacaine,Ketamine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Ketamine.,increase,risk
Mepivacaine,Ketazolam,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Ketazolam.,increase,risk
Mepivacaine,Ketoprofen,Ketoprofen may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Ketorolac,Ketorolac may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Mepivacaine.,increase,risk
Mepivacaine,Octinoxate,Mepivacaine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Mepivacaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Mepivacaine.,increase,risk
Mepivacaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Mepivacaine.,increase,risk
Mepivacaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Mepivacaine.,increase,risk
Mepivacaine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Mepivacaine.,increase,risk
Mepivacaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Mepivacaine.,increase,risk
Mepivacaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Mepivacaine.,increase,risk
Mepivacaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mepivacaine is combined with Oliceridine.",increase,risk
Mepivacaine,Olsalazine,Olsalazine may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Mepivacaine.,increase,risk
Mepivacaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Mepivacaine.,increase,risk
Mepivacaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Mepivacaine.,increase,risk
Mepivacaine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Mepivacaine.,increase,risk
Mepivacaine,Opium,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Opium.,increase,risk
Mepivacaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Mepivacaine.,increase,risk
Mepivacaine,Orphenadrine,Mepivacaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Mepivacaine,Oseltamivir,Oseltamivir may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Mepivacaine.,increase,risk
Mepivacaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Mepivacaine.,increase,risk
Mepivacaine,Oxaprozin,Oxaprozin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Mepivacaine.,increase,risk
Mepivacaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Mepivacaine.,increase,risk
Mepivacaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mepivacaine is combined with Oxetacaine.,increase,risk
Mepivacaine,Oxitriptan,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Oxitriptan.,increase,risk
Mepivacaine,Oxprenolol,The serum concentration of Mepivacaine can be increased when it is combined with Oxprenolol.,increase,no risk
Mepivacaine,Oxybenzone,Mepivacaine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Mepivacaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Mepivacaine.,increase,risk
Mepivacaine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Mepivacaine.,increase,risk
Mepivacaine,Oxymorphone,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Oxymorphone.,increase,risk
Mepivacaine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Oxyquinoline,Mepivacaine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Mepivacaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Mepivacaine.,increase,risk
Mepivacaine,Quazepam,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Quazepam.,increase,risk
Mepivacaine,Quetiapine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Quetiapine.,increase,risk
Mepivacaine,Quinethazone,Quinethazone may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mepivacaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Mepivacaine.,increase,risk
Mepivacaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Mepivacaine.,increase,risk
Mepivacaine,Quinupramine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Quinupramine.,increase,risk
Mepivacaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Mepivacaine.,increase,risk
Mepivacaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Mepivacaine.,increase,risk
Mepivacaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Mepivacaine.,increase,risk
Mepivacaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Mepivacaine.,increase,risk
Mepivacaine,Vaborbactam,Mepivacaine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Mepivacaine,Valaciclovir,Valaciclovir may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Valbenazine,Mepivacaine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Valdecoxib,Valdecoxib may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Valganciclovir,Mepivacaine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Mepivacaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Mepivacaine.,increase,risk
Mepivacaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Mepivacaine.,increase,risk
Mepivacaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Mepivacaine.,increase,risk
Mepivacaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Mepivacaine.,increase,risk
Mepivacaine,Varenicline,Mepivacaine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Mepivacaine,Vecuronium,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Vecuronium.,increase,risk
Mepivacaine,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Mepivacaine.,increase,risk
Mepivacaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Mepivacaine.,increase,risk
Mepivacaine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Mepivacaine.,increase,risk
Mepivacaine,Verapamil,Verapamil may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Mepivacaine.,increase,risk
Mepivacaine,Vilanterol,Mepivacaine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Mepivacaine,Vilazodone,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Vilazodone.,increase,risk
Mepivacaine,Viloxazine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Viloxazine.,increase,risk
Mepivacaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Mepivacaine.,increase,risk
Mepivacaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Mepivacaine.,increase,risk
Mepivacaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Mepivacaine.,increase,risk
Mepivacaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Mepivacaine.,increase,risk
Mepivacaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Mepivacaine.,increase,risk
Mepivacaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Mepivacaine.,increase,risk
Mepivacaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Mepivacaine.,increase,risk
Mepivacaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Mepivacaine.,increase,risk
Mepivacaine,Vortioxetine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Vortioxetine.,increase,risk
Mepivacaine,Warfarin,Mepivacaine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Mepivacaine,Yohimbine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Yohimbine.,increase,risk
Mepivacaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Mepivacaine.,increase,risk
Mepivacaine,Zanamivir,Zanamivir may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,decrease,no risk
Mepivacaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Mepivacaine.,increase,risk
Mepivacaine,Ziconotide,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Ziconotide.,increase,risk
Mepivacaine,Zimelidine,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Zimelidine.,increase,risk
Mepivacaine,Ziprasidone,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Ziprasidone.,increase,risk
Mepivacaine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Mepivacaine.,increase,risk
Mepivacaine,Zolpidem,Mepivacaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Mepivacaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Mepivacaine.,increase,risk
Mepivacaine,Zopiclone,The risk or severity of adverse effects can be increased when Mepivacaine is combined with Zopiclone.,increase,risk
Mepivacaine,Zotepine,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Zotepine.,increase,risk
Mepivacaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Mepivacaine is combined with Zuclopenthixol.,increase,risk
Mepivacaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Mepivacaine.,increase,risk
Zaleplon,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Zaleplon.,increase,risk
Zaleplon,Benzthiazide,Benzthiazide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zaleplon,Benzydamine,Benzydamine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Benzyl alcohol.,increase,risk
Zaleplon,Bepotastine,Zaleplon may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Zaleplon,Berotralstat,The metabolism of Zaleplon can be decreased when combined with Berotralstat.,decrease,no risk
Zaleplon,Betamethasone,The metabolism of Zaleplon can be increased when combined with Betamethasone.,increase,no risk
Zaleplon,Betamethasone phosphate,The metabolism of Zaleplon can be increased when combined with Betamethasone phosphate.,increase,no risk
Zaleplon,Bicisate,Zaleplon may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Zaleplon,Bimekizumab,The metabolism of Zaleplon can be increased when combined with Bimekizumab.,increase,no risk
Zaleplon,Bismuth subgallate,Zaleplon may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Zaleplon,Bisoprolol,Bisoprolol may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Bisoxatin,Zaleplon may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Zaleplon,Bleomycin,Bleomycin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Boceprevir,The metabolism of Zaleplon can be decreased when combined with Boceprevir.,decrease,no risk
Zaleplon,Borage oil,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Borage oil.,decrease,no risk
Zaleplon,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zaleplon.,increase,risk
Zaleplon,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zaleplon.,increase,risk
Zaleplon,Brexanolone,The risk or severity of CNS depression can be increased when Zaleplon is combined with Brexanolone.,increase,risk
Zaleplon,Brexpiprazole,The risk or severity of CNS depression can be increased when Zaleplon is combined with Brexpiprazole.,increase,risk
Zaleplon,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Zaleplon,Brivaracetam,The risk or severity of CNS depression can be increased when Zaleplon is combined with Brivaracetam.,increase,risk
Zaleplon,Bromazepam,The risk or severity of CNS depression can be increased when Zaleplon is combined with Bromazepam.,increase,risk
Zaleplon,Bromocriptine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Bromocriptine.,increase,risk
Zaleplon,Bromotheophylline,Zaleplon may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zaleplon,Bromperidol,The risk or severity of CNS depression can be increased when Zaleplon is combined with Bromperidol.,increase,risk
Zaleplon,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Zaleplon.,increase,risk
Zaleplon,Budesonide,The metabolism of Zaleplon can be increased when combined with Budesonide.,increase,no risk
Zaleplon,Bumadizone,Bumadizone may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Bumetanide,Bumetanide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zaleplon,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Bupivacaine.,increase,risk
Zaleplon,Buprenorphine,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Zaleplon,Bupropion,The risk or severity of CNS depression can be increased when Zaleplon is combined with Bupropion.,increase,risk
Zaleplon,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Zaleplon.,increase,risk
Zaleplon,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Zaleplon.,increase,risk
Zaleplon,Butacaine,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Butacaine.,increase,risk
Zaleplon,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Zaleplon.,increase,risk
Zaleplon,Butamben,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Butamben.,increase,risk
Zaleplon,Butaperazine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Butaperazine.,increase,risk
Zaleplon,Butobarbital,The risk or severity of CNS depression can be increased when Zaleplon is combined with Butobarbital.,increase,risk
Zaleplon,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Zaleplon.,increase,risk
Zaleplon,Butriptyline,The risk or severity of CNS depression can be increased when Zaleplon is combined with Butriptyline.,increase,risk
Zaleplon,Gabapentin,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gabapentin.,increase,risk
Zaleplon,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gabapentin enacarbil.,increase,risk
Zaleplon,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Gadodiamide,Gadodiamide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Gadofosveset trisodium,Zaleplon may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Zaleplon,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Gadoteric acid,Zaleplon may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Zaleplon,Gadoteridol,Gadoteridol may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Zaleplon.,increase,risk
Zaleplon,Gamolenic acid,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Zaleplon,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zaleplon is combined with Ganaxolone.",increase,risk
Zaleplon,Ganciclovir,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Ganciclovir.,decrease,no risk
Zaleplon,Gefitinib,The metabolism of Zaleplon can be decreased when combined with Gefitinib.,decrease,no risk
Zaleplon,Gemcitabine,Gemcitabine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Gemfibrozil,Zaleplon may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Zaleplon,Gentamicin,Zaleplon may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Zaleplon,Gepirone,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gepirone.,increase,risk
Zaleplon,Gestrinone,The metabolism of Gestrinone can be increased when combined with Zaleplon.,increase,no risk
Zaleplon,Gimeracil,Zaleplon may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Zaleplon,Givosiran,Givosiran may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Glipizide,Zaleplon may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Zaleplon,Glofitamab,The serum concentration of Zaleplon can be increased when it is combined with Glofitamab.,increase,no risk
Zaleplon,Glutethimide,The risk or severity of CNS depression can be increased when Zaleplon is combined with Glutethimide.,increase,risk
Zaleplon,Glyburide,The metabolism of Glyburide can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Glycerol phenylbutyrate,Zaleplon may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Zaleplon,Golimumab,The metabolism of Zaleplon can be increased when combined with Golimumab.,increase,no risk
Zaleplon,Golodirsen,Zaleplon may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Zaleplon,Goserelin,Goserelin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Zaleplon.,increase,risk
Zaleplon,Guanethidine,Zaleplon may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Zaleplon,Guanfacine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Guanfacine.,increase,risk
Zaleplon,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Zaleplon.,increase,risk
Zaleplon,Halofantrine,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Halofantrine.,decrease,no risk
Zaleplon,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Zaleplon.,increase,risk
Zaleplon,Halothane,The risk or severity of CNS depression can be increased when Zaleplon is combined with Halothane.,increase,risk
Zaleplon,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Zaleplon.,increase,risk
Zaleplon,Hydralazine,Zaleplon may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Zaleplon,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zaleplon,Hydrocodone,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zaleplon,Hydrocortisone,The metabolism of Zaleplon can be decreased when combined with Hydrocortisone.,decrease,no risk
Zaleplon,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zaleplon,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Zaleplon.,increase,risk
Zaleplon,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Hydroxychloroquine,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Zaleplon,Hydroxyethyl Starch,Zaleplon may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Zaleplon,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Zaleplon.,increase,no risk
Zaleplon,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Zaleplon,Kanamycin,Zaleplon may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Zaleplon,Ketamine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ketamine.,increase,risk
Zaleplon,Ketazolam,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ketazolam.,increase,risk
Zaleplon,Ketoconazole,The metabolism of Zaleplon can be decreased when combined with Ketoconazole.,decrease,no risk
Zaleplon,Ketoprofen,Ketoprofen may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Ketorolac,Ketorolac may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Octinoxate,Zaleplon may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Zaleplon,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Zaleplon.,increase,risk
Zaleplon,Olaparib,The metabolism of Olaparib can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zaleplon is combined with Oliceridine.",increase,risk
Zaleplon,Olsalazine,Olsalazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Omaveloxolone,The serum concentration of Zaleplon can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Zaleplon,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Zaleplon.,increase,risk
Zaleplon,Opium,The risk or severity of CNS depression can be increased when Zaleplon is combined with Opium.,increase,risk
Zaleplon,Orlistat,Orlistat can cause a decrease in the absorption of Zaleplon resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zaleplon,Orphenadrine,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Zaleplon,Oseltamivir,Oseltamivir may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Osilodrostat,The metabolism of Zaleplon can be decreased when combined with Osilodrostat.,decrease,no risk
Zaleplon,Oxacillin,Oxacillin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Oxaprozin,Oxaprozin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zaleplon.,increase,risk
Zaleplon,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Zaleplon.,increase,risk
Zaleplon,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Oxetacaine.,increase,risk
Zaleplon,Oxitriptan,The risk or severity of CNS depression can be increased when Zaleplon is combined with Oxitriptan.,increase,risk
Zaleplon,Oxprenolol,The risk or severity of CNS depression can be increased when Zaleplon is combined with Oxprenolol.,increase,risk
Zaleplon,Oxtriphylline,Zaleplon may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zaleplon,Oxybenzone,Zaleplon may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Zaleplon,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Oxybuprocaine.,increase,risk
Zaleplon,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Zaleplon.,increase,risk
Zaleplon,Oxymorphone,The risk or severity of CNS depression can be increased when Zaleplon is combined with Oxymorphone.,increase,risk
Zaleplon,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Oxyquinoline,Zaleplon may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Zaleplon,Quazepam,The risk or severity of CNS depression can be increased when Zaleplon is combined with Quazepam.,increase,risk
Zaleplon,Quetiapine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Quetiapine.,increase,risk
Zaleplon,Quinethazone,Quinethazone may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Zaleplon,Quinidine,The metabolism of Quinidine can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Zaleplon.,increase,risk
Zaleplon,Quinupramine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Quinupramine.,increase,risk
Zaleplon,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Udenafil,The metabolism of Udenafil can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Ulipristal,The metabolism of Ulipristal can be increased when combined with Zaleplon.,increase,no risk
Zaleplon,Urethane,The risk or severity of CNS depression can be increased when Zaleplon is combined with Urethane.,increase,risk
Zaleplon,Vaborbactam,Zaleplon may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Zaleplon,Vadadustat,The serum concentration of Zaleplon can be increased when it is combined with Vadadustat.,increase,no risk
Zaleplon,Valaciclovir,Valaciclovir may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Valbenazine,Zaleplon may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Zaleplon,Valdecoxib,Valdecoxib may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Valganciclovir,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Valganciclovir.,decrease,no risk
Zaleplon,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Zaleplon.,increase,risk
Zaleplon,Vancomycin,Zaleplon may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Zaleplon,Vardenafil,The metabolism of Zaleplon can be decreased when combined with Vardenafil.,decrease,no risk
Zaleplon,Varenicline,Zaleplon may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Zaleplon,Vecuronium,The risk or severity of CNS depression can be increased when Zaleplon is combined with Vecuronium.,increase,risk
Zaleplon,Venetoclax,The metabolism of Zaleplon can be decreased when combined with Venetoclax.,decrease,no risk
Zaleplon,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Zaleplon.,increase,risk
Zaleplon,Verapamil,The metabolism of Zaleplon can be decreased when combined with Verapamil.,decrease,no risk
Zaleplon,Vigabatrin,The risk or severity of CNS depression can be increased when Zaleplon is combined with Vigabatrin.,increase,risk
Zaleplon,Vilanterol,Zaleplon may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Zaleplon,Vilazodone,The risk or severity of CNS depression can be increased when Zaleplon is combined with Vilazodone.,increase,risk
Zaleplon,Viloxazine,The metabolism of Zaleplon can be decreased when combined with Viloxazine.,decrease,no risk
Zaleplon,Vincristine,The metabolism of Vincristine can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Zaleplon.,decrease,no risk
Zaleplon,Voriconazole,The metabolism of Zaleplon can be decreased when combined with Voriconazole.,decrease,no risk
Zaleplon,Vortioxetine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Vortioxetine.,increase,risk
Zaleplon,Warfarin,Zaleplon may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Zaleplon,Yohimbine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Yohimbine.,increase,risk
Zaleplon,Zanamivir,Zanamivir may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zaleplon,Ziconotide,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ziconotide.,increase,risk
Zaleplon,Zimelidine,The risk or severity of adverse effects can be increased when Zaleplon is combined with Zimelidine.,increase,risk
Zaleplon,Ziprasidone,The risk or severity of adverse effects can be increased when Zaleplon is combined with Ziprasidone.,increase,risk
Zaleplon,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Zaleplon.,increase,risk
Zaleplon,Zolpidem,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zaleplon,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Zaleplon.,increase,risk
Zaleplon,Zopiclone,The risk or severity of adverse effects can be increased when Zaleplon is combined with Zopiclone.,increase,risk
Zaleplon,Zotepine,The risk or severity of CNS depression can be increased when Zaleplon is combined with Zotepine.,increase,risk
Zaleplon,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zaleplon is combined with Zuclopenthixol.,increase,risk
Zaleplon,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Zaleplon.,increase,risk
Bromfenac,Balsalazide,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Bromfenac.,decrease,no risk
Bromfenac,Bendazac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Bendazac.,increase,risk
Bromfenac,Benorilate,The risk or severity of adverse effects can be increased when Bromfenac is combined with Benorilate.,increase,risk
Bromfenac,Benoxaprofen,The risk or severity of adverse effects can be increased when Bromfenac is combined with Benoxaprofen.,increase,risk
Bromfenac,Benzydamine,The risk or severity of adverse effects can be increased when Bromfenac is combined with Benzydamine.,increase,risk
Bromfenac,Betulinic Acid,The risk or severity of adverse effects can be increased when Bromfenac is combined with Betulinic Acid.,increase,risk
Bromfenac,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Bromfenac.,decrease,no risk
Bromfenac,Bufexamac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Bufexamac.,increase,risk
Bromfenac,Bumadizone,The risk or severity of adverse effects can be increased when Bromfenac is combined with Bumadizone.,increase,risk
Bromfenac,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Bromfenac.,increase,risk
Bromfenac,Glycol salicylate,The risk or severity of adverse effects can be increased when Bromfenac is combined with Glycol salicylate.,increase,risk
Bromfenac,Ketoprofen,The risk or severity of adverse effects can be increased when Bromfenac is combined with Ketoprofen.,increase,risk
Bromfenac,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Bromfenac.,increase,risk
Bromfenac,Olsalazine,The risk or severity of nephrotoxicity can be increased when Bromfenac is combined with Olsalazine.,increase,risk
Bromfenac,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Bromfenac.,increase,risk
Bromfenac,Oxaprozin,The risk or severity of adverse effects can be increased when Bromfenac is combined with Oxaprozin.,increase,risk
Bromfenac,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Bromfenac is combined with Oxyphenbutazone.,increase,risk
Bromfenac,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Bromfenac.,increase,risk
Bromfenac,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Bromfenac.,increase,risk
Bromfenac,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Bromfenac.,decrease,no risk
Bromfenac,Voriconazole,The serum concentration of Bromfenac can be increased when it is combined with Voriconazole.,increase,no risk
Apraclonidine,Oxymetazoline,Apraclonidine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Apraclonidine,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Apraclonidine.,increase,risk
Apraclonidine,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Apraclonidine.,increase,risk
Telmisartan,Gefitinib,Telmisartan may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Telmisartan,Gemfibrozil,The metabolism of Telmisartan can be decreased when combined with Gemfibrozil.,decrease,no risk
Telmisartan,Glasdegib,Telmisartan may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Telmisartan,Glecaprevir,Telmisartan may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Telmisartan,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Telmisartan.,decrease,no risk
Telmisartan,Glimepiride,Glimepiride may decrease the excretion rate of Telmisartan which could result in a higher serum level.,decrease,no risk
Telmisartan,Glipizide,Telmisartan may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Telmisartan,Glyburide,Glyburide may decrease the excretion rate of Telmisartan which could result in a higher serum level.,decrease,no risk
Telmisartan,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Glycol salicylate.",increase,risk
Telmisartan,Glycyrrhizic acid,Telmisartan may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Telmisartan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Telmisartan.,decrease,no risk
Telmisartan,Guanadrel,Guanadrel may increase the hypotensive activities of Telmisartan.,increase,no risk
Telmisartan,Guanethidine,Telmisartan may increase the hypotensive activities of Guanethidine.,increase,no risk
Telmisartan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Telmisartan.,decrease,no risk
Telmisartan,Guanoxan,Telmisartan may increase the hypotensive activities of Guanoxan.,increase,no risk
Telmisartan,Halothane,Halothane may decrease the antihypertensive activities of Telmisartan.,decrease,no risk
Telmisartan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Telmisartan.,increase,risk
Telmisartan,Hydralazine,Telmisartan may increase the hypotensive activities of Hydralazine.,increase,no risk
Telmisartan,Hydroflumethiazide,The therapeutic efficacy of Telmisartan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Telmisartan,Ketoconazole,Ketoconazole may decrease the excretion rate of Telmisartan which could result in a higher serum level.,decrease,no risk
Telmisartan,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Ketoprofen.",increase,risk
Telmisartan,Ketorolac,The therapeutic efficacy of Telmisartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Telmisartan,Obinutuzumab,Telmisartan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Telmisartan,Ofloxacin,Telmisartan may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Telmisartan,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Telmisartan.,increase,risk
Telmisartan,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Olmesartan is combined with Telmisartan.",increase,risk
Telmisartan,Olodaterol,Olodaterol may decrease the antihypertensive activities of Telmisartan.,decrease,no risk
Telmisartan,Ombitasvir,Telmisartan may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Telmisartan,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Telmisartan.,decrease,no risk
Telmisartan,Opicapone,The risk or severity of adverse effects can be increased when Telmisartan is combined with Opicapone.,increase,risk
Telmisartan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Telmisartan.,decrease,no risk
Telmisartan,Osimertinib,Telmisartan may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Telmisartan,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Telmisartan.,increase,no risk
Telmisartan,Oxaliplatin,Telmisartan may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Telmisartan,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Oxaprozin.",increase,risk
Telmisartan,Oxprenolol,Telmisartan may increase the hypotensive activities of Oxprenolol.,increase,no risk
Telmisartan,Oxymetazoline,The therapeutic efficacy of Telmisartan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Telmisartan,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Oxyphenbutazone.",increase,risk
Telmisartan,Ozanimod,Telmisartan may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Telmisartan,Quetiapine,Quetiapine may increase the hypotensive activities of Telmisartan.,increase,no risk
Telmisartan,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Telmisartan.",increase,risk
Telmisartan,Quinidine,Quinidine may decrease the excretion rate of Telmisartan which could result in a higher serum level.,decrease,no risk
Telmisartan,Quinine,The metabolism of Quinine can be decreased when combined with Telmisartan.,decrease,no risk
Telmisartan,Quinupramine,Quinupramine may decrease the antihypertensive activities of Telmisartan.,decrease,no risk
Desloratadine,Gabapentin,The risk or severity of CNS depression can be increased when Desloratadine is combined with Gabapentin.,increase,risk
Desloratadine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Desloratadine is combined with Gabapentin enacarbil.,increase,risk
Desloratadine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Desloratadine.,increase,risk
Desloratadine,Galantamine,The therapeutic efficacy of Desloratadine can be decreased when used in combination with Galantamine.,decrease,no risk
Desloratadine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Desloratadine.,increase,risk
Desloratadine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Desloratadine is combined with Ganaxolone.",increase,risk
Desloratadine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Desloratadine.,increase,risk
Desloratadine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Gemifloxacin.,increase,risk
Desloratadine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Desloratadine.,increase,risk
Desloratadine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Gilteritinib.,increase,risk
Desloratadine,Ginkgo biloba,The therapeutic efficacy of Desloratadine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Desloratadine,Glasdegib,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Glasdegib.,increase,risk
Desloratadine,Glutethimide,The risk or severity of CNS depression can be increased when Desloratadine is combined with Glutethimide.,increase,risk
Desloratadine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Desloratadine.,decrease,no risk
Desloratadine,Glycopyrronium,The risk or severity of adverse effects can be increased when Desloratadine is combined with Glycopyrronium.,increase,risk
Desloratadine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Desloratadine.,increase,risk
Desloratadine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Desloratadine.,increase,risk
Desloratadine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Grepafloxacin.,increase,risk
Desloratadine,Guanfacine,The risk or severity of CNS depression can be increased when Desloratadine is combined with Guanfacine.,increase,risk
Desloratadine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Desloratadine.,increase,risk
Desloratadine,Halofantrine,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Halofantrine.,increase,risk
Desloratadine,Haloperidol,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Haloperidol.,increase,risk
Desloratadine,Halothane,The risk or severity of CNS depression can be increased when Desloratadine is combined with Halothane.,increase,risk
Desloratadine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Desloratadine.,increase,risk
Desloratadine,Hexocyclium,The risk or severity of adverse effects can be increased when Desloratadine is combined with Hexocyclium.,increase,risk
Desloratadine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Desloratadine.,increase,risk
Desloratadine,Homatropine,The risk or severity of adverse effects can be increased when Desloratadine is combined with Homatropine.,increase,risk
Desloratadine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Desloratadine.,increase,risk
Desloratadine,Huperzine A,The therapeutic efficacy of Desloratadine can be decreased when used in combination with Huperzine A.,decrease,no risk
Desloratadine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Desloratadine.,increase,no risk
Desloratadine,Hydrocodone,Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Desloratadine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Desloratadine.,increase,no risk
Desloratadine,Hydromorphone,The risk or severity of adverse effects can be increased when Desloratadine is combined with Hydromorphone.,increase,risk
Desloratadine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Desloratadine.,increase,risk
Desloratadine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Hydroxyzine.,increase,risk
Desloratadine,Hyoscyamine,Desloratadine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Desloratadine,Ketamine,The risk or severity of CNS depression can be increased when Desloratadine is combined with Ketamine.,increase,risk
Desloratadine,Ketazolam,The risk or severity of CNS depression can be increased when Desloratadine is combined with Ketazolam.,increase,risk
Desloratadine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Desloratadine.,increase,risk
Desloratadine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Desloratadine.,increase,risk
Desloratadine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Ofloxacin.,increase,risk
Desloratadine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Desloratadine.,increase,risk
Desloratadine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Desloratadine is combined with Oliceridine.",increase,risk
Desloratadine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Desloratadine.,increase,risk
Desloratadine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Desloratadine.,increase,risk
Desloratadine,Opium,The risk or severity of adverse effects can be increased when Desloratadine is combined with Opium.,increase,risk
Desloratadine,Orphenadrine,Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Desloratadine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Desloratadine.,increase,risk
Desloratadine,Oxatomide,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Oxatomide.,increase,risk
Desloratadine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Desloratadine.,increase,risk
Desloratadine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Desloratadine.,increase,risk
Desloratadine,Oxitriptan,The risk or severity of CNS depression can be increased when Desloratadine is combined with Oxitriptan.,increase,risk
Desloratadine,Oxprenolol,The risk or severity of CNS depression can be increased when Desloratadine is combined with Oxprenolol.,increase,risk
Desloratadine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Desloratadine.,increase,risk
Desloratadine,Oxybutynin,The risk or severity of adverse effects can be increased when Desloratadine is combined with Oxybutynin.,increase,risk
Desloratadine,Oxycodone,The risk or severity of adverse effects can be increased when Desloratadine is combined with Oxycodone.,increase,risk
Desloratadine,Oxymorphone,The risk or severity of adverse effects can be increased when Desloratadine is combined with Oxymorphone.,increase,risk
Desloratadine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Desloratadine.,increase,risk
Desloratadine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Desloratadine.,decrease,no risk
Desloratadine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Desloratadine.,increase,risk
Desloratadine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Desloratadine.,increase,risk
Desloratadine,Quazepam,The risk or severity of CNS depression can be increased when Desloratadine is combined with Quazepam.,increase,risk
Desloratadine,Quetiapine,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Quetiapine.,increase,risk
Desloratadine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Desloratadine.,increase,no risk
Desloratadine,Quinidine,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Quinidine.,increase,risk
Desloratadine,Quinine,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Quinine.,increase,risk
Desloratadine,Quinupramine,The risk or severity of CNS depression can be increased when Desloratadine is combined with Quinupramine.,increase,risk
Desloratadine,Quizartinib,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Quizartinib.,increase,risk
Desloratadine,Umeclidinium,The risk or severity of adverse effects can be increased when Desloratadine is combined with Umeclidinium.,increase,risk
Desloratadine,Urethane,The risk or severity of CNS depression can be increased when Desloratadine is combined with Urethane.,increase,risk
Desloratadine,Valproic acid,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Valproic acid.,increase,risk
Desloratadine,Vandetanib,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Vandetanib.,increase,risk
Desloratadine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Desloratadine.,increase,risk
Desloratadine,Vecuronium,The risk or severity of CNS depression can be increased when Desloratadine is combined with Vecuronium.,increase,risk
Desloratadine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Vemurafenib.,increase,risk
Desloratadine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Desloratadine.,increase,risk
Desloratadine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Desloratadine.,increase,risk
Desloratadine,Vigabatrin,The risk or severity of CNS depression can be increased when Desloratadine is combined with Vigabatrin.,increase,risk
Desloratadine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Desloratadine.,increase,risk
Desloratadine,Vilazodone,The risk or severity of CNS depression can be increased when Desloratadine is combined with Vilazodone.,increase,risk
Desloratadine,Viloxazine,The risk or severity of CNS depression can be increased when Desloratadine is combined with Viloxazine.,increase,risk
Desloratadine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Desloratadine.,increase,risk
Desloratadine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Desloratadine.,increase,risk
Desloratadine,Vortioxetine,The risk or severity of CNS depression can be increased when Desloratadine is combined with Vortioxetine.,increase,risk
Desloratadine,Yohimbine,The risk or severity of CNS depression can be increased when Desloratadine is combined with Yohimbine.,increase,risk
Desloratadine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Desloratadine.,increase,risk
Desloratadine,Ziconotide,The risk or severity of CNS depression can be increased when Desloratadine is combined with Ziconotide.,increase,risk
Desloratadine,Zimelidine,The risk or severity of adverse effects can be increased when Desloratadine is combined with Zimelidine.,increase,risk
Desloratadine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Ziprasidone.,increase,risk
Desloratadine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Desloratadine.,increase,risk
Desloratadine,Zolpidem,Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Desloratadine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Desloratadine.,increase,risk
Desloratadine,Zopiclone,The risk or severity of adverse effects can be increased when Desloratadine is combined with Zopiclone.,increase,risk
Desloratadine,Zotepine,The risk or severity of CNS depression can be increased when Desloratadine is combined with Zotepine.,increase,risk
Desloratadine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Zuclopenthixol.,increase,risk
Desloratadine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Desloratadine.,increase,risk
Methyldopa,Bretylium,Methyldopa may increase the hypotensive activities of Bretylium.,increase,no risk
Methyldopa,Brexpiprazole,The therapeutic efficacy of Methyldopa can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Methyldopa,Brimonidine,Brimonidine may increase the antihypertensive activities of Methyldopa.,increase,no risk
Methyldopa,Brivaracetam,Methyldopa may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Methyldopa,Bromazepam,Methyldopa may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Methyldopa,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Methyldopa.,increase,no risk
Methyldopa,Bromotheophylline,Bromotheophylline may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyldopa,Budesonide,Methyldopa may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Methyldopa,Bumadizone,The therapeutic efficacy of Methyldopa can be decreased when used in combination with Bumadizone.,decrease,no risk
Methyldopa,Bumetanide,Bumetanide may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyldopa,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Methyldopa.,increase,risk
Methyldopa,Bupropion,Methyldopa may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Methyldopa,Buspirone,Buspirone may decrease the antihypertensive activities of Methyldopa.,decrease,no risk
Methyldopa,Butabarbital,Butabarbital may increase the hypotensive activities of Methyldopa.,increase,no risk
Methyldopa,Butalbital,Butalbital may increase the hypotensive activities of Methyldopa.,increase,no risk
Methyldopa,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Methyldopa.,increase,risk
Alosetron,Gabapentin,The risk or severity of CNS depression can be increased when Alosetron is combined with Gabapentin.,increase,risk
Alosetron,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Alosetron is combined with Gabapentin enacarbil.,increase,risk
Alosetron,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Alosetron.,increase,risk
Alosetron,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Alosetron is combined with Ganaxolone.",increase,risk
Alosetron,Gatifloxacin,The metabolism of Alosetron can be decreased when combined with Gatifloxacin.,decrease,no risk
Alosetron,Gemfibrozil,The metabolism of Alosetron can be decreased when combined with Gemfibrozil.,decrease,no risk
Alosetron,Gemifloxacin,The metabolism of Alosetron can be decreased when combined with Gemifloxacin.,decrease,no risk
Alosetron,Gepirone,The risk or severity of CNS depression can be increased when Alosetron is combined with Gepirone.,increase,risk
Alosetron,Gilteritinib,The therapeutic efficacy of Alosetron can be decreased when used in combination with Gilteritinib.,decrease,no risk
Alosetron,Ginkgo biloba,The metabolism of Alosetron can be decreased when combined with Ginkgo biloba.,decrease,no risk
Alosetron,Givosiran,The serum concentration of Alosetron can be increased when it is combined with Givosiran.,increase,no risk
Alosetron,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Glimepiride,The metabolism of Alosetron can be decreased when combined with Glimepiride.,decrease,no risk
Alosetron,Glipizide,The metabolism of Glipizide can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Glofitamab,The serum concentration of Alosetron can be increased when it is combined with Glofitamab.,increase,no risk
Alosetron,Glutethimide,The risk or severity of CNS depression can be increased when Alosetron is combined with Glutethimide.,increase,risk
Alosetron,Glyburide,The metabolism of Alosetron can be decreased when combined with Glyburide.,decrease,no risk
Alosetron,Golimumab,The metabolism of Alosetron can be increased when combined with Golimumab.,increase,no risk
Alosetron,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Alosetron.,increase,risk
Alosetron,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Guanfacine,The risk or severity of CNS depression can be increased when Alosetron is combined with Guanfacine.,increase,risk
Alosetron,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Alosetron.,increase,risk
Alosetron,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Alosetron.,increase,risk
Alosetron,Halothane,The risk or severity of CNS depression can be increased when Alosetron is combined with Halothane.,increase,risk
Alosetron,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Alosetron.,increase,risk
Alosetron,Hydrocodone,Alosetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Alosetron,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Alosetron.,increase,risk
Alosetron,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alosetron.,increase,no risk
Alosetron,Ketamine,The risk or severity of CNS depression can be increased when Alosetron is combined with Ketamine.,increase,risk
Alosetron,Ketazolam,The risk or severity of CNS depression can be increased when Alosetron is combined with Ketazolam.,increase,risk
Alosetron,Ketoconazole,The metabolism of Alosetron can be decreased when combined with Ketoconazole.,decrease,no risk
Alosetron,Ketorolac,The metabolism of Alosetron can be decreased when combined with Ketorolac.,decrease,no risk
Alosetron,Obeticholic acid,The metabolism of Alosetron can be decreased when combined with Obeticholic acid.,decrease,no risk
Alosetron,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Alosetron is combined with Oliceridine.",increase,risk
Alosetron,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Omaveloxolone,The serum concentration of Alosetron can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Alosetron,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Opium,The risk or severity of CNS depression can be increased when Alosetron is combined with Opium.,increase,risk
Alosetron,Oritavancin,The metabolism of Alosetron can be decreased when combined with Oritavancin.,decrease,no risk
Alosetron,Orphenadrine,Alosetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Alosetron,Osilodrostat,The metabolism of Alosetron can be decreased when combined with Osilodrostat.,decrease,no risk
Alosetron,Osimertinib,The serum concentration of Alosetron can be decreased when it is combined with Osimertinib.,decrease,no risk
Alosetron,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Oxandrolone,The metabolism of Alosetron can be decreased when combined with Oxandrolone.,decrease,no risk
Alosetron,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Alosetron.,increase,risk
Alosetron,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Alosetron.,increase,risk
Alosetron,Oxitriptan,The risk or severity of CNS depression can be increased when Alosetron is combined with Oxitriptan.,increase,risk
Alosetron,Oxprenolol,The risk or severity of CNS depression can be increased when Alosetron is combined with Oxprenolol.,increase,risk
Alosetron,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Alosetron.,increase,risk
Alosetron,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Alosetron.,increase,risk
Alosetron,Oxymorphone,The risk or severity of CNS depression can be increased when Alosetron is combined with Oxymorphone.,increase,risk
Alosetron,Quazepam,The risk or severity of CNS depression can be increased when Alosetron is combined with Quazepam.,increase,risk
Alosetron,Quetiapine,The risk or severity of CNS depression can be increased when Alosetron is combined with Quetiapine.,increase,risk
Alosetron,Quinidine,The metabolism of Alosetron can be decreased when combined with Quinidine.,decrease,no risk
Alosetron,Quinine,The metabolism of Quinine can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Quinupramine,The risk or severity of CNS depression can be increased when Alosetron is combined with Quinupramine.,increase,risk
Alosetron,Urethane,The risk or severity of CNS depression can be increased when Alosetron is combined with Urethane.,increase,risk
Alosetron,Vadadustat,The serum concentration of Alosetron can be increased when it is combined with Vadadustat.,increase,no risk
Alosetron,Valdecoxib,The metabolism of Alosetron can be decreased when combined with Valdecoxib.,decrease,no risk
Alosetron,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Alosetron.,increase,risk
Alosetron,Valsartan,The metabolism of Alosetron can be decreased when combined with Valsartan.,decrease,no risk
Alosetron,Vardenafil,The metabolism of Alosetron can be decreased when combined with Vardenafil.,decrease,no risk
Alosetron,Vecuronium,The risk or severity of CNS depression can be increased when Alosetron is combined with Vecuronium.,increase,risk
Alosetron,Vemurafenib,The serum concentration of Alosetron can be increased when it is combined with Vemurafenib.,increase,no risk
Alosetron,Venetoclax,The metabolism of Alosetron can be decreased when combined with Venetoclax.,decrease,no risk
Alosetron,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Alosetron.,increase,risk
Alosetron,Verapamil,The metabolism of Alosetron can be decreased when combined with Verapamil.,decrease,no risk
Alosetron,Vigabatrin,The risk or severity of CNS depression can be increased when Alosetron is combined with Vigabatrin.,increase,risk
Alosetron,Vilazodone,The risk or severity of CNS depression can be increased when Alosetron is combined with Vilazodone.,increase,risk
Alosetron,Viloxazine,The metabolism of Alosetron can be decreased when combined with Viloxazine.,decrease,no risk
Alosetron,Voriconazole,The metabolism of Alosetron can be decreased when combined with Voriconazole.,decrease,no risk
Alosetron,Vortioxetine,The risk or severity of CNS depression can be increased when Alosetron is combined with Vortioxetine.,increase,risk
Alosetron,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Warfarin,The metabolism of Warfarin can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Yohimbine,The risk or severity of CNS depression can be increased when Alosetron is combined with Yohimbine.,increase,risk
Alosetron,Zafirlukast,The metabolism of Alosetron can be decreased when combined with Zafirlukast.,decrease,no risk
Alosetron,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Alosetron.,increase,risk
Alosetron,Ziconotide,The risk or severity of CNS depression can be increased when Alosetron is combined with Ziconotide.,increase,risk
Alosetron,Zidovudine,The metabolism of Alosetron can be decreased when combined with Zidovudine.,decrease,no risk
Alosetron,Zileuton,The metabolism of Zileuton can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Zimelidine,The risk or severity of adverse effects can be increased when Alosetron is combined with Zimelidine.,increase,risk
Alosetron,Ziprasidone,The risk or severity of adverse effects can be increased when Alosetron is combined with Ziprasidone.,increase,risk
Alosetron,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Zolpidem,Alosetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Alosetron,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Alosetron.,increase,risk
Alosetron,Zopiclone,The risk or severity of adverse effects can be increased when Alosetron is combined with Zopiclone.,increase,risk
Alosetron,Zotepine,The metabolism of Zotepine can be decreased when combined with Alosetron.,decrease,no risk
Alosetron,Zuclopenthixol,The risk or severity of CNS depression can be increased when Alosetron is combined with Zuclopenthixol.,increase,risk
Alosetron,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Alosetron.,increase,risk
Dactinomycin,Gefitinib,Gefitinib may decrease the excretion rate of Dactinomycin which could result in a higher serum level.,decrease,no risk
Dactinomycin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dactinomycin.,increase,risk
Dactinomycin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dactinomycin.,increase,risk
Dactinomycin,Gilteritinib,Gilteritinib may decrease the excretion rate of Dactinomycin which could result in a higher serum level.,decrease,no risk
Dactinomycin,Glasdegib,The serum concentration of Dactinomycin can be increased when it is combined with Glasdegib.,increase,no risk
Dactinomycin,Glatiramer,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Glatiramer.,increase,risk
Dactinomycin,Glecaprevir,The serum concentration of Dactinomycin can be increased when it is combined with Glecaprevir.,increase,no risk
Dactinomycin,Golimumab,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Golimumab.,increase,risk
Dactinomycin,Grazoprevir,Grazoprevir may decrease the excretion rate of Dactinomycin which could result in a higher serum level.,decrease,no risk
Dactinomycin,Guselkumab,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Guselkumab.,increase,risk
Dactinomycin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dactinomycin.,decrease,no risk
Dactinomycin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Dactinomycin.,increase,risk
Dactinomycin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dactinomycin.,decrease,no risk
Dactinomycin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dactinomycin.,decrease,no risk
Dactinomycin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Dactinomycin.,increase,risk
Dactinomycin,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Dactinomycin.,increase,risk
Dactinomycin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Hydrocortisone acetate.,increase,risk
Dactinomycin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Hydrocortisone butyrate.,increase,risk
Dactinomycin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Hydrocortisone succinate.,increase,risk
Dactinomycin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Dactinomycin.,increase,risk
Dactinomycin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Hydroxychloroquine.,increase,risk
Dactinomycin,Hydroxyurea,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Hydroxyurea.,increase,risk
Dactinomycin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dactinomycin.,decrease,no risk
Dactinomycin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dactinomycin.,decrease,no risk
Dactinomycin,Ketoconazole,The serum concentration of Dactinomycin can be increased when it is combined with Ketoconazole.,increase,no risk
Dactinomycin,Obinutuzumab,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Obinutuzumab.,increase,risk
Dactinomycin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Dactinomycin.,increase,no risk
Dactinomycin,Ofatumumab,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Ofatumumab.,increase,risk
Dactinomycin,Olaparib,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Olaparib.,increase,risk
Dactinomycin,Omadacycline,The serum concentration of Dactinomycin can be increased when it is combined with Omadacycline.,increase,no risk
Dactinomycin,Ombitasvir,The serum concentration of Dactinomycin can be increased when it is combined with Ombitasvir.,increase,no risk
Dactinomycin,Osimertinib,Osimertinib may decrease the excretion rate of Dactinomycin which could result in a higher serum level.,decrease,no risk
Dactinomycin,Oteseconazole,The serum concentration of Dactinomycin can be increased when it is combined with Oteseconazole.,increase,no risk
Dactinomycin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dactinomycin.,increase,risk
Dactinomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dactinomycin is combined with Oxetacaine.,increase,risk
Dactinomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dactinomycin is combined with Oxybuprocaine.,increase,risk
Dactinomycin,Ozanimod,The risk or severity of adverse effects can be increased when Dactinomycin is combined with Ozanimod.,increase,risk
Dactinomycin,Quinidine,The serum concentration of Dactinomycin can be increased when it is combined with Quinidine.,increase,no risk
Dactinomycin,Quinine,The serum concentration of Dactinomycin can be increased when it is combined with Quinine.,increase,no risk
Dactinomycin,Quizartinib,The serum concentration of Dactinomycin can be increased when it is combined with Quizartinib.,increase,no risk
Azelastine,Brexanolone,Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Brexpiprazole,Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Brivaracetam,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Bromazepam,Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Budesonide,The metabolism of Azelastine can be increased when combined with Budesonide.,increase,no risk
Azelastine,Bupivacaine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Buprenorphine,Buprenorphine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Bupropion,Bupropion may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Buspirone,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Butorphanol,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Butriptyline,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Galantamine,The metabolism of Azelastine can be decreased when combined with Galantamine.,decrease,no risk
Azelastine,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Gatifloxacin,The metabolism of Azelastine can be decreased when combined with Gatifloxacin.,decrease,no risk
Azelastine,Gefitinib,The metabolism of Azelastine can be decreased when combined with Gefitinib.,decrease,no risk
Azelastine,Gemfibrozil,The metabolism of Azelastine can be decreased when combined with Gemfibrozil.,decrease,no risk
Azelastine,Gemifloxacin,The metabolism of Azelastine can be decreased when combined with Gemifloxacin.,decrease,no risk
Azelastine,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Ginkgo biloba,The metabolism of Azelastine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Azelastine,Givosiran,The serum concentration of Azelastine can be increased when it is combined with Givosiran.,increase,no risk
Azelastine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Glimepiride,The metabolism of Azelastine can be decreased when combined with Glimepiride.,decrease,no risk
Azelastine,Glipizide,The metabolism of Glipizide can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Glofitamab,The serum concentration of Azelastine can be increased when it is combined with Glofitamab.,increase,no risk
Azelastine,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Glyburide,The metabolism of Azelastine can be decreased when combined with Glyburide.,decrease,no risk
Azelastine,Glycerol phenylbutyrate,The metabolism of Azelastine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Azelastine,Golimumab,The metabolism of Azelastine can be increased when combined with Golimumab.,increase,no risk
Azelastine,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Grepafloxacin,The metabolism of Azelastine can be decreased when combined with Grepafloxacin.,decrease,no risk
Azelastine,Guanabenz,The metabolism of Azelastine can be decreased when combined with Guanabenz.,decrease,no risk
Azelastine,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Halofantrine,The metabolism of Azelastine can be decreased when combined with Halofantrine.,decrease,no risk
Azelastine,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Azelastine.,decrease,no risk
Azelastine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Azelastine.,decrease,no risk
Azelastine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Azelastine.,decrease,no risk
Azelastine,Hydrocodone,Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Hydrocortisone,The metabolism of Azelastine can be increased when combined with Hydrocortisone.,increase,no risk
Azelastine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Hyoscyamine,Azelastine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Azelastine,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Ketoconazole,The metabolism of Azelastine can be decreased when combined with Ketoconazole.,decrease,no risk
Azelastine,Ketoprofen,The metabolism of Azelastine can be decreased when combined with Ketoprofen.,decrease,no risk
Azelastine,Ketorolac,The metabolism of Azelastine can be decreased when combined with Ketorolac.,decrease,no risk
Azelastine,Obeticholic acid,The metabolism of Azelastine can be decreased when combined with Obeticholic acid.,decrease,no risk
Azelastine,Olanzapine,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Olaparib,The metabolism of Olaparib can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Oliceridine,Oliceridine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Omaveloxolone,The serum concentration of Azelastine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Azelastine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Ondansetron,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Opium,Opium may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Oritavancin,The metabolism of Azelastine can be decreased when combined with Oritavancin.,decrease,no risk
Azelastine,Orphenadrine,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Osilodrostat,The metabolism of Azelastine can be decreased when combined with Osilodrostat.,decrease,no risk
Azelastine,Osimertinib,The serum concentration of Azelastine can be decreased when it is combined with Osimertinib.,decrease,no risk
Azelastine,Ospemifene,The metabolism of Azelastine can be decreased when combined with Ospemifene.,decrease,no risk
Azelastine,Oxamniquine,The metabolism of Azelastine can be decreased when combined with Oxamniquine.,decrease,no risk
Azelastine,Oxandrolone,The metabolism of Azelastine can be decreased when combined with Oxandrolone.,decrease,no risk
Azelastine,Oxazepam,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Oxcarbazepine,Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Oxitriptan,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Oxprenolol,Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Oxybuprocaine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Oxybutynin,The metabolism of Azelastine can be decreased when combined with Oxybutynin.,decrease,no risk
Azelastine,Oxycodone,Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Oxymetazoline,The absorption of Azelastine can be decreased when combined with Oxymetazoline.,decrease,no risk
Azelastine,Oxymorphone,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Quazepam,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Quetiapine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Quinidine,The metabolism of Azelastine can be decreased when combined with Quinidine.,decrease,no risk
Azelastine,Quinine,Quinine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Quinupramine,Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Udenafil,The metabolism of Udenafil can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Urethane,Urethane may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Vadadustat,The serum concentration of Azelastine can be increased when it is combined with Vadadustat.,increase,no risk
Azelastine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Valdecoxib,The metabolism of Azelastine can be decreased when combined with Valdecoxib.,decrease,no risk
Azelastine,Valproic acid,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Valsartan,The metabolism of Azelastine can be decreased when combined with Valsartan.,decrease,no risk
Azelastine,Vardenafil,The metabolism of Azelastine can be decreased when combined with Vardenafil.,decrease,no risk
Azelastine,Vecuronium,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Vemurafenib,The serum concentration of Azelastine can be increased when it is combined with Vemurafenib.,increase,no risk
Azelastine,Venetoclax,The metabolism of Azelastine can be decreased when combined with Venetoclax.,decrease,no risk
Azelastine,Venlafaxine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Verapamil,The metabolism of Azelastine can be decreased when combined with Verapamil.,decrease,no risk
Azelastine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Vigabatrin,Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Vilazodone,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Viloxazine,Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Vinblastine,The metabolism of Azelastine can be decreased when combined with Vinblastine.,decrease,no risk
Azelastine,Vincristine,The metabolism of Vincristine can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Vinorelbine,The metabolism of Azelastine can be decreased when combined with Vinorelbine.,decrease,no risk
Azelastine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Voriconazole,The metabolism of Azelastine can be decreased when combined with Voriconazole.,decrease,no risk
Azelastine,Vortioxetine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Warfarin,The metabolism of Azelastine can be decreased when combined with Warfarin.,decrease,no risk
Azelastine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Azelastine.,decrease,no risk
Azelastine,Yohimbine,Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zafirlukast,The metabolism of Azelastine can be decreased when combined with Zafirlukast.,decrease,no risk
Azelastine,Zaleplon,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Ziconotide,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zidovudine,The metabolism of Azelastine can be decreased when combined with Zidovudine.,decrease,no risk
Azelastine,Zileuton,The metabolism of Azelastine can be decreased when combined with Zileuton.,decrease,no risk
Azelastine,Zimelidine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Ziprasidone,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zolmitriptan,Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zolpidem,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zonisamide,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zopiclone,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zotepine,Zotepine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zuclopenthixol,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Azelastine,Zuranolone,Zuranolone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,increase,no risk
Ezetimibe,Gefitinib,Gefitinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Gemfibrozil,The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Ezetimibe.,increase,risk
Ezetimibe,Gilteritinib,Gilteritinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Glasdegib,Glasdegib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Glecaprevir,Glecaprevir may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Glimepiride,Glimepiride may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Glipizide,Ezetimibe may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ezetimibe,Glyburide,Glyburide may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Glycyrrhizic acid,Ezetimibe may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Ezetimibe,Grazoprevir,Grazoprevir may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Ketoconazole,Ketoconazole may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Ofloxacin,Ezetimibe may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Ezetimibe,Olmesartan,Olmesartan may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Ombitasvir,The metabolism of Ezetimibe can be decreased when combined with Ombitasvir.,decrease,no risk
Ezetimibe,Osimertinib,Osimertinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Oteseconazole,The serum concentration of Ezetimibe can be increased when it is combined with Oteseconazole.,increase,no risk
Ezetimibe,Ouabain,The excretion of Ezetimibe can be decreased when combined with Ouabain.,decrease,no risk
Ezetimibe,Quinidine,Quinidine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Quinine,The excretion of Ezetimibe can be decreased when combined with Quinine.,decrease,no risk
Ezetimibe,Quizartinib,The metabolism of Ezetimibe can be decreased when combined with Quizartinib.,decrease,no risk
Ezetimibe,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Vadadustat,Vadadustat may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Valproic acid,The metabolism of Ezetimibe can be decreased when combined with Valproic acid.,decrease,no risk
Ezetimibe,Valsartan,The excretion of Ezetimibe can be decreased when combined with Valsartan.,decrease,no risk
Ezetimibe,Vandetanib,Vandetanib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Velpatasvir,Velpatasvir may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Vemurafenib,Vemurafenib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Venetoclax,Venetoclax may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Venlafaxine,Venlafaxine may increase the excretion rate of Ezetimibe which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ezetimibe,Vinblastine,Vinblastine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Vincristine,Vincristine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Vismodegib,Vismodegib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Ezetimibe which could result in a higher serum level.,decrease,no risk
Ezetimibe,Zidovudine,The metabolism of Ezetimibe can be increased when combined with Zidovudine.,increase,no risk
Edetic acid,Gemcitabine,The risk or severity of bleeding can be increased when Edetic acid is combined with Gemcitabine.,increase,risk
Edetic acid,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Edetic acid is combined with Gemtuzumab ozogamicin.,increase,risk
Edetic acid,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Edetic acid.,increase,risk
Edetic acid,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Edetic acid.,increase,no risk
Edetic acid,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Edetic acid.,increase,risk
Edetic acid,Hemin,Hemin may increase the anticoagulant activities of Edetic acid.,increase,no risk
Edetic acid,Heparin,The risk or severity of bleeding can be increased when Edetic acid is combined with Heparin.,increase,risk
Edetic acid,Hydrochlorothiazide,The therapeutic efficacy of Edetic acid can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Edetic acid,Hydroflumethiazide,The therapeutic efficacy of Edetic acid can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Edetic acid,Hydroxyprogesterone caproate,The therapeutic efficacy of Edetic acid can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Edetic acid,Hydroxyurea,The risk or severity of bleeding can be increased when Edetic acid is combined with Hydroxyurea.,increase,risk
Edetic acid,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Edetic acid.,increase,risk
Edetic acid,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Edetic acid.,increase,risk
Edetic acid,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Edetic acid is combined with Obeticholic acid.,increase,risk
Edetic acid,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Edetic acid is combined with Obinutuzumab.,increase,risk
Edetic acid,Olaparib,The risk or severity of bleeding can be increased when Edetic acid is combined with Olaparib.,increase,risk
Edetic acid,Olive oil,The therapeutic efficacy of Edetic acid can be decreased when used in combination with Olive oil.,decrease,no risk
Edetic acid,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Edetic acid.,increase,risk
Edetic acid,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Edetic acid is combined with Omacetaxine mepesuccinate.,increase,risk
Edetic acid,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Edetic acid.,increase,no risk
Edetic acid,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Edetic acid.,increase,risk
Edetic acid,Omega-3-carboxylic acids,The therapeutic efficacy of Edetic acid can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Edetic acid,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Edetic acid.,increase,risk
Edetic acid,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Edetic acid.,increase,risk
Edetic acid,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Edetic acid.,increase,risk
Edetic acid,Quinestrol,Quinestrol may decrease the anticoagulant activities of Edetic acid.,decrease,no risk
Edetic acid,Quinidine,The therapeutic efficacy of Edetic acid can be increased when used in combination with Quinidine.,increase,no risk
Edetic acid,Quinine,The therapeutic efficacy of Edetic acid can be increased when used in combination with Quinine.,increase,no risk
Edetic acid,Ulipristal,The therapeutic efficacy of Edetic acid can be decreased when used in combination with Ulipristal.,decrease,no risk
Edetic acid,Urokinase,Urokinase may increase the anticoagulant activities of Edetic acid.,increase,no risk
Edetic acid,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Edetic acid is combined with Ursodeoxycholic acid.,increase,risk
Edetic acid,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Edetic acid.,increase,risk
Edetic acid,Venlafaxine,The risk or severity of bleeding can be increased when Edetic acid is combined with Venlafaxine.,increase,risk
Edetic acid,Vinblastine,The risk or severity of bleeding can be increased when Edetic acid is combined with Vinblastine.,increase,risk
Edetic acid,Vindesine,The risk or severity of bleeding can be increased when Edetic acid is combined with Vindesine.,increase,risk
Edetic acid,Vinorelbine,The risk or severity of bleeding can be increased when Edetic acid is combined with Vinorelbine.,increase,risk
Edetic acid,Vitamin E,Vitamin E may increase the anticoagulant activities of Edetic acid.,increase,no risk
Edetic acid,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Edetic acid.,decrease,no risk
Edetic acid,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Edetic acid.,increase,risk
Edetic acid,Vorinostat,The risk or severity of bleeding can be increased when Edetic acid is combined with Vorinostat.,increase,risk
Edetic acid,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Edetic acid.,increase,risk
Edetic acid,Ximelagatran,The risk or severity of bleeding can be increased when Edetic acid is combined with Ximelagatran.,increase,risk
Edetic acid,Zidovudine,The risk or severity of bleeding can be increased when Edetic acid is combined with Zidovudine.,increase,risk
Edetic acid,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Edetic acid.,increase,risk
Dipyridamole,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Dipyridamole.,increase,risk
Dipyridamole,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Dipyridamole.,increase,risk
Dipyridamole,Busulfan,The risk or severity of bleeding can be increased when Dipyridamole is combined with Busulfan.,increase,risk
Dipyridamole,Butabarbital,Butabarbital may increase the hypotensive activities of Dipyridamole.,increase,no risk
Dipyridamole,Butalbital,Butalbital may increase the hypotensive activities of Dipyridamole.,increase,no risk
Dipyridamole,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Dipyridamole.,decrease,no risk
Dipyridamole,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Dipyridamole.,decrease,no risk
Dipyridamole,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Dipyridamole.,decrease,no risk
Dipyridamole,Gemcitabine,The risk or severity of bleeding can be increased when Dipyridamole is combined with Gemcitabine.,increase,risk
Dipyridamole,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Dipyridamole is combined with Gemtuzumab ozogamicin.,increase,risk
Dipyridamole,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Dipyridamole.,increase,risk
Dipyridamole,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Dipyridamole.,decrease,no risk
Dipyridamole,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Dipyridamole.,decrease,no risk
Dipyridamole,Glimepiride,Glimepiride may decrease the excretion rate of Dipyridamole which could result in a higher serum level.,decrease,no risk
Dipyridamole,Glipizide,Dipyridamole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Dipyridamole,Glucosamine,Glucosamine may increase the antiplatelet activities of Dipyridamole.,increase,no risk
Dipyridamole,Glyburide,Glyburide may decrease the excretion rate of Dipyridamole which could result in a higher serum level.,decrease,no risk
Dipyridamole,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Dipyridamole.,increase,risk
Dipyridamole,Glycyrrhizic acid,Dipyridamole may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Dipyridamole,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Dipyridamole.,decrease,no risk
Dipyridamole,Guanabenz,Dipyridamole may increase the antihypertensive activities of Guanabenz.,increase,no risk
Dipyridamole,Guanadrel,Dipyridamole may increase the antihypertensive activities of Guanadrel.,increase,no risk
Dipyridamole,Guanethidine,Dipyridamole may increase the antihypertensive activities of Guanethidine.,increase,no risk
Dipyridamole,Guanfacine,Dipyridamole may increase the antihypertensive activities of Guanfacine.,increase,no risk
Dipyridamole,Guanoxan,Dipyridamole may increase the antihypertensive activities of Guanoxan.,increase,no risk
Dipyridamole,Halothane,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Halothane.,increase,risk
Dipyridamole,Hemin,Hemin may increase the anticoagulant activities of Dipyridamole.,increase,no risk
Dipyridamole,Heparin,The risk or severity of bleeding can be increased when Dipyridamole is combined with Heparin.,increase,risk
Dipyridamole,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Dipyridamole.,decrease,no risk
Dipyridamole,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Dipyridamole.,decrease,no risk
Dipyridamole,Hydralazine,Dipyridamole may increase the antihypertensive activities of Hydralazine.,increase,no risk
Dipyridamole,Hydrochlorothiazide,Dipyridamole may increase the antihypertensive activities of Hydrochlorothiazide.,increase,no risk
Dipyridamole,Hydroflumethiazide,Dipyridamole may increase the antihypertensive activities of Hydroflumethiazide.,increase,no risk
Dipyridamole,Hydroxyprogesterone caproate,The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Dipyridamole,Hydroxyurea,The risk or severity of bleeding can be increased when Dipyridamole is combined with Hydroxyurea.,increase,risk
Dipyridamole,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Dipyridamole.,decrease,no risk
Dipyridamole,Ketoconazole,Ketoconazole may decrease the excretion rate of Dipyridamole which could result in a higher serum level.,decrease,no risk
Dipyridamole,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Dipyridamole.,increase,risk
Dipyridamole,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Dipyridamole.,increase,risk
Dipyridamole,Obeticholic acid,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Obeticholic acid.,increase,risk
Dipyridamole,Obinutuzumab,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Obinutuzumab.,increase,risk
Dipyridamole,Ofloxacin,Dipyridamole may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Dipyridamole,Olanzapine,The risk or severity of hypotension and syncope can be increased when Dipyridamole is combined with Olanzapine.,increase,risk
Dipyridamole,Olaparib,The risk or severity of bleeding can be increased when Dipyridamole is combined with Olaparib.,increase,risk
Dipyridamole,Olive oil,The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Olive oil.,decrease,no risk
Dipyridamole,Olmesartan,Olmesartan may decrease the excretion rate of Dipyridamole which could result in a higher serum level.,decrease,no risk
Dipyridamole,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Dipyridamole.,increase,risk
Dipyridamole,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Dipyridamole is combined with Omacetaxine mepesuccinate.,increase,risk
Dipyridamole,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Dipyridamole.,increase,no risk
Dipyridamole,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Dipyridamole.,increase,risk
Dipyridamole,Omega-3-carboxylic acids,The therapeutic efficacy of Dipyridamole can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Dipyridamole,Opicapone,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Opicapone.,increase,risk
Dipyridamole,Ouabain,The excretion of Ouabain can be decreased when combined with Dipyridamole.,decrease,no risk
Dipyridamole,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Dipyridamole.,increase,risk
Dipyridamole,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Dipyridamole.,increase,risk
Dipyridamole,Oxprenolol,Dipyridamole may increase the bradycardic activities of Oxprenolol.,increase,no risk
Dipyridamole,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Dipyridamole.,increase,risk
Dipyridamole,Quetiapine,The risk or severity of hypotension and syncope can be increased when Dipyridamole is combined with Quetiapine.,increase,risk
Dipyridamole,Quinapril,Dipyridamole may increase the antihypertensive activities of Quinapril.,increase,no risk
Dipyridamole,Quinestrol,Quinestrol may decrease the anticoagulant activities of Dipyridamole.,decrease,no risk
Dipyridamole,Quinidine,The therapeutic efficacy of Dipyridamole can be increased when used in combination with Quinidine.,increase,no risk
Dipyridamole,Quinine,The therapeutic efficacy of Dipyridamole can be increased when used in combination with Quinine.,increase,no risk
Dipyridamole,Udenafil,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Udenafil.,increase,risk
Dipyridamole,Ulipristal,The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Ulipristal.,decrease,no risk
Dipyridamole,Urokinase,Urokinase may increase the anticoagulant activities of Dipyridamole.,increase,no risk
Dipyridamole,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Ursodeoxycholic acid.,increase,risk
Dipyridamole,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Dipyridamole.,increase,risk
Dipyridamole,Valsartan,Dipyridamole may increase the antihypertensive activities of Valsartan.,increase,no risk
Dipyridamole,Vardenafil,The risk or severity of adverse effects can be increased when Vardenafil is combined with Dipyridamole.,increase,risk
Dipyridamole,Venlafaxine,The risk or severity of bleeding can be increased when Dipyridamole is combined with Venlafaxine.,increase,risk
Dipyridamole,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Dipyridamole.,increase,risk
Dipyridamole,Vericiguat,The risk or severity of hypotension can be increased when Dipyridamole is combined with Vericiguat.,increase,risk
Dipyridamole,Vinblastine,Vinblastine may decrease the excretion rate of Dipyridamole which could result in a higher serum level.,decrease,no risk
Dipyridamole,Vincristine,Vincristine may decrease the excretion rate of Dipyridamole which could result in a higher serum level.,decrease,no risk
Dipyridamole,Vindesine,The risk or severity of bleeding can be increased when Dipyridamole is combined with Vindesine.,increase,risk
Dipyridamole,Vinorelbine,The risk or severity of bleeding can be increased when Dipyridamole is combined with Vinorelbine.,increase,risk
Dipyridamole,Vitamin E,Vitamin E may increase the antiplatelet activities of Dipyridamole.,increase,no risk
Dipyridamole,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Dipyridamole.,decrease,no risk
Dipyridamole,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Dipyridamole.,increase,risk
Dipyridamole,Vorinostat,The risk or severity of bleeding can be increased when Dipyridamole is combined with Vorinostat.,increase,risk
Dipyridamole,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Dipyridamole.,increase,risk
Dipyridamole,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Dipyridamole.,decrease,no risk
Dipyridamole,Warfarin,The risk or severity of bleeding can be increased when Dipyridamole is combined with Warfarin.,increase,risk
Dipyridamole,Ximelagatran,The risk or severity of bleeding can be increased when Dipyridamole is combined with Ximelagatran.,increase,risk
Dipyridamole,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Dipyridamole.,increase,no risk
Dipyridamole,Zidovudine,The risk or severity of bleeding can be increased when Dipyridamole is combined with Zidovudine.,increase,risk
Dipyridamole,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Dipyridamole.,increase,risk
Dipyridamole,Ziprasidone,The risk or severity of hypotension and syncope can be increased when Dipyridamole is combined with Ziprasidone.,increase,risk
Dipyridamole,Zofenopril,Dipyridamole may increase the antihypertensive activities of Zofenopril.,increase,no risk
Dipyridamole,Zuclopenthixol,The risk or severity of hypotension and syncope can be increased when Dipyridamole is combined with Zuclopenthixol.,increase,risk
Telithromycin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Telithromycin.,increase,risk
Telithromycin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Telithromycin.,increase,risk
Telithromycin,Budesonide,The metabolism of Budesonide can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Telithromycin.,increase,risk
Telithromycin,Buspirone,The metabolism of Buspirone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Busulfan,The metabolism of Busulfan can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Telithromycin is combined with Butacaine.,increase,risk
Telithromycin,Butamben,The risk or severity of methemoglobinemia can be increased when Telithromycin is combined with Butamben.,increase,risk
Telithromycin,Butriptyline,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Butriptyline.,increase,risk
Telithromycin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Telithromycin.,increase,risk
Telithromycin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Galantamine,The metabolism of Galantamine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Telithromycin.,increase,risk
Telithromycin,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Gemifloxacin.,increase,risk
Telithromycin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Glofitamab,The serum concentration of Telithromycin can be increased when it is combined with Glofitamab.,increase,no risk
Telithromycin,Glyburide,The metabolism of Glyburide can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Golimumab,The metabolism of Telithromycin can be increased when combined with Golimumab.,increase,no risk
Telithromycin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Telithromycin.,increase,risk
Telithromycin,Granisetron,The metabolism of Granisetron can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Haloperidol,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Haloperidol.,increase,risk
Telithromycin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Telithromycin.,increase,risk
Telithromycin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Telithromycin.,increase,risk
Telithromycin,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Hydroxyzine.,increase,risk
Telithromycin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Telithromycin.,increase,risk
Telithromycin,Ketamine,The metabolism of Ketamine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Telithromycin.,increase,risk
Telithromycin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Ofloxacin.,increase,risk
Telithromycin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Telithromycin.,increase,risk
Telithromycin,Olaparib,The metabolism of Olaparib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Telithromycin.,increase,risk
Telithromycin,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Opium,The metabolism of Opium can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Telithromycin.,increase,risk
Telithromycin,Oxatomide,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Oxatomide.,increase,risk
Telithromycin,Oxcarbazepine,The metabolism of Telithromycin can be increased when combined with Oxcarbazepine.,increase,no risk
Telithromycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Telithromycin is combined with Oxetacaine.,increase,risk
Telithromycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Telithromycin is combined with Oxybuprocaine.,increase,risk
Telithromycin,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Telithromycin.,increase,risk
Telithromycin,Quazepam,The metabolism of Quazepam can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Quinidine,The metabolism of Quinidine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Quinine,The serum concentration of Quinine can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Udenafil,The metabolism of Udenafil can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vadadustat,The serum concentration of Telithromycin can be increased when it is combined with Vadadustat.,increase,no risk
Telithromycin,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Valproic acid,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Valproic acid.,increase,risk
Telithromycin,Valsartan,The excretion of Valsartan can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Telithromycin.,increase,risk
Telithromycin,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Verapamil,The risk or severity of adverse effects can be increased when Telithromycin is combined with Verapamil.,increase,risk
Telithromycin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Telithromycin.,increase,risk
Telithromycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Telithromycin.,decrease,no risk
Telithromycin,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Viloxazine,The metabolism of Telithromycin can be decreased when combined with Viloxazine.,decrease,no risk
Telithromycin,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vincristine,The metabolism of Vincristine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vindesine,The metabolism of Vindesine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Voriconazole,The metabolism of Telithromycin can be decreased when combined with Voriconazole.,decrease,no risk
Telithromycin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Telithromycin.,increase,risk
Telithromycin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Warfarin,The metabolism of Warfarin can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Xylometazoline,The risk or severity of QTc prolongation and hypotension can be increased when Telithromycin is combined with Xylometazoline.,increase,risk
Telithromycin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Telithromycin.,increase,no risk
Telithromycin,Ziconotide,The risk or severity of QTc prolongation and hypotension can be increased when Telithromycin is combined with Ziconotide.,increase,risk
Telithromycin,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zileuton,The metabolism of Zileuton can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zimelidine,The metabolism of Telithromycin can be decreased when combined with Zimelidine.,decrease,no risk
Telithromycin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Ziprasidone.,increase,risk
Telithromycin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zotepine,The metabolism of Zotepine can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Telithromycin.,decrease,no risk
Telithromycin,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Telithromycin.,increase,no risk
Ethinylestradiol,Beclomethasone dipropionate,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Belantamab mafodotin,Ethinylestradiol may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Ethinylestradiol,Belimumab,Ethinylestradiol may increase the thrombogenic activities of Belimumab.,increase,no risk
Ethinylestradiol,Belinostat,The metabolism of Belinostat can be increased when combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Bemiparin,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Bemiparin.,increase,risk
Ethinylestradiol,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Benralizumab,Ethinylestradiol may increase the thrombogenic activities of Benralizumab.,increase,no risk
Ethinylestradiol,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Benzylpenicillin,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Benzylpenicillin.,decrease,no risk
Ethinylestradiol,Benzylpenicilloyl polylysine,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Ethinylestradiol,Berotralstat,The metabolism of Ethinylestradiol can be decreased when combined with Berotralstat.,decrease,no risk
Ethinylestradiol,Besilesomab,Ethinylestradiol may increase the thrombogenic activities of Besilesomab.,increase,no risk
Ethinylestradiol,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Betaxolol,The metabolism of Ethinylestradiol can be decreased when combined with Betaxolol.,decrease,no risk
Ethinylestradiol,Betrixaban,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Betrixaban.,increase,risk
Ethinylestradiol,Bevacizumab,Ethinylestradiol may increase the thrombogenic activities of Bevacizumab.,increase,no risk
Ethinylestradiol,Bexagliflozin,The metabolism of Bexagliflozin can be increased when combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Bexarotene,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Bexarotene.,decrease,no risk
Ethinylestradiol,Bezafibrate,The metabolism of Ethinylestradiol can be decreased when combined with Bezafibrate.,decrease,no risk
Ethinylestradiol,Bezlotoxumab,Ethinylestradiol may increase the thrombogenic activities of Bezlotoxumab.,increase,no risk
Ethinylestradiol,Bictegravir,The metabolism of Bictegravir can be increased when combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Bimekizumab,The metabolism of Ethinylestradiol can be increased when combined with Bimekizumab.,increase,no risk
Ethinylestradiol,Binimetinib,The metabolism of Binimetinib can be increased when combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Bivalirudin,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Bivalirudin.,increase,risk
Ethinylestradiol,Blinatumomab,Ethinylestradiol may increase the thrombogenic activities of Blinatumomab.,increase,no risk
Ethinylestradiol,Boceprevir,The serum concentration of Ethinylestradiol can be increased when it is combined with Boceprevir.,increase,no risk
Ethinylestradiol,Bortezomib,The metabolism of Ethinylestradiol can be decreased when combined with Bortezomib.,decrease,no risk
Ethinylestradiol,Bosentan,The serum concentration of Ethinylestradiol can be decreased when it is combined with Bosentan.,decrease,no risk
Ethinylestradiol,Bosutinib,The metabolism of Ethinylestradiol can be decreased when combined with Bosutinib.,decrease,no risk
Ethinylestradiol,Brentuximab vedotin,Ethinylestradiol may increase the thrombogenic activities of Brentuximab vedotin.,increase,no risk
Ethinylestradiol,Brexanolone,The metabolism of Ethinylestradiol can be increased when combined with Brexanolone.,increase,no risk
Ethinylestradiol,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Brivaracetam,The metabolism of Ethinylestradiol can be increased when combined with Brivaracetam.,increase,no risk
Ethinylestradiol,Brodalumab,Ethinylestradiol may increase the thrombogenic activities of Brodalumab.,increase,no risk
Ethinylestradiol,Brolucizumab,Ethinylestradiol may increase the thrombogenic activities of Brolucizumab.,increase,no risk
Ethinylestradiol,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Bupropion,The metabolism of Bupropion can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Burosumab,Ethinylestradiol may increase the thrombogenic activities of Burosumab.,increase,no risk
Ethinylestradiol,Buspirone,The metabolism of Ethinylestradiol can be decreased when combined with Buspirone.,decrease,no risk
Ethinylestradiol,Butabarbital,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Butabarbital.,decrease,no risk
Ethinylestradiol,Butalbital,The metabolism of Ethinylestradiol can be increased when combined with Butalbital.,increase,no risk
Ethinylestradiol,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Gabapentin,The metabolism of Ethinylestradiol can be increased when combined with Gabapentin.,increase,no risk
Ethinylestradiol,Galcanezumab,Ethinylestradiol may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Ethinylestradiol,Ganaxolone,The metabolism of Ethinylestradiol can be increased when combined with Ganaxolone.,increase,no risk
Ethinylestradiol,Gatifloxacin,The metabolism of Ethinylestradiol can be decreased when combined with Gatifloxacin.,decrease,no risk
Ethinylestradiol,Gefitinib,The metabolism of Ethinylestradiol can be decreased when combined with Gefitinib.,decrease,no risk
Ethinylestradiol,Gemfibrozil,The metabolism of Ethinylestradiol can be decreased when combined with Gemfibrozil.,decrease,no risk
Ethinylestradiol,Gemifloxacin,The metabolism of Ethinylestradiol can be decreased when combined with Gemifloxacin.,decrease,no risk
Ethinylestradiol,Gemtuzumab ozogamicin,Ethinylestradiol may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Ethinylestradiol,Ginkgo biloba,The metabolism of Ethinylestradiol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ethinylestradiol,Givosiran,The serum concentration of Ethinylestradiol can be increased when it is combined with Givosiran.,increase,no risk
Ethinylestradiol,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Glecaprevir,The metabolism of Ethinylestradiol can be decreased when combined with Glecaprevir.,decrease,no risk
Ethinylestradiol,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Glofitamab,The serum concentration of Ethinylestradiol can be increased when it is combined with Glofitamab.,increase,no risk
Ethinylestradiol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Glycerol phenylbutyrate,The metabolism of Ethinylestradiol can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ethinylestradiol,Glycyrrhizic acid,Ethinylestradiol may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Ethinylestradiol,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Golimumab,The metabolism of Ethinylestradiol can be increased when combined with Golimumab.,increase,no risk
Ethinylestradiol,Grepafloxacin,The metabolism of Ethinylestradiol can be decreased when combined with Grepafloxacin.,decrease,no risk
Ethinylestradiol,Griseofulvin,The metabolism of Ethinylestradiol can be increased when combined with Griseofulvin.,increase,no risk
Ethinylestradiol,Guanabenz,The metabolism of Ethinylestradiol can be decreased when combined with Guanabenz.,decrease,no risk
Ethinylestradiol,Guselkumab,Ethinylestradiol may increase the thrombogenic activities of Guselkumab.,increase,no risk
Ethinylestradiol,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Halothane,The metabolism of Halothane can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Heparin,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Heparin.,increase,risk
Ethinylestradiol,Hepatitis B immune globulin,Ethinylestradiol may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Ethinylestradiol,Hetacillin,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Hetacillin.,decrease,no risk
Ethinylestradiol,Human cytomegalovirus immune globulin,Ethinylestradiol may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Ethinylestradiol,Human immunoglobulin G,Ethinylestradiol may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Ethinylestradiol,Human Rho(D) immune globulin,Ethinylestradiol may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Ethinylestradiol,Human varicella-zoster immune globulin,Ethinylestradiol may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Ethinylestradiol,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Hydrocortamate,The metabolism of Ethinylestradiol can be increased when combined with Hydrocortamate.,increase,no risk
Ethinylestradiol,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Hydromorphone,The metabolism of Ethinylestradiol can be decreased when combined with Hydromorphone.,decrease,no risk
Ethinylestradiol,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Hydroxyzine,The metabolism of Ethinylestradiol can be decreased when combined with Hydroxyzine.,decrease,no risk
Ethinylestradiol,Ketamine,The metabolism of Ketamine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Ketoconazole,The metabolism of Ethinylestradiol can be decreased when combined with Ketoconazole.,decrease,no risk
Ethinylestradiol,Ketoprofen,The metabolism of Ketoprofen can be increased when combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Obeticholic acid,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Obeticholic acid.,increase,risk
Ethinylestradiol,Obiltoxaximab,Ethinylestradiol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Ethinylestradiol,Obinutuzumab,Ethinylestradiol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Ethinylestradiol,Ocrelizumab,Ethinylestradiol may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Ethinylestradiol,Octreotide,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Octreotide.,decrease,no risk
Ethinylestradiol,Odesivimab,Ethinylestradiol may increase the thrombogenic activities of Odesivimab.,increase,no risk
Ethinylestradiol,Ofatumumab,Ethinylestradiol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Ethinylestradiol,Ofloxacin,Ethinylestradiol may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Ethinylestradiol,Olanzapine,The metabolism of Ethinylestradiol can be decreased when combined with Olanzapine.,decrease,no risk
Ethinylestradiol,Olaparib,The metabolism of Olaparib can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Olaratumab,Ethinylestradiol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Ethinylestradiol,Olmesartan,The risk or severity of liver damage can be increased when Olmesartan is combined with Ethinylestradiol.,increase,risk
Ethinylestradiol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Olutasidenib,The metabolism of Ethinylestradiol can be increased when combined with Olutasidenib.,increase,no risk
Ethinylestradiol,Omadacycline,The serum concentration of Ethinylestradiol can be decreased when it is combined with Omadacycline.,decrease,no risk
Ethinylestradiol,Omalizumab,Ethinylestradiol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Ethinylestradiol,Omaveloxolone,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Ethinylestradiol,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Ethinylestradiol is combined with Ombitasvir.,increase,risk
Ethinylestradiol,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Ondansetron,The metabolism of Ethinylestradiol can be decreased when combined with Ondansetron.,decrease,no risk
Ethinylestradiol,Opicapone,The metabolism of Ethinylestradiol can be decreased when combined with Opicapone.,decrease,no risk
Ethinylestradiol,Oritavancin,The metabolism of Ethinylestradiol can be increased when combined with Oritavancin.,increase,no risk
Ethinylestradiol,Orphenadrine,The metabolism of Ethinylestradiol can be decreased when combined with Orphenadrine.,decrease,no risk
Ethinylestradiol,Osilodrostat,The metabolism of Ethinylestradiol can be decreased when combined with Osilodrostat.,decrease,no risk
Ethinylestradiol,Osimertinib,The serum concentration of Ethinylestradiol can be decreased when it is combined with Osimertinib.,decrease,no risk
Ethinylestradiol,Ospemifene,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Ospemifene.,increase,risk
Ethinylestradiol,Ox bile extract,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Oxacillin,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Oxacillin.,decrease,no risk
Ethinylestradiol,Oxandrolone,The metabolism of Ethinylestradiol can be decreased when combined with Oxandrolone.,decrease,no risk
Ethinylestradiol,Oxcarbazepine,The serum concentration of Ethinylestradiol can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Ethinylestradiol,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Oxybutynin,The metabolism of Ethinylestradiol can be decreased when combined with Oxybutynin.,decrease,no risk
Ethinylestradiol,Oxycodone,The metabolism of Ethinylestradiol can be decreased when combined with Oxycodone.,decrease,no risk
Ethinylestradiol,Oxytetracycline,The serum concentration of Ethinylestradiol can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Ethinylestradiol,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Quinidine,The metabolism of Ethinylestradiol can be decreased when combined with Quinidine.,decrease,no risk
Ethinylestradiol,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Quizartinib,The metabolism of Ethinylestradiol can be decreased when combined with Quizartinib.,decrease,no risk
Ethinylestradiol,Ublituximab,Ethinylestradiol may increase the thrombogenic activities of Ublituximab.,increase,no risk
Ethinylestradiol,Udenafil,The metabolism of Udenafil can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Urokinase,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Urokinase.,increase,risk
Ethinylestradiol,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Ustekinumab,Ethinylestradiol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Ethinylestradiol,Vadadustat,The serum concentration of Ethinylestradiol can be increased when it is combined with Vadadustat.,increase,no risk
Ethinylestradiol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Valdecoxib,Valdecoxib may increase the thrombogenic activities of Ethinylestradiol.,increase,no risk
Ethinylestradiol,Valproic acid,The metabolism of Ethinylestradiol can be increased when combined with Valproic acid.,increase,no risk
Ethinylestradiol,Valsartan,The metabolism of Ethinylestradiol can be decreased when combined with Valsartan.,decrease,no risk
Ethinylestradiol,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Vardenafil,The metabolism of Ethinylestradiol can be decreased when combined with Vardenafil.,decrease,no risk
Ethinylestradiol,Vedolizumab,Ethinylestradiol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Ethinylestradiol,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Vemurafenib,The serum concentration of Ethinylestradiol can be increased when it is combined with Vemurafenib.,increase,no risk
Ethinylestradiol,Venetoclax,The metabolism of Ethinylestradiol can be decreased when combined with Venetoclax.,decrease,no risk
Ethinylestradiol,Verapamil,The metabolism of Ethinylestradiol can be decreased when combined with Verapamil.,decrease,no risk
Ethinylestradiol,Vigabatrin,The metabolism of Ethinylestradiol can be increased when combined with Vigabatrin.,increase,no risk
Ethinylestradiol,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Viloxazine,The metabolism of Ethinylestradiol can be decreased when combined with Viloxazine.,decrease,no risk
Ethinylestradiol,Vinblastine,Ethinylestradiol may decrease the excretion rate of Vinblastine which could result in a higher serum level.,decrease,no risk
Ethinylestradiol,Vincristine,The metabolism of Vincristine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Vitamin A,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Vitamin A.,decrease,no risk
Ethinylestradiol,Vitamin E,The metabolism of Ethinylestradiol can be increased when combined with Vitamin E.,increase,no risk
Ethinylestradiol,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Vorapaxar,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Vorapaxar.,increase,risk
Ethinylestradiol,Voriconazole,The serum concentration of Voriconazole can be increased when it is combined with Ethinylestradiol.,increase,no risk
Ethinylestradiol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Warfarin,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Warfarin.,increase,risk
Ethinylestradiol,Ximelagatran,The risk or severity of adverse effects can be increased when Ethinylestradiol is combined with Ximelagatran.,increase,risk
Ethinylestradiol,Zafirlukast,The metabolism of Ethinylestradiol can be decreased when combined with Zafirlukast.,decrease,no risk
Ethinylestradiol,Zaleplon,The metabolism of Ethinylestradiol can be increased when combined with Zaleplon.,increase,no risk
Ethinylestradiol,Zidovudine,The metabolism of Ethinylestradiol can be increased when combined with Zidovudine.,increase,no risk
Ethinylestradiol,Zileuton,The metabolism of Ethinylestradiol can be decreased when combined with Zileuton.,decrease,no risk
Ethinylestradiol,Zimelidine,The metabolism of Ethinylestradiol can be decreased when combined with Zimelidine.,decrease,no risk
Ethinylestradiol,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Ziprasidone,The metabolism of Ethinylestradiol can be decreased when combined with Ziprasidone.,decrease,no risk
Ethinylestradiol,Zolmitriptan,The metabolism of Ethinylestradiol can be decreased when combined with Zolmitriptan.,decrease,no risk
Ethinylestradiol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ethinylestradiol.,decrease,no risk
Ethinylestradiol,Zonisamide,The metabolism of Ethinylestradiol can be increased when combined with Zonisamide.,increase,no risk
Ethinylestradiol,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ethinylestradiol.,decrease,no risk
Lomefloxacin,Butriptyline,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Butriptyline.,increase,risk
Lomefloxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Gatifloxacin,The metabolism of Lomefloxacin can be decreased when combined with Gatifloxacin.,decrease,no risk
Lomefloxacin,Gemfibrozil,The metabolism of Lomefloxacin can be decreased when combined with Gemfibrozil.,decrease,no risk
Lomefloxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Gemifloxacin.,increase,risk
Lomefloxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Gilteritinib.,increase,risk
Lomefloxacin,Givosiran,The serum concentration of Lomefloxacin can be increased when it is combined with Givosiran.,increase,no risk
Lomefloxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Glasdegib.,increase,risk
Lomefloxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Glofitamab,The serum concentration of Lomefloxacin can be increased when it is combined with Glofitamab.,increase,no risk
Lomefloxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Lomefloxacin.,increase,no risk
Lomefloxacin,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Golimumab,The metabolism of Lomefloxacin can be increased when combined with Golimumab.,increase,no risk
Lomefloxacin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Grepafloxacin.,increase,risk
Lomefloxacin,Guanabenz,The metabolism of Lomefloxacin can be decreased when combined with Guanabenz.,decrease,no risk
Lomefloxacin,Halofantrine,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Halofantrine.,increase,risk
Lomefloxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Haloperidol.,increase,risk
Lomefloxacin,Hetacillin,The serum concentration of Lomefloxacin can be increased when it is combined with Hetacillin.,increase,no risk
Lomefloxacin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Hydroxyzine.,increase,risk
Lomefloxacin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Ketoconazole,The metabolism of Lomefloxacin can be decreased when combined with Ketoconazole.,decrease,no risk
Lomefloxacin,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Lomefloxacin.,increase,no risk
Lomefloxacin,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Lomefloxacin.,increase,no risk
Lomefloxacin,Obeticholic acid,The metabolism of Lomefloxacin can be decreased when combined with Obeticholic acid.,decrease,no risk
Lomefloxacin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Ofloxacin.,increase,risk
Lomefloxacin,Olanzapine,The metabolism of Lomefloxacin can be decreased when combined with Olanzapine.,decrease,no risk
Lomefloxacin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Orphenadrine,The metabolism of Lomefloxacin can be decreased when combined with Orphenadrine.,decrease,no risk
Lomefloxacin,Osilodrostat,The metabolism of Lomefloxacin can be decreased when combined with Osilodrostat.,decrease,no risk
Lomefloxacin,Osimertinib,The serum concentration of Lomefloxacin can be decreased when it is combined with Osimertinib.,decrease,no risk
Lomefloxacin,Oxacillin,The serum concentration of Lomefloxacin can be increased when it is combined with Oxacillin.,increase,no risk
Lomefloxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Lomefloxacin.,increase,no risk
Lomefloxacin,Oxatomide,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Oxatomide.,increase,risk
Lomefloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lomefloxacin is combined with Oxetacaine.,increase,risk
Lomefloxacin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Lomefloxacin.,decrease,no risk
Lomefloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lomefloxacin is combined with Oxybuprocaine.,increase,risk
Lomefloxacin,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Lomefloxacin.,increase,no risk
Lomefloxacin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Quetiapine,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Quetiapine.,increase,risk
Lomefloxacin,Quinapril,Quinapril can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Quinidine,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Quinidine.,increase,risk
Lomefloxacin,Quinine,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Quinine.,increase,risk
Lomefloxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Quizartinib.,increase,risk
Lomefloxacin,Valdecoxib,Valdecoxib may increase the neuroexcitatory activities of Lomefloxacin.,increase,no risk
Lomefloxacin,Valproic acid,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Valproic acid.,increase,risk
Lomefloxacin,Vamorolone,The risk or severity of tendinopathy can be increased when Vamorolone is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Vandetanib,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Vandetanib.,increase,risk
Lomefloxacin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Vemurafenib,The serum concentration of Lomefloxacin can be increased when it is combined with Vemurafenib.,increase,no risk
Lomefloxacin,Verapamil,The metabolism of Lomefloxacin can be decreased when combined with Verapamil.,decrease,no risk
Lomefloxacin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Lomefloxacin.,decrease,no risk
Lomefloxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Viloxazine,The metabolism of Lomefloxacin can be decreased when combined with Viloxazine.,decrease,no risk
Lomefloxacin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Lomefloxacin.,decrease,no risk
Lomefloxacin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Lomefloxacin.,increase,no risk
Lomefloxacin,Zileuton,The metabolism of Lomefloxacin can be decreased when combined with Zileuton.,decrease,no risk
Lomefloxacin,Zinc,Zinc can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lomefloxacin,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Lomefloxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Ziprasidone.,increase,risk
Lomefloxacin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Lomefloxacin.,decrease,no risk
Lomefloxacin,Zolpidem,The metabolism of Lomefloxacin can be decreased when combined with Zolpidem.,decrease,no risk
Lomefloxacin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Lomefloxacin.,increase,risk
Lomefloxacin,Zotepine,The metabolism of Zotepine can be decreased when combined with Lomefloxacin.,decrease,no risk
Cyclopentolate,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Cyclopentolate.,increase,risk
Cyclopentolate,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Cyclopentolate is combined with Oliceridine.",increase,risk
Cyclopentolate,Orphenadrine,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Orphenadrine.,increase,risk
Cyclopentolate,Oxybutynin,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Oxybutynin.,increase,risk
Cyclopentolate,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Cyclopentolate.,increase,risk
Cyclopentolate,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Cyclopentolate.,decrease,no risk
Cyclopentolate,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cyclopentolate.,increase,risk
Cyclopentolate,Quetiapine,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Quetiapine.,increase,risk
Cyclopentolate,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Cyclopentolate.,increase,risk
Cyclopentolate,Umeclidinium,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Umeclidinium.,increase,risk
Cyclopentolate,Vecuronium,The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Vecuronium.,increase,risk
Cyclopentolate,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Cyclopentolate.,increase,risk
Ramelteon,Belinostat,The metabolism of Ramelteon can be increased when combined with Belinostat.,increase,no risk
Ramelteon,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Ramelteon.,decrease,no risk
Ramelteon,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Ramelteon.,decrease,no risk
Ramelteon,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ramelteon,Benorilate,Benorilate may decrease the excretion rate of Ramelteon which could result in a higher serum level.,decrease,no risk
Ramelteon,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Ramelteon which could result in a higher serum level.,decrease,no risk
Ramelteon,Benperidol,The risk or severity of CNS depression can be increased when Ramelteon is combined with Benperidol.,increase,risk
Ramelteon,Benserazide,Ramelteon may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Ramelteon,Benzatropine,Benzatropine may decrease the excretion rate of Ramelteon which could result in a higher serum level.,decrease,no risk
Ramelteon,Benznidazole,Ramelteon may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Ramelteon,Benzocaine,The risk or severity of CNS depression can be increased when Ramelteon is combined with Benzocaine.,increase,risk
Ramelteon,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Ramelteon.,increase,risk
Ramelteon,Benzthiazide,Benzthiazide may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ramelteon,Benzydamine,Benzydamine may decrease the excretion rate of Ramelteon which could result in a higher serum level.,decrease,no risk
Ramelteon,Benzyl alcohol,The risk or severity of CNS depression can be increased when Ramelteon is combined with Benzyl alcohol.,increase,risk
Ramelteon,Bepotastine,Ramelteon may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Ramelteon,Berotralstat,The metabolism of Ramelteon can be decreased when combined with Berotralstat.,decrease,no risk
Ramelteon,Betaxolol,The metabolism of Ramelteon can be decreased when combined with Betaxolol.,decrease,no risk
Ramelteon,Bexarotene,The metabolism of Ramelteon can be decreased when combined with Bexarotene.,decrease,no risk
Ramelteon,Bicisate,Ramelteon may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ramelteon,Bimekizumab,The metabolism of Ramelteon can be increased when combined with Bimekizumab.,increase,no risk
Ramelteon,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Ramelteon.,decrease,no risk
Ramelteon,Bismuth subgallate,Ramelteon may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ramelteon,Bisoprolol,Bisoprolol may decrease the excretion rate of Ramelteon which could result in a higher serum level.,decrease,no risk
Ramelteon,Bisoxatin,Ramelteon may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ramelteon,Bleomycin,Bleomycin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,decrease,no risk
Ramelteon,Boceprevir,The metabolism of Ramelteon can be decreased when combined with Boceprevir.,decrease,no risk
Ramelteon,Bortezomib,The metabolism of Ramelteon can be decreased when combined with Bortezomib.,decrease,no risk
Ramelteon,Bosentan,The metabolism of Ramelteon can be increased when combined with Bosentan.,increase,no risk
Ramelteon,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ramelteon.,increase,risk
Ramelteon,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ramelteon.,increase,risk
Ramelteon,Brexanolone,The risk or severity of CNS depression can be increased when Ramelteon is combined with Brexanolone.,increase,risk
Ramelteon,Brexpiprazole,The risk or severity of CNS depression can be increased when Ramelteon is combined with Brexpiprazole.,increase,risk
Ramelteon,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.,increase,no risk
Ramelteon,Brivaracetam,The risk or severity of CNS depression can be increased when Ramelteon is combined with Brivaracetam.,increase,risk
Ramelteon,Bromazepam,The risk or severity of CNS depression can be increased when Ramelteon is combined with Bromazepam.,increase,risk
Ramelteon,Bromocriptine,The risk or severity of CNS depression can be increased when Ramelteon is combined with Bromocriptine.,increase,risk
Ramelteon,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ramelteon,Bromperidol,The risk or severity of CNS depression can be increased when Ramelteon is combined with Bromperidol.,increase,risk
Ramelteon,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ramelteon.,increase,risk
Ramelteon,Budesonide,Ramelteon may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Ramelteon,Bumadizone,Bumadizone may decrease the excretion rate of Ramelteon which could result in a higher serum level.,decrease,no risk
Ramelteon,Bumetanide,Bumetanide may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ramelteon,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ramelteon.,increase,risk
Ramelteon,Buprenorphine,Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ramelteon,Bupropion,The risk or severity of CNS depression can be increased when Ramelteon is combined with Bupropion.,increase,risk
Ramelteon,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Ramelteon.,increase,risk
Ramelteon,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ramelteon.,increase,risk
Ramelteon,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Ramelteon.,increase,risk
Ramelteon,Butaperazine,The risk or severity of CNS depression can be increased when Ramelteon is combined with Butaperazine.,increase,risk
Ramelteon,Butobarbital,The risk or severity of CNS depression can be increased when Ramelteon is combined with Butobarbital.,increase,risk
Ramelteon,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Ramelteon.,increase,risk
Ramelteon,Butriptyline,The risk or severity of CNS depression can be increased when Ramelteon is combined with Butriptyline.,increase,risk
Physostigmine,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Oxprenolol,Physostigmine may increase the bradycardic activities of Oxprenolol.,increase,no risk
Physostigmine,Oxybuprocaine,Physostigmine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Physostigmine,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Vamorolone,The therapeutic efficacy of Physostigmine can be decreased when used in combination with Vamorolone.,decrease,no risk
Physostigmine,Varenicline,The risk or severity of adverse effects can be increased when Physostigmine is combined with Varenicline.,increase,risk
Physostigmine,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Physostigmine.,decrease,no risk
Physostigmine,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Physostigmine.,decrease,no risk
Isotretinoin,Gabapentin enacarbil,Isotretinoin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gadodiamide,Gadodiamide may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gadofosveset trisodium,Isotretinoin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gadoteric acid,Isotretinoin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gadoteridol,Gadoteridol may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Ganciclovir.",increase,risk
Isotretinoin,Gemcitabine,Gemcitabine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Gemfibrozil.",increase,risk
Isotretinoin,Gentamicin,Isotretinoin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Isotretinoin.,decrease,no risk
Isotretinoin,Gimeracil,Isotretinoin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Isotretinoin,Givosiran,Givosiran may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Glipizide,Isotretinoin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Isotretinoin,Glofitamab,The serum concentration of Isotretinoin can be increased when it is combined with Glofitamab.,increase,no risk
Isotretinoin,Glycerol phenylbutyrate,Isotretinoin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Isotretinoin,Golodirsen,Isotretinoin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Isotretinoin,Goserelin,Goserelin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Guanethidine,Isotretinoin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Guanfacine,Isotretinoin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Isotretinoin.,increase,no risk
Isotretinoin,Hydralazine,Isotretinoin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isotretinoin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isotretinoin,Hydromorphone,Hydromorphone may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Hydroxyethyl Starch,Isotretinoin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Isotretinoin,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Isotretinoin.,decrease,no risk
Isotretinoin,Kanamycin,Isotretinoin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Ketamine,Isotretinoin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Ketazolam,Isotretinoin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Isotretinoin,Ketoconazole,The metabolism of Isotretinoin can be decreased when combined with Ketoconazole.,decrease,no risk
Isotretinoin,Ketoprofen,Ketoprofen may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Ketorolac,Ketorolac may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Octinoxate,Isotretinoin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Isotretinoin,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Ofloxacin.",increase,risk
Isotretinoin,Olsalazine,Olsalazine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Isotretinoin is combined with Omadacycline.,increase,risk
Isotretinoin,Omaveloxolone,The serum concentration of Isotretinoin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Isotretinoin,Opium,Isotretinoin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oseltamivir,Oseltamivir may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oxacillin,Oxacillin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oxaprozin,Oxaprozin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oxazepam,Oxazepam may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oxybenzone,Isotretinoin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oxyquinoline,Isotretinoin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Isotretinoin,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Isotretinoin is combined with Oxytetracycline.,increase,risk
Isotretinoin,Quetiapine,Isotretinoin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Quinethazone,Quinethazone may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isotretinoin,Quinidine,Isotretinoin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Ubidecarenone.",increase,risk
Isotretinoin,Vaborbactam,Isotretinoin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Isotretinoin,Vadadustat,The serum concentration of Isotretinoin can be increased when it is combined with Vadadustat.,increase,no risk
Isotretinoin,Valaciclovir,Valaciclovir may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Valbenazine,Isotretinoin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Valdecoxib,Valdecoxib may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Valganciclovir,Isotretinoin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Isotretinoin,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Isotretinoin.,decrease,no risk
Isotretinoin,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Isotretinoin.,increase,no risk
Isotretinoin,Vancomycin,Isotretinoin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Varenicline,Isotretinoin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Isotretinoin,Venetoclax,The metabolism of Isotretinoin can be decreased when combined with Venetoclax.,decrease,no risk
Isotretinoin,Venlafaxine,Venlafaxine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Verapamil,The metabolism of Isotretinoin can be decreased when combined with Verapamil.,decrease,no risk
Isotretinoin,Vilanterol,Isotretinoin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Isotretinoin,Viloxazine,The metabolism of Isotretinoin can be decreased when combined with Viloxazine.,decrease,no risk
Isotretinoin,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Isotretinoin.",increase,risk
Isotretinoin,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Isotretinoin.,increase,risk
Isotretinoin,Voriconazole,The metabolism of Isotretinoin can be decreased when combined with Voriconazole.,decrease,no risk
Isotretinoin,Vortioxetine,Isotretinoin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Isotretinoin,Warfarin,Isotretinoin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Zaleplon,Zaleplon may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Zanamivir,Zanamivir may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,decrease,no risk
Isotretinoin,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Isotretinoin.",increase,risk
Isotretinoin,Zimelidine,The metabolism of Isotretinoin can be decreased when combined with Zimelidine.,decrease,no risk
Isotretinoin,Ziprasidone,The metabolism of Isotretinoin can be decreased when combined with Ziprasidone.,decrease,no risk
Isotretinoin,Zonisamide,Zonisamide may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Formoterol,Bethanidine,Bethanidine may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Bexarotene,The metabolism of Formoterol can be decreased when combined with Bexarotene.,decrease,no risk
Formoterol,Bilastine,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Bilastine.,increase,risk
Formoterol,Bimekizumab,The metabolism of Formoterol can be increased when combined with Bimekizumab.,increase,no risk
Formoterol,Biperiden,The metabolism of Formoterol can be decreased when combined with Biperiden.,decrease,no risk
Formoterol,Bisoprolol,The therapeutic efficacy of Formoterol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Formoterol,Bortezomib,The metabolism of Formoterol can be decreased when combined with Bortezomib.,decrease,no risk
Formoterol,Bosentan,The metabolism of Formoterol can be increased when combined with Bosentan.,increase,no risk
Formoterol,Bretylium,Formoterol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Formoterol,Brexpiprazole,The therapeutic efficacy of Formoterol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Formoterol,Brimonidine,Brimonidine may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Bromocriptine,Bromocriptine may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Bromotheophylline,The risk or severity of hypokalemia can be increased when Bromotheophylline is combined with Formoterol.,increase,risk
Formoterol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Formoterol.,increase,risk
Formoterol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Formoterol.,increase,risk
Formoterol,Bumadizone,The risk or severity of hypertension can be increased when Formoterol is combined with Bumadizone.,increase,risk
Formoterol,Bumetanide,The risk or severity of hypokalemia can be increased when Formoterol is combined with Bumetanide.,increase,risk
Formoterol,Bupivacaine,The metabolism of Formoterol can be decreased when combined with Bupivacaine.,decrease,no risk
Formoterol,Buprenorphine,The metabolism of Formoterol can be decreased when combined with Buprenorphine.,decrease,no risk
Formoterol,Bupropion,The metabolism of Formoterol can be decreased when combined with Bupropion.,decrease,no risk
Formoterol,Buserelin,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Buserelin.,increase,risk
Formoterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Formoterol.,increase,risk
Formoterol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Formoterol.,increase,risk
Formoterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Formoterol is combined with Butylscopolamine.,increase,risk
Formoterol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Gadobenic acid.,increase,risk
Formoterol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Formoterol.,increase,risk
Formoterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Formoterol.,increase,risk
Formoterol,Ganciclovir,The risk or severity of adverse effects can be increased when Formoterol is combined with Ganciclovir.,increase,risk
Formoterol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Gatifloxacin.,increase,risk
Formoterol,Gefitinib,The metabolism of Formoterol can be decreased when combined with Gefitinib.,decrease,no risk
Formoterol,Gemfibrozil,The metabolism of Formoterol can be decreased when combined with Gemfibrozil.,decrease,no risk
Formoterol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Gemifloxacin.,increase,risk
Formoterol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Formoterol.,increase,risk
Formoterol,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Formoterol.,increase,risk
Formoterol,Ginkgo biloba,The metabolism of Formoterol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Formoterol,Givosiran,The serum concentration of Formoterol can be increased when it is combined with Givosiran.,increase,no risk
Formoterol,Glasdegib,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Glasdegib.,increase,risk
Formoterol,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Glimepiride,The metabolism of Formoterol can be decreased when combined with Glimepiride.,decrease,no risk
Formoterol,Glipizide,The metabolism of Glipizide can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Glofitamab,The serum concentration of Formoterol can be increased when it is combined with Glofitamab.,increase,no risk
Formoterol,Glyburide,The metabolism of Glyburide can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Glycerol phenylbutyrate,The metabolism of Formoterol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Formoterol,Golimumab,The metabolism of Formoterol can be increased when combined with Golimumab.,increase,no risk
Formoterol,Goserelin,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Goserelin.,increase,risk
Formoterol,Granisetron,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Granisetron.,increase,risk
Formoterol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Grepafloxacin.,increase,risk
Formoterol,Guanabenz,Guanabenz may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Guanadrel,Formoterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Formoterol,Guanethidine,Formoterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Formoterol,Guanfacine,Guanfacine may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Formoterol.,increase,risk
Formoterol,Guanoxan,Formoterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Formoterol,Halofantrine,The metabolism of Formoterol can be decreased when combined with Halofantrine.,decrease,no risk
Formoterol,Haloperidol,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Haloperidol.,increase,risk
Formoterol,Halothane,Halothane may increase the arrhythmogenic activities of Formoterol.,increase,no risk
Formoterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Formoterol is combined with Hexocyclium.,increase,risk
Formoterol,Histamine,The risk or severity of adverse effects can be increased when Formoterol is combined with Histamine.,increase,risk
Formoterol,Histrelin,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Histrelin.,increase,risk
Formoterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Formoterol.,increase,risk
Formoterol,Hydralazine,Formoterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Formoterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Formoterol is combined with Hydrochlorothiazide.,increase,risk
Formoterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Formoterol.,increase,risk
Formoterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Formoterol.,increase,risk
Formoterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Formoterol.,increase,risk
Formoterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Formoterol.,increase,risk
Formoterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Formoterol.,increase,risk
Formoterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Formoterol is combined with Hydroflumethiazide.,increase,risk
Formoterol,Hydromorphone,The metabolism of Formoterol can be decreased when combined with Hydromorphone.,decrease,no risk
Formoterol,Hydroxyamphetamine,Hydroxyamphetamine may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Hydroxychloroquine,The metabolism of Formoterol can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Formoterol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Hydroxyzine.,increase,risk
Formoterol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Formoterol.,increase,risk
Formoterol,Ketamine,The metabolism of Ketamine can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Ketoconazole,The metabolism of Formoterol can be decreased when combined with Ketoconazole.,decrease,no risk
Formoterol,Ketoprofen,The risk or severity of hypertension can be increased when Formoterol is combined with Ketoprofen.,increase,risk
Formoterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Formoterol.,increase,risk
Formoterol,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Formoterol.,increase,risk
Formoterol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Ofloxacin.,increase,risk
Formoterol,Olanzapine,The therapeutic efficacy of Formoterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Formoterol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Olmesartan,Formoterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Formoterol,Olodaterol,Olodaterol may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Omeprazole,The metabolism of Formoterol can be decreased when combined with Omeprazole.,decrease,no risk
Formoterol,Ondansetron,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Ondansetron.,increase,risk
Formoterol,Opium,The metabolism of Opium can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Orciprenaline,Orciprenaline may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Oritavancin,The metabolism of Formoterol can be decreased when combined with Oritavancin.,decrease,no risk
Formoterol,Orphenadrine,The metabolism of Formoterol can be decreased when combined with Orphenadrine.,decrease,no risk
Formoterol,Osilodrostat,The metabolism of Formoterol can be decreased when combined with Osilodrostat.,decrease,no risk
Formoterol,Ospemifene,The metabolism of Formoterol can be decreased when combined with Ospemifene.,decrease,no risk
Formoterol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Formoterol.,increase,risk
Formoterol,Oxamniquine,The metabolism of Formoterol can be decreased when combined with Oxamniquine.,decrease,no risk
Formoterol,Oxandrolone,The metabolism of Formoterol can be decreased when combined with Oxandrolone.,decrease,no risk
Formoterol,Oxaprozin,The risk or severity of hypertension can be increased when Formoterol is combined with Oxaprozin.,increase,risk
Formoterol,Oxatomide,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Oxatomide.,increase,risk
Formoterol,Oxcarbazepine,The metabolism of Formoterol can be decreased when combined with Oxcarbazepine.,decrease,no risk
Formoterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Formoterol.,decrease,no risk
Formoterol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Formoterol.,increase,risk
Formoterol,Oxybutynin,The metabolism of Formoterol can be decreased when combined with Oxybutynin.,decrease,no risk
Formoterol,Oxycodone,The metabolism of Formoterol can be decreased when combined with Oxycodone.,decrease,no risk
Formoterol,Oxymetazoline,Oxymetazoline may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Formoterol is combined with Oxyphenbutazone.,increase,risk
Formoterol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Formoterol.,increase,risk
Formoterol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Formoterol.,increase,risk
Formoterol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Formoterol.,increase,risk
Formoterol,Quetiapine,The therapeutic efficacy of Formoterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Formoterol,Quinapril,Formoterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Formoterol,Quinethazone,Formoterol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Formoterol,Quinidine,The metabolism of Formoterol can be decreased when combined with Quinidine.,decrease,no risk
Formoterol,Quinine,The metabolism of Formoterol can be decreased when combined with Quinine.,decrease,no risk
Formoterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Formoterol.,increase,risk
Formoterol,Quizartinib,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Quizartinib.,increase,risk
Formoterol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Vadadustat,The metabolism of Formoterol can be decreased when combined with Vadadustat.,decrease,no risk
Formoterol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Formoterol.,increase,risk
Formoterol,Valproic acid,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Valproic acid.,increase,risk
Formoterol,Valsartan,The metabolism of Formoterol can be decreased when combined with Valsartan.,decrease,no risk
Formoterol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Formoterol.,increase,risk
Formoterol,Vandetanib,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Vandetanib.,increase,risk
Formoterol,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Formoterol.,increase,risk
Formoterol,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Formoterol.,increase,risk
Formoterol,Venlafaxine,The metabolism of Formoterol can be decreased when combined with Venlafaxine.,decrease,no risk
Formoterol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Formoterol.,increase,risk
Formoterol,Vernakalant,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Vernakalant.,increase,risk
Formoterol,Vibegron,Vibegron may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Vilanterol,Vilanterol may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Vilazodone,The metabolism of Formoterol can be decreased when combined with Vilazodone.,decrease,no risk
Formoterol,Viloxazine,The metabolism of Formoterol can be decreased when combined with Viloxazine.,decrease,no risk
Formoterol,Vinblastine,The metabolism of Formoterol can be decreased when combined with Vinblastine.,decrease,no risk
Formoterol,Vinorelbine,The metabolism of Formoterol can be decreased when combined with Vinorelbine.,decrease,no risk
Formoterol,Vonoprazan,The metabolism of Formoterol can be decreased when combined with Vonoprazan.,decrease,no risk
Formoterol,Voriconazole,The metabolism of Formoterol can be decreased when combined with Voriconazole.,decrease,no risk
Formoterol,Vorinostat,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Vorinostat.,increase,risk
Formoterol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Warfarin,The metabolism of Formoterol can be increased when combined with Warfarin.,increase,no risk
Formoterol,Xamoterol,Xamoterol may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Formoterol.,decrease,no risk
Formoterol,Xylometazoline,Xylometazoline may increase the sympathomimetic activities of Formoterol.,increase,no risk
Formoterol,Yohimbine,The risk or severity of hypertension can be increased when Formoterol is combined with Yohimbine.,increase,risk
Formoterol,Zafirlukast,The metabolism of Formoterol can be decreased when combined with Zafirlukast.,decrease,no risk
Formoterol,Zidovudine,The metabolism of Formoterol can be decreased when combined with Zidovudine.,decrease,no risk
Formoterol,Zileuton,The metabolism of Formoterol can be decreased when combined with Zileuton.,decrease,no risk
Formoterol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Formoterol is combined with Ziprasidone.,increase,risk
Formoterol,Zofenopril,Formoterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Formoterol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Formoterol.,increase,risk
Formoterol,Zolpidem,The metabolism of Formoterol can be decreased when combined with Zolpidem.,decrease,no risk
Formoterol,Zonisamide,The metabolism of Formoterol can be decreased when combined with Zonisamide.,decrease,no risk
Formoterol,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Formoterol.,decrease,no risk
Nandrolone phenpropionate,Quinine,Nandrolone phenpropionate may increase the hypoglycemic activities of Quinine.,increase,no risk
Nandrolone phenpropionate,Vamorolone,The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Vamorolone.,increase,risk
Nandrolone phenpropionate,Vildagliptin,Nandrolone phenpropionate may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Nandrolone phenpropionate,Warfarin,Nandrolone phenpropionate may increase the anticoagulant activities of Warfarin.,increase,no risk
Dimenhydrinate,Gabapentin,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Gabapentin.,increase,risk
Dimenhydrinate,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Gabapentin enacarbil.,increase,risk
Dimenhydrinate,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dimenhydrinate is combined with Ganaxolone.",increase,risk
Dimenhydrinate,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Gemifloxacin.,increase,risk
Dimenhydrinate,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Gilteritinib,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Gilteritinib.,increase,risk
Dimenhydrinate,Glasdegib,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Glasdegib.,increase,risk
Dimenhydrinate,Glutethimide,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Glutethimide.,increase,risk
Dimenhydrinate,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Grepafloxacin.,increase,risk
Dimenhydrinate,Guanfacine,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Guanfacine.,increase,risk
Dimenhydrinate,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Halofantrine,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Halofantrine.,increase,risk
Dimenhydrinate,Haloperidol,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Haloperidol.,increase,risk
Dimenhydrinate,Halothane,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Halothane.,increase,risk
Dimenhydrinate,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimenhydrinate.,decrease,no risk
Dimenhydrinate,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Dimenhydrinate.,decrease,no risk
Dimenhydrinate,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Dimenhydrinate.,decrease,no risk
Dimenhydrinate,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Hydrocodone,Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dimenhydrinate,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Hydroxyzine.,increase,risk
Dimenhydrinate,Hyoscyamine,Dimenhydrinate may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Dimenhydrinate,Ketamine,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Ketamine.,increase,risk
Dimenhydrinate,Ketazolam,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Ketazolam.,increase,risk
Dimenhydrinate,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Ofloxacin,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Ofloxacin.,increase,risk
Dimenhydrinate,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dimenhydrinate is combined with Oliceridine.",increase,risk
Dimenhydrinate,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Opium,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Opium.,increase,risk
Dimenhydrinate,Orphenadrine,Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dimenhydrinate,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Oxatomide,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Oxatomide.,increase,risk
Dimenhydrinate,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Oxitriptan,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Oxitriptan.,increase,risk
Dimenhydrinate,Oxprenolol,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Oxprenolol.,increase,risk
Dimenhydrinate,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Oxymorphone,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Oxymorphone.,increase,risk
Dimenhydrinate,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Quazepam,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Quazepam.,increase,risk
Dimenhydrinate,Quetiapine,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Quetiapine.,increase,risk
Dimenhydrinate,Quinidine,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Quinidine.,increase,risk
Dimenhydrinate,Quinine,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Quinine.,increase,risk
Dimenhydrinate,Quinupramine,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Quinupramine.,increase,risk
Dimenhydrinate,Quizartinib,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Quizartinib.,increase,risk
Dimenhydrinate,Urethane,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Urethane.,increase,risk
Dimenhydrinate,Valproic acid,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Valproic acid.,increase,risk
Dimenhydrinate,Vandetanib,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Vandetanib.,increase,risk
Dimenhydrinate,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Vecuronium,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Vecuronium.,increase,risk
Dimenhydrinate,Vemurafenib,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Vemurafenib.,increase,risk
Dimenhydrinate,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Vigabatrin,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Vigabatrin.,increase,risk
Dimenhydrinate,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Vilazodone,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Vilazodone.,increase,risk
Dimenhydrinate,Viloxazine,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Viloxazine.,increase,risk
Dimenhydrinate,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Vortioxetine,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Vortioxetine.,increase,risk
Dimenhydrinate,Yohimbine,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Yohimbine.,increase,risk
Dimenhydrinate,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Ziconotide,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Ziconotide.,increase,risk
Dimenhydrinate,Zimelidine,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Zimelidine.,increase,risk
Dimenhydrinate,Ziprasidone,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Ziprasidone.,increase,risk
Dimenhydrinate,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Zolpidem,Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dimenhydrinate,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Dimenhydrinate.,increase,risk
Dimenhydrinate,Zopiclone,The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Zopiclone.,increase,risk
Dimenhydrinate,Zotepine,The risk or severity of CNS depression can be increased when Dimenhydrinate is combined with Zotepine.,increase,risk
Dimenhydrinate,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Zuclopenthixol.,increase,risk
Dimenhydrinate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dimenhydrinate.,increase,risk
Glycopyrronium,Galantamine,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.,decrease,no risk
Glycopyrronium,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Ginkgo biloba,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Glycopyrronium,Glucagon,Glycopyrronium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Glycopyrronium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Glycopyrronium,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Guanfacine,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Guanfacine.,increase,risk
Glycopyrronium,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Homatropine,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Homatropine.,increase,risk
Glycopyrronium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Huperzine A,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Huperzine A.,decrease,no risk
Glycopyrronium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Glycopyrronium.,increase,no risk
Glycopyrronium,Hydrocodone,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Hydrocodone.,increase,risk
Glycopyrronium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Glycopyrronium.,increase,no risk
Glycopyrronium,Hydromorphone,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Hydromorphone.,increase,risk
Glycopyrronium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Ketamine,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ketamine.,decrease,no risk
Glycopyrronium,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Glycopyrronium is combined with Oliceridine.",increase,risk
Glycopyrronium,Olodaterol,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Olodaterol.,increase,risk
Glycopyrronium,Opium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Opium.,increase,risk
Glycopyrronium,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Oxycodone,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Oxycodone.,increase,risk
Glycopyrronium,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Oxymorphone,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Oxymorphone.,increase,risk
Glycopyrronium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Glycopyrronium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Glycopyrronium.,increase,no risk
Glycopyrronium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Quinupramine,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Quinupramine.,increase,risk
Glycopyrronium,Umeclidinium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Umeclidinium.,increase,risk
Glycopyrronium,Vecuronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Vecuronium.,increase,risk
Glycopyrronium,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Glycopyrronium.,increase,risk
Glycopyrronium,Vilanterol,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Vilanterol.,increase,risk
Glycopyrronium,Xamoterol,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Xamoterol.,increase,risk
Glycopyrronium,Xylometazoline,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Xylometazoline.,increase,risk
Glycopyrronium,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Glycopyrronium.,increase,risk
Cytarabine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Ganciclovir.",increase,risk
Cytarabine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cytarabine.,increase,risk
Cytarabine,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Gemfibrozil.",increase,risk
Cytarabine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cytarabine.,increase,risk
Cytarabine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Cytarabine.,increase,risk
Cytarabine,Glatiramer,The risk or severity of adverse effects can be increased when Cytarabine is combined with Glatiramer.,increase,risk
Cytarabine,Golimumab,The risk or severity of adverse effects can be increased when Cytarabine is combined with Golimumab.,increase,risk
Cytarabine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Cytarabine.,increase,risk
Cytarabine,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Cytarabine.,increase,risk
Cytarabine,Guselkumab,The risk or severity of adverse effects can be increased when Cytarabine is combined with Guselkumab.,increase,risk
Cytarabine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Cytarabine.,increase,risk
Cytarabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Cytarabine.,increase,risk
Cytarabine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Cytarabine.,increase,risk
Cytarabine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Cytarabine is combined with Hydrocortisone acetate.,increase,risk
Cytarabine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Cytarabine is combined with Hydrocortisone butyrate.,increase,risk
Cytarabine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Cytarabine is combined with Hydrocortisone succinate.,increase,risk
Cytarabine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Cytarabine.,increase,risk
Cytarabine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Cytarabine is combined with Hydroxychloroquine.,increase,risk
Cytarabine,Hydroxyurea,The risk or severity of adverse effects can be increased when Cytarabine is combined with Hydroxyurea.,increase,risk
Cytarabine,Obinutuzumab,The risk or severity of adverse effects can be increased when Cytarabine is combined with Obinutuzumab.,increase,risk
Cytarabine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Cytarabine.,increase,no risk
Cytarabine,Ofatumumab,The risk or severity of adverse effects can be increased when Cytarabine is combined with Ofatumumab.,increase,risk
Cytarabine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Ofloxacin.",increase,risk
Cytarabine,Olaparib,The risk or severity of adverse effects can be increased when Cytarabine is combined with Olaparib.,increase,risk
Cytarabine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Cytarabine.,increase,risk
Cytarabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cytarabine is combined with Oxetacaine.,increase,risk
Cytarabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cytarabine is combined with Oxybuprocaine.,increase,risk
Cytarabine,Ozanimod,The risk or severity of adverse effects can be increased when Cytarabine is combined with Ozanimod.,increase,risk
Cytarabine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Cytarabine.,increase,risk
Cytarabine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Cytarabine.,increase,risk
Dopamine,Bumadizone,The risk or severity of hypertension can be increased when Dopamine is combined with Bumadizone.,increase,risk
Dopamine,Bumetanide,Bumetanide may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dopamine,Bupropion,The excretion of Dopamine can be decreased when combined with Bupropion.,decrease,no risk
Dopamine,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Dopamine.,increase,risk
Dopamine,Butabarbital,Butabarbital may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Butriptyline,The risk or severity of hypertension can be increased when Dopamine is combined with Butriptyline.,increase,risk
Dopamine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Dopamine is combined with Butylscopolamine.,increase,risk
Dopamine,Gabapentin enacarbil,Dopamine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Dopamine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Gadodiamide,Gadodiamide may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Gadofosveset trisodium,Dopamine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Dopamine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Gadoteric acid,Dopamine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Dopamine,Gadoteridol,Gadoteridol may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Dopamine.,increase,risk
Dopamine,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Dopamine.,increase,risk
Dopamine,Gemcitabine,Gemcitabine may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Gemfibrozil,Dopamine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Dopamine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Dopamine.,increase,no risk
Dopamine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Dopamine.,increase,risk
Dopamine,Gimeracil,Dopamine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Dopamine,Ginkgo biloba,The metabolism of Dopamine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dopamine,Givosiran,Givosiran may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Glipizide,Dopamine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Dopamine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Dopamine.,decrease,no risk
Dopamine,Glycerol phenylbutyrate,Dopamine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Dopamine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Dopamine.,increase,risk
Dopamine,Golodirsen,Dopamine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Dopamine,Goserelin,Goserelin may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Grepafloxacin,The serum concentration of Dopamine can be increased when it is combined with Grepafloxacin.,increase,no risk
Dopamine,Guanabenz,Dopamine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Dopamine,Guanadrel,Dopamine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Dopamine,Guanethidine,Dopamine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Dopamine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Dopamine.,increase,risk
Dopamine,Guanidine,The serum concentration of Dopamine can be increased when it is combined with Guanidine.,increase,no risk
Dopamine,Guanoxan,Dopamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Dopamine,Haloperidol,Haloperidol may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Halothane,Halothane may increase the arrhythmogenic activities of Dopamine.,increase,no risk
Dopamine,Hexocyclium,The risk or severity of Tachycardia can be increased when Dopamine is combined with Hexocyclium.,increase,risk
Dopamine,Histamine,The serum concentration of Histamine can be increased when it is combined with Dopamine.,increase,no risk
Dopamine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Dopamine.,increase,risk
Dopamine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Dopamine.,increase,risk
Dopamine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Dopamine.,increase,risk
Dopamine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Dopamine.,increase,risk
Dopamine,Hydralazine,Dopamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Dopamine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dopamine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dopamine,Hydromorphone,Hydromorphone may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Hydroxyethyl Starch,Dopamine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Dopamine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Dopamine.,increase,risk
Dopamine,Kanamycin,Dopamine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Dopamine,Ketamine,Dopamine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Dopamine,Ketazolam,Dopamine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Dopamine,Ketoprofen,The risk or severity of hypertension can be increased when Dopamine is combined with Ketoprofen.,increase,risk
Dopamine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Dopamine.,increase,risk
Dopamine,Octinoxate,Dopamine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Dopamine,Olanzapine,The risk or severity of Tachycardia can be increased when Olanzapine is combined with Dopamine.,increase,risk
Dopamine,Olmesartan,Dopamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Dopamine,Olodaterol,The risk or severity of hypertension can be increased when Dopamine is combined with Olodaterol.,increase,risk
Dopamine,Olsalazine,Olsalazine may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Opicapone,The metabolism of Dopamine can be decreased when combined with Opicapone.,decrease,no risk
Dopamine,Opium,Dopamine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Dopamine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Dopamine.,increase,risk
Dopamine,Orphenadrine,The risk or severity of Tachycardia can be increased when Dopamine is combined with Orphenadrine.,increase,risk
Dopamine,Oseltamivir,Oseltamivir may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Oxacillin,Oxacillin may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Dopamine.,increase,no risk
Dopamine,Oxaprozin,The risk or severity of hypertension can be increased when Dopamine is combined with Oxaprozin.,increase,risk
Dopamine,Oxazepam,Oxazepam may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Oxprenolol,The serum concentration of Dopamine can be increased when it is combined with Oxprenolol.,increase,no risk
Dopamine,Oxtriphylline,The risk or severity of adverse effects can be increased when Dopamine is combined with Oxtriphylline.,increase,risk
Dopamine,Oxybenzone,Dopamine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Dopamine,Oxybutynin,The risk or severity of Tachycardia can be increased when Dopamine is combined with Oxybutynin.,increase,risk
Dopamine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Dopamine.,increase,risk
Dopamine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Dopamine is combined with Oxyphenbutazone.,increase,risk
Dopamine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Dopamine.,increase,risk
Dopamine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Dopamine.,increase,risk
Dopamine,Oxyquinoline,Dopamine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Dopamine,Quetiapine,The risk or severity of hypertension can be increased when Dopamine is combined with Quetiapine.,increase,risk
Dopamine,Quinapril,Dopamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Dopamine,Quinethazone,Quinethazone may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dopamine,Quinidine,Dopamine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Dopamine,Quinine,The serum concentration of Dopamine can be increased when it is combined with Quinine.,increase,no risk
Dopamine,Quinupramine,The risk or severity of hypertension can be increased when Dopamine is combined with Quinupramine.,increase,risk
Dopamine,Umeclidinium,The risk or severity of Tachycardia can be increased when Dopamine is combined with Umeclidinium.,increase,risk
Dopamine,Vaborbactam,Dopamine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Dopamine,Valaciclovir,Valaciclovir may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Valbenazine,Dopamine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Dopamine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Dopamine.,increase,risk
Dopamine,Valganciclovir,Dopamine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Dopamine,Valsartan,Dopamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Dopamine,Vancomycin,Dopamine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Dopamine,Vandetanib,The serum concentration of Dopamine can be increased when it is combined with Vandetanib.,increase,no risk
Dopamine,Varenicline,The excretion of Varenicline can be decreased when combined with Dopamine.,decrease,no risk
Dopamine,Vasopressin,Vasopressin may increase the hypertensive activities of Dopamine.,increase,no risk
Dopamine,Venlafaxine,Venlafaxine may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Dopamine.,increase,risk
Dopamine,Vilanterol,The risk or severity of hypertension can be increased when Dopamine is combined with Vilanterol.,increase,risk
Dopamine,Vilazodone,The risk or severity of hypertension can be increased when Dopamine is combined with Vilazodone.,increase,risk
Dopamine,Viloxazine,Dopamine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Dopamine,Vortioxetine,The risk or severity of hypertension can be increased when Dopamine is combined with Vortioxetine.,increase,risk
Dopamine,Warfarin,Dopamine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Dopamine,Xamoterol,The risk or severity of hypertension can be increased when Dopamine is combined with Xamoterol.,increase,risk
Dopamine,Xylometazoline,The risk or severity of hypertension can be increased when Dopamine is combined with Xylometazoline.,increase,risk
Dopamine,Yohimbine,The risk or severity of hypertension can be increased when Dopamine is combined with Yohimbine.,increase,risk
Dopamine,Zaleplon,Zaleplon may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Zanamivir,Zanamivir may decrease the excretion rate of Dopamine which could result in a higher serum level.,decrease,no risk
Dopamine,Zimelidine,The metabolism of Dopamine can be decreased when combined with Zimelidine.,decrease,no risk
Dopamine,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Dopamine.,increase,risk
Dopamine,Zofenopril,Dopamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Dopamine,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dopamine.,increase,risk
Dopamine,Zonisamide,The metabolism of Dopamine can be decreased when combined with Zonisamide.,decrease,no risk
Dopamine,Zuclopenthixol,The risk or severity of hypertension can be increased when Dopamine is combined with Zuclopenthixol.,increase,risk
Rivastigmine,Galantamine,Galantamine may increase the bradycardic activities of Rivastigmine.,increase,no risk
Rivastigmine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Guanfacine,Rivastigmine may increase the bradycardic activities of Guanfacine.,increase,no risk
Rivastigmine,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Hydrocortisone,The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Rivastigmine,Hydrocortisone acetate,The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Rivastigmine,Hydrocortisone butyrate,The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Rivastigmine,Hydrocortisone cypionate,The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Rivastigmine,Hydrocortisone succinate,The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Rivastigmine,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Rivastigmine.,increase,no risk
Rivastigmine,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Oxprenolol,Oxprenolol may increase the bradycardic activities of Rivastigmine.,increase,no risk
Rivastigmine,Oxybuprocaine,Rivastigmine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Rivastigmine,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Vamorolone,The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Vamorolone.,decrease,no risk
Rivastigmine,Varenicline,The risk or severity of adverse effects can be increased when Rivastigmine is combined with Varenicline.,increase,risk
Rivastigmine,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Verapamil,Verapamil may increase the bradycardic activities of Rivastigmine.,increase,no risk
Rivastigmine,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Rivastigmine.,decrease,no risk
Rivastigmine,Zonisamide,Zonisamide may increase the bradycardic activities of Rivastigmine.,increase,no risk
Exemestane,Omaveloxolone,The serum concentration of Exemestane can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Exemestane,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Exemestane is combined with Oxetacaine.,increase,risk
Exemestane,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Exemestane is combined with Oxybuprocaine.,increase,risk
Exemestane,Quinestrol,The therapeutic efficacy of Exemestane can be decreased when used in combination with Quinestrol.,decrease,no risk
Exemestane,Vadadustat,The serum concentration of Exemestane can be increased when it is combined with Vadadustat.,increase,no risk
Exemestane,Venetoclax,The metabolism of Exemestane can be decreased when combined with Venetoclax.,decrease,no risk
Exemestane,Verapamil,The metabolism of Exemestane can be decreased when combined with Verapamil.,decrease,no risk
Exemestane,Viloxazine,The metabolism of Exemestane can be decreased when combined with Viloxazine.,decrease,no risk
Exemestane,Voriconazole,The metabolism of Exemestane can be decreased when combined with Voriconazole.,decrease,no risk
Exemestane,Zimelidine,The metabolism of Exemestane can be decreased when combined with Zimelidine.,decrease,no risk
Exemestane,Ziprasidone,The metabolism of Exemestane can be decreased when combined with Ziprasidone.,decrease,no risk
Oxaprozin,Bicisate,Oxaprozin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Oxaprozin,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Bismuth subgallate,Oxaprozin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Oxaprozin,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Bisoprolol,Oxaprozin may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Oxaprozin,Bisoxatin,Oxaprozin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Oxaprozin,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Bivalirudin.,increase,risk
Oxaprozin,Bleomycin,Oxaprozin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Oxaprozin,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Brexpiprazole,The risk or severity of hypertension can be increased when Oxaprozin is combined with Brexpiprazole.,increase,risk
Oxaprozin,Brivaracetam,Oxaprozin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Oxaprozin,Bromazepam,Oxaprozin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Oxaprozin,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Oxaprozin.,increase,risk
Oxaprozin,Bromocriptine,The risk or severity of hypertension can be increased when Oxaprozin is combined with Bromocriptine.,increase,risk
Oxaprozin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Oxaprozin,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Oxaprozin.,increase,risk
Oxaprozin,Bufexamac,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Bufexamac.,increase,risk
Oxaprozin,Bumadizone,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Bumadizone.,increase,risk
Oxaprozin,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Bupropion,Oxaprozin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Oxaprozin,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Oxaprozin.,increase,risk
Oxaprozin,Butabarbital,Oxaprozin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Oxaprozin,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Oxaprozin.,increase,risk
Oxaprozin,Gabapentin enacarbil,Oxaprozin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gadobenic acid,Oxaprozin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gadodiamide,Oxaprozin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gadofosveset trisodium,Oxaprozin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gadopentetic acid,Oxaprozin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gadoteric acid,Oxaprozin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gadoteridol,Oxaprozin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Oxaprozin,Ganciclovir,Oxaprozin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gatifloxacin,Oxaprozin may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Oxaprozin,Gemcitabine,Oxaprozin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gemfibrozil,Oxaprozin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gemifloxacin,Oxaprozin may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Oxaprozin,Gentamicin,Oxaprozin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Oxaprozin,Gimeracil,Oxaprozin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Oxaprozin,Givosiran,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Givosiran.,increase,risk
Oxaprozin,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Oxaprozin.,decrease,no risk
Oxaprozin,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Oxaprozin.,decrease,no risk
Oxaprozin,Glipizide,The protein binding of Glipizide can be decreased when combined with Oxaprozin.,decrease,no risk
Oxaprozin,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Oxaprozin.,decrease,no risk
Oxaprozin,Glyburide,The protein binding of Glyburide can be decreased when combined with Oxaprozin.,decrease,no risk
Oxaprozin,Glycerol phenylbutyrate,Oxaprozin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Oxaprozin,Glycol salicylate,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Glycol salicylate.,increase,risk
Oxaprozin,Golodirsen,Oxaprozin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Oxaprozin,Goserelin,Oxaprozin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Oxaprozin,Grepafloxacin,Oxaprozin may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Oxaprozin,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Oxaprozin.,increase,no risk
Oxaprozin,Halothane,The risk or severity of hypertension can be increased when Oxaprozin is combined with Halothane.,increase,risk
Oxaprozin,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Heparin.,increase,risk
Oxaprozin,Hydralazine,Oxaprozin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Oxaprozin,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Oxaprozin.,increase,risk
Oxaprozin,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Oxaprozin.,increase,risk
Oxaprozin,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Oxaprozin.,increase,risk
Oxaprozin,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Oxaprozin.,increase,risk
Oxaprozin,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Oxaprozin.,increase,risk
Oxaprozin,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Oxaprozin,Hydromorphone,Oxaprozin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Oxaprozin,Hydroxocobalamin,Oxaprozin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Oxaprozin,Hydroxyethyl Starch,Oxaprozin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Oxaprozin,Kanamycin,Oxaprozin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Oxaprozin,Ketamine,Oxaprozin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Oxaprozin,Ketazolam,Oxaprozin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Oxaprozin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Ketoconazole.,increase,risk
Oxaprozin,Ketoprofen,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Ketoprofen.,increase,risk
Oxaprozin,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Oxaprozin.,increase,risk
Oxaprozin,Octinoxate,Oxaprozin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Oxaprozin,Ofloxacin,Oxaprozin may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Oxaprozin,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Oxaprozin.",increase,risk
Oxaprozin,Olodaterol,The risk or severity of hypertension can be increased when Oxaprozin is combined with Olodaterol.,increase,risk
Oxaprozin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Olsalazine.,increase,risk
Oxaprozin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Oxaprozin is combined with Omacetaxine mepesuccinate.,increase,risk
Oxaprozin,Opium,Oxaprozin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Oxaprozin,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Oxaprozin.,increase,risk
Oxaprozin,Oseltamivir,Oxaprozin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Oxaprozin,Oxacillin,Oxaprozin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Oxaprozin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Oxaprozin.,increase,risk
Oxaprozin,Oxazepam,Oxaprozin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Oxaprozin,Oxprenolol,Oxaprozin may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Oxaprozin,Oxybenzone,Oxaprozin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Oxaprozin,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxaprozin.,increase,risk
Oxaprozin,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Oxyphenbutazone.,increase,risk
Oxaprozin,Oxyquinoline,Oxaprozin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Azathioprine,Benzthiazide,Benzthiazide may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azathioprine,Benzydamine,Benzydamine may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Azathioprine.,decrease,no risk
Azathioprine,Bepotastine,Azathioprine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Azathioprine,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Azathioprine.,increase,risk
Azathioprine,Betaxolol,The metabolism of Azathioprine can be decreased when combined with Betaxolol.,decrease,no risk
Azathioprine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Azathioprine.,increase,risk
Azathioprine,Bicisate,Azathioprine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Azathioprine,Bimekizumab,The metabolism of Azathioprine can be increased when combined with Bimekizumab.,increase,no risk
Azathioprine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Azathioprine.,decrease,no risk
Azathioprine,Bismuth subgallate,Azathioprine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Azathioprine,Bismuth subsalicylate,The metabolism of Azathioprine can be decreased when combined with Bismuth subsalicylate.,decrease,no risk
Azathioprine,Bisoprolol,Bisoprolol may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Bisoxatin,Azathioprine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Azathioprine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Azathioprine.,increase,risk
Azathioprine,Blinatumomab,The risk or severity of adverse effects can be increased when Azathioprine is combined with Blinatumomab.,increase,risk
Azathioprine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Azathioprine.",decrease,no risk
Azathioprine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Azathioprine.,increase,risk
Azathioprine,Bosutinib,The risk or severity of adverse effects can be increased when Azathioprine is combined with Bosutinib.,increase,risk
Azathioprine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Azathioprine is combined with Brentuximab vedotin.,increase,risk
Azathioprine,Brivaracetam,Azathioprine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Azathioprine,Brodalumab,The risk or severity of adverse effects can be increased when Azathioprine is combined with Brodalumab.,increase,risk
Azathioprine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Azathioprine.,decrease,no risk
Azathioprine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azathioprine,Budesonide,The risk or severity of adverse effects can be increased when Azathioprine is combined with Budesonide.,increase,risk
Azathioprine,Bumadizone,Bumadizone may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Bumetanide,Bumetanide may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azathioprine,Bupropion,Azathioprine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Azathioprine,Buspirone,Buspirone may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Busulfan,The risk or severity of adverse effects can be increased when Azathioprine is combined with Busulfan.,increase,risk
Azathioprine,Butabarbital,Butabarbital may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Gabapentin enacarbil,Azathioprine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Azathioprine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Gadodiamide,Gadodiamide may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Gadofosveset trisodium,Azathioprine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Azathioprine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Gadoteric acid,Azathioprine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Azathioprine,Gadoteridol,Gadoteridol may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Azathioprine.,decrease,no risk
Azathioprine,Ganciclovir,Azathioprine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Azathioprine,Gatifloxacin,The metabolism of Azathioprine can be decreased when combined with Gatifloxacin.,decrease,no risk
Azathioprine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Azathioprine.,increase,risk
Azathioprine,Gemfibrozil,The metabolism of Azathioprine can be decreased when combined with Gemfibrozil.,decrease,no risk
Azathioprine,Gemifloxacin,The metabolism of Azathioprine can be decreased when combined with Gemifloxacin.,decrease,no risk
Azathioprine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Azathioprine.,increase,risk
Azathioprine,Gentamicin,Azathioprine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Azathioprine,Gimeracil,Azathioprine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Azathioprine,Givosiran,The serum concentration of Azathioprine can be increased when it is combined with Givosiran.,increase,no risk
Azathioprine,Glatiramer,The risk or severity of adverse effects can be increased when Azathioprine is combined with Glatiramer.,increase,risk
Azathioprine,Glipizide,Azathioprine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Azathioprine,Glofitamab,The serum concentration of Azathioprine can be increased when it is combined with Glofitamab.,increase,no risk
Azathioprine,Glycerol phenylbutyrate,Azathioprine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Azathioprine,Golimumab,The metabolism of Azathioprine can be increased when combined with Golimumab.,increase,no risk
Azathioprine,Golodirsen,Azathioprine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Azathioprine,Goserelin,Goserelin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Grepafloxacin,The metabolism of Azathioprine can be decreased when combined with Grepafloxacin.,decrease,no risk
Azathioprine,Guanabenz,The metabolism of Azathioprine can be decreased when combined with Guanabenz.,decrease,no risk
Azathioprine,Guanethidine,Azathioprine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Azathioprine,Guanfacine,Azathioprine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Azathioprine,Guselkumab,The risk or severity of adverse effects can be increased when Azathioprine is combined with Guselkumab.,increase,risk
Azathioprine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Azathioprine.,decrease,no risk
Azathioprine,Haloperidol,The metabolism of Azathioprine can be decreased when combined with Haloperidol.,decrease,no risk
Azathioprine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Azathioprine.,decrease,no risk
Azathioprine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Azathioprine.,decrease,no risk
Azathioprine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Azathioprine.,increase,risk
Azathioprine,Hydralazine,Azathioprine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Azathioprine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azathioprine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Azathioprine is combined with Hydrocortisone acetate.,increase,risk
Azathioprine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Azathioprine is combined with Hydrocortisone butyrate.,increase,risk
Azathioprine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Azathioprine is combined with Hydrocortisone succinate.,increase,risk
Azathioprine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Azathioprine,Hydromorphone,Hydromorphone may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Azathioprine is combined with Hydroxychloroquine.,increase,risk
Azathioprine,Hydroxyethyl Starch,Azathioprine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Azathioprine,Hydroxyurea,The risk or severity of adverse effects can be increased when Azathioprine is combined with Hydroxyurea.,increase,risk
Azathioprine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Azathioprine.,decrease,no risk
Azathioprine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Azathioprine.,decrease,no risk
Azathioprine,Kanamycin,Azathioprine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Azathioprine,Ketamine,Azathioprine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Azathioprine,Ketazolam,Azathioprine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Azathioprine,Ketoconazole,The metabolism of Azathioprine can be decreased when combined with Ketoconazole.,decrease,no risk
Azathioprine,Ketoprofen,Ketoprofen may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Ketorolac,Ketorolac may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Obeticholic acid,The metabolism of Azathioprine can be decreased when combined with Obeticholic acid.,decrease,no risk
Azathioprine,Obinutuzumab,The risk or severity of adverse effects can be increased when Azathioprine is combined with Obinutuzumab.,increase,risk
Azathioprine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Azathioprine.,increase,no risk
Azathioprine,Octinoxate,Azathioprine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Azathioprine,Ofatumumab,The risk or severity of adverse effects can be increased when Azathioprine is combined with Ofatumumab.,increase,risk
Azathioprine,Olanzapine,The metabolism of Azathioprine can be decreased when combined with Olanzapine.,decrease,no risk
Azathioprine,Olaparib,The risk or severity of adverse effects can be increased when Azathioprine is combined with Olaparib.,increase,risk
Azathioprine,Olsalazine,The risk or severity of myelosuppression can be increased when Azathioprine is combined with Olsalazine.,increase,risk
Azathioprine,Ondansetron,The metabolism of Azathioprine can be decreased when combined with Ondansetron.,decrease,no risk
Azathioprine,Opium,Azathioprine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Azathioprine,Orphenadrine,The metabolism of Azathioprine can be decreased when combined with Orphenadrine.,decrease,no risk
Azathioprine,Oseltamivir,Oseltamivir may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Osilodrostat,The metabolism of Azathioprine can be decreased when combined with Osilodrostat.,decrease,no risk
Azathioprine,Osimertinib,The serum concentration of Azathioprine can be decreased when it is combined with Osimertinib.,decrease,no risk
Azathioprine,Oxacillin,Oxacillin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Azathioprine.,increase,risk
Azathioprine,Oxaprozin,Oxaprozin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Oxazepam,Oxazepam may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Azathioprine.,decrease,no risk
Azathioprine,Oxybenzone,Azathioprine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Azathioprine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Azathioprine which could result in a higher serum level.,decrease,no risk
Azathioprine,Oxyquinoline,Azathioprine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Azathioprine,Ozanimod,The risk or severity of adverse effects can be increased when Azathioprine is combined with Ozanimod.,increase,risk
Neomycin,Bupropion,Bupropion may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Buspirone,Buspirone may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Butabarbital,Butabarbital may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Butacaine.,increase,risk
Neomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Butamben.,increase,risk
Neomycin,Butaperazine,Neomycin may increase the neurotoxic activities of Butaperazine.,increase,no risk
Neomycin,Butriptyline,Neomycin may increase the neurotoxic activities of Butriptyline.,increase,no risk
Neomycin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gadodiamide,Gadodiamide may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gadoteridol,Gadoteridol may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Neomycin.,increase,no risk
Neomycin,Ganciclovir,Ganciclovir may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gemcitabine,Gemcitabine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Gentamicin,The risk or severity of nephrotoxicity can be increased when Gentamicin is combined with Neomycin.,increase,risk
Neomycin,Gimeracil,Gimeracil may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Givosiran,The risk or severity of nephrotoxicity can be increased when Givosiran is combined with Neomycin.,increase,risk
Neomycin,Glipizide,Glipizide may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Neomycin.,increase,risk
Neomycin,Golodirsen,Golodirsen may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Goserelin,Goserelin may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Guanethidine,Guanethidine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Guanfacine,Guanfacine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Haloperidol,Haloperidol may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Heparin,The therapeutic efficacy of Neomycin can be decreased when used in combination with Heparin.,decrease,no risk
Neomycin,Hetacillin,The serum concentration of Neomycin can be decreased when it is combined with Hetacillin.,decrease,no risk
Neomycin,Hydralazine,Hydralazine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Neomycin.,increase,risk
Neomycin,Hydromorphone,Hydromorphone may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Kanamycin,The risk or severity of nephrotoxicity can be increased when Kanamycin is combined with Neomycin.,increase,risk
Neomycin,Ketamine,Ketamine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Ketazolam,Ketazolam may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Neomycin.,increase,risk
Neomycin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Neomycin.,increase,risk
Neomycin,Octinoxate,Octinoxate may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Olsalazine is combined with Neomycin.,increase,risk
Neomycin,Opium,Opium may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Oseltamivir,Oseltamivir may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Ouabain,The risk or severity of adverse effects can be increased when Neomycin is combined with Ouabain.,increase,risk
Neomycin,Oxacillin,Oxacillin may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Neomycin.,increase,risk
Neomycin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Neomycin.,increase,risk
Neomycin,Oxazepam,Oxazepam may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Oxetacaine.,increase,risk
Neomycin,Oxybenzone,Oxybenzone may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Oxybuprocaine.,increase,risk
Neomycin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Neomycin.,increase,risk
Neomycin,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Neomycin.,increase,risk
Neomycin,Quetiapine,Quetiapine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Quinidine,Neomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Neomycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Neomycin.,increase,risk
Neomycin,Quinupramine,Neomycin may increase the neurotoxic activities of Quinupramine.,increase,no risk
Neomycin,Vaborbactam,Vaborbactam may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Neomycin.,increase,risk
Neomycin,Valbenazine,Valbenazine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Neomycin.,increase,risk
Neomycin,Valganciclovir,Valganciclovir may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Valproate bismuth,Neomycin may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Neomycin,Vancomycin,The risk or severity of nephrotoxicity can be increased when Vancomycin is combined with Neomycin.,increase,risk
Neomycin,Varenicline,Varenicline may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Neomycin.,increase,no risk
Neomycin,Venlafaxine,Venlafaxine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Verapamil,Verapamil may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Neomycin.,decrease,no risk
Neomycin,Vilanterol,Vilanterol may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Viloxazine,Viloxazine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Vincristine,Vincristine may increase the neurotoxic activities of Neomycin.,increase,no risk
Neomycin,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Neomycin.,increase,no risk
Neomycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Viomycin.,increase,risk
Neomycin,Vortioxetine,Vortioxetine may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Warfarin,Neomycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Neomycin,Zaleplon,Zaleplon may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Zanamivir,Zanamivir may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Ziprasidone,Ziprasidone may increase the neurotoxic activities of Neomycin.,increase,no risk
Neomycin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Zoledronic acid.,increase,risk
Neomycin,Zonisamide,Zonisamide may decrease the excretion rate of Neomycin which could result in a higher serum level.,decrease,no risk
Neomycin,Zotepine,Neomycin may increase the neurotoxic activities of Zotepine.,increase,no risk
Neomycin,Zuclopenthixol,Neomycin may increase the neurotoxic activities of Zuclopenthixol.,increase,no risk
Auranofin,Gabapentin enacarbil,Auranofin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Auranofin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Gadodiamide,Gadodiamide may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Gadofosveset trisodium,Auranofin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Auranofin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Gadoteric acid,Auranofin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Auranofin,Gadoteridol,Gadoteridol may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Ganciclovir,Auranofin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Auranofin,Gemcitabine,Gemcitabine may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Gemfibrozil,Auranofin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Auranofin,Gentamicin,Auranofin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Auranofin,Gimeracil,Auranofin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Auranofin,Givosiran,Givosiran may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Glipizide,Auranofin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Auranofin,Glycerol phenylbutyrate,Auranofin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Auranofin,Golodirsen,Auranofin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Auranofin,Goserelin,Goserelin may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Guanethidine,Auranofin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Auranofin,Guanfacine,Auranofin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Auranofin,Haloperidol,Haloperidol may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Hydralazine,Auranofin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Auranofin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Auranofin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Auranofin,Hydromorphone,Hydromorphone may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Hydroxyethyl Starch,Auranofin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Auranofin,Kanamycin,Auranofin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Auranofin,Ketamine,Auranofin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Auranofin,Ketazolam,Auranofin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Auranofin,Ketoprofen,Ketoprofen may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Ketorolac,Ketorolac may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Octinoxate,Auranofin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Auranofin,Olsalazine,Olsalazine may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Opium,Auranofin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Auranofin,Oseltamivir,Oseltamivir may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Oxacillin,Oxacillin may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Oxaprozin,Oxaprozin may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Oxazepam,Oxazepam may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Oxybenzone,Auranofin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Auranofin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Oxyquinoline,Auranofin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Auranofin,Quetiapine,Auranofin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Auranofin,Quinethazone,Quinethazone may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Auranofin,Quinidine,Auranofin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Auranofin,Vaborbactam,Auranofin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Auranofin,Valaciclovir,Valaciclovir may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Valbenazine,Auranofin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Auranofin,Valdecoxib,Valdecoxib may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Valganciclovir,Auranofin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Auranofin,Vancomycin,Auranofin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Auranofin,Varenicline,Auranofin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Auranofin,Venlafaxine,Venlafaxine may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Verapamil,Verapamil may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Vilanterol,Auranofin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Auranofin,Viloxazine,Auranofin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Auranofin,Vortioxetine,Auranofin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Auranofin,Warfarin,Auranofin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Auranofin,Zaleplon,Zaleplon may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Zanamivir,Zanamivir may decrease the excretion rate of Auranofin which could result in a higher serum level.,decrease,no risk
Auranofin,Zonisamide,Zonisamide may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gabapentin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin is combined with Gabapentin enacarbil.,increase,risk
Gabapentin,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Gabapentin.,increase,risk
Gabapentin,Gamolenic acid,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Gabapentin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gabapentin is combined with Ganaxolone.",increase,risk
Gabapentin,Ganciclovir,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Ganciclovir.,decrease,no risk
Gabapentin,Gepirone,The risk or severity of CNS depression can be increased when Gabapentin is combined with Gepirone.,increase,risk
Gabapentin,Gestrinone,The metabolism of Gestrinone can be increased when combined with Gabapentin.,increase,no risk
Gabapentin,Glutethimide,The risk or severity of CNS depression can be increased when Gabapentin is combined with Glutethimide.,increase,risk
Gabapentin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Gabapentin.,increase,risk
Gabapentin,Guanfacine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Guanfacine.,increase,risk
Gabapentin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Gabapentin.,increase,risk
Gabapentin,Halofantrine,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Halofantrine.,decrease,no risk
Gabapentin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Gabapentin.,increase,risk
Gabapentin,Halothane,The risk or severity of CNS depression can be increased when Gabapentin is combined with Halothane.,increase,risk
Gabapentin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gabapentin.,increase,risk
Gabapentin,Hydrocodone,The serum concentration of Hydrocodone can be decreased when it is combined with Gabapentin.,decrease,no risk
Gabapentin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Gabapentin.,increase,risk
Gabapentin,Hydrotalcite,The bioavailability of Gabapentin can be decreased when combined with Hydrotalcite.,decrease,no risk
Gabapentin,Hydroxychloroquine,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Gabapentin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Gabapentin.,increase,no risk
Gabapentin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Gabapentin,Ketamine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ketamine.,increase,risk
Gabapentin,Ketazolam,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ketazolam.,increase,risk
Gabapentin,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gabapentin.,increase,risk
Gabapentin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Gabapentin is combined with Oliceridine.",increase,risk
Gabapentin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gabapentin.,increase,risk
Gabapentin,Opium,The risk or severity of CNS depression can be increased when Gabapentin is combined with Opium.,increase,risk
Gabapentin,Orlistat,Orlistat can cause a decrease in the absorption of Gabapentin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Gabapentin,Orphenadrine,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Gabapentin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gabapentin.,increase,risk
Gabapentin,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Gabapentin.,increase,risk
Gabapentin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Oxetacaine.,increase,risk
Gabapentin,Oxitriptan,The risk or severity of CNS depression can be increased when Gabapentin is combined with Oxitriptan.,increase,risk
Gabapentin,Oxprenolol,The risk or severity of CNS depression can be increased when Gabapentin is combined with Oxprenolol.,increase,risk
Gabapentin,Oxtriphylline,Gabapentin may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gabapentin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Oxybuprocaine.,increase,risk
Gabapentin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Gabapentin.,increase,risk
Gabapentin,Oxymorphone,The risk or severity of CNS depression can be increased when Gabapentin is combined with Oxymorphone.,increase,risk
Gabapentin,Quazepam,The risk or severity of CNS depression can be increased when Gabapentin is combined with Quazepam.,increase,risk
Gabapentin,Quetiapine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Quetiapine.,increase,risk
Gabapentin,Quinidine,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Quinidine.,decrease,no risk
Gabapentin,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Gabapentin.,increase,risk
Gabapentin,Quinupramine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Quinupramine.,increase,risk
Gabapentin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Gabapentin.,increase,no risk
Gabapentin,Urethane,The risk or severity of CNS depression can be increased when Gabapentin is combined with Urethane.,increase,risk
Gabapentin,Valganciclovir,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Valganciclovir.,decrease,no risk
Gabapentin,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gabapentin.,increase,risk
Gabapentin,Vecuronium,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vecuronium.,increase,risk
Gabapentin,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gabapentin.,increase,risk
Gabapentin,Vigabatrin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vigabatrin.,increase,risk
Gabapentin,Vilazodone,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vilazodone.,increase,risk
Gabapentin,Viloxazine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Viloxazine.,increase,risk
Gabapentin,Vortioxetine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vortioxetine.,increase,risk
Gabapentin,Yohimbine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Yohimbine.,increase,risk
Gabapentin,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gabapentin.,increase,risk
Gabapentin,Ziconotide,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ziconotide.,increase,risk
Gabapentin,Zimelidine,The risk or severity of adverse effects can be increased when Gabapentin is combined with Zimelidine.,increase,risk
Gabapentin,Ziprasidone,The risk or severity of adverse effects can be increased when Gabapentin is combined with Ziprasidone.,increase,risk
Gabapentin,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gabapentin.,increase,risk
Gabapentin,Zolpidem,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Gabapentin,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gabapentin.,increase,risk
Gabapentin,Zopiclone,The risk or severity of adverse effects can be increased when Gabapentin is combined with Zopiclone.,increase,risk
Gabapentin,Zotepine,The risk or severity of CNS depression can be increased when Gabapentin is combined with Zotepine.,increase,risk
Gabapentin,Zuclopenthixol,The risk or severity of CNS depression can be increased when Gabapentin is combined with Zuclopenthixol.,increase,risk
Gabapentin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Gabapentin.,increase,risk
Doxorubicin,Belzutifan,The serum concentration of Doxorubicin can be decreased when it is combined with Belzutifan.,decrease,no risk
Doxorubicin,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Doxorubicin.,increase,risk
Doxorubicin,Bendamustine,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Bendamustine.,increase,risk
Doxorubicin,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Doxorubicin.,increase,risk
Doxorubicin,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Benzocaine.,increase,risk
Doxorubicin,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Doxorubicin.,increase,risk
Doxorubicin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Benzyl alcohol.,increase,risk
Doxorubicin,Bepridil,The serum concentration of Doxorubicin can be increased when it is combined with Bepridil.,increase,no risk
Doxorubicin,Berotralstat,The serum concentration of Doxorubicin can be increased when it is combined with Berotralstat.,increase,no risk
Doxorubicin,Betamethasone,The serum concentration of Doxorubicin can be decreased when it is combined with Betamethasone.,decrease,no risk
Doxorubicin,Betamethasone phosphate,The metabolism of Doxorubicin can be increased when combined with Betamethasone phosphate.,increase,no risk
Doxorubicin,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Doxorubicin.,increase,risk
Doxorubicin,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Doxorubicin.,increase,risk
Doxorubicin,Bexarotene,The serum concentration of Doxorubicin can be decreased when it is combined with Bexarotene.,decrease,no risk
Doxorubicin,Bicalutamide,The serum concentration of Doxorubicin can be increased when it is combined with Bicalutamide.,increase,no risk
Doxorubicin,Bifonazole,The serum concentration of Doxorubicin can be increased when it is combined with Bifonazole.,increase,no risk
Doxorubicin,Bimekizumab,The metabolism of Doxorubicin can be increased when combined with Bimekizumab.,increase,no risk
Doxorubicin,Biperiden,The serum concentration of Doxorubicin can be increased when it is combined with Biperiden.,increase,no risk
Doxorubicin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Doxorubicin.,increase,risk
Doxorubicin,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Doxorubicin.,increase,risk
Doxorubicin,Blinatumomab,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Blinatumomab.,increase,risk
Doxorubicin,Boceprevir,The serum concentration of Doxorubicin can be increased when it is combined with Boceprevir.,increase,no risk
Doxorubicin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Doxorubicin.",decrease,no risk
Doxorubicin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Bosentan,The serum concentration of Doxorubicin can be decreased when it is combined with Bosentan.,decrease,no risk
Doxorubicin,Bosutinib,The serum concentration of Doxorubicin can be increased when it is combined with Bosutinib.,increase,no risk
Doxorubicin,Brentuximab vedotin,The serum concentration of Doxorubicin can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Doxorubicin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Brigatinib,The serum concentration of Doxorubicin can be decreased when it is combined with Brigatinib.,decrease,no risk
Doxorubicin,Brodalumab,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Brodalumab.,increase,risk
Doxorubicin,Bromocriptine,The serum concentration of Doxorubicin can be increased when it is combined with Bromocriptine.,increase,no risk
Doxorubicin,Budesonide,The serum concentration of Doxorubicin can be decreased when it is combined with Budesonide.,decrease,no risk
Doxorubicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Bupivacaine.,increase,risk
Doxorubicin,Buprenorphine,The serum concentration of Doxorubicin can be increased when it is combined with Buprenorphine.,increase,no risk
Doxorubicin,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Buspirone,The metabolism of Buspirone can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Butacaine.,increase,risk
Doxorubicin,Butalbital,The serum concentration of Doxorubicin can be decreased when it is combined with Butalbital.,decrease,no risk
Doxorubicin,Butamben,The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Butamben.,increase,risk
Doxorubicin,Galantamine,The metabolism of Galantamine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Gefitinib,The serum concentration of Doxorubicin can be increased when it is combined with Gefitinib.,increase,no risk
Doxorubicin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Doxorubicin.,increase,risk
Doxorubicin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Doxorubicin.,increase,risk
Doxorubicin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Gilteritinib,The metabolism of Doxorubicin can be decreased when combined with Gilteritinib.,decrease,no risk
Doxorubicin,Ginkgo biloba,The metabolism of Doxorubicin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Doxorubicin,Glasdegib,The serum concentration of Doxorubicin can be increased when it is combined with Glasdegib.,increase,no risk
Doxorubicin,Glatiramer,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Glatiramer.,increase,risk
Doxorubicin,Glecaprevir,The serum concentration of Doxorubicin can be increased when it is combined with Glecaprevir.,increase,no risk
Doxorubicin,Glimepiride,Glimepiride may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,decrease,no risk
Doxorubicin,Glipizide,Doxorubicin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Doxorubicin,Glofitamab,The serum concentration of Doxorubicin can be increased when it is combined with Glofitamab.,increase,no risk
Doxorubicin,Glyburide,The serum concentration of Doxorubicin can be increased when it is combined with Glyburide.,increase,no risk
Doxorubicin,Glycerol phenylbutyrate,The serum concentration of Doxorubicin can be decreased when it is combined with Glycerol phenylbutyrate.,decrease,no risk
Doxorubicin,Glycyrrhizic acid,Doxorubicin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Doxorubicin,Golimumab,The metabolism of Doxorubicin can be increased when combined with Golimumab.,increase,no risk
Doxorubicin,Grapefruit,The serum concentration of Doxorubicin can be increased when it is combined with Grapefruit.,increase,no risk
Doxorubicin,Grazoprevir,Grazoprevir may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,decrease,no risk
Doxorubicin,Griseofulvin,The serum concentration of Doxorubicin can be decreased when it is combined with Griseofulvin.,decrease,no risk
Doxorubicin,Guselkumab,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Guselkumab.,increase,risk
Doxorubicin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Doxorubicin.,decrease,no risk
Doxorubicin,Halofantrine,The serum concentration of Doxorubicin can be increased when it is combined with Halofantrine.,increase,no risk
Doxorubicin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Doxorubicin.,increase,risk
Doxorubicin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Doxorubicin.,decrease,no risk
Doxorubicin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Doxorubicin.,decrease,no risk
Doxorubicin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Doxorubicin.,increase,risk
Doxorubicin,Hydralazine,The serum concentration of Doxorubicin can be increased when it is combined with Hydralazine.,increase,no risk
Doxorubicin,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Doxorubicin.,increase,risk
Doxorubicin,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Hydrocortamate,The serum concentration of Doxorubicin can be decreased when it is combined with Hydrocortamate.,decrease,no risk
Doxorubicin,Hydrocortisone,The serum concentration of Doxorubicin can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Doxorubicin,Hydrocortisone acetate,The serum concentration of Doxorubicin can be decreased when it is combined with Hydrocortisone acetate.,decrease,no risk
Doxorubicin,Hydrocortisone butyrate,The serum concentration of Doxorubicin can be decreased when it is combined with Hydrocortisone butyrate.,decrease,no risk
Doxorubicin,Hydrocortisone probutate,The serum concentration of Doxorubicin can be decreased when it is combined with Hydrocortisone probutate.,decrease,no risk
Doxorubicin,Hydrocortisone succinate,The serum concentration of Doxorubicin can be decreased when it is combined with Hydrocortisone succinate.,decrease,no risk
Doxorubicin,Hydrocortisone valerate,The serum concentration of Doxorubicin can be decreased when it is combined with Hydrocortisone valerate.,decrease,no risk
Doxorubicin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Doxorubicin.,increase,risk
Doxorubicin,Hydroxychloroquine,The serum concentration of Doxorubicin can be increased when it is combined with Hydroxychloroquine.,increase,no risk
Doxorubicin,Hydroxyurea,The serum concentration of Doxorubicin can be increased when it is combined with Hydroxyurea.,increase,no risk
Doxorubicin,Hydroxyzine,The serum concentration of Doxorubicin can be increased when it is combined with Hydroxyzine.,increase,no risk
Doxorubicin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Doxorubicin.,decrease,no risk
Doxorubicin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Doxorubicin.,decrease,no risk
Doxorubicin,Ketamine,The serum concentration of Doxorubicin can be decreased when it is combined with Ketamine.,decrease,no risk
Doxorubicin,Ketazolam,The serum concentration of Doxorubicin can be increased when it is combined with Ketazolam.,increase,no risk
Doxorubicin,Ketoconazole,The serum concentration of Doxorubicin can be increased when it is combined with Ketoconazole.,increase,no risk
Doxorubicin,Obinutuzumab,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Obinutuzumab.,increase,risk
Doxorubicin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Doxorubicin.,increase,no risk
Doxorubicin,Octreotide,The serum concentration of Doxorubicin can be increased when it is combined with Octreotide.,increase,no risk
Doxorubicin,Ofatumumab,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Ofatumumab.,increase,risk
Doxorubicin,Ofloxacin,Doxorubicin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Doxorubicin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Olaparib,The serum concentration of Doxorubicin can be increased when it is combined with Olaparib.,increase,no risk
Doxorubicin,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Olmesartan,Olmesartan may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,decrease,no risk
Doxorubicin,Olutasidenib,The serum concentration of Doxorubicin can be decreased when it is combined with Olutasidenib.,decrease,no risk
Doxorubicin,Omaveloxolone,The serum concentration of Doxorubicin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Doxorubicin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Opium,The metabolism of Opium can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Oritavancin,The serum concentration of Doxorubicin can be decreased when it is combined with Oritavancin.,decrease,no risk
Doxorubicin,Orphenadrine,The serum concentration of Doxorubicin can be increased when it is combined with Orphenadrine.,increase,no risk
Doxorubicin,Osilodrostat,The serum concentration of Doxorubicin can be increased when it is combined with Osilodrostat.,increase,no risk
Doxorubicin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Ospemifene,The serum concentration of Doxorubicin can be increased when it is combined with Ospemifene.,increase,no risk
Doxorubicin,Oteseconazole,The serum concentration of Doxorubicin can be increased when it is combined with Oteseconazole.,increase,no risk
Doxorubicin,Ouabain,Ouabain may decrease the cardiotoxic activities of Doxorubicin.,decrease,no risk
Doxorubicin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Doxorubicin.,increase,risk
Doxorubicin,Oxamniquine,The serum concentration of Doxorubicin can be increased when it is combined with Oxamniquine.,increase,no risk
Doxorubicin,Oxcarbazepine,The serum concentration of Doxorubicin can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Doxorubicin,Oxetacaine,The serum concentration of Doxorubicin can be increased when it is combined with Oxetacaine.,increase,no risk
Doxorubicin,Oxiconazole,The serum concentration of Doxorubicin can be decreased when it is combined with Oxiconazole.,decrease,no risk
Doxorubicin,Oxprenolol,The serum concentration of Doxorubicin can be increased when it is combined with Oxprenolol.,increase,no risk
Doxorubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Oxybuprocaine.,increase,risk
Doxorubicin,Oxybutynin,The serum concentration of Doxorubicin can be increased when it is combined with Oxybutynin.,increase,no risk
Doxorubicin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Oxymetholone,The serum concentration of Doxorubicin can be increased when it is combined with Oxymetholone.,increase,no risk
Doxorubicin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Ozanimod,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Ozanimod.,increase,risk
Doxorubicin,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Quinidine,The serum concentration of Doxorubicin can be increased when it is combined with Quinidine.,increase,no risk
Doxorubicin,Quinine,The serum concentration of Doxorubicin can be increased when it is combined with Quinine.,increase,no risk
Doxorubicin,Quinupristin,The serum concentration of Doxorubicin can be increased when it is combined with Quinupristin.,increase,no risk
Doxorubicin,Quizartinib,The serum concentration of Doxorubicin can be increased when it is combined with Quizartinib.,increase,no risk
Doxorubicin,Ubidecarenone,The risk or severity of cardiotoxicity can be decreased when Ubidecarenone is combined with Doxorubicin.,decrease,risk
Doxorubicin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Doxorubicin.,increase,risk
Doxorubicin,Umbralisib,The serum concentration of Doxorubicin can be increased when it is combined with Umbralisib.,increase,no risk
Doxorubicin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Upadacitinib,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Upadacitinib.,increase,risk
Doxorubicin,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Doxorubicin.,increase,risk
Doxorubicin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,decrease,no risk
Doxorubicin,Vadadustat,The serum concentration of Doxorubicin can be increased when it is combined with Vadadustat.,increase,no risk
Doxorubicin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Valproic acid,The serum concentration of Doxorubicin can be increased when it is combined with Valproic acid.,increase,no risk
Doxorubicin,Vandetanib,The serum concentration of Doxorubicin can be increased when it is combined with Vandetanib.,increase,no risk
Doxorubicin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Doxorubicin.,increase,risk
Doxorubicin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Doxorubicin.,decrease,no risk
Doxorubicin,Vedolizumab,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Vedolizumab.,increase,risk
Doxorubicin,Velpatasvir,The serum concentration of Doxorubicin can be increased when it is combined with Velpatasvir.,increase,no risk
Doxorubicin,Vemurafenib,The serum concentration of Doxorubicin can be decreased when it is combined with Vemurafenib.,decrease,no risk
Doxorubicin,Venetoclax,The serum concentration of Doxorubicin can be increased when it is combined with Venetoclax.,increase,no risk
Doxorubicin,Venlafaxine,The serum concentration of Doxorubicin can be increased when it is combined with Venlafaxine.,increase,no risk
Doxorubicin,Verapamil,The serum concentration of Doxorubicin can be increased when it is combined with Verapamil.,increase,no risk
Doxorubicin,Vernakalant,The serum concentration of Doxorubicin can be increased when it is combined with Vernakalant.,increase,no risk
Doxorubicin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Doxorubicin.,decrease,no risk
Doxorubicin,Vilanterol,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Vilanterol.,increase,risk
Doxorubicin,Vilazodone,The serum concentration of Doxorubicin can be increased when it is combined with Vilazodone.,increase,no risk
Doxorubicin,Viloxazine,The serum concentration of Doxorubicin can be increased when it is combined with Viloxazine.,increase,no risk
Doxorubicin,Vinblastine,The serum concentration of Doxorubicin can be increased when it is combined with Vinblastine.,increase,no risk
Doxorubicin,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Vinorelbine,The serum concentration of Doxorubicin can be increased when it is combined with Vinorelbine.,increase,no risk
Doxorubicin,Vismodegib,Vismodegib may decrease the excretion rate of Doxorubicin which could result in a higher serum level.,decrease,no risk
Doxorubicin,Vitamin E,The serum concentration of Doxorubicin can be decreased when it is combined with Vitamin E.,decrease,no risk
Doxorubicin,Voclosporin,The serum concentration of Doxorubicin can be increased when it is combined with Voclosporin.,increase,no risk
Doxorubicin,Vorapaxar,The serum concentration of Doxorubicin can be increased when it is combined with Vorapaxar.,increase,no risk
Doxorubicin,Voriconazole,The serum concentration of Doxorubicin can be increased when it is combined with Voriconazole.,increase,no risk
Doxorubicin,Vorinostat,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Vorinostat.,increase,risk
Doxorubicin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Voxelotor,The serum concentration of Doxorubicin can be increased when it is combined with Voxelotor.,increase,no risk
Doxorubicin,Voxilaprevir,The serum concentration of Doxorubicin can be increased when it is combined with Voxilaprevir.,increase,no risk
Doxorubicin,Warfarin,The serum concentration of Doxorubicin can be decreased when it is combined with Warfarin.,decrease,no risk
Doxorubicin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Doxorubicin.,increase,risk
Doxorubicin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Doxorubicin.,increase,risk
Doxorubicin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Zafirlukast,The serum concentration of Doxorubicin can be increased when it is combined with Zafirlukast.,increase,no risk
Doxorubicin,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Doxorubicin.,increase,no risk
Doxorubicin,Zidovudine,The risk or severity of adverse effects can be increased when Doxorubicin is combined with Zidovudine.,increase,risk
Doxorubicin,Zimelidine,The serum concentration of Doxorubicin can be increased when it is combined with Zimelidine.,increase,no risk
Doxorubicin,Ziprasidone,The serum concentration of Doxorubicin can be increased when it is combined with Ziprasidone.,increase,no risk
Doxorubicin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Zonisamide,The serum concentration of Doxorubicin can be increased when it is combined with Zonisamide.,increase,no risk
Doxorubicin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Doxorubicin.,decrease,no risk
Doxorubicin,Zuclopenthixol,The metabolism of Doxorubicin can be decreased when combined with Zuclopenthixol.,decrease,no risk
Frovatriptan,Butaperazine,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Butaperazine.,increase,risk
Frovatriptan,Butobarbital,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Butobarbital.,increase,risk
Frovatriptan,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Frovatriptan.,increase,risk
Frovatriptan,Butriptyline,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Butriptyline.,increase,risk
Frovatriptan,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Frovatriptan.,increase,risk
Frovatriptan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Gabapentin enacarbil.,increase,risk
Frovatriptan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Frovatriptan.,increase,risk
Frovatriptan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Frovatriptan is combined with Ganaxolone.",increase,risk
Frovatriptan,Gatifloxacin,The metabolism of Frovatriptan can be decreased when combined with Gatifloxacin.,decrease,no risk
Frovatriptan,Gemfibrozil,The metabolism of Frovatriptan can be decreased when combined with Gemfibrozil.,decrease,no risk
Frovatriptan,Gemifloxacin,The metabolism of Frovatriptan can be decreased when combined with Gemifloxacin.,decrease,no risk
Frovatriptan,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Frovatriptan.,increase,risk
Frovatriptan,Gilteritinib,The therapeutic efficacy of Frovatriptan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Frovatriptan,Givosiran,The serum concentration of Frovatriptan can be increased when it is combined with Givosiran.,increase,no risk
Frovatriptan,Glofitamab,The serum concentration of Frovatriptan can be increased when it is combined with Glofitamab.,increase,no risk
Frovatriptan,Glutethimide,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Glutethimide.,increase,risk
Frovatriptan,Golimumab,The metabolism of Frovatriptan can be increased when combined with Golimumab.,increase,no risk
Frovatriptan,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Frovatriptan.,increase,risk
Frovatriptan,Grepafloxacin,The metabolism of Frovatriptan can be decreased when combined with Grepafloxacin.,decrease,no risk
Frovatriptan,Guanabenz,The metabolism of Frovatriptan can be decreased when combined with Guanabenz.,decrease,no risk
Frovatriptan,Guanadrel,Frovatriptan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Frovatriptan,Guanethidine,Frovatriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Frovatriptan,Guanfacine,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Guanfacine.,increase,risk
Frovatriptan,Guanoxan,Frovatriptan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Frovatriptan,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Frovatriptan.,increase,risk
Frovatriptan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Frovatriptan.,increase,risk
Frovatriptan,Halothane,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Halothane.,increase,risk
Frovatriptan,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Frovatriptan.,increase,risk
Frovatriptan,Hydralazine,Frovatriptan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Frovatriptan,Hydrochlorothiazide,Frovatriptan may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Frovatriptan,Hydrocodone,Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Frovatriptan,Hydroflumethiazide,Frovatriptan may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Frovatriptan,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Frovatriptan.,increase,risk
Frovatriptan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Frovatriptan.,increase,no risk
Frovatriptan,Ketamine,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Ketamine.,increase,risk
Frovatriptan,Ketazolam,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Ketazolam.,increase,risk
Frovatriptan,Ketoconazole,The metabolism of Frovatriptan can be decreased when combined with Ketoconazole.,decrease,no risk
Frovatriptan,Ketoprofen,The risk or severity of hypertension can be increased when Frovatriptan is combined with Ketoprofen.,increase,risk
Frovatriptan,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Frovatriptan.,increase,risk
Frovatriptan,Obeticholic acid,The metabolism of Frovatriptan can be decreased when combined with Obeticholic acid.,decrease,no risk
Frovatriptan,Olanzapine,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Olanzapine.,increase,risk
Frovatriptan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Frovatriptan is combined with Oliceridine.",increase,risk
Frovatriptan,Olmesartan,Frovatriptan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Frovatriptan,Olodaterol,The risk or severity of hypertension can be increased when Frovatriptan is combined with Olodaterol.,increase,risk
Frovatriptan,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Frovatriptan.,increase,risk
Frovatriptan,Opium,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Opium.,increase,risk
Frovatriptan,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Frovatriptan.,increase,risk
Frovatriptan,Orphenadrine,Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Frovatriptan,Osilodrostat,The metabolism of Frovatriptan can be decreased when combined with Osilodrostat.,decrease,no risk
Frovatriptan,Osimertinib,The serum concentration of Frovatriptan can be decreased when it is combined with Osimertinib.,decrease,no risk
Frovatriptan,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Frovatriptan.,increase,risk
Frovatriptan,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Frovatriptan.,increase,risk
Frovatriptan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Frovatriptan.,increase,risk
Frovatriptan,Oxitriptan,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Oxitriptan.,increase,risk
Frovatriptan,Oxprenolol,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Oxprenolol.,increase,risk
Frovatriptan,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Frovatriptan.,decrease,no risk
Frovatriptan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Frovatriptan.,increase,risk
Frovatriptan,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Frovatriptan.,increase,risk
Frovatriptan,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Frovatriptan.,increase,risk
Frovatriptan,Oxymorphone,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Oxymorphone.,increase,risk
Frovatriptan,Oxyphenbutazone,The risk or severity of hypertension can be increased when Frovatriptan is combined with Oxyphenbutazone.,increase,risk
Frovatriptan,Quazepam,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Quazepam.,increase,risk
Frovatriptan,Quetiapine,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Quetiapine.,increase,risk
Frovatriptan,Quinapril,Frovatriptan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Frovatriptan,Quinidine,The metabolism of Frovatriptan can be decreased when combined with Quinidine.,decrease,no risk
Frovatriptan,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Frovatriptan.,increase,risk
Frovatriptan,Quinupramine,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Quinupramine.,increase,risk
Frovatriptan,Urethane,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Urethane.,increase,risk
Frovatriptan,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Frovatriptan.,increase,risk
Frovatriptan,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Frovatriptan is combined with Valproate bismuth.,increase,risk
Frovatriptan,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Frovatriptan.,increase,risk
Frovatriptan,Valsartan,Frovatriptan may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Frovatriptan,Vecuronium,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Vecuronium.,increase,risk
Frovatriptan,Vemurafenib,The serum concentration of Frovatriptan can be increased when it is combined with Vemurafenib.,increase,no risk
Frovatriptan,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Frovatriptan is combined with Venlafaxine.,increase,risk
Frovatriptan,Verapamil,The metabolism of Frovatriptan can be decreased when combined with Verapamil.,decrease,no risk
Frovatriptan,Vigabatrin,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Vigabatrin.,increase,risk
Frovatriptan,Vilanterol,The risk or severity of hypertension can be increased when Frovatriptan is combined with Vilanterol.,increase,risk
Frovatriptan,Vilazodone,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Vilazodone.,increase,risk
Frovatriptan,Viloxazine,The metabolism of Frovatriptan can be decreased when combined with Viloxazine.,decrease,no risk
Frovatriptan,Vortioxetine,The risk or severity of adverse effects can be increased when Frovatriptan is combined with Vortioxetine.,increase,risk
Frovatriptan,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Frovatriptan.,decrease,no risk
Frovatriptan,Warfarin,The metabolism of Frovatriptan can be decreased when combined with Warfarin.,decrease,no risk
Frovatriptan,Xamoterol,The risk or severity of hypertension can be increased when Frovatriptan is combined with Xamoterol.,increase,risk
Frovatriptan,Xylometazoline,The risk or severity of hypertension can be increased when Frovatriptan is combined with Xylometazoline.,increase,risk
Frovatriptan,Yohimbine,The risk or severity of CNS depression can be increased when Frovatriptan is combined with Yohimbine.,increase,risk
Frovatriptan,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Frovatriptan.,increase,risk
Hydrochlorothiazide,Bacitracin,The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Balsalazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Balsalazide.,decrease,no risk
Hydrochlorothiazide,Baricitinib,Hydrochlorothiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Beclomethasone dipropionate,The risk or severity of electrolyte imbalance can be increased when Beclomethasone dipropionate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Bedaquiline,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Bedaquiline.,increase,risk
Hydrochlorothiazide,Belinostat,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Belinostat.,increase,risk
Hydrochlorothiazide,Belladonna,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Belladonna.,increase,no risk
Hydrochlorothiazide,Bemiparin,The therapeutic efficacy of Bemiparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Benazepril,Hydrochlorothiazide may increase the hypotensive activities of Benazepril.,increase,no risk
Hydrochlorothiazide,Bendamustine,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Bendamustine.,increase,risk
Hydrochlorothiazide,Bendroflumethiazide,The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Hydrochlorothiazide,Benorilate,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Benorilate.,decrease,no risk
Hydrochlorothiazide,Benoxaprofen,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Hydrochlorothiazide,Benserazide,Hydrochlorothiazide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Benzatropine,Hydrochlorothiazide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Benzhydrocodone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Hydrochlorothiazide,Benziodarone,The therapeutic efficacy of Benziodarone can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Benznidazole,Hydrochlorothiazide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Benzoic acid,The excretion of Hydrochlorothiazide can be decreased when combined with Benzoic acid.,decrease,no risk
Hydrochlorothiazide,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Benzthiazide,The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Benzthiazide.,increase,no risk
Hydrochlorothiazide,Benzydamine,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Benzydamine.,decrease,no risk
Hydrochlorothiazide,Benzylpenicillin,Hydrochlorothiazide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Hydrochlorothiazide,Bepotastine,Hydrochlorothiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Bepridil,The therapeutic efficacy of Bepridil can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Berotralstat,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Berotralstat.,increase,risk
Hydrochlorothiazide,Betamethasone,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Betamethasone phosphate,The risk or severity of electrolyte imbalance can be increased when Betamethasone phosphate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Betaxolol,The therapeutic efficacy of Betaxolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Bethanidine,The therapeutic efficacy of Bethanidine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Betrixaban,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Bexarotene,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Bexarotene.,increase,risk
Hydrochlorothiazide,Bicisate,Hydrochlorothiazide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Bilastine,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Bilastine.,increase,risk
Hydrochlorothiazide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Biperiden,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Biperiden.,increase,no risk
Hydrochlorothiazide,Bisacodyl,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Bisacodyl.,increase,risk
Hydrochlorothiazide,Bismuth subgallate,Hydrochlorothiazide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Bisoxatin,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Bisoxatin.,increase,risk
Hydrochlorothiazide,Bivalirudin,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Bleomycin,Hydrochlorothiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Blinatumomab,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Blinatumomab.,increase,risk
Hydrochlorothiazide,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Bosentan,The therapeutic efficacy of Bosentan can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Bosutinib,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Bosutinib.,increase,risk
Hydrochlorothiazide,Bretylium,The therapeutic efficacy of Bretylium can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Brimonidine,Brimonidine may increase the antihypertensive activities of Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Brivaracetam,Hydrochlorothiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Bromazepam,Hydrochlorothiazide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Brompheniramine,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Hydrochlorothiazide,Buclizine,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Buclizine.,increase,no risk
Hydrochlorothiazide,Budesonide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Bumadizone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Bumadizone.,decrease,no risk
Hydrochlorothiazide,Bumetanide,The excretion of Hydrochlorothiazide can be decreased when combined with Bumetanide.,decrease,no risk
Hydrochlorothiazide,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Buprenorphine,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Hydrochlorothiazide,Bupropion,Hydrochlorothiazide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Buserelin,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Buserelin.,increase,risk
Hydrochlorothiazide,Buspirone,Hydrochlorothiazide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Busulfan,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Busulfan.,increase,risk
Hydrochlorothiazide,Butabarbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Butalbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Butobarbital,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Butobarbital.,increase,no risk
Hydrochlorothiazide,Butorphanol,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Butorphanol.,decrease,no risk
Hydrochlorothiazide,Butriptyline,Butriptyline may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Butylscopolamine,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Butylscopolamine.,increase,no risk
Hydrochlorothiazide,Gabapentin enacarbil,Hydrochlorothiazide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Gadobenic acid,Hydrochlorothiazide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Gadodiamide,Hydrochlorothiazide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Gadofosveset trisodium,Hydrochlorothiazide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Gadopentetic acid,Hydrochlorothiazide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Gadoteric acid,Hydrochlorothiazide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Gadoteridol,Hydrochlorothiazide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Ganciclovir,The excretion of Hydrochlorothiazide can be decreased when combined with Ganciclovir.,decrease,no risk
Hydrochlorothiazide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Gatifloxacin.,increase,risk
Hydrochlorothiazide,Gemcitabine,Hydrochlorothiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Gemfibrozil,The excretion of Hydrochlorothiazide can be decreased when combined with Gemfibrozil.,decrease,no risk
Hydrochlorothiazide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Gemifloxacin.,increase,risk
Hydrochlorothiazide,Gemtuzumab ozogamicin,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Gemtuzumab ozogamicin.,increase,risk
Hydrochlorothiazide,Gentamicin,Hydrochlorothiazide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Hydrochlorothiazide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Gilteritinib.,increase,risk
Hydrochlorothiazide,Gimeracil,Hydrochlorothiazide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Givosiran,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Givosiran.,increase,risk
Hydrochlorothiazide,Glasdegib,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Glasdegib.,increase,risk
Hydrochlorothiazide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Gluconic Acid,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Gluconic Acid.,increase,risk
Hydrochlorothiazide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Glycerin,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Glycerin.,increase,risk
Hydrochlorothiazide,Glycerol phenylbutyrate,Hydrochlorothiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Glycol salicylate,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Hydrochlorothiazide,Glycopyrronium,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Glycopyrronium.,increase,no risk
Hydrochlorothiazide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Golodirsen,Hydrochlorothiazide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Goserelin,Hydrochlorothiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Granisetron,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Granisetron.,increase,risk
Hydrochlorothiazide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Grepafloxacin.,increase,risk
Hydrochlorothiazide,Guanabenz,The therapeutic efficacy of Guanabenz can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Guanadrel,The therapeutic efficacy of Guanadrel can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Guanethidine,The therapeutic efficacy of Guanethidine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Guanfacine,The therapeutic efficacy of Guanfacine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Guanidine,The excretion of Hydrochlorothiazide can be decreased when combined with Guanidine.,decrease,no risk
Hydrochlorothiazide,Guanoxan,The therapeutic efficacy of Guanoxan can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Halcinonide,The risk or severity of electrolyte imbalance can be increased when Halcinonide is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Halofantrine,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Halofantrine.,increase,risk
Hydrochlorothiazide,Haloperidol,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Haloperidol.,increase,risk
Hydrochlorothiazide,Halothane,Halothane may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Hydrochlorothiazide,Hexafluronium,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Hexafluronium.,increase,no risk
Hydrochlorothiazide,Hexocyclium,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Hexocyclium.,increase,no risk
Hydrochlorothiazide,Histrelin,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Histrelin.,increase,risk
Hydrochlorothiazide,Homatropine methylbromide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Homatropine methylbromide.,increase,no risk
Hydrochlorothiazide,Hydrocodone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Hydrochlorothiazide,Hydrocortisone,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Hydrocortisone acetate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone acetate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Hydrocortisone butyrate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone butyrate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Hydrocortisone cypionate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone cypionate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Hydrocortisone probutate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone probutate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Hydrocortisone succinate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone succinate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Hydrocortisone valerate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone valerate is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Hydroflumethiazide,The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Hydrochlorothiazide,Hydromorphone,Hydrochlorothiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Hydroxocobalamin,Hydrochlorothiazide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Hydroxychloroquine.,increase,risk
Hydrochlorothiazide,Hydroxyethyl Starch,Hydrochlorothiazide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Hydroxyurea,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Hydroxyurea.,increase,risk
Hydrochlorothiazide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Hydroxyzine.,increase,risk
Hydrochlorothiazide,Hyoscyamine,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Hyoscyamine.,increase,no risk
Hydrochlorothiazide,Kanamycin,Hydrochlorothiazide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Hydrochlorothiazide,Ketamine,Hydrochlorothiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Ketazolam,Hydrochlorothiazide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Ketoconazole,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ketoconazole.,increase,risk
Hydrochlorothiazide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Ketorolac,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ketorolac.,decrease,no risk
Hydrochlorothiazide,Obinutuzumab,Hydrochlorothiazide may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Hydrochlorothiazide,Octinoxate,Hydrochlorothiazide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ofloxacin.,increase,risk
Hydrochlorothiazide,Olanzapine,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Olanzapine.,increase,no risk
Hydrochlorothiazide,Olaparib,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Olaparib.,increase,risk
Hydrochlorothiazide,Oliceridine,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oliceridine.,decrease,no risk
Hydrochlorothiazide,Olodaterol,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Olsalazine,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Olsalazine.,increase,risk
Hydrochlorothiazide,Ondansetron,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ondansetron.,increase,risk
Hydrochlorothiazide,Opicapone,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Opicapone.,increase,risk
Hydrochlorothiazide,Opium,Hydrochlorothiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Orciprenaline,The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Orphenadrine,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Orphenadrine.,increase,no risk
Hydrochlorothiazide,Oseltamivir,Hydrochlorothiazide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Ouabain,Hydrochlorothiazide may increase the hypokalemic activities of Ouabain.,increase,no risk
Hydrochlorothiazide,Oxacillin,Hydrochlorothiazide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Hydrochlorothiazide.,increase,risk
Hydrochlorothiazide,Oxaprozin,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Hydrochlorothiazide,Oxatomide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Oxatomide.,increase,risk
Hydrochlorothiazide,Oxazepam,Hydrochlorothiazide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Oxcarbazepine,The risk or severity of hyponatremia can be increased when Hydrochlorothiazide is combined with Oxcarbazepine.,increase,risk
Hydrochlorothiazide,Oxprenolol,The therapeutic efficacy of Oxprenolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Hydrochlorothiazide,Oxybenzone,Hydrochlorothiazide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Oxybutynin,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxybutynin.,increase,no risk
Hydrochlorothiazide,Oxycodone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxycodone.,decrease,no risk
Hydrochlorothiazide,Oxymetazoline,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Hydrochlorothiazide,Oxymorphone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Hydrochlorothiazide,Oxyphenbutazone,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Hydrochlorothiazide,Oxyphencyclimine,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Hydrochlorothiazide,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Oxyphenisatin acetate.,increase,risk
Hydrochlorothiazide,Oxyphenonium,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxyphenonium.,increase,no risk
Hydrochlorothiazide,Oxyquinoline,Hydrochlorothiazide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrochlorothiazide,Oxytetracycline,The excretion of Hydrochlorothiazide can be decreased when combined with Oxytetracycline.,decrease,no risk
Hydrochlorothiazide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hydrochlorothiazide.,increase,risk
Cyclacillin,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Cyclacillin.,decrease,no risk
Cyclacillin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Cyclacillin.,increase,no risk
Cyclacillin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cyclacillin.,decrease,no risk
Cyclacillin,Warfarin,Cyclacillin may increase the anticoagulant activities of Warfarin.,increase,no risk
Salbutamol,Betaxolol,The therapeutic efficacy of Salbutamol can be decreased when used in combination with Betaxolol.,decrease,no risk
Salbutamol,Bethanidine,Salbutamol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Salbutamol,Bicisate,Salbutamol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Salbutamol,Bilastine,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Bilastine.,increase,risk
Salbutamol,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Salbutamol.,increase,risk
Salbutamol,Bismuth subgallate,Salbutamol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Salbutamol,Bisoprolol,The therapeutic efficacy of Salbutamol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Salbutamol,Bisoxatin,Salbutamol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Salbutamol,Bleomycin,Bleomycin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Salbutamol.,increase,risk
Salbutamol,Bosentan,Salbutamol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Salbutamol,Bretylium,Salbutamol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Salbutamol,Brexpiprazole,The therapeutic efficacy of Salbutamol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Salbutamol,Brivaracetam,Salbutamol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Salbutamol,Bromazepam,Salbutamol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Salbutamol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Salbutamol.,increase,no risk
Salbutamol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Salbutamol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Salbutamol.,increase,risk
Salbutamol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Salbutamol.,increase,risk
Salbutamol,Bumadizone,The risk or severity of hypertension can be increased when Salbutamol is combined with Bumadizone.,increase,risk
Salbutamol,Bumetanide,The risk or severity of hypokalemia can be increased when Salbutamol is combined with Bumetanide.,increase,risk
Salbutamol,Bupropion,Salbutamol may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Salbutamol,Buserelin,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Buserelin.,increase,risk
Salbutamol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Salbutamol.,increase,risk
Salbutamol,Butabarbital,Butabarbital may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Salbutamol.,increase,risk
Salbutamol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Salbutamol is combined with Butylscopolamine.,increase,risk
Salbutamol,Gabapentin enacarbil,Salbutamol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Salbutamol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Gadobenic acid.,increase,risk
Salbutamol,Gadodiamide,Gadodiamide may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Gadofosveset trisodium,Salbutamol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Salbutamol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Gadoteric acid,Salbutamol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Salbutamol,Gadoteridol,Gadoteridol may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Salbutamol.,increase,risk
Salbutamol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Salbutamol.,increase,risk
Salbutamol,Ganciclovir,Salbutamol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Salbutamol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Gatifloxacin.,increase,risk
Salbutamol,Gemcitabine,Gemcitabine may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Gemfibrozil,Salbutamol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Salbutamol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Gemifloxacin.,increase,risk
Salbutamol,Gentamicin,Salbutamol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Salbutamol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Salbutamol.,increase,risk
Salbutamol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Gilteritinib.,increase,risk
Salbutamol,Gimeracil,Salbutamol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Salbutamol,Givosiran,Givosiran may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Glasdegib,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Glasdegib.,increase,risk
Salbutamol,Glipizide,Salbutamol may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Salbutamol,Glycerol phenylbutyrate,Salbutamol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Salbutamol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Salbutamol.,increase,risk
Salbutamol,Golodirsen,Salbutamol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Salbutamol,Goserelin,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Goserelin.,increase,risk
Salbutamol,Granisetron,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Granisetron.,increase,risk
Salbutamol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Grepafloxacin.,increase,risk
Salbutamol,Guanabenz,Salbutamol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Salbutamol,Guanadrel,Salbutamol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Salbutamol,Guanethidine,Salbutamol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Salbutamol,Guanfacine,Salbutamol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Salbutamol,Guanoxan,Salbutamol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Salbutamol,Halofantrine,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Halofantrine.,increase,risk
Salbutamol,Haloperidol,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Haloperidol.,increase,risk
Salbutamol,Halothane,The risk or severity of hypertension can be increased when Salbutamol is combined with Halothane.,increase,risk
Salbutamol,Hexocyclium,The risk or severity of Tachycardia can be increased when Salbutamol is combined with Hexocyclium.,increase,risk
Salbutamol,Histrelin,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Histrelin.,increase,risk
Salbutamol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Salbutamol.,increase,risk
Salbutamol,Hydralazine,Salbutamol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Salbutamol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Salbutamol is combined with Hydrochlorothiazide.,increase,risk
Salbutamol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Salbutamol.,increase,risk
Salbutamol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Salbutamol.,increase,risk
Salbutamol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Salbutamol.,increase,risk
Salbutamol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Salbutamol.,increase,risk
Salbutamol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Salbutamol.,increase,risk
Salbutamol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Salbutamol is combined with Hydroflumethiazide.,increase,risk
Salbutamol,Hydromorphone,Hydromorphone may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxychloroquine.,increase,risk
Salbutamol,Hydroxyethyl Starch,Salbutamol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Salbutamol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxyzine.,increase,risk
Salbutamol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Salbutamol.,increase,risk
Salbutamol,Kanamycin,Salbutamol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Salbutamol,Ketamine,Salbutamol may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Salbutamol,Ketazolam,Salbutamol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Salbutamol,Ketoconazole,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ketoconazole.,increase,risk
Salbutamol,Ketoprofen,The risk or severity of hypertension can be increased when Salbutamol is combined with Ketoprofen.,increase,risk
Salbutamol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Salbutamol.,increase,risk
Salbutamol,Octinoxate,Salbutamol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Salbutamol,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Salbutamol.,increase,risk
Salbutamol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ofloxacin.,increase,risk
Salbutamol,Olanzapine,The therapeutic efficacy of Salbutamol can be decreased when used in combination with Olanzapine.,decrease,no risk
Salbutamol,Olmesartan,Salbutamol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Salbutamol,Olodaterol,The risk or severity of adverse effects can be increased when Salbutamol is combined with Olodaterol.,increase,risk
Salbutamol,Olsalazine,Olsalazine may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Ondansetron,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ondansetron.,increase,risk
Salbutamol,Opium,Salbutamol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Salbutamol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Salbutamol.,increase,risk
Salbutamol,Orphenadrine,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Orphenadrine.,increase,risk
Salbutamol,Oseltamivir,Oseltamivir may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Oxacillin,Oxacillin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Salbutamol.,increase,risk
Salbutamol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Salbutamol.,increase,risk
Salbutamol,Oxatomide,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Oxatomide.,increase,risk
Salbutamol,Oxazepam,Oxazepam may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Salbutamol.,decrease,no risk
Salbutamol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Salbutamol.,increase,risk
Salbutamol,Oxybenzone,Salbutamol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Salbutamol,Oxybutynin,The risk or severity of Tachycardia can be increased when Salbutamol is combined with Oxybutynin.,increase,risk
Salbutamol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Salbutamol.,increase,risk
Salbutamol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Salbutamol is combined with Oxyphenbutazone.,increase,risk
Salbutamol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Salbutamol.,increase,risk
Salbutamol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Salbutamol.,increase,risk
Salbutamol,Oxyquinoline,Salbutamol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Salbutamol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Salbutamol.,increase,risk
Salbutamol,Quetiapine,The therapeutic efficacy of Salbutamol can be decreased when used in combination with Quetiapine.,decrease,no risk
Salbutamol,Quinapril,Salbutamol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Salbutamol,Quinethazone,Quinethazone may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Salbutamol,Quinidine,Salbutamol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Salbutamol,Quinine,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Quinine.,increase,risk
Salbutamol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Salbutamol.,increase,risk
Salbutamol,Quizartinib,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Quizartinib.,increase,risk
Salbutamol,Umeclidinium,The risk or severity of Tachycardia can be increased when Salbutamol is combined with Umeclidinium.,increase,risk
Salbutamol,Vaborbactam,Salbutamol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Salbutamol,Valaciclovir,Valaciclovir may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Valbenazine,Salbutamol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Salbutamol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Salbutamol.,increase,risk
Salbutamol,Valganciclovir,Salbutamol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Salbutamol,Valproic acid,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Valproic acid.,increase,risk
Salbutamol,Valsartan,Salbutamol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Salbutamol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Salbutamol.,increase,risk
Salbutamol,Vancomycin,Salbutamol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Salbutamol,Vandetanib,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Vandetanib.,increase,risk
Salbutamol,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Salbutamol.,increase,risk
Salbutamol,Varenicline,Salbutamol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Salbutamol,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Salbutamol.,increase,risk
Salbutamol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Salbutamol.,increase,no risk
Salbutamol,Verapamil,Verapamil may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Vernakalant,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Vernakalant.,increase,risk
Salbutamol,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Salbutamol.,increase,risk
Salbutamol,Vilazodone,The risk or severity of hypertension can be increased when Salbutamol is combined with Vilazodone.,increase,risk
Salbutamol,Viloxazine,Salbutamol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Salbutamol,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Salbutamol.,increase,risk
Salbutamol,Vorinostat,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Vorinostat.,increase,risk
Salbutamol,Vortioxetine,The risk or severity of hypertension can be increased when Salbutamol is combined with Vortioxetine.,increase,risk
Salbutamol,Warfarin,Salbutamol may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Salbutamol,Xamoterol,The risk or severity of hypertension can be increased when Salbutamol is combined with Xamoterol.,increase,risk
Salbutamol,Xylometazoline,The risk or severity of hypertension can be increased when Salbutamol is combined with Xylometazoline.,increase,risk
Salbutamol,Yohimbine,The risk or severity of hypertension can be increased when Salbutamol is combined with Yohimbine.,increase,risk
Salbutamol,Zaleplon,Zaleplon may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Zanamivir,Zanamivir may decrease the excretion rate of Salbutamol which could result in a higher serum level.,decrease,no risk
Salbutamol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ziprasidone.,increase,risk
Salbutamol,Zofenopril,Salbutamol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Salbutamol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Salbutamol.,increase,risk
Salbutamol,Zonisamide,Zonisamide may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Bacampicillin,The risk or severity of methemoglobinemia can be increased when Bacampicillin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bacitracin,The risk or severity of methemoglobinemia can be increased when Bacitracin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.,increase,no risk
Levobupivacaine,Balsalazide,Balsalazide may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Baricitinib,Levobupivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Bedaquiline,The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Belinostat,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Belzutifan,The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Benazepril,The risk or severity of adverse effects can be increased when Benazepril is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bendamustine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Benorilate,Benorilate may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Benperidol,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Benperidol.,increase,risk
Levobupivacaine,Benserazide,Levobupivacaine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Benzatropine,Benzatropine may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Benznidazole,Levobupivacaine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Levobupivacaine is combined with Benzocaine.,increase,risk
Levobupivacaine,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Benzthiazide,Benzthiazide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Benzydamine,Benzydamine may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Levobupivacaine is combined with Benzyl alcohol.,increase,risk
Levobupivacaine,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bepotastine,Levobupivacaine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Bepridil,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bepridil.,increase,risk
Levobupivacaine,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Betaxolol,The metabolism of Levobupivacaine can be decreased when combined with Betaxolol.,decrease,no risk
Levobupivacaine,Bethanidine,Levobupivacaine may increase the hypotensive activities of Bethanidine.,increase,no risk
Levobupivacaine,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bicisate,Levobupivacaine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Bimekizumab,The metabolism of Levobupivacaine can be increased when combined with Bimekizumab.,increase,no risk
Levobupivacaine,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bismuth subgallate,Levobupivacaine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bisoxatin,Levobupivacaine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bosentan,Levobupivacaine may increase the hypotensive activities of Bosentan.,increase,no risk
Levobupivacaine,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bretylium,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Bretylium.,increase,risk
Levobupivacaine,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Brexpiprazole,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Brexpiprazole.,increase,risk
Levobupivacaine,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.,increase,no risk
Levobupivacaine,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Bromazepam,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Bromazepam.,increase,risk
Levobupivacaine,Bromocriptine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Bromocriptine.,increase,risk
Levobupivacaine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Bromperidol,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Bromperidol.,increase,risk
Levobupivacaine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Budesonide,Levobupivacaine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Bumadizone,Bumadizone may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Bumetanide,Bumetanide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Buprenorphine,Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Levobupivacaine,Bupropion,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Bupropion.,increase,risk
Levobupivacaine,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Butabarbital,Butabarbital may increase the hypotensive activities of Levobupivacaine.,increase,no risk
Levobupivacaine,Butacaine,The risk or severity of methemoglobinemia can be increased when Levobupivacaine is combined with Butacaine.,increase,risk
Levobupivacaine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Butamben,The risk or severity of methemoglobinemia can be increased when Levobupivacaine is combined with Butamben.,increase,risk
Levobupivacaine,Butaperazine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Butaperazine.,increase,risk
Levobupivacaine,Butobarbital,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Butobarbital.,increase,risk
Levobupivacaine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Butriptyline,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Butriptyline.,increase,risk
Levobupivacaine,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Gabapentin enacarbil.,increase,risk
Levobupivacaine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Gadodiamide,Gadodiamide may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Gadofosveset trisodium,Levobupivacaine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Gadoteric acid,Levobupivacaine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Gadoteridol,Gadoteridol may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Levobupivacaine is combined with Ganaxolone.",increase,risk
Levobupivacaine,Ganciclovir,Levobupivacaine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gemfibrozil,The metabolism of Levobupivacaine can be decreased when combined with Gemfibrozil.,decrease,no risk
Levobupivacaine,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gepirone,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Gepirone.,increase,risk
Levobupivacaine,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gimeracil,Levobupivacaine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Givosiran,The serum concentration of Levobupivacaine can be increased when it is combined with Givosiran.,increase,no risk
Levobupivacaine,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Glipizide,Levobupivacaine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Glofitamab,The serum concentration of Levobupivacaine can be increased when it is combined with Glofitamab.,increase,no risk
Levobupivacaine,Glutethimide,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Glutethimide.,increase,risk
Levobupivacaine,Glycerol phenylbutyrate,Levobupivacaine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Golimumab,The metabolism of Levobupivacaine can be increased when combined with Golimumab.,increase,no risk
Levobupivacaine,Golodirsen,Levobupivacaine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Guanabenz,The metabolism of Levobupivacaine can be decreased when combined with Guanabenz.,decrease,no risk
Levobupivacaine,Guanadrel,Levobupivacaine may increase the hypotensive activities of Guanadrel.,increase,no risk
Levobupivacaine,Guanethidine,Levobupivacaine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Guanfacine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Guanfacine.,increase,risk
Levobupivacaine,Guanoxan,Levobupivacaine may increase the hypotensive activities of Guanoxan.,increase,no risk
Levobupivacaine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Halothane,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Halothane.,increase,risk
Levobupivacaine,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Hydralazine,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Hydralazine.,increase,risk
Levobupivacaine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Hydrocodone,Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Levobupivacaine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Hydroxyethyl Starch,Levobupivacaine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.,increase,no risk
Levobupivacaine,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Ketamine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Ketamine.,increase,risk
Levobupivacaine,Ketazolam,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Ketazolam.,increase,risk
Levobupivacaine,Ketoconazole,The metabolism of Levobupivacaine can be decreased when combined with Ketoconazole.,decrease,no risk
Levobupivacaine,Ketoprofen,Ketoprofen may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Ketorolac,Ketorolac may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Obeticholic acid,The metabolism of Levobupivacaine can be decreased when combined with Obeticholic acid.,decrease,no risk
Levobupivacaine,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Octinoxate,Levobupivacaine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levobupivacaine is combined with Oliceridine.",increase,risk
Levobupivacaine,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Olsalazine,Olsalazine may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Omaveloxolone,The serum concentration of Levobupivacaine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Levobupivacaine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Opicapone,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Opicapone.,increase,risk
Levobupivacaine,Opium,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Opium.,increase,risk
Levobupivacaine,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Orphenadrine,Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Levobupivacaine,Oseltamivir,Oseltamivir may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Osilodrostat,The metabolism of Levobupivacaine can be decreased when combined with Osilodrostat.,decrease,no risk
Levobupivacaine,Osimertinib,The serum concentration of Levobupivacaine can be decreased when it is combined with Osimertinib.,decrease,no risk
Levobupivacaine,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Oxaprozin,Oxaprozin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Levobupivacaine is combined with Oxetacaine.,increase,risk
Levobupivacaine,Oxitriptan,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Oxitriptan.,increase,risk
Levobupivacaine,Oxprenolol,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Oxprenolol.,increase,risk
Levobupivacaine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Levobupivacaine.,decrease,no risk
Levobupivacaine,Oxybenzone,Levobupivacaine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Oxymorphone,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Oxymorphone.,increase,risk
Levobupivacaine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Oxyquinoline,Levobupivacaine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Quazepam,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Quazepam.,increase,risk
Levobupivacaine,Quetiapine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Quetiapine.,increase,risk
Levobupivacaine,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Quinethazone,Quinethazone may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levobupivacaine,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Quinupramine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Quinupramine.,increase,risk
Levobupivacaine,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vaborbactam,Levobupivacaine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Vadadustat,The serum concentration of Levobupivacaine can be increased when it is combined with Vadadustat.,increase,no risk
Levobupivacaine,Valaciclovir,Valaciclovir may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Valbenazine,Levobupivacaine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Valdecoxib,Valdecoxib may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Valganciclovir,Levobupivacaine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Varenicline,Levobupivacaine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Vecuronium,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Vecuronium.,increase,risk
Levobupivacaine,Vemurafenib,The serum concentration of Levobupivacaine can be increased when it is combined with Vemurafenib.,increase,no risk
Levobupivacaine,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Verapamil,The metabolism of Levobupivacaine can be decreased when combined with Verapamil.,decrease,no risk
Levobupivacaine,Vericiguat,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Vericiguat.,increase,risk
Levobupivacaine,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vilanterol,Levobupivacaine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Vilazodone,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Vilazodone.,increase,risk
Levobupivacaine,Viloxazine,The metabolism of Levobupivacaine can be decreased when combined with Viloxazine.,decrease,no risk
Levobupivacaine,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Vortioxetine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Vortioxetine.,increase,risk
Levobupivacaine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Levobupivacaine.,decrease,no risk
Levobupivacaine,Warfarin,Levobupivacaine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Yohimbine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Yohimbine.,increase,risk
Levobupivacaine,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Zanamivir,Zanamivir may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,decrease,no risk
Levobupivacaine,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Ziconotide,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Ziconotide.,increase,risk
Levobupivacaine,Zileuton,The metabolism of Levobupivacaine can be decreased when combined with Zileuton.,decrease,no risk
Levobupivacaine,Zimelidine,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Zimelidine.,increase,risk
Levobupivacaine,Ziprasidone,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ziprasidone.,increase,risk
Levobupivacaine,Zofenopril,Levobupivacaine may increase the hypotensive activities of Zofenopril.,increase,no risk
Levobupivacaine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Zolpidem,Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Levobupivacaine,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Levobupivacaine.,increase,risk
Levobupivacaine,Zopiclone,The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Zopiclone.,increase,risk
Levobupivacaine,Zotepine,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Zotepine.,increase,risk
Levobupivacaine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Levobupivacaine is combined with Zuclopenthixol.,increase,risk
Levobupivacaine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Levobupivacaine.,increase,risk
Cromoglicic acid,Oxymetazoline,The absorption of Cromoglicic acid can be decreased when combined with Oxymetazoline.,decrease,no risk
Ganciclovir,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Gabapentin enacarbil,Ganciclovir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gadodiamide,Gadodiamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gadofosveset trisodium,Ganciclovir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gadoteric acid,Ganciclovir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gadoteridol,Gadoteridol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Gemcitabine,Gemcitabine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Gemfibrozil.",increase,risk
Ganciclovir,Gentamicin,Ganciclovir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ganciclovir,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Ganciclovir.,increase,risk
Ganciclovir,Gimeracil,Ganciclovir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ganciclovir,Givosiran,Givosiran may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Glasdegib,The excretion of Ganciclovir can be decreased when combined with Glasdegib.,decrease,no risk
Ganciclovir,Glipizide,Ganciclovir may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ganciclovir,Glycerol phenylbutyrate,Ganciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ganciclovir,Golodirsen,Ganciclovir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ganciclovir,Goserelin,Goserelin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Guanethidine,Ganciclovir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Guanfacine,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Guanfacine.,increase,risk
Ganciclovir,Guanidine,The excretion of Ganciclovir can be decreased when combined with Guanidine.,decrease,no risk
Ganciclovir,Haloperidol,Haloperidol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Histamine,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Histamine.,increase,risk
Ganciclovir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Hydralazine,Ganciclovir may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ganciclovir,Hydromorphone,Hydromorphone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Ganciclovir.,increase,risk
Ganciclovir,Hydroxyethyl Starch,Ganciclovir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ganciclovir,Kanamycin,Ganciclovir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ganciclovir,Ketamine,Ganciclovir may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Ketazolam,Ganciclovir may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ganciclovir,Ketoprofen,Ketoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Ketorolac,Ketorolac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Octinoxate,Ganciclovir may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ganciclovir,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Ofloxacin.",increase,risk
Ganciclovir,Olsalazine,Olsalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Opium,Ganciclovir may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ganciclovir,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Oxacillin,Oxacillin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Oxaprozin,Oxaprozin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Oxazepam,Oxazepam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Oxybenzone,Ganciclovir may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ganciclovir,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Oxyquinoline,Ganciclovir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ganciclovir,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Quetiapine,Ganciclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Quinapril,The excretion of Quinapril can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Quinethazone,Quinethazone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ganciclovir,Quinidine,Ganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Ganciclovir.,increase,risk
Ganciclovir,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Ubidecarenone.",increase,risk
Ganciclovir,Vaborbactam,Ganciclovir may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ganciclovir,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Ganciclovir.,increase,no risk
Ganciclovir,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Valbenazine,Ganciclovir may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Valdecoxib,Valdecoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Valganciclovir,Ganciclovir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Valproic acid,The excretion of Valproic acid can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Vancomycin,Ganciclovir may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ganciclovir,Varenicline,Ganciclovir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ganciclovir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Venlafaxine,Venlafaxine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Ganciclovir.,increase,risk
Ganciclovir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Vilanterol,Ganciclovir may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ganciclovir,Viloxazine,Ganciclovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Ganciclovir.",increase,risk
Ganciclovir,Vortioxetine,Ganciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ganciclovir,Warfarin,Ganciclovir may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ganciclovir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Zalcitabine,The risk or severity of cytopenia can be increased when Ganciclovir is combined with Zalcitabine.,increase,risk
Ganciclovir,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganciclovir,Zanamivir,Zanamivir may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ganciclovir,Zidovudine,The excretion of Zidovudine can be decreased when combined with Ganciclovir.,decrease,no risk
Ganciclovir,Zonisamide,Zonisamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydroxyurea,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Glatiramer,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Glatiramer.,increase,risk
Hydroxyurea,Golimumab,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Golimumab.,increase,risk
Hydroxyurea,Guselkumab,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Guselkumab.,increase,risk
Hydroxyurea,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Hydroxyurea,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Hydroxyurea.,increase,no risk
Hydroxyurea,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Hydroxyurea,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Hydroxyurea,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Hydrocortisone acetate.,increase,risk
Hydroxyurea,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Hydrocortisone butyrate.,increase,risk
Hydroxyurea,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Hydrocortisone succinate.,increase,risk
Hydroxyurea,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Hydroxychloroquine.,increase,risk
Hydroxyurea,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Hydroxyurea,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Hydroxyurea,Obinutuzumab,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Obinutuzumab.,increase,risk
Hydroxyurea,Ocrelizumab,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ocrelizumab.,increase,risk
Hydroxyurea,Ofatumumab,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ofatumumab.,increase,risk
Hydroxyurea,Olaparib,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Olaparib.,increase,risk
Hydroxyurea,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Oxetacaine.,increase,risk
Hydroxyurea,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Oxybuprocaine.,increase,risk
Hydroxyurea,Ozanimod,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ozanimod.,increase,risk
Hydroxyurea,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Upadacitinib,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Upadacitinib.,increase,risk
Hydroxyurea,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Hydroxyurea,Vedolizumab,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Vedolizumab.,increase,risk
Hydroxyurea,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Hydroxyurea,Vilanterol,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Vilanterol.,increase,risk
Hydroxyurea,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Voclosporin,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Voclosporin.,increase,risk
Hydroxyurea,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Vorinostat,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Vorinostat.,increase,risk
Hydroxyurea,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Hydroxyurea.,increase,risk
Hydroxyurea,Zopiclone,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Zopiclone.,increase,risk
Letrozole,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Letrozole.",increase,risk
Letrozole,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Gemfibrozil.",increase,risk
Letrozole,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Glofitamab,The serum concentration of Letrozole can be increased when it is combined with Glofitamab.,increase,no risk
Letrozole,Glyburide,The metabolism of Glyburide can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Golimumab,The metabolism of Letrozole can be increased when combined with Golimumab.,increase,no risk
Letrozole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Letrozole.,increase,no risk
Letrozole,Halothane,The metabolism of Halothane can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Hydrocortisone,The metabolism of Letrozole can be increased when combined with Hydrocortisone.,increase,no risk
Letrozole,Ketoconazole,The metabolism of Letrozole can be decreased when combined with Ketoconazole.,decrease,no risk
Letrozole,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Ofloxacin.",increase,risk
Letrozole,Omaveloxolone,The serum concentration of Letrozole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Letrozole,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Letrozole is combined with Oxetacaine.,increase,risk
Letrozole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Letrozole is combined with Oxybuprocaine.,increase,risk
Letrozole,Quinine,The metabolism of Quinine can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Ubidecarenone.",increase,risk
Letrozole,Vadadustat,The serum concentration of Letrozole can be increased when it is combined with Vadadustat.,increase,no risk
Letrozole,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Venetoclax,The metabolism of Letrozole can be decreased when combined with Venetoclax.,decrease,no risk
Letrozole,Verapamil,The metabolism of Letrozole can be decreased when combined with Verapamil.,decrease,no risk
Letrozole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Viloxazine,The metabolism of Letrozole can be decreased when combined with Viloxazine.,decrease,no risk
Letrozole,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Letrozole.",increase,risk
Letrozole,Voriconazole,The metabolism of Letrozole can be decreased when combined with Voriconazole.,decrease,no risk
Letrozole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Zimelidine,The metabolism of Letrozole can be decreased when combined with Zimelidine.,decrease,no risk
Letrozole,Ziprasidone,The metabolism of Letrozole can be decreased when combined with Ziprasidone.,decrease,no risk
Letrozole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Letrozole.,decrease,no risk
Letrozole,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Letrozole.,decrease,no risk
Tioconazole,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Tioconazole.,decrease,no risk
Tioconazole,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Tioconazole.,decrease,no risk
Tioconazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Tioconazole.,increase,no risk
Tioconazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Tioconazole.,decrease,no risk
Tioconazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Tioconazole.,decrease,no risk
Busulfan,Butamben,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Butamben.,increase,risk
Busulfan,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Busulfan.,increase,risk
Busulfan,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Busulfan.,increase,risk
Busulfan,Gilteritinib,The metabolism of Busulfan can be decreased when combined with Gilteritinib.,decrease,no risk
Busulfan,Ginkgo biloba,The metabolism of Busulfan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Busulfan,Glatiramer,The risk or severity of adverse effects can be increased when Busulfan is combined with Glatiramer.,increase,risk
Busulfan,Glecaprevir,The metabolism of Busulfan can be decreased when combined with Glecaprevir.,decrease,no risk
Busulfan,Glofitamab,The serum concentration of Busulfan can be increased when it is combined with Glofitamab.,increase,no risk
Busulfan,Glyburide,The metabolism of Busulfan can be decreased when combined with Glyburide.,decrease,no risk
Busulfan,Glycerol phenylbutyrate,The metabolism of Busulfan can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Busulfan,Golimumab,The metabolism of Busulfan can be increased when combined with Golimumab.,increase,no risk
Busulfan,Grapefruit,The serum concentration of Busulfan can be increased when it is combined with Grapefruit.,increase,no risk
Busulfan,Griseofulvin,The metabolism of Busulfan can be increased when combined with Griseofulvin.,increase,no risk
Busulfan,Guselkumab,The risk or severity of adverse effects can be increased when Busulfan is combined with Guselkumab.,increase,risk
Busulfan,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Busulfan.,decrease,no risk
Busulfan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Busulfan.,increase,no risk
Busulfan,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Busulfan.,increase,risk
Busulfan,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Busulfan.,decrease,no risk
Busulfan,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Busulfan.,decrease,no risk
Busulfan,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Busulfan.,increase,risk
Busulfan,Hydralazine,The serum concentration of Busulfan can be increased when it is combined with Hydralazine.,increase,no risk
Busulfan,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Busulfan.,increase,risk
Busulfan,Hydrocortamate,The metabolism of Busulfan can be increased when combined with Hydrocortamate.,increase,no risk
Busulfan,Hydrocortisone,The metabolism of Busulfan can be increased when combined with Hydrocortisone.,increase,no risk
Busulfan,Hydrocortisone acetate,The metabolism of Busulfan can be increased when combined with Hydrocortisone acetate.,increase,no risk
Busulfan,Hydrocortisone butyrate,The metabolism of Busulfan can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Busulfan,Hydrocortisone succinate,The metabolism of Busulfan can be increased when combined with Hydrocortisone succinate.,increase,no risk
Busulfan,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Busulfan.,increase,risk
Busulfan,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Busulfan is combined with Hydroxychloroquine.,increase,risk
Busulfan,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Busulfan.,increase,risk
Busulfan,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Busulfan.,decrease,no risk
Busulfan,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Busulfan.,decrease,no risk
Busulfan,Ketazolam,The serum concentration of Busulfan can be increased when it is combined with Ketazolam.,increase,no risk
Busulfan,Ketoconazole,The metabolism of Busulfan can be decreased when combined with Ketoconazole.,decrease,no risk
Busulfan,Obinutuzumab,The risk or severity of adverse effects can be increased when Busulfan is combined with Obinutuzumab.,increase,risk
Busulfan,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Busulfan.,increase,no risk
Busulfan,Octreotide,The serum concentration of Busulfan can be increased when it is combined with Octreotide.,increase,no risk
Busulfan,Ofatumumab,The risk or severity of adverse effects can be increased when Busulfan is combined with Ofatumumab.,increase,risk
Busulfan,Olaparib,The metabolism of Busulfan can be decreased when combined with Olaparib.,decrease,no risk
Busulfan,Olutasidenib,The metabolism of Busulfan can be increased when combined with Olutasidenib.,increase,no risk
Busulfan,Omaveloxolone,The serum concentration of Busulfan can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Busulfan,Oritavancin,The metabolism of Busulfan can be increased when combined with Oritavancin.,increase,no risk
Busulfan,Orphenadrine,The metabolism of Busulfan can be decreased when combined with Orphenadrine.,decrease,no risk
Busulfan,Osilodrostat,The metabolism of Busulfan can be decreased when combined with Osilodrostat.,decrease,no risk
Busulfan,Osimertinib,The metabolism of Busulfan can be decreased when combined with Osimertinib.,decrease,no risk
Busulfan,Ouabain,Ouabain may decrease the cardiotoxic activities of Busulfan.,decrease,no risk
Busulfan,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Busulfan.,increase,risk
Busulfan,Oxcarbazepine,The metabolism of Busulfan can be increased when combined with Oxcarbazepine.,increase,no risk
Busulfan,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Oxetacaine.,increase,risk
Busulfan,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Oxybuprocaine.,increase,risk
Busulfan,Oxybutynin,The serum concentration of Busulfan can be increased when it is combined with Oxybutynin.,increase,no risk
Busulfan,Ozanimod,The risk or severity of adverse effects can be increased when Busulfan is combined with Ozanimod.,increase,risk
Busulfan,Quinidine,The metabolism of Busulfan can be decreased when combined with Quinidine.,decrease,no risk
Busulfan,Quinine,The metabolism of Busulfan can be increased when combined with Quinine.,increase,no risk
Busulfan,Quinupristin,The metabolism of Busulfan can be decreased when combined with Quinupristin.,decrease,no risk
Busulfan,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Busulfan.,increase,risk
Busulfan,Upadacitinib,The risk or severity of adverse effects can be increased when Busulfan is combined with Upadacitinib.,increase,risk
Busulfan,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Busulfan.,increase,risk
Busulfan,Vadadustat,The serum concentration of Busulfan can be increased when it is combined with Vadadustat.,increase,no risk
Busulfan,Valproic acid,The serum concentration of Busulfan can be increased when it is combined with Valproic acid.,increase,no risk
Busulfan,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Busulfan.,increase,risk
Busulfan,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Busulfan.,decrease,no risk
Busulfan,Vedolizumab,The risk or severity of adverse effects can be increased when Busulfan is combined with Vedolizumab.,increase,risk
Busulfan,Vemurafenib,The metabolism of Busulfan can be increased when combined with Vemurafenib.,increase,no risk
Busulfan,Venetoclax,The metabolism of Busulfan can be decreased when combined with Venetoclax.,decrease,no risk
Busulfan,Verapamil,The metabolism of Busulfan can be decreased when combined with Verapamil.,decrease,no risk
Busulfan,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Busulfan.,decrease,no risk
Busulfan,Vilanterol,The risk or severity of adverse effects can be increased when Busulfan is combined with Vilanterol.,increase,risk
Busulfan,Viloxazine,The metabolism of Busulfan can be decreased when combined with Viloxazine.,decrease,no risk
Busulfan,Vinblastine,The metabolism of Busulfan can be increased when combined with Vinblastine.,increase,no risk
Busulfan,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Busulfan.,increase,risk
Busulfan,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Busulfan.,increase,risk
Busulfan,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Busulfan.,increase,risk
Busulfan,Vitamin E,The metabolism of Busulfan can be increased when combined with Vitamin E.,increase,no risk
Busulfan,Voclosporin,The risk or severity of adverse effects can be increased when Busulfan is combined with Voclosporin.,increase,risk
Busulfan,Vorapaxar,The metabolism of Busulfan can be decreased when combined with Vorapaxar.,decrease,no risk
Busulfan,Voriconazole,The metabolism of Busulfan can be decreased when combined with Voriconazole.,decrease,no risk
Busulfan,Vorinostat,The risk or severity of adverse effects can be increased when Busulfan is combined with Vorinostat.,increase,risk
Busulfan,Voxelotor,The serum concentration of Busulfan can be increased when it is combined with Voxelotor.,increase,no risk
Busulfan,Warfarin,The metabolism of Busulfan can be increased when combined with Warfarin.,increase,no risk
Busulfan,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Busulfan.,increase,risk
Busulfan,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Busulfan.,increase,risk
Busulfan,Zafirlukast,The serum concentration of Busulfan can be increased when it is combined with Zafirlukast.,increase,no risk
Busulfan,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Busulfan.,increase,risk
Busulfan,Zimelidine,The metabolism of Busulfan can be decreased when combined with Zimelidine.,decrease,no risk
Busulfan,Ziprasidone,The metabolism of Busulfan can be decreased when combined with Ziprasidone.,decrease,no risk
Busulfan,Zuclopenthixol,The metabolism of Busulfan can be decreased when combined with Zuclopenthixol.,decrease,no risk
Ketoprofen,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Ketoprofen.,increase,risk
Ketoprofen,Benzthiazide,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Benzthiazide.,increase,risk
Ketoprofen,Benzydamine,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Benzydamine.,increase,risk
Ketoprofen,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Bepotastine,Ketoprofen may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Ketoprofen,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Ketoprofen.,increase,risk
Ketoprofen,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Ketoprofen.,increase,risk
Ketoprofen,Betaxolol,Ketoprofen may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Ketoprofen,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Ketoprofen.,increase,risk
Ketoprofen,Betulinic Acid,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Betulinic Acid.,increase,risk
Ketoprofen,Bicisate,Ketoprofen may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ketoprofen,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Bismuth subgallate,Ketoprofen may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ketoprofen,Bismuth subsalicylate,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Ketoprofen.,increase,risk
Ketoprofen,Bisoprolol,Ketoprofen may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Ketoprofen,Bisoxatin,Ketoprofen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ketoprofen,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Bivalirudin.,increase,risk
Ketoprofen,Bleomycin,Ketoprofen may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Ketoprofen,Bosentan,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Bosentan.,increase,risk
Ketoprofen,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Brexpiprazole,The risk or severity of hypertension can be increased when Ketoprofen is combined with Brexpiprazole.,increase,risk
Ketoprofen,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Brivaracetam,Ketoprofen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Ketoprofen,Bromazepam,Ketoprofen may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Ketoprofen,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Ketoprofen.,increase,risk
Ketoprofen,Bromocriptine,The risk or severity of hypertension can be increased when Ketoprofen is combined with Bromocriptine.,increase,risk
Ketoprofen,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ketoprofen,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Ketoprofen.,increase,risk
Ketoprofen,Bufexamac,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Bufexamac.,increase,risk
Ketoprofen,Bumadizone,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Bumadizone.,increase,risk
Ketoprofen,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Bupropion,Ketoprofen may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Ketoprofen,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Ketoprofen.,increase,risk
Ketoprofen,Butabarbital,Ketoprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Ketoprofen,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Ketoprofen.,increase,risk
Ketoprofen,Gabapentin enacarbil,Ketoprofen may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gadobenic acid,Ketoprofen may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gadodiamide,Ketoprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gadofosveset trisodium,Ketoprofen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gadopentetic acid,Ketoprofen may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gadoteric acid,Ketoprofen may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gadoteridol,Ketoprofen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ketoprofen,Ganciclovir,Ketoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gatifloxacin,Ketoprofen may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Ketoprofen,Gefapixant,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Gefapixant.,increase,risk
Ketoprofen,Gemcitabine,Ketoprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gemfibrozil,The metabolism of Ketoprofen can be decreased when combined with Gemfibrozil.,decrease,no risk
Ketoprofen,Gemifloxacin,Ketoprofen may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Ketoprofen,Gentamicin,Ketoprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ketoprofen,Gimeracil,Ketoprofen may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ketoprofen,Givosiran,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Givosiran.,increase,risk
Ketoprofen,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Glecaprevir,The metabolism of Ketoprofen can be decreased when combined with Glecaprevir.,decrease,no risk
Ketoprofen,Gliclazide,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Gliclazide.,increase,risk
Ketoprofen,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Glipizide,The protein binding of Glipizide can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Glyburide,The protein binding of Glyburide can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Glycerol phenylbutyrate,Ketoprofen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ketoprofen,Glycol salicylate,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Glycol salicylate.,increase,risk
Ketoprofen,Glymidine,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Glymidine.,increase,risk
Ketoprofen,Golodirsen,Ketoprofen may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ketoprofen,Goserelin,Ketoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ketoprofen,Grepafloxacin,Ketoprofen may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Ketoprofen,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Ketoprofen.,increase,no risk
Ketoprofen,Halothane,The risk or severity of hypertension can be increased when Ketoprofen is combined with Halothane.,increase,risk
Ketoprofen,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Heparin.,increase,risk
Ketoprofen,Hydralazine,Ketoprofen may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ketoprofen,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Hydrochlorothiazide.,increase,risk
Ketoprofen,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Ketoprofen.,increase,risk
Ketoprofen,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Ketoprofen.,increase,risk
Ketoprofen,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Ketoprofen.,increase,risk
Ketoprofen,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Ketoprofen.,increase,risk
Ketoprofen,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Ketoprofen.,increase,risk
Ketoprofen,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Hydroflumethiazide.,increase,risk
Ketoprofen,Hydromorphone,Ketoprofen may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ketoprofen,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Hydroxyethyl Starch,Ketoprofen may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ketoprofen,Kanamycin,Ketoprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ketoprofen,Ketamine,Ketoprofen may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketoprofen,Ketazolam,Ketoprofen may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ketoprofen,Ketoconazole,The metabolism of Ketoprofen can be decreased when combined with Ketoconazole.,decrease,no risk
Ketoprofen,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Ketoprofen.,increase,risk
Ketoprofen,Octinoxate,Ketoprofen may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ketoprofen,Ofloxacin,Ketoprofen may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Ketoprofen,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Ketoprofen.",increase,risk
Ketoprofen,Olodaterol,The risk or severity of hypertension can be increased when Ketoprofen is combined with Olodaterol.,increase,risk
Ketoprofen,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Olsalazine.,increase,risk
Ketoprofen,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ketoprofen is combined with Omacetaxine mepesuccinate.,increase,risk
Ketoprofen,Ombitasvir,The metabolism of Ketoprofen can be decreased when combined with Ombitasvir.,decrease,no risk
Ketoprofen,Opium,Ketoprofen may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ketoprofen,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Ketoprofen.,increase,risk
Ketoprofen,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Oxacillin,Ketoprofen may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ketoprofen,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ketoprofen.,increase,risk
Ketoprofen,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Ketoprofen.,increase,risk
Ketoprofen,Oxazepam,Ketoprofen may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ketoprofen,Oxprenolol,Ketoprofen may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Ketoprofen,Oxybenzone,Ketoprofen may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ketoprofen,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Ketoprofen.,increase,risk
Ketoprofen,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Oxyphenbutazone.,increase,risk
Ketoprofen,Oxyquinoline,Ketoprofen may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ketoprofen,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Quetiapine,The risk or severity of hypertension can be increased when Ketoprofen is combined with Quetiapine.,increase,risk
Ketoprofen,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Quinapril.",increase,risk
Ketoprofen,Quinethazone,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Quinethazone.,increase,risk
Ketoprofen,Quinidine,Ketoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ketoprofen,Quinine,The metabolism of Quinine can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Ketoprofen.,increase,risk
Ketoprofen,Quizartinib,The metabolism of Ketoprofen can be decreased when combined with Quizartinib.,decrease,no risk
Ketoprofen,Udenafil,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Udenafil.,increase,risk
Ketoprofen,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ketoprofen,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Urokinase.,increase,risk
Ketoprofen,Vaborbactam,Ketoprofen may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ketoprofen,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Ketoprofen.,increase,no risk
Ketoprofen,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Valbenazine,Ketoprofen may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ketoprofen,Valdecoxib,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Valdecoxib.,increase,risk
Ketoprofen,Valganciclovir,Ketoprofen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ketoprofen,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Ketoprofen.",increase,risk
Ketoprofen,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Ketoprofen.,increase,risk
Ketoprofen,Vancomycin,Ketoprofen may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ketoprofen,Varenicline,Ketoprofen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ketoprofen,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Vemurafenib,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Vemurafenib.,increase,risk
Ketoprofen,Venlafaxine,Venlafaxine may increase the antiplatelet activities of Ketoprofen.,increase,no risk
Ketoprofen,Verapamil,Ketoprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ketoprofen,Vilanterol,The risk or severity of hypertension can be increased when Ketoprofen is combined with Vilanterol.,increase,risk
Ketoprofen,Vilazodone,The risk or severity of hypertension can be increased when Ketoprofen is combined with Vilazodone.,increase,risk
Ketoprofen,Viloxazine,Ketoprofen may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ketoprofen,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Vorapaxar.,increase,risk
Ketoprofen,Voriconazole,The serum concentration of Ketoprofen can be increased when it is combined with Voriconazole.,increase,no risk
Ketoprofen,Vortioxetine,The risk or severity of hypertension can be increased when Ketoprofen is combined with Vortioxetine.,increase,risk
Ketoprofen,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Warfarin.,increase,risk
Ketoprofen,Xamoterol,The risk or severity of hypertension can be increased when Ketoprofen is combined with Xamoterol.,increase,risk
Ketoprofen,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ximelagatran.,increase,risk
Ketoprofen,Xylometazoline,The risk or severity of hypertension can be increased when Ketoprofen is combined with Xylometazoline.,increase,risk
Ketoprofen,Yohimbine,The risk or severity of hypertension can be increased when Ketoprofen is combined with Yohimbine.,increase,risk
Ketoprofen,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Ketoprofen.,decrease,no risk
Ketoprofen,Zaleplon,Ketoprofen may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ketoprofen,Zanamivir,Ketoprofen may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ketoprofen,Zidovudine,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zidovudine.,increase,risk
Ketoprofen,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Ketoprofen.,increase,risk
Ketoprofen,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Ketoprofen.,increase,risk
Ketoprofen,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Zofenopril.",increase,risk
Ketoprofen,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Zoledronic acid.,increase,risk
Ketoprofen,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ketoprofen.,increase,risk
Ketoprofen,Zonisamide,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zonisamide.,increase,risk
Ketoprofen,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ketoprofen.,decrease,no risk
Edrophonium,Gabapentin enacarbil,Edrophonium may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Edrophonium,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Gadodiamide,Gadodiamide may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Gadofosveset trisodium,Edrophonium may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Edrophonium,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Gadoteric acid,Edrophonium may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Edrophonium,Gadoteridol,Gadoteridol may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Ganciclovir,Ganciclovir may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Gemcitabine,Gemcitabine may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Gemfibrozil,Edrophonium may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Edrophonium,Gentamicin,Edrophonium may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Edrophonium,Gimeracil,Edrophonium may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Edrophonium,Givosiran,Givosiran may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Glipizide,Edrophonium may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Edrophonium,Glycerol phenylbutyrate,Edrophonium may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Edrophonium,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Golodirsen,Edrophonium may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Edrophonium,Goserelin,Goserelin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Guanethidine,Edrophonium may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Edrophonium,Guanfacine,Edrophonium may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Edrophonium,Haloperidol,Haloperidol may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Hydralazine,Edrophonium may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Edrophonium,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edrophonium,Hydrocortisone,The therapeutic efficacy of Edrophonium can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Edrophonium,Hydrocortisone acetate,The therapeutic efficacy of Edrophonium can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Edrophonium,Hydrocortisone butyrate,The therapeutic efficacy of Edrophonium can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Edrophonium,Hydrocortisone cypionate,The therapeutic efficacy of Edrophonium can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Edrophonium,Hydrocortisone succinate,The therapeutic efficacy of Edrophonium can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Edrophonium,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edrophonium,Hydromorphone,Hydromorphone may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Hydroxyethyl Starch,Edrophonium may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Edrophonium,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Kanamycin,Edrophonium may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Edrophonium,Ketamine,Edrophonium may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Edrophonium,Ketazolam,Edrophonium may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Edrophonium,Ketoprofen,Ketoprofen may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Ketorolac,Ketorolac may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Octinoxate,Edrophonium may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Edrophonium,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Olsalazine,Olsalazine may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Opium,Edrophonium may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Edrophonium,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Oseltamivir,Oseltamivir may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Ouabain,Edrophonium may increase the atrioventricular blocking (AV block) and arrhythmogenic activities of Ouabain.,increase,no risk
Edrophonium,Oxacillin,Oxacillin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Oxaprozin,Oxaprozin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Oxazepam,Oxazepam may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Oxprenolol,Edrophonium may increase the bradycardic activities of Oxprenolol.,increase,no risk
Edrophonium,Oxybenzone,Edrophonium may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Edrophonium,Oxybuprocaine,Edrophonium may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Edrophonium,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Oxyquinoline,Edrophonium may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Edrophonium,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Quinethazone,Quinethazone may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Edrophonium,Quinidine,Edrophonium may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Edrophonium,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Vaborbactam,Edrophonium may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Edrophonium,Valaciclovir,Valaciclovir may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Valbenazine,Edrophonium may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Edrophonium,Valdecoxib,Valdecoxib may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Valganciclovir,Edrophonium may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Edrophonium,Vamorolone,The therapeutic efficacy of Edrophonium can be decreased when used in combination with Vamorolone.,decrease,no risk
Edrophonium,Vancomycin,Edrophonium may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Edrophonium,Varenicline,The risk or severity of adverse effects can be increased when Edrophonium is combined with Varenicline.,increase,risk
Edrophonium,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Edrophonium.,decrease,no risk
Edrophonium,Venlafaxine,Venlafaxine may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Verapamil,Verapamil may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Vilanterol,Edrophonium may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Edrophonium,Viloxazine,Edrophonium may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Edrophonium,Vortioxetine,Edrophonium may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Edrophonium,Warfarin,Edrophonium may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Edrophonium,Zaleplon,Zaleplon may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Zanamivir,Zanamivir may decrease the excretion rate of Edrophonium which could result in a higher serum level.,decrease,no risk
Edrophonium,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Edrophonium.,decrease,no risk
Metyrapone,Gabapentin enacarbil,Metyrapone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Metyrapone,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Gadodiamide,Gadodiamide may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Gadofosveset trisodium,Metyrapone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Metyrapone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Gadoteric acid,Metyrapone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Metyrapone,Gadoteridol,Gadoteridol may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Ganciclovir,Ganciclovir may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Gemcitabine,Gemcitabine may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Gemfibrozil,Metyrapone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Metyrapone,Gentamicin,Metyrapone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Metyrapone,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Metyrapone.,increase,no risk
Metyrapone,Gestrinone,The metabolism of Gestrinone can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Gimeracil,Metyrapone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Metyrapone,Givosiran,Givosiran may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Glipizide,Metyrapone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Metyrapone,Glycerol phenylbutyrate,Metyrapone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Metyrapone,Golodirsen,Metyrapone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Metyrapone,Goserelin,Goserelin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Guanethidine,Metyrapone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Metyrapone,Guanfacine,Metyrapone may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Metyrapone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Metyrapone.,increase,no risk
Metyrapone,Halothane,The metabolism of Halothane can be decreased when combined with Metyrapone.,decrease,no risk
Metyrapone,Hydralazine,Metyrapone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Metyrapone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metyrapone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metyrapone,Hydromorphone,Hydromorphone may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Hydroxyethyl Starch,Metyrapone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Metyrapone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Kanamycin,Metyrapone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Metyrapone,Ketamine,Metyrapone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Metyrapone,Ketazolam,Metyrapone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Metyrapone,Ketoprofen,Ketoprofen may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Ketorolac,Ketorolac may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Octinoxate,Metyrapone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Metyrapone,Olaparib,The metabolism of Olaparib can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Metyrapone.,decrease,no risk
Metyrapone,Olsalazine,Olsalazine may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Opium,Metyrapone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Metyrapone,Oseltamivir,Oseltamivir may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Oxacillin,Oxacillin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Oxaprozin,Oxaprozin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Oxazepam,Oxazepam may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Oxybenzone,Metyrapone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Metyrapone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Oxyquinoline,Metyrapone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Metyrapone,Quetiapine,Metyrapone may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Metyrapone,Quinethazone,Quinethazone may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metyrapone,Quinidine,The metabolism of Quinidine can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Ulipristal,The metabolism of Ulipristal can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vaborbactam,Metyrapone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Metyrapone,Valaciclovir,Valaciclovir may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Valbenazine,Metyrapone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Metyrapone,Valdecoxib,Valdecoxib may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Valganciclovir,Metyrapone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Metyrapone,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Metyrapone.,decrease,no risk
Metyrapone,Vancomycin,Metyrapone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Metyrapone,Vandetanib,The metabolism of Vandetanib can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Metyrapone.,decrease,no risk
Metyrapone,Varenicline,Metyrapone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Metyrapone,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Venetoclax,The metabolism of Venetoclax can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Venlafaxine,Venlafaxine may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Verapamil,Verapamil may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Vilanterol,Metyrapone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Metyrapone,Viloxazine,Metyrapone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Metyrapone,Vinblastine,The metabolism of Vinblastine can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vincristine,The metabolism of Vincristine can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vindesine,The metabolism of Vindesine can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vinflunine,The metabolism of Vinflunine can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Metyrapone.,decrease,no risk
Metyrapone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Metyrapone.,increase,no risk
Metyrapone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Metyrapone.,increase,no risk
Metyrapone,Zaleplon,Zaleplon may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Zanamivir,Zanamivir may decrease the excretion rate of Metyrapone which could result in a higher serum level.,decrease,no risk
Metyrapone,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Metyrapone.,decrease,no risk
Metyrapone,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Zolpidem,The metabolism of Zolpidem can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Zonisamide,Zonisamide may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metyrapone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Metyrapone.,decrease,no risk
Metyrapone,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Metyrapone.,increase,no risk
Metyrapone,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Metyrapone.,decrease,no risk
Cinacalcet,Galantamine,The metabolism of Galantamine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Gatifloxacin,The metabolism of Cinacalcet can be decreased when combined with Gatifloxacin.,decrease,no risk
Cinacalcet,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Gemfibrozil,The metabolism of Cinacalcet can be decreased when combined with Gemfibrozil.,decrease,no risk
Cinacalcet,Gemifloxacin,The metabolism of Cinacalcet can be decreased when combined with Gemifloxacin.,decrease,no risk
Cinacalcet,Givosiran,The serum concentration of Cinacalcet can be increased when it is combined with Givosiran.,increase,no risk
Cinacalcet,Glofitamab,The serum concentration of Cinacalcet can be increased when it is combined with Glofitamab.,increase,no risk
Cinacalcet,Golimumab,The metabolism of Cinacalcet can be increased when combined with Golimumab.,increase,no risk
Cinacalcet,Grepafloxacin,The metabolism of Cinacalcet can be decreased when combined with Grepafloxacin.,decrease,no risk
Cinacalcet,Guanabenz,The metabolism of Cinacalcet can be decreased when combined with Guanabenz.,decrease,no risk
Cinacalcet,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cinacalcet.,increase,no risk
Cinacalcet,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Ketoconazole,The metabolism of Cinacalcet can be decreased when combined with Ketoconazole.,decrease,no risk
Cinacalcet,Obeticholic acid,The metabolism of Cinacalcet can be decreased when combined with Obeticholic acid.,decrease,no risk
Cinacalcet,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Cinacalcet.,increase,no risk
Cinacalcet,Omaveloxolone,The serum concentration of Cinacalcet can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cinacalcet,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Opium,The metabolism of Opium can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Orphenadrine,The metabolism of Cinacalcet can be decreased when combined with Orphenadrine.,decrease,no risk
Cinacalcet,Osilodrostat,The metabolism of Cinacalcet can be decreased when combined with Osilodrostat.,decrease,no risk
Cinacalcet,Osimertinib,The serum concentration of Cinacalcet can be decreased when it is combined with Osimertinib.,decrease,no risk
Cinacalcet,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Quinidine,The metabolism of Cinacalcet can be decreased when combined with Quinidine.,decrease,no risk
Cinacalcet,Quinine,The metabolism of Quinine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Vadadustat,The serum concentration of Cinacalcet can be increased when it is combined with Vadadustat.,increase,no risk
Cinacalcet,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Cinacalcet.,increase,no risk
Cinacalcet,Valproic acid,The metabolism of Cinacalcet can be decreased when combined with Valproic acid.,decrease,no risk
Cinacalcet,Vemurafenib,The serum concentration of Cinacalcet can be increased when it is combined with Vemurafenib.,increase,no risk
Cinacalcet,Venetoclax,The metabolism of Cinacalcet can be decreased when combined with Venetoclax.,decrease,no risk
Cinacalcet,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Verapamil,The metabolism of Cinacalcet can be decreased when combined with Verapamil.,decrease,no risk
Cinacalcet,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Viloxazine,The metabolism of Cinacalcet can be decreased when combined with Viloxazine.,decrease,no risk
Cinacalcet,Voriconazole,The metabolism of Cinacalcet can be decreased when combined with Voriconazole.,decrease,no risk
Cinacalcet,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Warfarin,The metabolism of Cinacalcet can be decreased when combined with Warfarin.,decrease,no risk
Cinacalcet,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Zileuton,The metabolism of Cinacalcet can be decreased when combined with Zileuton.,decrease,no risk
Cinacalcet,Zimelidine,The metabolism of Cinacalcet can be decreased when combined with Zimelidine.,decrease,no risk
Cinacalcet,Ziprasidone,The metabolism of Cinacalcet can be decreased when combined with Ziprasidone.,decrease,no risk
Cinacalcet,Zolmitriptan,The metabolism of Cinacalcet can be decreased when combined with Zolmitriptan.,decrease,no risk
Cinacalcet,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Zotepine,The metabolism of Zotepine can be decreased when combined with Cinacalcet.,decrease,no risk
Cinacalcet,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Cinacalcet.,decrease,no risk
Clobetasol propionate,Bimekizumab,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Bimekizumab.,increase,risk
Clobetasol propionate,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Clobetasol propionate.,increase,risk
Clobetasol propionate,Blinatumomab,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Blinatumomab.,increase,risk
Clobetasol propionate,Boceprevir,The metabolism of Clobetasol propionate can be decreased when combined with Boceprevir.,decrease,no risk
Clobetasol propionate,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Clobetasol propionate.",decrease,no risk
Clobetasol propionate,Bortezomib,The metabolism of Bortezomib can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Bosutinib,The metabolism of Bosutinib can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Clobetasol propionate.,increase,risk
Clobetasol propionate,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Brigatinib,The metabolism of Brigatinib can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Brodalumab,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Brodalumab.,increase,risk
Clobetasol propionate,Bromocriptine,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Bromocriptine.,increase,risk
Clobetasol propionate,Budesonide,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Budesonide.,increase,risk
Clobetasol propionate,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Bumadizone.,increase,risk
Clobetasol propionate,Bumetanide,The risk or severity of hypokalemia can be increased when Clobetasol propionate is combined with Bumetanide.,increase,risk
Clobetasol propionate,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Buspirone,The metabolism of Buspirone can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Busulfan,The metabolism of Busulfan can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Gatifloxacin,The risk or severity of tendinopathy can be increased when Clobetasol propionate is combined with Gatifloxacin.,increase,risk
Clobetasol propionate,Gefitinib,The metabolism of Gefitinib can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Clobetasol propionate.,increase,risk
Clobetasol propionate,Gemifloxacin,The risk or severity of tendinopathy can be increased when Clobetasol propionate is combined with Gemifloxacin.,increase,risk
Clobetasol propionate,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Clobetasol propionate.,increase,risk
Clobetasol propionate,Gestrinone,The serum concentration of Clobetasol propionate can be increased when it is combined with Gestrinone.,increase,no risk
Clobetasol propionate,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Glatiramer,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Glatiramer.,increase,risk
Clobetasol propionate,Gliclazide,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Gliclazide.,increase,risk
Clobetasol propionate,Glimepiride,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Glimepiride.,increase,risk
Clobetasol propionate,Glipizide,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Glipizide.,increase,risk
Clobetasol propionate,Gliquidone,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Gliquidone.,increase,risk
Clobetasol propionate,Glofitamab,The serum concentration of Clobetasol propionate can be increased when it is combined with Glofitamab.,increase,no risk
Clobetasol propionate,Glyburide,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Glyburide.,increase,risk
Clobetasol propionate,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Glycol salicylate.,increase,risk
Clobetasol propionate,Glymidine,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Glymidine.,increase,risk
Clobetasol propionate,Golimumab,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Golimumab.,increase,risk
Clobetasol propionate,Grepafloxacin,The risk or severity of tendinopathy can be increased when Clobetasol propionate is combined with Grepafloxacin.,increase,risk
Clobetasol propionate,Guselkumab,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Guselkumab.,increase,risk
Clobetasol propionate,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Halofantrine,The metabolism of Halofantrine can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Clobetasol propionate.,increase,risk
Clobetasol propionate,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Clobetasol propionate is combined with Hydrochlorothiazide.,increase,risk
Clobetasol propionate,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Hydrocortisone acetate.,increase,risk
Clobetasol propionate,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Hydrocortisone butyrate.,increase,risk
Clobetasol propionate,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Hydrocortisone succinate.,increase,risk
Clobetasol propionate,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Clobetasol propionate is combined with Hydroflumethiazide.,increase,risk
Clobetasol propionate,Hydrotalcite,The bioavailability of Clobetasol propionate can be decreased when combined with Hydrotalcite.,decrease,no risk
Clobetasol propionate,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Hydroxychloroquine.,increase,risk
Clobetasol propionate,Hydroxyprogesterone caproate,The serum concentration of Clobetasol propionate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Clobetasol propionate,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Clobetasol propionate.,increase,risk
Clobetasol propionate,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Ketoconazole,The metabolism of Clobetasol propionate can be decreased when combined with Ketoconazole.,decrease,no risk
Clobetasol propionate,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Ketoprofen.,increase,risk
Clobetasol propionate,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Ketorolac.,increase,risk
Clobetasol propionate,Obinutuzumab,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Obinutuzumab.,increase,risk
Clobetasol propionate,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Clobetasol propionate.,increase,no risk
Clobetasol propionate,Ofatumumab,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Ofatumumab.,increase,risk
Clobetasol propionate,Ofloxacin,The risk or severity of tendinopathy can be increased when Clobetasol propionate is combined with Ofloxacin.,increase,risk
Clobetasol propionate,Olaparib,The metabolism of Olaparib can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Clobetasol propionate.,decrease,no risk
Clobetasol propionate,Olodaterol,The risk or severity of hypokalemia can be increased when Clobetasol propionate is combined with Olodaterol.,increase,risk
Clobetasol propionate,Omaveloxolone,The serum concentration of Clobetasol propionate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Clobetasol propionate,Ondansetron,The metabolism of Ondansetron can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Orciprenaline,The risk or severity of hypokalemia can be increased when Clobetasol propionate is combined with Orciprenaline.,increase,risk
Clobetasol propionate,Osimertinib,The metabolism of Osimertinib can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Clobetasol propionate.,increase,risk
Clobetasol propionate,Oxandrolone,The risk or severity of fluid retention can be increased when Clobetasol propionate is combined with Oxandrolone.,increase,risk
Clobetasol propionate,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Oxaprozin.,increase,risk
Clobetasol propionate,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Oxycodone,The metabolism of Oxycodone can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Oxymetholone,The risk or severity of fluid retention can be increased when Clobetasol propionate is combined with Oxymetholone.,increase,risk
Clobetasol propionate,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Clobetasol propionate is combined with Oxyphenbutazone.,increase,risk
Clobetasol propionate,Ozanimod,The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Ozanimod.,increase,risk
Clobetasol propionate,Quetiapine,The metabolism of Quetiapine can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Quinethazone,Clobetasol propionate may increase the hypokalemic activities of Quinethazone.,increase,no risk
Clobetasol propionate,Quinidine,The metabolism of Quinidine can be increased when combined with Clobetasol propionate.,increase,no risk
Clobetasol propionate,Quinine,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Quinine.,increase,risk
Clobetasol propionate,Quizartinib,The metabolism of Quizartinib can be increased when combined with Clobetasol propionate.,increase,no risk
Balsalazide,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Balsalazide.,increase,risk
Balsalazide,Betulinic Acid,The risk or severity of adverse effects can be increased when Balsalazide is combined with Betulinic Acid.,increase,risk
Balsalazide,Bexagliflozin,Balsalazide may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Balsalazide,Bicisate,Balsalazide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Balsalazide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Balsalazide.,decrease,no risk
Balsalazide,Bismuth subgallate,Balsalazide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Balsalazide,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Balsalazide.,decrease,no risk
Balsalazide,Bisoprolol,Balsalazide may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Balsalazide,Bisoxatin,Balsalazide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Balsalazide,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Bivalirudin.,increase,risk
Balsalazide,Bleomycin,Balsalazide may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Balsalazide,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Balsalazide.,decrease,no risk
Balsalazide,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Balsalazide.,decrease,no risk
Balsalazide,Brexpiprazole,The risk or severity of hypertension can be increased when Balsalazide is combined with Brexpiprazole.,increase,risk
Balsalazide,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Balsalazide.,increase,risk
Balsalazide,Brivaracetam,Balsalazide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Balsalazide,Bromazepam,Balsalazide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Balsalazide,Bromfenac,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Bromfenac.,decrease,no risk
Balsalazide,Bromocriptine,Balsalazide may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Balsalazide,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Balsalazide.,increase,risk
Balsalazide,Bufexamac,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Bufexamac.,decrease,no risk
Balsalazide,Bumadizone,The risk or severity of adverse effects can be increased when Balsalazide is combined with Bumadizone.,increase,risk
Balsalazide,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Balsalazide.,decrease,no risk
Balsalazide,Bupropion,Balsalazide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Balsalazide,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Balsalazide.,increase,risk
Balsalazide,Butabarbital,Balsalazide may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Balsalazide,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Balsalazide.,increase,risk
Sulfamethoxazole,Bacitracin,Bacitracin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Baclofen,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Baclofen.,decrease,no risk
Sulfamethoxazole,Balsalazide,Balsalazide may increase the hypoglycemic activities of Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Baricitinib,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Baricitinib.,increase,risk
Sulfamethoxazole,Basiliximab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Basiliximab.,increase,risk
Sulfamethoxazole,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Beclomethasone dipropionate,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Beclomethasone dipropionate.,increase,risk
Sulfamethoxazole,Bedaquiline,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Bedaquiline.,increase,risk
Sulfamethoxazole,Belantamab mafodotin,Sulfamethoxazole may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Belatacept,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Belatacept.,increase,risk
Sulfamethoxazole,Belimumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Belimumab.,increase,risk
Sulfamethoxazole,Belinostat,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Belinostat.,increase,risk
Sulfamethoxazole,Belumosudil,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Belumosudil.,increase,risk
Sulfamethoxazole,Bemiparin,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Bemiparin.,increase,risk
Sulfamethoxazole,Benazepril,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Bendamustine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Bendamustine.,increase,risk
Sulfamethoxazole,Bendroflumethiazide,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Sulfamethoxazole,Benorilate,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Benorilate.,increase,risk
Sulfamethoxazole,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Benoxaprofen.,increase,risk
Sulfamethoxazole,Benserazide,Sulfamethoxazole may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Benznidazole,Sulfamethoxazole may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Benzocaine.,increase,risk
Sulfamethoxazole,Benzthiazide,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Benzthiazide.,decrease,no risk
Sulfamethoxazole,Benzydamine,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Benzydamine.,increase,risk
Sulfamethoxazole,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Benzyl alcohol.,increase,risk
Sulfamethoxazole,Benzylpenicillin,Sulfamethoxazole may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Bepotastine,Sulfamethoxazole may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Bepridil,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Bepridil.,increase,risk
Sulfamethoxazole,Berotralstat,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Berotralstat.,increase,risk
Sulfamethoxazole,Betamethasone,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Betamethasone.,increase,risk
Sulfamethoxazole,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Betaxolol,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Betaxolol.,increase,no risk
Sulfamethoxazole,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Bexarotene,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Bexarotene.,increase,risk
Sulfamethoxazole,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sulfamethoxazole is combined with Bezafibrate.",increase,risk
Sulfamethoxazole,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Bicisate,Sulfamethoxazole may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Bilastine,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Bilastine.,increase,risk
Sulfamethoxazole,Bimekizumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Bimekizumab.,increase,risk
Sulfamethoxazole,Bismuth subgallate,Sulfamethoxazole may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Bisoprolol,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Bisoprolol.,increase,no risk
Sulfamethoxazole,Bisoxatin,Sulfamethoxazole may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Bleomycin,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Bleomycin.,increase,risk
Sulfamethoxazole,Blinatumomab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Blinatumomab.,increase,risk
Sulfamethoxazole,Bortezomib,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Bortezomib.,increase,risk
Sulfamethoxazole,Bosentan,Bosentan may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Bosutinib,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Bosutinib.,increase,risk
Sulfamethoxazole,Brentuximab vedotin,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Brentuximab vedotin.,increase,risk
Sulfamethoxazole,Bretylium,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Bretylium.,increase,risk
Sulfamethoxazole,Brexpiprazole,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Sulfamethoxazole,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Brodalumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Brodalumab.,increase,risk
Sulfamethoxazole,Bromazepam,Sulfamethoxazole may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Bromocriptine,The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Bromocriptine.,increase,risk
Sulfamethoxazole,Bromotheophylline,Bromotheophylline may increase the excretion rate of Sulfamethoxazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sulfamethoxazole,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Budesonide,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Budesonide.,increase,risk
Sulfamethoxazole,Bumadizone,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Bumadizone.,increase,risk
Sulfamethoxazole,Bumetanide,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Bumetanide.,decrease,no risk
Sulfamethoxazole,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Bupivacaine.,increase,risk
Sulfamethoxazole,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Bupropion,The metabolism of Bupropion can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Buserelin,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Buserelin.,decrease,no risk
Sulfamethoxazole,Buspirone,Buspirone may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Busulfan,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Busulfan.,increase,risk
Sulfamethoxazole,Butabarbital,Butabarbital may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Butacaine,The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Butacaine.,increase,risk
Sulfamethoxazole,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Butamben,The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Butamben.,increase,risk
Sulfamethoxazole,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Gabapentin enacarbil,Sulfamethoxazole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Gadobenic acid.,increase,risk
Sulfamethoxazole,Gadodiamide,Gadodiamide may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Gadofosveset trisodium,Sulfamethoxazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Gadoteric acid,Sulfamethoxazole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Gadoteridol,Gadoteridol may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Sulfamethoxazole.",increase,risk
Sulfamethoxazole,Gatifloxacin,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Gatifloxacin.,increase,no risk
Sulfamethoxazole,Gefapixant,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Gefapixant.,increase,no risk
Sulfamethoxazole,Gemcitabine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Gemcitabine.,increase,risk
Sulfamethoxazole,Gemfibrozil,The metabolism of Sulfamethoxazole can be decreased when combined with Gemfibrozil.,decrease,no risk
Sulfamethoxazole,Gemifloxacin,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Gemifloxacin.,increase,no risk
Sulfamethoxazole,Gemtuzumab ozogamicin,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Gemtuzumab ozogamicin.,increase,risk
Sulfamethoxazole,Gentamicin,Sulfamethoxazole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Gimeracil,Sulfamethoxazole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Ginkgo biloba,The metabolism of Sulfamethoxazole can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sulfamethoxazole,Givosiran,Givosiran may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Glasdegib,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Glasdegib.,increase,risk
Sulfamethoxazole,Glatiramer,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Glatiramer.,increase,risk
Sulfamethoxazole,Gliclazide,The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Gliclazide.,increase,risk
Sulfamethoxazole,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Glipizide,The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Glipizide.,increase,risk
Sulfamethoxazole,Gliquidone,The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Gliquidone.,increase,risk
Sulfamethoxazole,Glofitamab,The serum concentration of Sulfamethoxazole can be increased when it is combined with Glofitamab.,increase,no risk
Sulfamethoxazole,Glyburide,Glyburide may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Glycerol phenylbutyrate,Sulfamethoxazole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Glycyrrhizic acid,Sulfamethoxazole may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Glymidine,The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Glymidine.,increase,risk
Sulfamethoxazole,Golimumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Golimumab.,increase,risk
Sulfamethoxazole,Golodirsen,Sulfamethoxazole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Goserelin,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Goserelin.,decrease,no risk
Sulfamethoxazole,Granisetron,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Granisetron.,increase,risk
Sulfamethoxazole,Grepafloxacin,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Grepafloxacin.,increase,no risk
Sulfamethoxazole,Guanethidine,Sulfamethoxazole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Guanfacine,Sulfamethoxazole may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Guselkumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Guselkumab.,increase,risk
Sulfamethoxazole,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Halofantrine,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Halofantrine.,increase,risk
Sulfamethoxazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Haloperidol.,increase,risk
Sulfamethoxazole,Halothane,The metabolism of Halothane can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Heparin,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Heparin.,increase,risk
Sulfamethoxazole,Histrelin,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Histrelin.,decrease,no risk
Sulfamethoxazole,Hydralazine,Sulfamethoxazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Hydrochlorothiazide,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Sulfamethoxazole,Hydrocortisone,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Hydrocortisone.,increase,risk
Sulfamethoxazole,Hydrocortisone acetate,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Hydrocortisone acetate.,increase,risk
Sulfamethoxazole,Hydrocortisone butyrate,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Hydrocortisone butyrate.,increase,risk
Sulfamethoxazole,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Hydrocortisone succinate,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Hydrocortisone succinate.,increase,risk
Sulfamethoxazole,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Hydroflumethiazide,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Sulfamethoxazole,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Hydroxychloroquine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Hydroxychloroquine.,increase,risk
Sulfamethoxazole,Hydroxyethyl Starch,Sulfamethoxazole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Hydroxyprogesterone caproate,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Sulfamethoxazole,Hydroxyurea,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Hydroxyurea.,increase,risk
Sulfamethoxazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Hydroxyzine.,increase,risk
Sulfamethoxazole,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Kanamycin,Sulfamethoxazole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Ketazolam,Sulfamethoxazole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Ketoconazole,Ketoconazole may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Obinutuzumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Obinutuzumab.,increase,risk
Sulfamethoxazole,Ocrelizumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Ocrelizumab.,increase,risk
Sulfamethoxazole,Octinoxate,Sulfamethoxazole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Octreotide,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Octreotide.,decrease,no risk
Sulfamethoxazole,Ofatumumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Ofatumumab.,increase,risk
Sulfamethoxazole,Ofloxacin,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Ofloxacin.,increase,no risk
Sulfamethoxazole,Olanzapine,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Olanzapine.,decrease,no risk
Sulfamethoxazole,Olaparib,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Olaparib.,increase,risk
Sulfamethoxazole,Olmesartan,Olmesartan may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Olsalazine,Olsalazine may increase the hypoglycemic activities of Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Opium,Sulfamethoxazole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Oritavancin,The metabolism of Sulfamethoxazole can be decreased when combined with Oritavancin.,decrease,no risk
Sulfamethoxazole,Orphenadrine,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Orphenadrine.,increase,risk
Sulfamethoxazole,Oseltamivir,Oseltamivir may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Oxacillin,Oxacillin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Oxaliplatin,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Oxaliplatin.,increase,risk
Sulfamethoxazole,Oxandrolone,The metabolism of Sulfamethoxazole can be decreased when combined with Oxandrolone.,decrease,no risk
Sulfamethoxazole,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Oxatomide,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Oxatomide.,increase,risk
Sulfamethoxazole,Oxazepam,Oxazepam may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Oxetacaine.,increase,risk
Sulfamethoxazole,Oxprenolol,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Oxprenolol.,increase,no risk
Sulfamethoxazole,Oxybenzone,Sulfamethoxazole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Oxybuprocaine.,increase,risk
Sulfamethoxazole,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Oxyphenbutazone.,increase,risk
Sulfamethoxazole,Oxyquinoline,Sulfamethoxazole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Ozanimod,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Ozanimod.,increase,risk
Sulfamethoxazole,Quetiapine,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Quetiapine.,decrease,no risk
Sulfamethoxazole,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Quinethazone,The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Quinethazone.,decrease,no risk
Sulfamethoxazole,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Quizartinib,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Quizartinib.,increase,risk
Sulfamethoxazole,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Ublituximab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Ublituximab.,increase,risk
Sulfamethoxazole,Udenafil,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Udenafil.,increase,no risk
Sulfamethoxazole,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Upadacitinib,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Upadacitinib.,increase,risk
Sulfamethoxazole,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Vaborbactam,Sulfamethoxazole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Vadadustat,The metabolism of Sulfamethoxazole can be decreased when combined with Vadadustat.,decrease,no risk
Sulfamethoxazole,Valaciclovir,Valaciclovir may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Valbenazine,Sulfamethoxazole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Valdecoxib,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Valdecoxib.,increase,no risk
Sulfamethoxazole,Valganciclovir,Sulfamethoxazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Valproic acid,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Valproic acid.,increase,risk
Sulfamethoxazole,Valsartan,The metabolism of Sulfamethoxazole can be decreased when combined with Valsartan.,decrease,no risk
Sulfamethoxazole,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Vancomycin,Sulfamethoxazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Varenicline,Sulfamethoxazole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Vedolizumab,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vedolizumab.,increase,risk
Sulfamethoxazole,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Vernakalant,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Vernakalant.,increase,risk
Sulfamethoxazole,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Vilanterol,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vilanterol.,increase,risk
Sulfamethoxazole,Vildagliptin,The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Vildagliptin.,increase,risk
Sulfamethoxazole,Viloxazine,Sulfamethoxazole may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Vinblastine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vinblastine.,increase,risk
Sulfamethoxazole,Vincristine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vincristine.,increase,risk
Sulfamethoxazole,Vindesine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vindesine.,increase,risk
Sulfamethoxazole,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Vinorelbine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vinorelbine.,increase,risk
Sulfamethoxazole,Voclosporin,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Voclosporin.,increase,risk
Sulfamethoxazole,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Vorinostat,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Vorinostat.,increase,risk
Sulfamethoxazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Zafirlukast,The metabolism of Sulfamethoxazole can be decreased when combined with Zafirlukast.,decrease,no risk
Sulfamethoxazole,Zaleplon,Zaleplon may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Zanamivir,Zanamivir may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,decrease,no risk
Sulfamethoxazole,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Sulfamethoxazole.,increase,no risk
Sulfamethoxazole,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Zidovudine,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Zidovudine.,increase,risk
Sulfamethoxazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Sulfamethoxazole.,increase,risk
Sulfamethoxazole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Ziprasidone.,increase,risk
Sulfamethoxazole,Zofenopril,The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Zofenopril.,increase,risk
Sulfamethoxazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Sulfamethoxazole,Zonisamide,The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Zonisamide.,increase,no risk
Sulfamethoxazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sulfamethoxazole.,decrease,no risk
Glyburide,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Bimekizumab,The metabolism of Glyburide can be increased when combined with Bimekizumab.,increase,no risk
Glyburide,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Glyburide.,increase,no risk
Glyburide,Bisoprolol,The therapeutic efficacy of Glyburide can be increased when used in combination with Bisoprolol.,increase,no risk
Glyburide,Boceprevir,The metabolism of Glyburide can be decreased when combined with Boceprevir.,decrease,no risk
Glyburide,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Bosentan,Glyburide may increase the hepatotoxic activities of Bosentan.,increase,no risk
Glyburide,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Brexpiprazole,The therapeutic efficacy of Glyburide can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Glyburide,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Bromocriptine,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Bromocriptine.,increase,risk
Glyburide,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Glyburide.,increase,risk
Glyburide,Bumadizone,The protein binding of Glyburide can be decreased when combined with Bumadizone.,decrease,no risk
Glyburide,Bumetanide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Bumetanide.,decrease,no risk
Glyburide,Buprenorphine,Buprenorphine may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Bupropion,The metabolism of Bupropion can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Buserelin,The therapeutic efficacy of Glyburide can be decreased when used in combination with Buserelin.,decrease,no risk
Glyburide,Buspirone,The metabolism of Glyburide can be decreased when combined with Buspirone.,decrease,no risk
Glyburide,Busulfan,The metabolism of Busulfan can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Butaperazine,The therapeutic efficacy of Glyburide can be decreased when used in combination with Butaperazine.,decrease,no risk
Glyburide,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Glyburide,Gatifloxacin,The therapeutic efficacy of Glyburide can be increased when used in combination with Gatifloxacin.,increase,no risk
Glyburide,Gefapixant,The therapeutic efficacy of Glyburide can be increased when used in combination with Gefapixant.,increase,no risk
Glyburide,Gefitinib,Gefitinib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Gemfibrozil,The metabolism of Glyburide can be decreased when combined with Gemfibrozil.,decrease,no risk
Glyburide,Gemifloxacin,The therapeutic efficacy of Glyburide can be increased when used in combination with Gemifloxacin.,increase,no risk
Glyburide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Glyburide.,increase,no risk
Glyburide,Gestrinone,The therapeutic efficacy of Glyburide can be decreased when used in combination with Gestrinone.,decrease,no risk
Glyburide,Gilteritinib,Gilteritinib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Ginkgo biloba,The metabolism of Glyburide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Glyburide,Glasdegib,Glasdegib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Glecaprevir,Glecaprevir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Gliclazide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Gliclazide.,increase,risk
Glyburide,Glimepiride,Glyburide may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Glyburide,Glipizide,Glyburide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Glyburide,Gliquidone,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Gliquidone.,increase,risk
Glyburide,Glofitamab,The serum concentration of Glyburide can be increased when it is combined with Glofitamab.,increase,no risk
Glyburide,Glycol salicylate,The protein binding of Glyburide can be decreased when combined with Glycol salicylate.,decrease,no risk
Glyburide,Glycyrrhizic acid,Glyburide may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Glyburide,Glymidine,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Glymidine.,increase,risk
Glyburide,Golimumab,The metabolism of Glyburide can be increased when combined with Golimumab.,increase,no risk
Glyburide,Goserelin,The therapeutic efficacy of Glyburide can be decreased when used in combination with Goserelin.,decrease,no risk
Glyburide,Grazoprevir,Grazoprevir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Grepafloxacin,The therapeutic efficacy of Glyburide can be increased when used in combination with Grepafloxacin.,increase,no risk
Glyburide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Glyburide.,increase,risk
Glyburide,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Glyburide.,increase,no risk
Glyburide,Halothane,The metabolism of Halothane can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Histrelin,The therapeutic efficacy of Glyburide can be decreased when used in combination with Histrelin.,decrease,no risk
Glyburide,Hydrochlorothiazide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Glyburide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Glyburide.,increase,risk
Glyburide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Glyburide.,increase,risk
Glyburide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glyburide.,increase,risk
Glyburide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Glyburide.,increase,risk
Glyburide,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Glyburide.,increase,risk
Glyburide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Glyburide.,increase,risk
Glyburide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glyburide.,increase,risk
Glyburide,Hydroflumethiazide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Glyburide,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Hydroxyamphetamine,The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroxyamphetamine.,decrease,no risk
Glyburide,Hydroxychloroquine,The therapeutic efficacy of Glyburide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Glyburide,Hydroxyprogesterone caproate,The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Glyburide,Hydroxyzine,The metabolism of Glyburide can be decreased when combined with Hydroxyzine.,decrease,no risk
Glyburide,Ketamine,The metabolism of Ketamine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Ketoconazole,The metabolism of Glyburide can be decreased when combined with Ketoconazole.,decrease,no risk
Glyburide,Ketoprofen,The protein binding of Glyburide can be decreased when combined with Ketoprofen.,decrease,no risk
Glyburide,Ketorolac,The protein binding of Glyburide can be decreased when combined with Ketorolac.,decrease,no risk
Glyburide,Ketotifen,The risk or severity of thrombocytopenia can be increased when Glyburide is combined with Ketotifen.,increase,risk
Glyburide,Obeticholic acid,The risk or severity of adverse effects can be increased when Glyburide is combined with Obeticholic acid.,increase,risk
Glyburide,Octreotide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Octreotide.,decrease,no risk
Glyburide,Ofloxacin,Glyburide may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Glyburide,Olanzapine,The therapeutic efficacy of Glyburide can be decreased when used in combination with Olanzapine.,decrease,no risk
Glyburide,Olaparib,The metabolism of Olaparib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Olmesartan,Olmesartan may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Glyburide.,increase,no risk
Glyburide,Omaveloxolone,The serum concentration of Glyburide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Glyburide,Omeprazole,The metabolism of Glyburide can be decreased when combined with Omeprazole.,decrease,no risk
Glyburide,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Orciprenaline,The therapeutic efficacy of Glyburide can be decreased when used in combination with Orciprenaline.,decrease,no risk
Glyburide,Oritavancin,The metabolism of Glyburide can be decreased when combined with Oritavancin.,decrease,no risk
Glyburide,Osilodrostat,The metabolism of Glyburide can be decreased when combined with Osilodrostat.,decrease,no risk
Glyburide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Oteseconazole,The serum concentration of Glyburide can be increased when it is combined with Oteseconazole.,increase,no risk
Glyburide,Oxandrolone,The metabolism of Glyburide can be decreased when combined with Oxandrolone.,decrease,no risk
Glyburide,Oxaprozin,The protein binding of Glyburide can be decreased when combined with Oxaprozin.,decrease,no risk
Glyburide,Oxcarbazepine,The metabolism of Glyburide can be increased when combined with Oxcarbazepine.,increase,no risk
Glyburide,Oxprenolol,The therapeutic efficacy of Glyburide can be increased when used in combination with Oxprenolol.,increase,no risk
Glyburide,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Oxycodone,The metabolism of Glyburide can be decreased when combined with Oxycodone.,decrease,no risk
Glyburide,Oxymetazoline,The therapeutic efficacy of Glyburide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Glyburide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Glyburide.,increase,no risk
Glyburide,Oxyphenbutazone,The protein binding of Glyburide can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Glyburide,Quetiapine,The therapeutic efficacy of Glyburide can be decreased when used in combination with Quetiapine.,decrease,no risk
Glyburide,Quinestrol,The therapeutic efficacy of Glyburide can be decreased when used in combination with Quinestrol.,decrease,no risk
Glyburide,Quinethazone,The therapeutic efficacy of Glyburide can be decreased when used in combination with Quinethazone.,decrease,no risk
Glyburide,Quinidine,The metabolism of Quinidine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Glyburide.,increase,risk
Glyburide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Glyburide,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Glyburide.,increase,risk
Glyburide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Glyburide.,increase,no risk
Glyburide,Udenafil,The therapeutic efficacy of Glyburide can be increased when used in combination with Udenafil.,increase,no risk
Glyburide,Ulipristal,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ulipristal.,decrease,no risk
Glyburide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glyburide.,increase,risk
Glyburide,Ursodeoxycholic acid,Glyburide may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Glyburide,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Glyburide.,increase,no risk
Glyburide,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Valdecoxib,The protein binding of Glyburide can be decreased when combined with Valdecoxib.,decrease,no risk
Glyburide,Valproic acid,The metabolism of Glyburide can be decreased when combined with Valproic acid.,decrease,no risk
Glyburide,Valsartan,The metabolism of Glyburide can be decreased when combined with Valsartan.,decrease,no risk
Glyburide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Glyburide.,increase,risk
Glyburide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Velpatasvir,Velpatasvir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Glyburide.,increase,risk
Glyburide,Verapamil,The metabolism of Glyburide can be decreased when combined with Verapamil.,decrease,no risk
Glyburide,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Vildagliptin,Vildagliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Glyburide,Viloxazine,The metabolism of Glyburide can be decreased when combined with Viloxazine.,decrease,no risk
Glyburide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Vincristine,The metabolism of Vincristine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Vindesine,The metabolism of Vindesine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Vismodegib,Vismodegib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Vonoprazan,The metabolism of Glyburide can be decreased when combined with Vonoprazan.,decrease,no risk
Glyburide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Voriconazole,The serum concentration of Glyburide can be increased when it is combined with Voriconazole.,increase,no risk
Glyburide,Vorinostat,The therapeutic efficacy of Glyburide can be decreased when used in combination with Vorinostat.,decrease,no risk
Glyburide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Glyburide.,increase,no risk
Glyburide,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Glyburide,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Glyburide.,increase,no risk
Glyburide,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Glyburide.,increase,risk
Glyburide,Zafirlukast,The metabolism of Glyburide can be decreased when combined with Zafirlukast.,decrease,no risk
Glyburide,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Zaleplon,The metabolism of Glyburide can be decreased when combined with Zaleplon.,decrease,no risk
Glyburide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Glyburide.,increase,risk
Glyburide,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Zileuton,The metabolism of Zileuton can be decreased when combined with Glyburide.,decrease,no risk
Glyburide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Glyburide.,increase,risk
Glyburide,Ziprasidone,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Glyburide,Zolpidem,The metabolism of Glyburide can be decreased when combined with Zolpidem.,decrease,no risk
Glyburide,Zonisamide,The therapeutic efficacy of Glyburide can be increased when used in combination with Zonisamide.,increase,no risk
Glyburide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Glyburide.,decrease,no risk
Minocycline,Gabapentin,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Minocycline,Gabapentin enacarbil,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Minocycline,Gallamine triethiodide,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Gallamine triethiodide.,increase,no risk
Minocycline,Ganaxolone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ganaxolone.,increase,no risk
Minocycline,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Minocycline.",increase,risk
Minocycline,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Gemfibrozil.",increase,risk
Minocycline,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Minocycline.,increase,risk
Minocycline,Gepirone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Gepirone.,increase,no risk
Minocycline,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Minocycline.,decrease,no risk
Minocycline,Glutethimide,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Minocycline,Granisetron,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Minocycline,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Guanfacine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Minocycline,Halazepam,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Minocycline,Haloperidol,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Haloperidol.,increase,no risk
Minocycline,Halothane,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Minocycline,Hetacillin,The therapeutic efficacy of Hetacillin can be decreased when used in combination with Minocycline.,decrease,no risk
Minocycline,Hexafluronium,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Minocycline,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Hydrocodone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Minocycline,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Hydromorphone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Minocycline,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Minocycline.,decrease,no risk
Minocycline,Hydroxyzine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Hydroxyzine.,increase,no risk
Minocycline,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Kanamycin.,increase,risk
Minocycline,Ketamine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Minocycline,Ketazolam,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,increase,no risk
Minocycline,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Ofloxacin.",increase,risk
Minocycline,Olanzapine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Minocycline,Oliceridine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oliceridine.,increase,no risk
Minocycline,Ondansetron,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Minocycline,Opium,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Minocycline,Orphenadrine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Minocycline,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Oxacillin,The therapeutic efficacy of Oxacillin can be decreased when used in combination with Minocycline.,decrease,no risk
Minocycline,Oxazepam,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Minocycline,Oxcarbazepine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.,increase,no risk
Minocycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Minocycline is combined with Oxetacaine.,increase,risk
Minocycline,Oxitriptan,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Minocycline,Oxprenolol,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.,increase,no risk
Minocycline,Oxybuprocaine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Minocycline,Oxycodone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Minocycline,Oxymorphone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Minocycline,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Quazepam,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Quazepam.,increase,no risk
Minocycline,Quetiapine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Minocycline,Quinapril,Quinapril can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Quinidine,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Minocycline.,increase,risk
Minocycline,Quinine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Quinine.,increase,no risk
Minocycline,Quinupramine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.,increase,no risk
Minocycline,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Ubidecarenone.",increase,risk
Minocycline,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Minocycline.,decrease,no risk
Minocycline,Urethane,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Minocycline,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Minocycline.,increase,no risk
Minocycline,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Valproic acid,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.,increase,no risk
Minocycline,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Minocycline.,increase,risk
Minocycline,Vecuronium,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Minocycline,Venlafaxine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Minocycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Minocycline.,decrease,no risk
Minocycline,Vigabatrin,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,increase,no risk
Minocycline,Vilazodone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Minocycline,Viloxazine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.,increase,no risk
Minocycline,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Minocycline.",increase,risk
Minocycline,Viomycin,The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Viomycin.,increase,risk
Minocycline,Vitamin A,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Minocycline.,increase,risk
Minocycline,Vortioxetine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Minocycline,Warfarin,Minocycline may increase the anticoagulant activities of Warfarin.,increase,no risk
Minocycline,Yohimbine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Minocycline,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Zaleplon,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Minocycline,Ziconotide,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.,increase,no risk
Minocycline,Zidovudine,The excretion of Zidovudine can be decreased when combined with Minocycline.,decrease,no risk
Minocycline,Zimelidine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Minocycline,Zinc,Zinc can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Minocycline,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Minocycline,Ziprasidone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ziprasidone.,increase,no risk
Minocycline,Zolmitriptan,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.,increase,no risk
Minocycline,Zolpidem,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Minocycline,Zonisamide,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Minocycline,Zopiclone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Minocycline,Zotepine,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zotepine.,increase,no risk
Minocycline,Zuclopenthixol,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Minocycline,Zuranolone,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zuranolone.,increase,no risk
Guanfacine,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Guanfacine.,increase,risk
Guanfacine,Benzthiazide,The therapeutic efficacy of Guanfacine can be increased when used in combination with Benzthiazide.,increase,no risk
Guanfacine,Benzydamine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Benzydamine.,decrease,no risk
Guanfacine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Guanfacine is combined with Benzyl alcohol.,increase,risk
Guanfacine,Benzylpenicilloyl polylysine,Guanfacine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Guanfacine,Bepotastine,Guanfacine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Guanfacine,Bepridil,Guanfacine may decrease the antihypertensive activities of Bepridil.,decrease,no risk
Guanfacine,Beractant,Guanfacine may increase the bradycardic activities of Beractant.,increase,no risk
Guanfacine,Berotralstat,The metabolism of Guanfacine can be decreased when combined with Berotralstat.,decrease,no risk
Guanfacine,Betaxolol,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Betaxolol.,decrease,no risk
Guanfacine,Bethanidine,Bethanidine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Guanfacine,Bicisate,Guanfacine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Guanfacine,Bimatoprost,Bimatoprost may increase the hypotensive activities of Guanfacine.,increase,no risk
Guanfacine,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Guanfacine.,increase,risk
Guanfacine,Bismuth subgallate,Guanfacine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Guanfacine,Bisoprolol,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bisoprolol.,decrease,no risk
Guanfacine,Bisoxatin,Guanfacine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Guanfacine,Bleomycin,Bleomycin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Boceprevir,The metabolism of Guanfacine can be decreased when combined with Boceprevir.,decrease,no risk
Guanfacine,Bosentan,Guanfacine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Guanfacine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Guanfacine.,increase,risk
Guanfacine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Guanfacine.,increase,risk
Guanfacine,Bretylium,Guanfacine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Guanfacine,Brexanolone,The risk or severity of CNS depression can be increased when Guanfacine is combined with Brexanolone.,increase,risk
Guanfacine,Brexpiprazole,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Guanfacine,Brimonidine,Brimonidine may increase the antihypertensive activities of Guanfacine.,increase,no risk
Guanfacine,Brivaracetam,The risk or severity of CNS depression can be increased when Guanfacine is combined with Brivaracetam.,increase,risk
Guanfacine,Bromazepam,The risk or severity of CNS depression can be increased when Guanfacine is combined with Bromazepam.,increase,risk
Guanfacine,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Guanfacine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanfacine,Bromperidol,The risk or severity of CNS depression can be increased when Guanfacine is combined with Bromperidol.,increase,risk
Guanfacine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Guanfacine.,increase,risk
Guanfacine,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Guanfacine.,increase,risk
Guanfacine,Budesonide,Guanfacine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Guanfacine,Bumadizone,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bumadizone.,decrease,no risk
Guanfacine,Bumetanide,Bumetanide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanfacine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Guanfacine.,increase,risk
Guanfacine,Buprenorphine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Guanfacine,Bupropion,The risk or severity of CNS depression can be increased when Guanfacine is combined with Bupropion.,increase,risk
Guanfacine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Guanfacine.,increase,risk
Guanfacine,Butabarbital,Butabarbital may increase the hypotensive activities of Guanfacine.,increase,no risk
Guanfacine,Butalbital,Butalbital may increase the hypotensive activities of Guanfacine.,increase,no risk
Guanfacine,Butaperazine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Butaperazine.,increase,risk
Guanfacine,Butobarbital,The risk or severity of CNS depression can be increased when Guanfacine is combined with Butobarbital.,increase,risk
Guanfacine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Guanfacine.,increase,risk
Guanfacine,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Guanfacine.,increase,risk
Guanfacine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Butylscopolamine.,increase,risk
Guanfacine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Guanfacine.,increase,risk
Guanfacine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Guanfacine is combined with Gabapentin enacarbil.,increase,risk
Guanfacine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Gadodiamide,Gadodiamide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Gadofosveset trisodium,Guanfacine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Guanfacine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Gadoteric acid,Guanfacine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Guanfacine,Gadoteridol,Gadoteridol may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Galantamine,Galantamine may increase the bradycardic activities of Guanfacine.,increase,no risk
Guanfacine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Guanfacine.,increase,risk
Guanfacine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Guanfacine is combined with Ganaxolone.",increase,risk
Guanfacine,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Guanfacine.,increase,risk
Guanfacine,Gemcitabine,Gemcitabine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Gemfibrozil,Guanfacine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Guanfacine,Gentamicin,Guanfacine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Guanfacine,Gepirone,The risk or severity of CNS depression can be increased when Guanfacine is combined with Gepirone.,increase,risk
Guanfacine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Guanfacine.,increase,risk
Guanfacine,Gimeracil,Guanfacine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Guanfacine,Givosiran,Givosiran may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Glipizide,Guanfacine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Guanfacine,Glofitamab,The serum concentration of Guanfacine can be increased when it is combined with Glofitamab.,increase,no risk
Guanfacine,Glutethimide,The risk or severity of CNS depression can be increased when Guanfacine is combined with Glutethimide.,increase,risk
Guanfacine,Glycerol phenylbutyrate,Guanfacine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Guanfacine,Glycol salicylate,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Guanfacine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Guanfacine.,increase,risk
Guanfacine,Golodirsen,Guanfacine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Guanfacine,Goserelin,Goserelin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Guanfacine.,increase,risk
Guanfacine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Guanfacine,Guanadrel,Guanfacine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Guanfacine,Guanethidine,Guanfacine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanfacine,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Guanfacine.,increase,risk
Guanfacine,Guanoxan,Guanfacine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Guanfacine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Guanfacine.,increase,risk
Guanfacine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Guanfacine.,increase,risk
Guanfacine,Halothane,The risk or severity of CNS depression can be increased when Guanfacine is combined with Halothane.,increase,risk
Guanfacine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Guanfacine.,increase,risk
Guanfacine,Hexocyclium,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Hexocyclium.,increase,risk
Guanfacine,Histamine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Histamine.,increase,risk
Guanfacine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Guanfacine.,increase,risk
Guanfacine,Hydralazine,Guanfacine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Guanfacine,Hydrochlorothiazide,The therapeutic efficacy of Guanfacine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Guanfacine,Hydrocodone,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Guanfacine,Hydroflumethiazide,The therapeutic efficacy of Guanfacine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Guanfacine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Guanfacine.,increase,risk
Guanfacine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Hydroxyethyl Starch,Guanfacine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Guanfacine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Guanfacine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Guanfacine.,increase,risk
Guanfacine,Kanamycin,Guanfacine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Guanfacine,Ketamine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ketamine.,increase,risk
Guanfacine,Ketazolam,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ketazolam.,increase,risk
Guanfacine,Ketoconazole,The metabolism of Guanfacine can be decreased when combined with Ketoconazole.,decrease,no risk
Guanfacine,Ketoprofen,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Guanfacine,Ketorolac,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Ketorolac.,decrease,no risk
Guanfacine,Obinutuzumab,Guanfacine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Guanfacine,Octinoxate,Guanfacine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Guanfacine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Guanfacine.,increase,no risk
Guanfacine,Olanzapine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Olanzapine.,decrease,no risk
Guanfacine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Guanfacine is combined with Oliceridine.",increase,risk
Guanfacine,Olmesartan,Guanfacine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Guanfacine,Olodaterol,Olodaterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Guanfacine,Olsalazine,Olsalazine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Omaveloxolone,The serum concentration of Guanfacine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Guanfacine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Guanfacine.,increase,risk
Guanfacine,Opicapone,The risk or severity of adverse effects can be increased when Guanfacine is combined with Opicapone.,increase,risk
Guanfacine,Opium,The risk or severity of CNS depression can be increased when Guanfacine is combined with Opium.,increase,risk
Guanfacine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Guanfacine,Orphenadrine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Guanfacine,Oseltamivir,Oseltamivir may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Oxacillin,Oxacillin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Oxaprozin,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Guanfacine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Guanfacine.,increase,risk
Guanfacine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Guanfacine.,increase,risk
Guanfacine,Oxitriptan,The risk or severity of CNS depression can be increased when Guanfacine is combined with Oxitriptan.,increase,risk
Guanfacine,Oxprenolol,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Guanfacine,Oxybenzone,Guanfacine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Guanfacine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Guanfacine.,increase,risk
Guanfacine,Oxybutynin,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Oxybutynin.,increase,risk
Guanfacine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Guanfacine.,increase,risk
Guanfacine,Oxymetazoline,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Guanfacine,Oxymorphone,The risk or severity of CNS depression can be increased when Guanfacine is combined with Oxymorphone.,increase,risk
Guanfacine,Oxyphenbutazone,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Guanfacine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Guanfacine.,increase,risk
Guanfacine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Guanfacine.,increase,risk
Guanfacine,Oxyquinoline,Guanfacine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Guanfacine,Quazepam,The risk or severity of CNS depression can be increased when Guanfacine is combined with Quazepam.,increase,risk
Guanfacine,Quetiapine,Quetiapine may increase the hypotensive activities of Guanfacine.,increase,no risk
Guanfacine,Quinapril,Guanfacine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Guanfacine,Quinethazone,Quinethazone may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanfacine,Quinidine,Guanfacine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Guanfacine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Guanfacine.,increase,risk
Guanfacine,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Guanfacine.,increase,risk
Guanfacine,Udenafil,Udenafil may increase the antihypertensive activities of Guanfacine.,increase,no risk
Guanfacine,Umeclidinium,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Umeclidinium.,increase,risk
Guanfacine,Unoprostone,Guanfacine may increase the hypotensive activities of Unoprostone.,increase,no risk
Guanfacine,Urethane,The risk or severity of CNS depression can be increased when Guanfacine is combined with Urethane.,increase,risk
Guanfacine,Vaborbactam,Guanfacine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Guanfacine,Vadadustat,The serum concentration of Guanfacine can be increased when it is combined with Vadadustat.,increase,no risk
Guanfacine,Valaciclovir,Valaciclovir may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Valbenazine,Guanfacine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Guanfacine,Valdecoxib,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Valdecoxib.,decrease,no risk
Guanfacine,Valganciclovir,Guanfacine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Guanfacine,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Guanfacine.,increase,no risk
Guanfacine,Valsartan,Guanfacine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Guanfacine,Vancomycin,Guanfacine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Guanfacine,Vardenafil,Vardenafil may increase the antihypertensive activities of Guanfacine.,increase,no risk
Guanfacine,Varenicline,Guanfacine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Guanfacine,Vecuronium,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vecuronium.,increase,risk
Guanfacine,Venetoclax,The metabolism of Guanfacine can be decreased when combined with Venetoclax.,decrease,no risk
Guanfacine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Guanfacine.,increase,no risk
Guanfacine,Verapamil,The metabolism of Guanfacine can be decreased when combined with Verapamil.,decrease,no risk
Guanfacine,Vericiguat,The risk or severity of adverse effects can be increased when Guanfacine is combined with Vericiguat.,increase,risk
Guanfacine,Vigabatrin,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vigabatrin.,increase,risk
Guanfacine,Vilanterol,Vilanterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Guanfacine,Vilazodone,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vilazodone.,increase,risk
Guanfacine,Viloxazine,The metabolism of Guanfacine can be decreased when combined with Viloxazine.,decrease,no risk
Guanfacine,Voriconazole,The metabolism of Guanfacine can be decreased when combined with Voriconazole.,decrease,no risk
Guanfacine,Vortioxetine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vortioxetine.,increase,risk
Guanfacine,Warfarin,Guanfacine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Guanfacine,Xamoterol,Xamoterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Guanfacine,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Guanfacine,Yohimbine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Yohimbine.,increase,risk
Guanfacine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Guanfacine.,increase,risk
Guanfacine,Zanamivir,Zanamivir may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Guanfacine,Ziconotide,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ziconotide.,increase,risk
Guanfacine,Zimelidine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Zimelidine.,increase,risk
Guanfacine,Ziprasidone,The risk or severity of adverse effects can be increased when Guanfacine is combined with Ziprasidone.,increase,risk
Guanfacine,Zofenopril,Guanfacine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Guanfacine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Guanfacine.,increase,risk
Guanfacine,Zolpidem,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Guanfacine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Guanfacine.,increase,risk
Guanfacine,Zopiclone,The risk or severity of adverse effects can be increased when Guanfacine is combined with Zopiclone.,increase,risk
Guanfacine,Zotepine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Zotepine.,increase,risk
Guanfacine,Zuclopenthixol,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Guanfacine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Guanfacine.,increase,risk
Bethanechol,Betaine,The risk or severity of adverse effects can be increased when Betaine is combined with Bethanechol.,increase,risk
Bethanechol,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Bethanechol.,increase,risk
Bethanechol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bethanechol.,increase,risk
Bethanechol,Botulinum toxin type A,The risk or severity of hypotension can be increased when Botulinum toxin type A is combined with Bethanechol.,increase,risk
Bethanechol,Botulinum toxin type B,The risk or severity of hypotension can be increased when Botulinum toxin type B is combined with Bethanechol.,increase,risk
Bethanechol,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Bethanechol.,increase,risk
Bethanechol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Bethanechol.,increase,risk
Bethanechol,Gentamicin,The therapeutic efficacy of Bethanechol can be decreased when used in combination with Gentamicin.,decrease,no risk
Bethanechol,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Bethanechol.,increase,risk
Bethanechol,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Bethanechol.,increase,risk
Bethanechol,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Bethanechol.,increase,risk
Bethanechol,Kanamycin,The therapeutic efficacy of Bethanechol can be decreased when used in combination with Kanamycin.,decrease,no risk
Bethanechol,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Bethanechol.,increase,risk
Bethanechol,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Bethanechol.,increase,risk
Isosorbide mononitrate,Buspirone,Buspirone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Butabarbital,Butabarbital may increase the hypotensive activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Butalbital,Butalbital may increase the hypotensive activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Gabapentin enacarbil,Isosorbide mononitrate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gadodiamide,Gadodiamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gadofosveset trisodium,Isosorbide mononitrate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gadoteric acid,Isosorbide mononitrate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gadoteridol,Gadoteridol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Ganciclovir,Ganciclovir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gemcitabine,Gemcitabine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gemfibrozil,Isosorbide mononitrate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gentamicin,Isosorbide mononitrate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Gimeracil,Isosorbide mononitrate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Givosiran,Givosiran may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Glipizide,Isosorbide mononitrate may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Glycerol phenylbutyrate,Isosorbide mononitrate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Golodirsen,Isosorbide mononitrate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Goserelin,Goserelin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Guanabenz,Isosorbide mononitrate may increase the hypotensive activities of Guanabenz.,increase,no risk
Isosorbide mononitrate,Guanadrel,Isosorbide mononitrate may increase the hypotensive activities of Guanadrel.,increase,no risk
Isosorbide mononitrate,Guanethidine,Isosorbide mononitrate may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Guanoxan,Isosorbide mononitrate may increase the hypotensive activities of Guanoxan.,increase,no risk
Isosorbide mononitrate,Haloperidol,Haloperidol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Halothane,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Halothane.,increase,risk
Isosorbide mononitrate,Hexobendine,Hexobendine may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Hydralazine,Hydralazine may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide mononitrate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide mononitrate,Hydromorphone,Hydromorphone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Hydroxyethyl Starch,Isosorbide mononitrate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Kanamycin,Isosorbide mononitrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Ketamine,Ketamine may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Ketazolam,Isosorbide mononitrate may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Ketoprofen,Ketoprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Ketorolac,Ketorolac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Obinutuzumab,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Obinutuzumab.,increase,risk
Isosorbide mononitrate,Octinoxate,Isosorbide mononitrate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Olsalazine,Olsalazine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Opicapone,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Opicapone.,increase,risk
Isosorbide mononitrate,Opium,Isosorbide mononitrate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Oseltamivir,Oseltamivir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Oxacillin,Oxacillin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Oxaprozin,Oxaprozin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Oxazepam,Oxazepam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Oxprenolol,Oxprenolol may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Oxybenzone,Isosorbide mononitrate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Oxyquinoline,Isosorbide mononitrate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Quetiapine,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Quetiapine.,increase,risk
Isosorbide mononitrate,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Quinethazone,Quinethazone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide mononitrate,Quinidine,Isosorbide mononitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Udenafil,Udenafil may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Vaborbactam,Isosorbide mononitrate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Valaciclovir,Valaciclovir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Valbenazine,Isosorbide mononitrate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Valdecoxib,Valdecoxib may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Valganciclovir,Isosorbide mononitrate may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Isosorbide mononitrate.,increase,risk
Isosorbide mononitrate,Vancomycin,Isosorbide mononitrate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Vardenafil,Vardenafil may increase the hypotensive activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Varenicline,Isosorbide mononitrate may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Venlafaxine,Venlafaxine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Verapamil,Verapamil may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Vericiguat,The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Vericiguat.,increase,risk
Isosorbide mononitrate,Vilanterol,Isosorbide mononitrate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Viloxazine,Isosorbide mononitrate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Vortioxetine,Isosorbide mononitrate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Warfarin,Isosorbide mononitrate may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Xanthinol,Xanthinol may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Zaleplon,Zaleplon may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Zanamivir,Zanamivir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,decrease,no risk
Isosorbide mononitrate,Zofenopril,Isosorbide mononitrate may increase the hypotensive activities of Zofenopril.,increase,no risk
Isosorbide mononitrate,Zonisamide,Zonisamide may increase the vasodilatory activities of Isosorbide mononitrate.,increase,no risk
Isosorbide mononitrate,Zopiclone,The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Zopiclone.,increase,risk
Trichlormethiazide,Benserazide,Trichlormethiazide may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Benzatropine,Trichlormethiazide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Benzhydrocodone,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Trichlormethiazide,Benziodarone,The therapeutic efficacy of Benziodarone can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Benznidazole,Trichlormethiazide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Benzthiazide,The therapeutic efficacy of Trichlormethiazide can be increased when used in combination with Benzthiazide.,increase,no risk
Trichlormethiazide,Benzydamine,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Benzydamine.,decrease,no risk
Trichlormethiazide,Benzylpenicillin,Trichlormethiazide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Trichlormethiazide,Bepotastine,Trichlormethiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Bepridil,The therapeutic efficacy of Bepridil can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Betamethasone,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Betamethasone phosphate,The risk or severity of electrolyte imbalance can be increased when Betamethasone phosphate is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Betaxolol,The therapeutic efficacy of Betaxolol can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Bethanidine,The therapeutic efficacy of Bethanidine can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Betrixaban,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Bexarotene,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Bexarotene.,increase,risk
Trichlormethiazide,Bicisate,Trichlormethiazide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Biperiden,The serum concentration of Trichlormethiazide can be increased when it is combined with Biperiden.,increase,no risk
Trichlormethiazide,Bisacodyl,The risk or severity of dehydration can be increased when Trichlormethiazide is combined with Bisacodyl.,increase,risk
Trichlormethiazide,Bismuth subgallate,Trichlormethiazide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Bisoprolol,The therapeutic efficacy of Bisoprolol can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Bisoxatin,The risk or severity of dehydration can be increased when Trichlormethiazide is combined with Bisoxatin.,increase,risk
Trichlormethiazide,Bivalirudin,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Bleomycin,Trichlormethiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Blinatumomab,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Blinatumomab.,increase,risk
Trichlormethiazide,Bortezomib,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Bortezomib.,increase,risk
Trichlormethiazide,Bosentan,The therapeutic efficacy of Bosentan can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Bosutinib,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Bosutinib.,increase,risk
Trichlormethiazide,Bretylium,The therapeutic efficacy of Bretylium can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Brimonidine,Brimonidine may increase the antihypertensive activities of Trichlormethiazide.,increase,no risk
Trichlormethiazide,Brivaracetam,Trichlormethiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Bromazepam,Trichlormethiazide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Brompheniramine,The serum concentration of Trichlormethiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Trichlormethiazide,Buclizine,The serum concentration of Trichlormethiazide can be increased when it is combined with Buclizine.,increase,no risk
Trichlormethiazide,Budesonide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Bumadizone,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Bumadizone.,decrease,no risk
Trichlormethiazide,Bumetanide,Trichlormethiazide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Bupivacaine,Bupivacaine may increase the hypotensive activities of Trichlormethiazide.,increase,no risk
Trichlormethiazide,Buprenorphine,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Trichlormethiazide,Bupropion,Trichlormethiazide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Buspirone,Trichlormethiazide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Busulfan,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Busulfan.,increase,risk
Trichlormethiazide,Butabarbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Butalbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Butobarbital,The serum concentration of Trichlormethiazide can be increased when it is combined with Butobarbital.,increase,no risk
Trichlormethiazide,Butorphanol,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Butorphanol.,decrease,no risk
Trichlormethiazide,Butriptyline,Butriptyline may decrease the antihypertensive activities of Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Butylscopolamine,The serum concentration of Trichlormethiazide can be increased when it is combined with Butylscopolamine.,increase,no risk
Trichlormethiazide,Gabapentin enacarbil,Trichlormethiazide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gadobenic acid,Trichlormethiazide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gadodiamide,Trichlormethiazide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gadofosveset trisodium,Trichlormethiazide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gadopentetic acid,Trichlormethiazide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gadoteric acid,Trichlormethiazide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gadoteridol,Trichlormethiazide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gallamine triethiodide,The serum concentration of Trichlormethiazide can be increased when it is combined with Gallamine triethiodide.,increase,no risk
Trichlormethiazide,Ganciclovir,Trichlormethiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gemcitabine,Trichlormethiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gemfibrozil,Trichlormethiazide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gemtuzumab ozogamicin,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Gemtuzumab ozogamicin.,increase,risk
Trichlormethiazide,Gimeracil,Trichlormethiazide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Gluconic Acid,The risk or severity of dehydration can be increased when Trichlormethiazide is combined with Gluconic Acid.,increase,risk
Trichlormethiazide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Glycerin,The risk or severity of dehydration can be increased when Trichlormethiazide is combined with Glycerin.,increase,risk
Trichlormethiazide,Glycerol phenylbutyrate,Trichlormethiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Glycol salicylate,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Trichlormethiazide,Glycopyrronium,The serum concentration of Trichlormethiazide can be increased when it is combined with Glycopyrronium.,increase,no risk
Trichlormethiazide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Golodirsen,Trichlormethiazide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Goserelin,Trichlormethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Guanabenz,The therapeutic efficacy of Guanabenz can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Guanadrel,The therapeutic efficacy of Guanadrel can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Guanethidine,The therapeutic efficacy of Guanethidine can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Guanfacine,The therapeutic efficacy of Guanfacine can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Guanoxan,The therapeutic efficacy of Guanoxan can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Halcinonide,The risk or severity of electrolyte imbalance can be increased when Halcinonide is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Haloperidol,Trichlormethiazide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Halothane,Halothane may decrease the antihypertensive activities of Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Hexafluronium,The serum concentration of Trichlormethiazide can be increased when it is combined with Hexafluronium.,increase,no risk
Trichlormethiazide,Hexocyclium,The serum concentration of Trichlormethiazide can be increased when it is combined with Hexocyclium.,increase,no risk
Trichlormethiazide,Homatropine methylbromide,The serum concentration of Trichlormethiazide can be increased when it is combined with Homatropine methylbromide.,increase,no risk
Trichlormethiazide,Hydralazine,The therapeutic efficacy of Hydralazine can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Hydrochlorothiazide,The therapeutic efficacy of Trichlormethiazide can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Trichlormethiazide,Hydrocodone,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Trichlormethiazide,Hydrocortisone,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Hydrocortisone acetate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone acetate is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Hydrocortisone butyrate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone butyrate is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Hydrocortisone cypionate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone cypionate is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Hydrocortisone probutate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone probutate is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Hydrocortisone succinate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone succinate is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Hydrocortisone valerate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone valerate is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Hydroflumethiazide,The therapeutic efficacy of Trichlormethiazide can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Trichlormethiazide,Hydromorphone,Trichlormethiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Hydroxocobalamin,Trichlormethiazide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Hydroxyethyl Starch,Trichlormethiazide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Hydroxyurea,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Hydroxyurea.,increase,risk
Trichlormethiazide,Hyoscyamine,The serum concentration of Trichlormethiazide can be increased when it is combined with Hyoscyamine.,increase,no risk
Trichlormethiazide,Ketamine,Trichlormethiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Ketazolam,Trichlormethiazide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Ketorolac,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Ketorolac.,decrease,no risk
Trichlormethiazide,Obinutuzumab,Trichlormethiazide may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Trichlormethiazide,Octinoxate,Trichlormethiazide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Olanzapine,The serum concentration of Trichlormethiazide can be increased when it is combined with Olanzapine.,increase,no risk
Trichlormethiazide,Olaparib,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Olaparib.,increase,risk
Trichlormethiazide,Oliceridine,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Oliceridine.,decrease,no risk
Trichlormethiazide,Olmesartan,The therapeutic efficacy of Olmesartan can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Olodaterol,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Opicapone,Opicapone may increase the hypotensive activities of Trichlormethiazide.,increase,no risk
Trichlormethiazide,Opium,Trichlormethiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Orciprenaline,The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Orphenadrine,The serum concentration of Trichlormethiazide can be increased when it is combined with Orphenadrine.,increase,no risk
Trichlormethiazide,Oseltamivir,Trichlormethiazide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Ouabain,Trichlormethiazide may increase the hypokalemic activities of Ouabain.,increase,no risk
Trichlormethiazide,Oxacillin,Trichlormethiazide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Oxaliplatin,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Oxaliplatin.,increase,risk
Trichlormethiazide,Oxaprozin,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Trichlormethiazide,Oxazepam,Trichlormethiazide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Oxcarbazepine,The risk or severity of hyponatremia can be increased when Trichlormethiazide is combined with Oxcarbazepine.,increase,risk
Trichlormethiazide,Oxprenolol,The therapeutic efficacy of Oxprenolol can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Oxybenzone,Trichlormethiazide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Oxybutynin,The serum concentration of Trichlormethiazide can be increased when it is combined with Oxybutynin.,increase,no risk
Trichlormethiazide,Oxycodone,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Oxycodone.,decrease,no risk
Trichlormethiazide,Oxymetazoline,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Trichlormethiazide,Oxymorphone,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Trichlormethiazide,Oxyphenbutazone,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Trichlormethiazide,Oxyphencyclimine,The serum concentration of Trichlormethiazide can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Trichlormethiazide,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Trichlormethiazide is combined with Oxyphenisatin acetate.,increase,risk
Trichlormethiazide,Oxyphenonium,The serum concentration of Trichlormethiazide can be increased when it is combined with Oxyphenonium.,increase,no risk
Trichlormethiazide,Oxyquinoline,Trichlormethiazide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Quetiapine,Quetiapine may increase the hypotensive activities of Trichlormethiazide.,increase,no risk
Trichlormethiazide,Quinapril,The therapeutic efficacy of Quinapril can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Quinidine,Trichlormethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Quinupramine,Quinupramine may decrease the antihypertensive activities of Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Udenafil,Udenafil may increase the antihypertensive activities of Trichlormethiazide.,increase,no risk
Trichlormethiazide,Ulobetasol,The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Umeclidinium,The serum concentration of Trichlormethiazide can be increased when it is combined with Umeclidinium.,increase,no risk
Trichlormethiazide,Unoprostone,The therapeutic efficacy of Unoprostone can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Vaborbactam,Trichlormethiazide may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Valaciclovir,Trichlormethiazide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Valbenazine,Trichlormethiazide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Valdecoxib,The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Valdecoxib.,decrease,no risk
Trichlormethiazide,Valganciclovir,Trichlormethiazide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Valsartan,The therapeutic efficacy of Valsartan can be increased when used in combination with Trichlormethiazide.,increase,no risk
Trichlormethiazide,Vamorolone,The risk or severity of electrolyte imbalance can be increased when Vamorolone is combined with Trichlormethiazide.,increase,risk
Trichlormethiazide,Vancomycin,Trichlormethiazide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Vardenafil,Vardenafil may increase the antihypertensive activities of Trichlormethiazide.,increase,no risk
Trichlormethiazide,Varenicline,Trichlormethiazide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Vecuronium,The serum concentration of Trichlormethiazide can be increased when it is combined with Vecuronium.,increase,no risk
Trichlormethiazide,Venlafaxine,Trichlormethiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Verapamil,Trichlormethiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Vericiguat,Vericiguat may increase the hypotensive activities of Trichlormethiazide.,increase,no risk
Trichlormethiazide,Vilanterol,The risk or severity of hypokalemia can be increased when Trichlormethiazide is combined with Vilanterol.,increase,risk
Trichlormethiazide,Vilazodone,Vilazodone may decrease the antihypertensive activities of Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Trichlormethiazide.,decrease,no risk
Trichlormethiazide,Viloxazine,Trichlormethiazide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trichlormethiazide,Vinblastine,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Vinblastine.,increase,risk
Vitamin K1,Gabapentin enacarbil,Phylloquinone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gadodiamide,Gadodiamide may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gadofosveset trisodium,Phylloquinone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gadoteric acid,Phylloquinone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gadoteridol,Gadoteridol may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Ganciclovir,Ganciclovir may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gemcitabine,Gemcitabine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gemfibrozil,Phylloquinone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gentamicin,Phylloquinone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Vitamin K1,Gimeracil,Phylloquinone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Vitamin K1,Givosiran,Givosiran may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Glipizide,Phylloquinone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Vitamin K1,Glycerol phenylbutyrate,Phylloquinone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Vitamin K1,Golodirsen,Phylloquinone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Vitamin K1,Goserelin,Goserelin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Guanethidine,Phylloquinone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Guanfacine,Guanfacine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Haloperidol,Haloperidol may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Hydralazine,Phylloquinone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vitamin K1,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vitamin K1,Hydromorphone,Hydromorphone may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Hydroxyethyl Starch,Phylloquinone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Vitamin K1,Kanamycin,Phylloquinone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Vitamin K1,Ketamine,Phylloquinone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Ketazolam,Phylloquinone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Vitamin K1,Ketoprofen,Ketoprofen may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Ketorolac,Ketorolac may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Octinoxate,Phylloquinone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Vitamin K1,Olsalazine,Olsalazine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Opium,Phylloquinone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Vitamin K1,Orlistat,Orlistat can cause a decrease in the absorption of Phylloquinone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Vitamin K1,Oseltamivir,Oseltamivir may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Oxacillin,Oxacillin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Oxaprozin,Oxaprozin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Oxazepam,Oxazepam may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Oxybenzone,Phylloquinone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Oxyquinoline,Phylloquinone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Vitamin K1,Quetiapine,Phylloquinone may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Quinethazone,Quinethazone may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vitamin K1,Quinidine,Phylloquinone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Vaborbactam,Phylloquinone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Vitamin K1,Valaciclovir,Valaciclovir may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Valbenazine,Phylloquinone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Valdecoxib,Valdecoxib may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Valganciclovir,Phylloquinone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Vitamin K1,Vancomycin,Phylloquinone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Vitamin K1,Varenicline,Phylloquinone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Vitamin K1,Venlafaxine,Venlafaxine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Verapamil,Verapamil may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Vilanterol,Phylloquinone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vitamin K1,Viloxazine,Phylloquinone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Vortioxetine,Phylloquinone may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vitamin K1,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Phylloquinone.,decrease,no risk
Vitamin K1,Zaleplon,Zaleplon may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Zanamivir,Zanamivir may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,decrease,no risk
Vitamin K1,Zonisamide,Zonisamide may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Felodipine,Benzydamine,The therapeutic efficacy of Felodipine can be decreased when used in combination with Benzydamine.,decrease,no risk
Felodipine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Bepridil,Felodipine may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Felodipine,Beractant,Felodipine may increase the bradycardic activities of Beractant.,increase,no risk
Felodipine,Berotralstat,The metabolism of Felodipine can be decreased when combined with Berotralstat.,decrease,no risk
Felodipine,Betamethasone,The metabolism of Felodipine can be increased when combined with Betamethasone.,increase,no risk
Felodipine,Betamethasone phosphate,The metabolism of Felodipine can be increased when combined with Betamethasone phosphate.,increase,no risk
Felodipine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Felodipine.,increase,no risk
Felodipine,Bethanidine,Bethanidine may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Bexagliflozin.,increase,risk
Felodipine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Felodipine.,increase,no risk
Felodipine,Bilastine,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Bilastine.,increase,risk
Felodipine,Bimatoprost,Bimatoprost may increase the hypotensive activities of Felodipine.,increase,no risk
Felodipine,Bimekizumab,The metabolism of Felodipine can be increased when combined with Bimekizumab.,increase,no risk
Felodipine,Bioallethrin,Felodipine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Felodipine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Felodipine.,decrease,no risk
Felodipine,Bisoprolol,The therapeutic efficacy of Felodipine can be increased when used in combination with Bisoprolol.,increase,no risk
Felodipine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Felodipine.,decrease,no risk
Felodipine,Boceprevir,The serum concentration of Felodipine can be increased when it is combined with Boceprevir.,increase,no risk
Felodipine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Bosentan,Bosentan may decrease the excretion rate of Felodipine which could result in a higher serum level.,decrease,no risk
Felodipine,Bretylium,Felodipine may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Felodipine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Brimonidine,Brimonidine may increase the antihypertensive activities of Felodipine.,increase,no risk
Felodipine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Bromocriptine,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Bromocriptine.,increase,risk
Felodipine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Felodipine.,increase,risk
Felodipine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Felodipine.,increase,risk
Felodipine,Budesonide,Felodipine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Felodipine,Bumadizone,The therapeutic efficacy of Felodipine can be decreased when used in combination with Bumadizone.,decrease,no risk
Felodipine,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Felodipine.,increase,risk
Felodipine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Bupropion,The metabolism of Bupropion can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Buserelin,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Buserelin.,increase,risk
Felodipine,Buspirone,The metabolism of Buspirone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Butabarbital,Butabarbital may increase the hypotensive activities of Felodipine.,increase,no risk
Felodipine,Butalbital,Butalbital may increase the hypotensive activities of Felodipine.,increase,no risk
Felodipine,Butriptyline,Butriptyline may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Gadobenic acid.,increase,risk
Felodipine,Galantamine,The metabolism of Galantamine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Gallamine triethiodide,Felodipine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Felodipine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Gatifloxacin.,increase,risk
Felodipine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Gemifloxacin.,increase,risk
Felodipine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Felodipine.,increase,risk
Felodipine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Gilteritinib.,increase,risk
Felodipine,Glasdegib,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Glasdegib.,increase,risk
Felodipine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Glimepiride,Glimepiride may decrease the excretion rate of Felodipine which could result in a higher serum level.,decrease,no risk
Felodipine,Glipizide,Felodipine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Felodipine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Glofitamab,The serum concentration of Felodipine can be increased when it is combined with Glofitamab.,increase,no risk
Felodipine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Felodipine.,decrease,no risk
Felodipine,Glyburide,Glyburide may decrease the excretion rate of Felodipine which could result in a higher serum level.,decrease,no risk
Felodipine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Felodipine.,decrease,no risk
Felodipine,Glycol salicylate,The therapeutic efficacy of Felodipine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Felodipine,Glycyrrhizic acid,Felodipine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Felodipine,Glymidine,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Glymidine.,increase,risk
Felodipine,Golimumab,The metabolism of Felodipine can be increased when combined with Golimumab.,increase,no risk
Felodipine,Goserelin,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Goserelin.,increase,risk
Felodipine,Granisetron,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Granisetron.,increase,risk
Felodipine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Grepafloxacin.,increase,risk
Felodipine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Guanadrel,Guanadrel may increase the hypotensive activities of Felodipine.,increase,no risk
Felodipine,Guanethidine,Felodipine may increase the hypotensive activities of Guanethidine.,increase,no risk
Felodipine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Guanoxan,Felodipine may increase the hypotensive activities of Guanoxan.,increase,no risk
Felodipine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Haloperidol,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Haloperidol.,increase,risk
Felodipine,Halothane,The metabolism of Halothane can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Heparin,The risk or severity of hyperkalemia can be increased when Felodipine is combined with Heparin.,increase,risk
Felodipine,Histrelin,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Histrelin.,increase,risk
Felodipine,Hydralazine,Felodipine may increase the hypotensive activities of Hydralazine.,increase,no risk
Felodipine,Hydrochlorothiazide,The therapeutic efficacy of Felodipine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Felodipine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydrocortisone,The metabolism of Felodipine can be decreased when combined with Hydrocortisone.,decrease,no risk
Felodipine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydroflumethiazide,The therapeutic efficacy of Felodipine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Felodipine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Felodipine.,increase,risk
Felodipine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Hydroxyzine.,increase,risk
Felodipine,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Felodipine.,increase,no risk
Felodipine,Ketamine,The metabolism of Ketamine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Ketoconazole,The metabolism of Felodipine can be decreased when combined with Ketoconazole.,decrease,no risk
Felodipine,Ketoprofen,The therapeutic efficacy of Felodipine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Felodipine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Obinutuzumab,Felodipine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Felodipine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Felodipine.,increase,no risk
Felodipine,Ofloxacin,Felodipine may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Felodipine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Olaparib,The metabolism of Olaparib can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Olmesartan,Olmesartan may decrease the excretion rate of Felodipine which could result in a higher serum level.,decrease,no risk
Felodipine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Olutasidenib,The therapeutic efficacy of Felodipine can be decreased when used in combination with Olutasidenib.,decrease,no risk
Felodipine,Omaveloxolone,The serum concentration of Felodipine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Felodipine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Opicapone,The risk or severity of adverse effects can be increased when Felodipine is combined with Opicapone.,increase,risk
Felodipine,Opium,The metabolism of Opium can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Orphenadrine.,increase,risk
Felodipine,Osilodrostat,The metabolism of Felodipine can be decreased when combined with Osilodrostat.,decrease,no risk
Felodipine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Felodipine.,increase,no risk
Felodipine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Felodipine.,increase,no risk
Felodipine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Felodipine.,increase,risk
Felodipine,Oxaprozin,The therapeutic efficacy of Felodipine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Felodipine,Oxatomide,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Oxatomide.,increase,risk
Felodipine,Oxcarbazepine,The serum concentration of Felodipine can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Felodipine,Oxprenolol,Felodipine may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Felodipine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Oxymetazoline,The therapeutic efficacy of Felodipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Felodipine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Oxyphenbutazone,The therapeutic efficacy of Felodipine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Felodipine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Felodipine.,decrease,no risk
Felodipine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Felodipine.,increase,risk
Felodipine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Quetiapine,Quetiapine may increase the hypotensive activities of Felodipine.,increase,no risk
Felodipine,Quinapril,Quinapril may increase the hypotensive activities of Felodipine.,increase,no risk
Felodipine,Quinidine,Quinidine may increase the arrhythmogenic activities of Felodipine.,increase,no risk
Felodipine,Quinine,The metabolism of Quinine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Quinupramine,Quinupramine may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Quizartinib,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Quizartinib.,increase,risk
Felodipine,Udenafil,Udenafil may increase the antihypertensive activities of Felodipine.,increase,no risk
Felodipine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Unoprostone,Felodipine may increase the hypotensive activities of Unoprostone.,increase,no risk
Felodipine,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Felodipine which could result in a higher serum level.,decrease,no risk
Felodipine,Vadadustat,The serum concentration of Felodipine can be increased when it is combined with Vadadustat.,increase,no risk
Felodipine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Valdecoxib,The therapeutic efficacy of Felodipine can be decreased when used in combination with Valdecoxib.,decrease,no risk
Felodipine,Valproic acid,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Valproic acid.,increase,risk
Felodipine,Valsartan,The metabolism of Valsartan can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Vandetanib,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Vandetanib.,increase,risk
Felodipine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Vecuronium,Felodipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Felodipine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Felodipine.,increase,risk
Felodipine,Venetoclax,The metabolism of Felodipine can be decreased when combined with Venetoclax.,decrease,no risk
Felodipine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Verapamil,Verapamil may increase the arrhythmogenic activities of Felodipine.,increase,no risk
Felodipine,Vericiguat,The risk or severity of adverse effects can be increased when Felodipine is combined with Vericiguat.,increase,risk
Felodipine,Vernakalant,Felodipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Felodipine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Felodipine.,increase,risk
Felodipine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Vildagliptin.,increase,risk
Felodipine,Viloxazine,The metabolism of Felodipine can be decreased when combined with Viloxazine.,decrease,no risk
Felodipine,Vinblastine,Vinblastine may decrease the excretion rate of Felodipine which could result in a higher serum level.,decrease,no risk
Felodipine,Vincristine,The metabolism of Vincristine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Voriconazole,The serum concentration of Felodipine can be increased when it is combined with Voriconazole.,increase,no risk
Felodipine,Vorinostat,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Vorinostat.,increase,risk
Felodipine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Warfarin,The metabolism of Warfarin can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Xamoterol,Xamoterol may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Xylometazoline,Felodipine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Felodipine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Zaleplon,The metabolism of Felodipine can be decreased when combined with Zaleplon.,decrease,no risk
Felodipine,Ziconotide,Felodipine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Felodipine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Zileuton,The metabolism of Zileuton can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Zimelidine,The metabolism of Felodipine can be decreased when combined with Zimelidine.,decrease,no risk
Felodipine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Ziprasidone.,increase,risk
Felodipine,Zofenopril,Felodipine may increase the hypotensive activities of Zofenopril.,increase,no risk
Felodipine,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Felodipine.,decrease,no risk
Felodipine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Felodipine.,increase,no risk
Felodipine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Felodipine.,decrease,no risk
Felodipine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Felodipine is combined with Zuclopenthixol.,increase,risk
Mycophenolic acid,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Bicisate,Mycophenolic acid may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Bimekizumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Bimekizumab.,increase,risk
Mycophenolic acid,Bismuth subgallate,Mycophenolic acid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mycophenolic acid,Bisoprolol,Bisoprolol may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Bisoxatin,Mycophenolic acid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Blinatumomab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Blinatumomab.,increase,risk
Mycophenolic acid,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Mycophenolic acid.",decrease,no risk
Mycophenolic acid,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Bosutinib,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Bosutinib.,increase,risk
Mycophenolic acid,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Brentuximab vedotin.,increase,risk
Mycophenolic acid,Brivaracetam,Mycophenolic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Brodalumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Brodalumab.,increase,risk
Mycophenolic acid,Bromazepam,Mycophenolic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Bromotheophylline,Bromotheophylline may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mycophenolic acid,Budesonide,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Budesonide.,increase,risk
Mycophenolic acid,Bumadizone,Bumadizone may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Bumetanide,Bumetanide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mycophenolic acid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Mycophenolic acid is combined with Bupivacaine.,increase,risk
Mycophenolic acid,Bupropion,Mycophenolic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Buspirone,Buspirone may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Butabarbital,Butabarbital may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Butacaine,The risk or severity of methemoglobinemia can be increased when Mycophenolic acid is combined with Butacaine.,increase,risk
Mycophenolic acid,Butamben,The risk or severity of methemoglobinemia can be increased when Mycophenolic acid is combined with Butamben.,increase,risk
Mycophenolic acid,Gabapentin enacarbil,Mycophenolic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Gadodiamide,Gadodiamide may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Gadofosveset trisodium,Mycophenolic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Gadoteric acid,Mycophenolic acid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Gadoteridol,Gadoteridol may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ganciclovir,The serum concentration of Mycophenolic acid can be increased when it is combined with Ganciclovir.,increase,no risk
Mycophenolic acid,Gatifloxacin,The serum concentration of Mycophenolic acid can be decreased when it is combined with Gatifloxacin.,decrease,no risk
Mycophenolic acid,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Gemfibrozil,The metabolism of Mycophenolic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Mycophenolic acid,Gemifloxacin,The serum concentration of Mycophenolic acid can be decreased when it is combined with Gemifloxacin.,decrease,no risk
Mycophenolic acid,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Gentamicin,Mycophenolic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Gimeracil,Mycophenolic acid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Givosiran,Givosiran may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Glatiramer,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Glatiramer.,increase,risk
Mycophenolic acid,Glecaprevir,The metabolism of Mycophenolic acid can be decreased when combined with Glecaprevir.,decrease,no risk
Mycophenolic acid,Glipizide,Mycophenolic acid may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Glycerol phenylbutyrate,Mycophenolic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Golimumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Golimumab.,increase,risk
Mycophenolic acid,Golodirsen,Mycophenolic acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Goserelin,Goserelin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Grepafloxacin,The serum concentration of Mycophenolic acid can be decreased when it is combined with Grepafloxacin.,decrease,no risk
Mycophenolic acid,Guanethidine,Mycophenolic acid may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Guanfacine,Guanfacine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Guselkumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Guselkumab.,increase,risk
Mycophenolic acid,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Haloperidol,Haloperidol may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Hetacillin,The serum concentration of Mycophenolic acid can be decreased when it is combined with Hetacillin.,decrease,no risk
Mycophenolic acid,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Hydralazine,Mycophenolic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mycophenolic acid,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Hydrocortisone acetate.,increase,risk
Mycophenolic acid,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Hydrocortisone butyrate.,increase,risk
Mycophenolic acid,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Hydrocortisone succinate.,increase,risk
Mycophenolic acid,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mycophenolic acid,Hydromorphone,Hydromorphone may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Hydrotalcite,The serum concentration of Mycophenolic acid can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Mycophenolic acid,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Hydroxychloroquine.,increase,risk
Mycophenolic acid,Hydroxyethyl Starch,Mycophenolic acid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Kanamycin,Mycophenolic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ketamine,Mycophenolic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ketazolam,Mycophenolic acid may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ketoconazole,The metabolism of Mycophenolic acid can be decreased when combined with Ketoconazole.,decrease,no risk
Mycophenolic acid,Ketoprofen,Ketoprofen may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ketorolac,Ketorolac may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Obinutuzumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Obinutuzumab.,increase,risk
Mycophenolic acid,Ocrelizumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ocrelizumab.,increase,risk
Mycophenolic acid,Octinoxate,Mycophenolic acid may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ofatumumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ofatumumab.,increase,risk
Mycophenolic acid,Ofloxacin,The serum concentration of Mycophenolic acid can be decreased when it is combined with Ofloxacin.,decrease,no risk
Mycophenolic acid,Olaparib,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Olaparib.,increase,risk
Mycophenolic acid,Olsalazine,Olsalazine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ombitasvir,The metabolism of Mycophenolic acid can be decreased when combined with Ombitasvir.,decrease,no risk
Mycophenolic acid,Omeprazole,Omeprazole can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mycophenolic acid,Opium,Mycophenolic acid may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Oseltamivir,Oseltamivir may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Oxacillin,The serum concentration of Mycophenolic acid can be decreased when it is combined with Oxacillin.,decrease,no risk
Mycophenolic acid,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Oxaprozin,Oxaprozin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Oxazepam,Oxazepam may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mycophenolic acid is combined with Oxetacaine.,increase,risk
Mycophenolic acid,Oxybenzone,Mycophenolic acid may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Mycophenolic acid is combined with Oxybuprocaine.,increase,risk
Mycophenolic acid,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Oxyquinoline,Mycophenolic acid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Ozanimod,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ozanimod.,increase,risk
Mycophenolic acid,Quetiapine,Mycophenolic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Quinethazone,Quinethazone may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mycophenolic acid,Quinidine,Mycophenolic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Quizartinib,The metabolism of Mycophenolic acid can be decreased when combined with Quizartinib.,decrease,no risk
Mycophenolic acid,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Upadacitinib,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Upadacitinib.,increase,risk
Mycophenolic acid,Vaborbactam,Mycophenolic acid may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Valaciclovir,Valaciclovir may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Valbenazine,Mycophenolic acid may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Valdecoxib,Valdecoxib may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Valganciclovir,The serum concentration of Mycophenolic acid can be increased when it is combined with Valganciclovir.,increase,no risk
Mycophenolic acid,Valproic acid,The metabolism of Mycophenolic acid can be decreased when combined with Valproic acid.,decrease,no risk
Mycophenolic acid,Vancomycin,Mycophenolic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Varenicline,Mycophenolic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Vedolizumab,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Vedolizumab.,increase,risk
Mycophenolic acid,Venlafaxine,Venlafaxine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Verapamil,Verapamil may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mycophenolic acid.,decrease,no risk
Mycophenolic acid,Vilanterol,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Vilanterol.,increase,risk
Mycophenolic acid,Viloxazine,Mycophenolic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Voclosporin,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Voclosporin.,increase,risk
Mycophenolic acid,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Mycophenolic acid,Vorinostat,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Vorinostat.,increase,risk
Mycophenolic acid,Vortioxetine,Mycophenolic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Warfarin,Mycophenolic acid may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Mycophenolic acid.,increase,risk
Mycophenolic acid,Zaleplon,Zaleplon may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
Mycophenolic acid,Zanamivir,Zanamivir may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,decrease,no risk
